No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2yn5A, 0.6849, 1.70, 0.111, 283, 90, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
2, 2yn3A, 0.6792, 1.76, 0.111, 270, 90, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
3, 2yn5B, 0.6784, 1.77, 0.111, 284, 90, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
4, 2yn3C, 0.6777, 1.77, 0.111, 281, 90, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
5, 2yn3B, 0.6544, 1.86, 0.116, 243, 86, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
6, 2yn3D, 0.6454, 1.98, 0.115, 205, 87, STRUCTURAL INSIGHT INTO THE GIANT CALCIUM-BINDING ADHESIN SIIE: IMPLICATIONS FOR THE ADHESION OF SALMONELLA ENTERICA TO POLARIZED EPITHELIAL CELLS
7, 1wf5A, 0.6423, 2.44, 0.117, 121, 94, SOLUTION STRUCTURE OF THE FIRST FN3 DOMAIN OF SIDEKICK-2 PROTEIN
8, 2jllA, 0.6420, 2.39, 0.086, 381, 93, CRYSTAL STRUCTURE OF NCAM2 IGIV-FN3II
9, 2ed7A, 0.6401, 2.26, 0.140, 119, 93, SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN NETRIN RECEPTOR DCC
10, 5u8qA, 0.6398, 2.08, 0.099, 801, 91, STRUCTURE OF THE ECTODOMAIN OF THE HUMAN TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR IN COMPLEX WITH IGF-I
11, 5u8rA, 0.6394, 2.08, 0.099, 801, 91, STRUCTURE OF THE ECTODOMAIN OF THE HUMAN TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR
12, 6hn4F, 0.6377, 2.30, 0.098, 498, 92, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  LOWER  MEMBRANE-PROXIMAL PART 
13, 2crmA, 0.6374, 2.34, 0.109, 120, 92, SOLUTION STRUCTURE OF THE FORTH FNIII DOMAIN OF HUMAN
14, 5oj6B, 0.6372, 3.13, 0.060, 689, 100, CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN IN COMPLEX WITH THE HUMAN NEUROLIGIN 1 (NL1(-A-B)) CHOLINESTERASE DOMAIN.
15, 6hn4E, 0.6370, 2.33, 0.098, 202, 92, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  LOWER  MEMBRANE-PROXIMAL PART 
16, 4zxbE, 0.6347, 2.29, 0.121, 800, 91, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
17, 1axiB, 0.6342, 2.84, 0.115, 191, 96, STRUCTURAL PLASTICITY AT THE HGH:HGHBP INTERFACE
18, 3utoB, 0.6333, 2.36, 0.120, 566, 92, TWITCHIN KINASE REGION FROM C.ELEGANS (FN31-NL-KIN-CRD-IG26)
19, 2vkxA, 0.6326, 2.42, 0.098, 198, 92, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
20, 1kf9B, 0.6326, 2.92, 0.124, 193, 97, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
21, 2vkxE, 0.6322, 2.13, 0.100, 202, 90, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
22, 3utoA, 0.6320, 2.35, 0.130, 559, 92, TWITCHIN KINASE REGION FROM C.ELEGANS (FN31-NL-KIN-CRD-IG26)
23, 2dlhA, 0.6319, 2.21, 0.157, 121, 89, SOLUTION STRUCTURE OF THE SECOND FN3 DOMAIN OF HUMAN RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE DELTA
24, 2vkxF, 0.6315, 2.15, 0.111, 198, 90, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
25, 1kf9E, 0.6314, 2.94, 0.124, 193, 97, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
26, 2hazA, 0.6302, 2.39, 0.087, 104, 92, CRYSTAL STRUCTURE OF THE FIRST FIBRONECTIN DOMAIN OF HUMAN NCAM1
27, 3mtrB, 0.6301, 2.37, 0.098, 197, 92, CRYSTAL STRUCTURE OF THE IG5-FN1 TANDEM OF HUMAN NCAM
28, 3mtrA, 0.6300, 2.46, 0.097, 197, 93, CRYSTAL STRUCTURE OF THE IG5-FN1 TANDEM OF HUMAN NCAM
29, 3di2B, 0.6298, 2.54, 0.086, 195, 93, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH UNGLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
30, 1hwgC, 0.6298, 2.75, 0.105, 191, 95, 1:2 COMPLEX OF HUMAN GROWTH HORMONE WITH ITS SOLUBLE BINDING PROTEIN
31, 5oj2B, 0.6290, 2.91, 0.061, 681, 98, CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN
32, 2vkxC, 0.6287, 2.18, 0.100, 198, 90, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
33, 2docA, 0.6285, 2.49, 0.076, 119, 92, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF HUMAN NEURAL CELL ADHESION MOLECULE 2
34, 1hwhB, 0.6284, 2.82, 0.125, 196, 96, 1:1 COMPLEX OF HUMAN GROWTH HORMONE MUTANT G120R WITH ITS SOLUBLE BINDING PROTEIN
35, 3hhrC, 0.6279, 2.79, 0.115, 194, 96, HUMAN GROWTH HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR: CRYSTAL STRUCTURE OF THE COMPLEX
36, 3di3B, 0.6279, 2.61, 0.074, 193, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH GLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
37, 3di2D, 0.6273, 2.60, 0.085, 196, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN INTERLEUKIN-7 WITH UNGLYCOSYLATED HUMAN INTERLEUKIN-7 RECEPTOR ALPHA ECTODOMAIN
38, 1kf9F, 0.6271, 2.84, 0.115, 184, 96, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
39, 5oj2A, 0.6270, 3.18, 0.061, 680, 99, CRYSTAL STRUCTURE OF THE CHICKEN MDGA1 ECTODOMAIN
40, 1kf9C, 0.6264, 2.85, 0.115, 175, 96, PHAGE DISPLAY DERIVED VARIANT OF HUMAN GROWTH HORMONE COMPLEXED WITH TWO COPIES OF THE EXTRACELLULAR DOMAIN OF ITS RECEPTOR
41, 2nziA, 0.6263, 2.45, 0.098, 292, 92, CRYSTAL STRUCTURE OF DOMAINS A168-A170 FROM TITIN
42, 2xycA, 0.6262, 2.59, 0.086, 291, 93, CRYSTAL STRUCTURE OF NCAM2 IGIV-FN3I
43, 2vkxB, 0.6262, 2.39, 0.098, 197, 92, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
44, 2vkwA, 0.6262, 2.52, 0.097, 197, 93, HUMAN NCAM FN3 DOMAINS 1 AND 2
45, 3up1A, 0.6260, 2.64, 0.085, 201, 94, CRYSTAL STRUCTURE OF THE UNLIGANDED HUMAN INTERLEUKIN-7 RECEPTOR EXTRACELLULAR DOMAIN
46, 3bpnB, 0.6259, 2.57, 0.109, 199, 92, CRYSTAL STRUCTURE OF THE IL4-IL4R-IL13RA TERNARY COMPLEX
47, 2aewB, 0.6259, 2.84, 0.094, 188, 96, A MODEL FOR GROWTH HORMONE RECEPTOR ACTIVATION BASED ON SUBUNIT ROTATION WITHIN A RECEPTOR DIMER
48, 3f7pC, 0.6250, 2.44, 0.088, 200, 91, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN INTEGRIN BETA4 AND PLECTIN
49, 2nziB, 0.6250, 2.45, 0.098, 292, 92, CRYSTAL STRUCTURE OF DOMAINS A168-A170 FROM TITIN
50, 1hwgB, 0.6248, 2.88, 0.125, 194, 96, 1:2 COMPLEX OF HUMAN GROWTH HORMONE WITH ITS SOLUBLE BINDING PROTEIN
51, 4hljA, 0.6244, 2.56, 0.174, 223, 92, AXON GUIDANCE RECEPTOR
52, 2vkxD, 0.6244, 2.28, 0.109, 198, 92, HUMAN NCAM FN3 DOMAINS 1 AND 2 M610R MUTANT
53, 2dbjA, 0.6244, 2.53, 0.110, 124, 91, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN PROTO- ONCOGENE TYROSINE-PROTEIN KINASE MER PRECURSOR
54, 1x3dA, 0.6243, 2.32, 0.077, 118, 91, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF HUMAN FIBRONECTIN TYPE-III DOMAIN CONTAINING PROTEIN 3A
55, 5j11B, 0.6239, 2.62, 0.096, 196, 94, STRUCTURE OF HUMAN TSLP IN COMPLEX WITH TSLPR AND IL-7RALPHA
56, 3f7pD, 0.6239, 2.44, 0.088, 196, 91, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN INTEGRIN BETA4 AND PLECTIN
57, 1x4zA, 0.6238, 2.44, 0.108, 121, 93, SOLUTION STRUCTURE OF THE 2ND FIBRONECTIN TYPE III DOMAIN FROM MOUSE BIREGIONAL CELL ADHESION MOLECULE-RELATED/DOWN- REGULATED ONCOGENES (CDON) BINDING PROTEIN
58, 2vkwB, 0.6235, 2.60, 0.097, 195, 93, HUMAN NCAM FN3 DOMAINS 1 AND 2
59, 1fg9C, 0.6235, 2.65, 0.054, 210, 92, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
60, 1v5jA, 0.6231, 2.42, 0.110, 108, 91, SOLUTION STRUCTURE OF RSGI RUH-008 FN3 DOMAIN IN HUMAN CDNA
61, 1qg3A, 0.6231, 2.42, 0.088, 195, 91, CRYSTAL STRUCTURE OF A TANDEM PAIR OF FIBRONECTIN TYPE III DOMAINS FROM THE CYTOPLASMIC TAIL OF INTEGRIN ALPHA6 BETA4
62, 4yh7A, 0.6229, 2.25, 0.124, 585, 89, CRYSTAL STRUCTURE OF PTPDELTA ECTODOMAIN IN COMPLEX WITH IL1RAPL1
63, 4o00A, 0.6229, 2.52, 0.098, 102, 92, CRYSTAL STRUCTURE OF THE TITIN A-BAND DOMAIN A3
64, 5fm4D, 0.6228, 2.52, 0.098, 101, 92, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P21)
65, 1ueyA, 0.6227, 2.44, 0.141, 127, 92, SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA0343 PROTEIN
66, 1cd9D, 0.6227, 2.42, 0.118, 204, 93, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
67, 6hyfA, 0.6226, 2.25, 0.101, 106, 89, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN FROM RAT BETA4 INTEGRIN; A BINDING SITE FOR PERIAXIN 
68, 3l5hA, 0.6224, 2.52, 0.087, 585, 92, CRYSTAL STRUCTURE OF THE FULL ECTODOMAIN OF HUMAN GP130: NEW INSIGHTS INTO THE MOLECULAR ASSEMBLY OF RECEPTOR COMPLEXES
69, 1x5hA, 0.6224, 2.39, 0.099, 132, 91, THE SOLUTION STRUCTURE OF THE THIRD FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN
70, 1x4xA, 0.6224, 2.28, 0.144, 106, 90, SOLUTION STRUCTURE OF THE 6TH FIBRONECTIN TYPE III DOMAIN FROM HUMAN FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3
71, 4o00B, 0.6223, 2.52, 0.098, 104, 92, CRYSTAL STRUCTURE OF THE TITIN A-BAND DOMAIN A3
72, 4m4pA, 0.6223, 2.23, 0.136, 513, 88, CRYSTAL STRUCTURE OF EPHA4 ECTODOMAIN
73, 5fm4F, 0.6221, 2.53, 0.098, 101, 92, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P21)
74, 2aewA, 0.6221, 2.62, 0.106, 189, 94, A MODEL FOR GROWTH HORMONE RECEPTOR ACTIVATION BASED ON SUBUNIT ROTATION WITHIN A RECEPTOR DIMER
75, 1uemA, 0.6221, 2.30, 0.110, 117, 91, SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA1568 PROTEIN
76, 4nn6B, 0.6220, 2.53, 0.065, 193, 92, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1B
77, 3f7pE, 0.6218, 2.48, 0.088, 212, 91, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN INTEGRIN BETA4 AND PLECTIN
78, 4q58D, 0.6216, 2.45, 0.088, 194, 91, CRYSTAL STRUCTURE OF THE PLECTIN 1A ACTIN-BINDING DOMAIN/INTEGRIN BETA 4 FRAGMENT COMPLEX
79, 4nn5B, 0.6215, 2.50, 0.065, 197, 92, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1A
80, 1n26A, 0.6215, 2.73, 0.065, 299, 92, CRYSTAL STRUCTURE OF THE EXTRA-CELLULAR DOMAINS OF HUMAN INTERLEUKIN-6 RECEPTOR ALPHA CHAIN
81, 1qg3B, 0.6212, 2.47, 0.088, 193, 91, CRYSTAL STRUCTURE OF A TANDEM PAIR OF FIBRONECTIN TYPE III DOMAINS FROM THE CYTOPLASMIC TAIL OF INTEGRIN ALPHA6 BETA4
82, 5j12B, 0.6211, 2.52, 0.065, 194, 92, CYTOKINE RECEPTOR COMPLEX
83, 4m4rC, 0.6210, 2.27, 0.136, 516, 88, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
84, 1cd9B, 0.6208, 2.44, 0.118, 206, 93, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
85, 4n5uA, 0.6207, 2.59, 0.118, 108, 93, CRYSTAL STRUCTURE OF THE 4TH FN3 DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE F [PSI-NYSGRC-006240]
86, 5fm4A, 0.6205, 2.55, 0.098, 101, 92, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P21)
87, 5fm4E, 0.6204, 2.56, 0.109, 101, 92, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P21)
88, 1bp3B, 0.6202, 2.87, 0.117, 197, 94, THE XRAY STRUCTURE OF A GROWTH HORMONE-PROLACTIN RECEPTOR COMPLEX
89, 5fm4B, 0.6200, 2.54, 0.098, 108, 92, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P21)
90, 3l5iA, 0.6199, 2.59, 0.075, 286, 93, CRYSTAL STRUCTURE OF FNIII DOMAINS OF HUMAN GP130 (DOMAINS 4-6)
91, 6e3kC, 0.6198, 2.81, 0.043, 207, 93, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
92, 4wtwA, 0.6197, 2.27, 0.101, 95, 89, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN OF INTEGRIN BETA4
93, 3ncfB, 0.6196, 2.79, 0.128, 206, 94, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H30A IN COMPLEX WITH THE MUTANT EXTRACELLULAR DOMAIN H188A OF THE HUMAN PROLACTIN RECEPTOR
94, 1pgrB, 0.6194, 2.53, 0.128, 208, 94, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
95, 1pgrF, 0.6193, 2.53, 0.128, 209, 94, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
96, 1uenA, 0.6192, 2.38, 0.087, 125, 92, SOLUTION STRUCTURE OF THE THIRD FIBRONECTIN III DOMAIN OF HUMAN KIAA0343 PROTEIN
97, 4nn7B, 0.6191, 2.53, 0.075, 195, 93, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 2
98, 3nccB, 0.6190, 2.79, 0.128, 206, 94, A HUMAN PROLACTIN RECEPTOR ANTAGONIST IN COMPLEX WITH THE MUTANT EXTRACELLULAR DOMAIN H188A OF THE HUMAN PROLACTIN RECEPTOR
99, 6e3lC, 0.6188, 2.67, 0.043, 204, 92, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
100, 3hhrB, 0.6187, 2.87, 0.125, 195, 96, HUMAN GROWTH HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR: CRYSTAL STRUCTURE OF THE COMPLEX
101, 1a22B, 0.6185, 2.64, 0.109, 192, 92, HUMAN GROWTH HORMONE BOUND TO SINGLE RECEPTOR
102, 3tgxO, 0.6184, 2.66, 0.120, 208, 92, IL-21:IL21R COMPLEX
103, 3lpwA, 0.6184, 2.48, 0.176, 197, 91, CRYSTAL STRUCTURE OF THE FNIII-TANDEM A77-A78 FROM THE A-BAND OF TITIN
104, 1x5lA, 0.6184, 2.38, 0.167, 111, 90, SOLUTION STRUCTURE OF THE SECOND FN3 DOMAIN OF EPH RECEPTOR A8 PROTEIN
105, 3n0pB, 0.6182, 2.82, 0.138, 206, 94, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H30A IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
106, 3bplB, 0.6182, 2.81, 0.106, 202, 94, CRYSTAL STRUCTURE OF THE IL4-IL4R-COMMON GAMMA TERNARY COMPLEX
107, 3mzgB, 0.6181, 2.93, 0.126, 206, 95, CRYSTAL STRUCTURE OF A HUMAN PROLACTIN RECEPTOR ANTAGONIST IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
108, 4m4rE, 0.6180, 2.40, 0.133, 516, 90, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
109, 3f7rA, 0.6180, 2.72, 0.077, 214, 91, FIRST PAIR OF FIBRONECTIN TYPE III DOMAINS AND PART OF THE CONNECTING SEGMENT OF THE INTEGRIN BETA4
110, 4bkaA, 0.6179, 2.37, 0.124, 507, 89, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
111, 3nceB, 0.6179, 2.82, 0.128, 206, 94, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H27A IN COMPLEX WITH THE MUTANT EXTRACELLULAR DOMAIN H188A OF THE HUMAN PROLACTIN RECEPTOR
112, 3ncbB, 0.6179, 2.82, 0.138, 206, 94, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H180A IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
113, 4bk5A, 0.6178, 2.37, 0.124, 507, 89, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
114, 3up1B, 0.6177, 2.52, 0.088, 196, 91, CRYSTAL STRUCTURE OF THE UNLIGANDED HUMAN INTERLEUKIN-7 RECEPTOR EXTRACELLULAR DOMAIN
115, 1wj3A, 0.6177, 2.01, 0.115, 117, 87, SOLUTION STRUCTURE OF THE FOURTH FN3 DOMAIN OF KIAA1496 PROTEIN
116, 1fyhE, 0.6174, 2.55, 0.044, 201, 91, 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR
117, 4m4rA, 0.6169, 2.36, 0.135, 516, 89, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
118, 3d1mD, 0.6169, 2.49, 0.065, 99, 92, CRYSTAL STRUCTURE OF SONIC HEDGEHOG BOUND TO THE THIRD FNIII DOMAIN OF CDO
119, 5fm8C, 0.6168, 2.46, 0.110, 101, 91, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P65)
120, 4m4rG, 0.6167, 2.41, 0.144, 516, 90, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
121, 3npzC, 0.6167, 2.76, 0.097, 199, 93, PROLACTIN RECEPTOR (PRLR) COMPLEXED WITH THE NATURAL HORMONE (PRL)
122, 3f7qB, 0.6167, 2.73, 0.077, 214, 91, FIRST PAIR OF FIBRONECTIN TYPE III DOMAINS AND PART OF THE CONNECTING SEGMENT OF THE INTEGRIN BETA4
123, 1fyhB, 0.6163, 2.55, 0.033, 201, 91, 1:1 COMPLEX BETWEEN AN INTERFERON GAMMA SINGLE-CHAIN VARIANT AND ITS RECEPTOR
124, 4yfeA, 0.6162, 2.44, 0.144, 193, 90, CRYSTAL STRUCTURE OF PTP DELTA FN1-FN2
125, 3lpwB, 0.6162, 2.50, 0.109, 195, 92, CRYSTAL STRUCTURE OF THE FNIII-TANDEM A77-A78 FROM THE A-BAND OF TITIN
126, 2ed8A, 0.6160, 2.23, 0.159, 106, 88, SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF HUMAN NETRIN RECEPTOR DCC
127, 3ew3B, 0.6157, 2.75, 0.097, 203, 93, THE 1:2 COMPLEX BETWEEN A NTERMINAL ELONGATED PROLACTIN AND THE EXTRA CELLULAR DOMAIN OF THE RAT PROLACTIN RECEPTOR
128, 3tgxI, 0.6155, 2.69, 0.120, 209, 92, IL-21:IL21R COMPLEX
129, 3f7qA, 0.6155, 2.74, 0.077, 214, 91, FIRST PAIR OF FIBRONECTIN TYPE III DOMAINS AND PART OF THE CONNECTING SEGMENT OF THE INTEGRIN BETA4
130, 2db8A, 0.6154, 2.60, 0.067, 110, 90, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN TRIPARTITE MOTIF PROTEIN 9
131, 6molB, 0.6153, 2.88, 0.109, 213, 92, MONOEXTENDED DARPIN M_R12 COMPLEX WITH EPOR 
132, 4eq2A, 0.6152, 2.64, 0.088, 206, 91, CRYSTAL STRUCTURE ANALYSIS OF CHICKEN INTERFERON GAMMA RECEPTOR ALPHA CHAIN
133, 3npzB, 0.6152, 2.63, 0.087, 202, 92, PROLACTIN RECEPTOR (PRLR) COMPLEXED WITH THE NATURAL HORMONE (PRL)
134, 4y5xF, 0.6148, 2.88, 0.109, 206, 92, DIABODY 305 COMPLEX WITH EPOR
135, 2yrzA, 0.6147, 2.40, 0.100, 118, 90, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE III DOMAIN OF HUMAN INTEGRIN BETA-4
136, 1cfbA, 0.6147, 2.48, 0.110, 205, 91, CRYSTAL STRUCTURE OF TANDEM TYPE III FIBRONECTIN DOMAINS FROM DROSOPHILA NEUROGLIAN AT 2.0 ANGSTROMS
137, 3n1gC, 0.6146, 2.38, 0.066, 104, 91, CRYSTAL STRUCTURE OF DHHN BOUND TO BOCFN3
138, 3tgxM, 0.6145, 2.76, 0.120, 208, 92, IL-21:IL21R COMPLEX
139, 5fm8B, 0.6144, 2.48, 0.110, 101, 91, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P65)
140, 5e55A, 0.6142, 2.60, 0.109, 304, 92, CRYSTAL STRUCTURE OF MOUSE CNTN6 FN1-FN3 DOMAINS
141, 5e53D, 0.6142, 2.69, 0.129, 301, 93, CRYSTAL STRUCTURE OF CHICKEN CNTN1 FN1-FN3 DOMAINS
142, 5fm8D, 0.6139, 2.48, 0.110, 101, 91, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P65)
143, 5fm8A, 0.6138, 2.49, 0.110, 101, 91, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P65)
144, 4wtwB, 0.6138, 2.36, 0.101, 93, 89, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN OF INTEGRIN BETA4
145, 1zlgA, 0.6136, 2.95, 0.083, 680, 96, SOLUTION STRUCTURE OF THE EXTRACELLULAR MATRIX PROTEIN ANOSMIN-1
146, 3n1fD, 0.6135, 2.51, 0.065, 102, 92, CRYSTAL STRUCTURE OF IHHN BOUND TO CDOFN3
147, 3n06B, 0.6135, 2.98, 0.117, 206, 94, A MUTANT HUMAN PROLACTIN RECEPTOR ANTAGONIST H27A IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF THE HUMAN PROLACTIN RECEPTOR
148, 1x5gA, 0.6135, 2.23, 0.193, 116, 88, THE SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN
149, 3l5jB, 0.6133, 2.50, 0.078, 286, 90, CRYSTAL STRUCTURE OF FNIII DOMAINS OF HUMAN GP130 (DOMAINS 4-6)
150, 1ernA, 0.6133, 2.89, 0.109, 207, 92, NATIVE STRUCTURE OF THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP]
151, 6molC, 0.6131, 2.96, 0.097, 211, 93, MONOEXTENDED DARPIN M_R12 COMPLEX WITH EPOR 
152, 3tgxE, 0.6131, 2.69, 0.120, 207, 92, IL-21:IL21R COMPLEX
153, 2jixB, 0.6130, 2.87, 0.098, 216, 92, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
154, 4yfeB, 0.6128, 2.46, 0.144, 193, 90, CRYSTAL STRUCTURE OF PTP DELTA FN1-FN2
155, 5uwcG, 0.6127, 2.64, 0.074, 253, 95, CYTOKINE-RECEPTOR COMPLEX
156, 3jvfC, 0.6126, 2.95, 0.073, 270, 96, CRYSTAL STRUCTURE OF AN INTERLEUKIN-17 RECEPTOR COMPLEX
157, 2ibbA, 0.6126, 2.69, 0.086, 208, 93, CRYSTAL STRUCTURE OF THE FIRST AND SECOND FNIII DOMAINS OF IHOG
158, 3tgxA, 0.6125, 2.77, 0.120, 208, 92, IL-21:IL21R COMPLEX
159, 5fucD, 0.6124, 2.62, 0.067, 198, 89, BIOPHYSICAL AND CELLULAR CHARACTERISATION OF A JUNCTIONAL EPITOPE ANTIBODY THAT LOCKS IL-6 AND GP80 TOGETHER IN A STABLE COMPLEX: IMPLICATIONS FOR NEW THERAPEUTIC STRATEGIES
160, 2crzA, 0.6124, 2.56, 0.087, 110, 92, SOLUTION STRUCTURE OF THE FIFTH FNIII DOMAIN OF HUMAN FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3A
161, 6mofB, 0.6123, 2.98, 0.118, 217, 93, MONOMERIC DARPIN G2 COMPLEX WITH EPOR 
162, 3tgxK, 0.6119, 2.75, 0.120, 209, 92, IL-21:IL21R COMPLEX
163, 4y5xC, 0.6118, 2.90, 0.099, 205, 91, DIABODY 305 COMPLEX WITH EPOR
164, 4eq3A, 0.6118, 2.54, 0.089, 203, 90, CRYSTAL STRUCTURE ANALYSIS OF SELENOMETHIONINE (SE-MET) SUBSTITUTED CHICKEN INTERFERON GAMMA RECEPTOR ALPHA CHAIN
165, 3tgxG, 0.6118, 2.76, 0.120, 209, 92, IL-21:IL21R COMPLEX
166, 4bkfB, 0.6117, 2.41, 0.124, 505, 89, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
167, 3zk4B, 0.6116, 2.48, 0.056, 571, 90, STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS
168, 3zk4A, 0.6116, 2.48, 0.056, 569, 90, STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS
169, 4yfgB, 0.6114, 2.42, 0.146, 481, 89, CRYSTAL STRUCTURE OF PTP DELTA MEA3/MEB MINUS VARIANT IG1-FN1
170, 6mojB, 0.6113, 2.91, 0.108, 219, 93, DIMERIC DARPIN A_ANGLE_R5 COMPLEX WITH EPOR 
171, 1ernB, 0.6113, 2.89, 0.097, 209, 93, NATIVE STRUCTURE OF THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP]
172, 1cn4B, 0.6111, 2.97, 0.108, 218, 93, ERYTHROPOIETIN COMPLEXED WITH EXTRACELLULAR DOMAINS OF ERYTHROPOIETIN RECEPTOR
173, 3bpoB, 0.6107, 2.71, 0.120, 198, 92, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
174, 5fm4C, 0.6106, 2.45, 0.111, 105, 90, STRUCTURE OF THE C-TERMINALLY EXTENDED DOMAIN MY4 OF HUMAN MYOMESIN (SPACE GROUP P21)
175, 5e4sA, 0.6106, 2.74, 0.108, 301, 93, CRYSTAL STRUCTURE OF MOUSE CNTN4 FN1-FN3 DOMAINS
176, 3n1pC, 0.6106, 2.44, 0.066, 100, 91, CRYSTAL STRUCTURE OF IHHN BOUND TO BOCFN3
177, 5i99A, 0.6105, 2.64, 0.085, 398, 94, CRYSTAL STRUCTURE OF MOUSE CNTN3 IG5-FN2 DOMAINS
178, 2ed9A, 0.6105, 2.37, 0.112, 124, 89, SOLUTION STRUCTURE OF THE THIRD FIBRONECTIN TYPE III DOMAIN OF HUMAN NETRIN RECEPTOR DCC
179, 2d0gA, 0.6105, 2.62, 0.078, 637, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P5 A PULLULAN MODEL OLIGOSACCHARIDE
180, 2yuwA, 0.6104, 2.44, 0.099, 110, 91, SOLUTION STRUCTURE OF 2ND FIBRONECTIN DOMAIN OF SLOW TYPE MYOSIN-BINDING PROTEIN C
181, 1uh4A, 0.6103, 2.61, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1/MALTO- TRIDECAOSE COMPLEX
182, 2d0fA, 0.6102, 2.61, 0.078, 637, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1 (TVAI) MUTANT D356N COMPLEXED WITH P2 A PULLULAN MODEL OLIGOSACCHARIDE
183, 6moeD, 0.6101, 2.90, 0.130, 216, 92, MONOMERIC DARPIN E2 COMPLEX WITH EPOR 
184, 4hsaC, 0.6100, 2.95, 0.074, 272, 95, STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR
185, 3n1mC, 0.6100, 2.62, 0.065, 104, 93, CRYSTAL STRUCTURE OF IHHN BOUND TO BOCFN3
186, 3tgxC, 0.6098, 2.80, 0.120, 209, 92, IL-21:IL21R COMPLEX
187, 5nanC, 0.6097, 3.04, 0.073, 271, 96, CRYSTAL STRUCTURE OF HUMAN IL-17AF IN COMPLEX WITH HUMAN IL-17RA
188, 1uh2A, 0.6097, 2.62, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/MALTO-HEXAOSE COMPLEX
189, 2jixE, 0.6096, 2.89, 0.097, 216, 93, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
190, 5nanB, 0.6095, 3.04, 0.071, 271, 98, CRYSTAL STRUCTURE OF HUMAN IL-17AF IN COMPLEX WITH HUMAN IL-17RA
191, 4y5xI, 0.6094, 2.90, 0.097, 207, 93, DIABODY 305 COMPLEX WITH EPOR
192, 4qqvD, 0.6094, 2.47, 0.144, 316, 90, EXTRACELLULAR DOMAINS OF MOUSE IL-3 BETA RECEPTOR
193, 1fg9E, 0.6093, 2.77, 0.056, 193, 90, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
194, 5z0tB, 0.6092, 2.62, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE I (TVA I) MUTANT A357V/Q359N/Y360E (AQY/VNE)
195, 4nkqA, 0.6091, 2.79, 0.099, 412, 91, STRUCTURE OF A CYTOKINE RECEPTOR COMPLEX
196, 4jzjC, 0.6091, 2.75, 0.063, 250, 95, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
197, 2jixC, 0.6090, 2.94, 0.097, 214, 93, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
198, 5ak7A, 0.6089, 2.56, 0.100, 419, 90, STRUCTURE OF WT PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE
199, 2a9cA, 0.6089, 2.34, 0.103, 359, 87, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
200, 1pgrH, 0.6089, 2.34, 0.122, 200, 90, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
201, 1pgrD, 0.6089, 2.34, 0.122, 200, 90, 2:2 COMPLEX OF G-CSF WITH ITS RECEPTOR
202, 1izjA, 0.6089, 2.63, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME F313A
203, 1cn4A, 0.6089, 2.95, 0.097, 217, 93, ERYTHROPOIETIN COMPLEXED WITH EXTRACELLULAR DOMAINS OF ERYTHROPOIETIN RECEPTOR
204, 4y5vC, 0.6087, 3.09, 0.108, 206, 93, DIABODY 305 COMPLEX WITH EPOR
205, 1pvhA, 0.6087, 2.46, 0.121, 201, 91, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH GP130
206, 2e3vC, 0.6086, 2.67, 0.118, 100, 93, CRYSTAL STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF NEURAL CELL ADHESION MOLECULE SPLICING ISOFORM FROM HUMAN MUSCLE CULTURE LAMBDA-4.4
207, 1x4yA, 0.6086, 2.53, 0.066, 114, 91, SOLUTION STRUCTURE OF THE 3RD FIBRONECTIN TYPE III DOMAIN FROM MOUSE BIREGIONAL CELL ADHESION MOLECULE-RELATED/DOWN- REGULATED ONCOGENES (CDON) BINDING PROTEIN
208, 5z0uA, 0.6085, 2.63, 0.078, 626, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE I (TVA I) 11 RESIDUES (FROM A363 TO N373) DELETION MUTANT (DEL11)
209, 6moeC, 0.6084, 3.00, 0.086, 217, 93, MONOMERIC DARPIN E2 COMPLEX WITH EPOR 
210, 2a9cB, 0.6084, 2.35, 0.103, 359, 87, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
211, 2a9dB, 0.6081, 2.27, 0.115, 359, 87, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH ARG AT RESIDUE 161
212, 1ji1B, 0.6081, 2.62, 0.078, 637, 90, CRYSTAL STRUCTURE ANALYSIS OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1
213, 5z0tA, 0.6080, 2.63, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE I (TVA I) MUTANT A357V/Q359N/Y360E (AQY/VNE)
214, 2d0hA, 0.6080, 2.53, 0.079, 637, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P2 A PULLULAN MODEL OLIGOSACCHARIDE
215, 2a9dA, 0.6079, 2.28, 0.115, 369, 87, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH ARG AT RESIDUE 161
216, 1uh3A, 0.6079, 2.64, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE/ACARBOSE COMPLEX
217, 5ze3B, 0.6078, 3.27, 0.067, 443, 105, CRYSTAL STRUCTURE OF HUMAN LYSYL OXIDASE-LIKE 2 (HLOXL2) IN A PRECURSOR STATE 
218, 3zk4C, 0.6077, 2.76, 0.087, 568, 92, STRUCTURE OF PURPLE ACID PHOSPHATASE PPD1 ISOLATED FROM YELLOW LUPIN (LUPINUS LUTEUS) SEEDS
219, 1pvhC, 0.6077, 2.48, 0.121, 201, 91, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH GP130
220, 4hsaF, 0.6076, 3.00, 0.083, 271, 96, STRUCTURE OF INTERLEUKIN 17A IN COMPLEX WITH IL17RA RECEPTOR
221, 1bpvA, 0.6076, 2.51, 0.098, 104, 92, TITIN MODULE A71 FROM HUMAN CARDIAC MUSCLE NMR 50 STRUCTURES
222, 1eerC, 0.6075, 2.96, 0.098, 213, 92, CRYSTAL STRUCTURE OF HUMAN ERYTHROPOIETIN COMPLEXED TO ITS RECEPTOR AT 1.9 ANGSTROMS
223, 4n68A, 0.6071, 2.48, 0.077, 99, 91, CRYSTAL STRUCTURE OF AN INTERNAL FN3 DOMAIN FROM HUMAN CONTACTIN-5 [PSI-NYSGRC-005804]
224, 6i0xA, 0.6070, 2.64, 0.088, 420, 91, PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEMINASE (PPAD) MUTANT G231N/E232T/N235D IN COMPLEX WITH CL-AMIDINE. 
225, 2a9aA, 0.6070, 2.36, 0.103, 371, 87, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
226, 5ak8A, 0.6067, 2.64, 0.110, 419, 91, STRUCTURE OF C351A MUTANT OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE
227, 2a9bA, 0.6067, 2.37, 0.103, 372, 87, CRYSTAL STRUCTURE OF R138Q MUTANT OF RECOMBINANT SULFITE OXIDASE AT RESTING STATE
228, 1bquA, 0.6067, 2.47, 0.121, 208, 91, CYTOKYNE-BINDING REGION OF GP130
229, 1ji1A, 0.6066, 2.65, 0.078, 637, 90, CRYSTAL STRUCTURE ANALYSIS OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 1
230, 1va9A, 0.6065, 2.63, 0.172, 122, 93, SOLUTION STRUCTURE OF THE SECOND FNIII DOMAIN OF DSCAML1 PROTEIN
231, 4kgjB, 0.6063, 2.70, 0.066, 607, 91, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE
232, 1i1rA, 0.6063, 2.75, 0.087, 301, 92, CRYSTAL STRUCTURE OF A CYTOKINE/RECEPTOR COMPLEX
233, 5mybA, 0.6060, 2.55, 0.079, 190, 89, HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 2 AND 3 IN SPACE GROUP P21
234, 5fm5M, 0.6058, 2.57, 0.110, 123, 91, CRYSTAL STRUCTURE OF THE MYOMESIN:OBSCURIN-LIKE-1 COMPLEX
235, 6mohD, 0.6056, 2.86, 0.100, 211, 90, DIMERIC DARPIN C_R3 COMPLEX WITH EPOR 
236, 1x5yA, 0.6055, 2.55, 0.099, 111, 91, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF MOUSE MYOSIN-BINDING PROTEIN C FAST-TYPE HOMOLOG
237, 5uv8A, 0.6052, 2.74, 0.084, 259, 95, INTERLEUKIN-3 RECEPTOR COMPLEX
238, 6gvkA, 0.6050, 2.48, 0.078, 201, 90, SECOND PAIR OF FIBRONECTIN TYPE III DOMAINS OF INTEGRIN BETA4 (T1663R MUTANT) BOUND TO THE BULLOUS PEMPHIGOID ANTIGEN BP230 (BPAG1E) 
239, 3w81A, 0.6049, 2.71, 0.066, 616, 91, HUMAN ALPHA-L-IDURONIDASE
240, 3r18A, 0.6048, 2.43, 0.114, 373, 88, CHICKEN SULFITE OXIDASE DOUBLE MUTANT WITH ALTERED ACTIVITY AND SUBSTRATE AFFINITY
241, 6hyfC, 0.6046, 2.39, 0.102, 91, 88, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN FROM RAT BETA4 INTEGRIN; A BINDING SITE FOR PERIAXIN 
242, 6dg5B, 0.6046, 2.82, 0.033, 206, 92, STRUCTURE OF A DE NOVO DESIGNED INTERLEUKIN-2/INTERLEUKIN-15 MIMETIC COMPLEX WITH IL-2RB AND IL-2RG 
243, 5fm5N, 0.6046, 2.58, 0.110, 123, 91, CRYSTAL STRUCTURE OF THE MYOMESIN:OBSCURIN-LIKE-1 COMPLEX
244, 1boyA, 0.6045, 2.53, 0.056, 211, 89, EXTRACELLULAR REGION OF HUMAN TISSUE FACTOR
245, 2dn7A, 0.6044, 2.52, 0.077, 107, 91, SOLUTION STRUCTURES OF THE 6TH FN3 DOMAIN OF HUMAN RECEPTOR- TYPE TYROSINE-PROTEIN PHOSPHATASE F
246, 6i0xB, 0.6043, 2.66, 0.088, 422, 91, PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEMINASE (PPAD) MUTANT G231N/E232T/N235D IN COMPLEX WITH CL-AMIDINE. 
247, 4mj2B, 0.6043, 2.71, 0.066, 607, 91, CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM
248, 3w82A, 0.6043, 2.71, 0.066, 616, 91, HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID
249, 4ylqT, 0.6042, 2.53, 0.045, 210, 89, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (FT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
250, 4qqvB, 0.6040, 2.75, 0.143, 395, 91, EXTRACELLULAR DOMAINS OF MOUSE IL-3 BETA RECEPTOR
251, 1soxB, 0.6039, 2.31, 0.115, 458, 87, SULFITE OXIDASE FROM CHICKEN LIVER
252, 1bquB, 0.6039, 2.80, 0.098, 215, 92, CYTOKYNE-BINDING REGION OF GP130
253, 4y5vF, 0.6037, 2.99, 0.120, 206, 92, DIABODY 305 COMPLEX WITH EPOR
254, 2a99A, 0.6037, 2.43, 0.114, 372, 88, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE AT RESTING STATE
255, 5fmvB, 0.6036, 2.35, 0.067, 347, 89, CRYSTAL STRUCTURE OF HUMAN CD45 EXTRACELLULAR REGION DOMAINS D1-D4
256, 3w82B, 0.6036, 2.75, 0.066, 616, 91, HUMAN ALPHA-L-IDURONIDASE IN COMPLEX WITH IDURONIC ACID
257, 5fmvA, 0.6034, 2.35, 0.067, 351, 89, CRYSTAL STRUCTURE OF HUMAN CD45 EXTRACELLULAR REGION DOMAINS D1-D4
258, 3hbpA, 0.6034, 2.45, 0.114, 373, 88, THE CRYSTAL STRUCTURE OF C185S MUTANT OF RECOMBINANT SULFITE OXIDASE WITH BOUND SUBSTRATE SULFITE AT THE ACTIVE SITE
259, 4obrB, 0.6032, 2.73, 0.066, 606, 91, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID
260, 4kh2B, 0.6032, 2.71, 0.066, 607, 91, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE
261, 2blfA, 0.6032, 2.41, 0.093, 373, 86, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA
262, 1z6jT, 0.6032, 2.35, 0.034, 207, 88, CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR
263, 1gh7B, 0.6032, 2.84, 0.109, 408, 92, CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA- COMMON RECEPTOR OF IL-3 IL-5 AND GM-CSF
264, 4v33A, 0.6031, 2.75, 0.110, 315, 91, CRYSTAL STRUCTURE OF THE PUTATIVE POLYSACCHARIDE DEACETYLASE BA0330 FROM BACILLUS ANTHRACIS
265, 2bpbA, 0.6031, 2.41, 0.093, 373, 86, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA
266, 1wisA, 0.6031, 2.78, 0.108, 124, 93, SOLUTION STRUCTURE OF THE FIFTH FNIII DOMAIN FROM HUMAN KIAA1514 PROTEIN
267, 1gh7A, 0.6031, 2.84, 0.109, 408, 92, CRYSTAL STRUCTURE OF THE COMPLETE EXTRACELLULAR DOMAIN OF THE BETA- COMMON RECEPTOR OF IL-3 IL-5 AND GM-CSF
268, 3lqmB, 0.6030, 2.46, 0.068, 196, 88, STRUCTURE OF THE IL-10R2 COMMON CHAIN
269, 2djsA, 0.6030, 2.42, 0.135, 108, 89, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN EPHRIN TYPE- B RECEPTOR 1
270, 6gvlA, 0.6028, 2.53, 0.078, 199, 90, SECOND PAIR OF FIBRONECTIN TYPE III DOMAINS OF INTEGRIN BETA4 BOUND TO THE BULLOUS PEMPHIGOID ANTIGEN BP230 (BPAG1E) 
271, 4kglB, 0.6028, 2.73, 0.066, 612, 91, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R3R4R 5S]-2-CARBOXY-345-TRIHYDROXY-PIPERIDINE
272, 4gs7C, 0.6028, 2.64, 0.101, 193, 89, STRUCTURE OF THE INTERLEUKIN-15 QUATERNARY COMPLEX
273, 3l5jA, 0.6027, 2.58, 0.089, 283, 90, CRYSTAL STRUCTURE OF FNIII DOMAINS OF HUMAN GP130 (DOMAINS 4-6)
274, 6go1B, 0.6025, 2.83, 0.076, 318, 92, CRYSTAL STRUCTURE OF A BACILLUS ANTHRACIS PEPTIDOGLYCAN DEACETYLASE 
275, 2ca3A, 0.6025, 2.41, 0.093, 373, 86, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA R55M MUTANT
276, 2c9xA, 0.6025, 2.41, 0.093, 373, 86, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA Y236F MUTANT
277, 4z6aT, 0.6024, 2.59, 0.045, 201, 89, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (YT) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
278, 3og4B, 0.6023, 2.86, 0.076, 197, 92, THE CRYSTAL STRUCTURE OF HUMAN INTERFERON LAMBDA 1 COMPLEXED WITH ITS HIGH AFFINITY RECEPTOR IN SPACE GROUP P21212
279, 3hbqA, 0.6023, 2.31, 0.115, 373, 87, STRUCTURE OF RECOMBINANT CHICKEN LIVER SULFITE OXIDASE MUTANT CYS 185 ALA
280, 5ze3A, 0.6022, 3.20, 0.048, 441, 104, CRYSTAL STRUCTURE OF HUMAN LYSYL OXIDASE-LIKE 2 (HLOXL2) IN A PRECURSOR STATE 
281, 4nzdA, 0.6022, 2.82, 0.121, 210, 91, INTERLEUKIN 21 RECEPTOR
282, 2gysA, 0.6022, 2.54, 0.100, 397, 90, 2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3 IL-5 AND GM-CSF SIGNALLING
283, 5e53A, 0.6021, 2.74, 0.064, 288, 94, CRYSTAL STRUCTURE OF CHICKEN CNTN1 FN1-FN3 DOMAINS
284, 3w81B, 0.6021, 2.77, 0.066, 616, 91, HUMAN ALPHA-L-IDURONIDASE
285, 3hc2A, 0.6021, 2.45, 0.114, 372, 88, CRYSTAL STRUCTURE OF CHICKEN SULFITE OXIDASE MUTANT TYR 322 PHE
286, 2a9aB, 0.6020, 2.45, 0.114, 359, 88, CRYSTAL STRUCTURE OF RECOMBINANT CHICKEN SULFITE OXIDASE WITH THE BOUND PRODUCT SULFATE AT THE ACTIVE SITE
287, 1tdqA, 0.6019, 2.37, 0.101, 271, 89, STRUCTURAL BASIS FOR THE INTERACTIONS BETWEEN TENASCINS AND THE C-TYPE LECTIN DOMAINS FROM LECTICANS: EVIDENCE FOR A CROSS-LINKING ROLE FOR TENASCINS
288, 6go1A, 0.6018, 2.76, 0.043, 318, 92, CRYSTAL STRUCTURE OF A BACILLUS ANTHRACIS PEPTIDOGLYCAN DEACETYLASE 
289, 2ee2A, 0.6018, 2.51, 0.156, 119, 90, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN CONTACTIN 1
290, 1j0iA, 0.6018, 2.35, 0.034, 588, 89, CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE
291, 4dohB, 0.6017, 2.41, 0.033, 193, 90, IL20/IL201/IL20R2 TERNARY COMPLEX
292, 3r19A, 0.6017, 2.46, 0.114, 372, 88, CHICKEN SULFITE OXIDASE TRIPLE MUTANT WITH ALTERED ACTIVITY AND SUBSTRATE AFFINITY
293, 3qb7C, 0.6017, 2.45, 0.092, 191, 87, INTERLEUKIN-4 MUTANT RGA BOUND TO CYTOKINE RECEPTOR COMMON GAMMA
294, 2e3vA, 0.6017, 2.57, 0.121, 102, 91, CRYSTAL STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF NEURAL CELL ADHESION MOLECULE SPLICING ISOFORM FROM HUMAN MUSCLE CULTURE LAMBDA-4.4
295, 3rp1C, 0.6016, 2.31, 0.080, 98, 87, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
296, 2m83A, 0.6016, 2.75, 0.044, 139, 90, SOLUTION STRUCTURE OF THE CARBOHYDRATE BINDING MODULE OF THE MUSCLE GLYCOGEN-TARGETING SUBUNIT OF PROTEIN PHOSPHATASE-1
297, 1izkA, 0.6016, 2.65, 0.078, 637, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 MUTANT ENZYME W398V
298, 2dm4A, 0.6015, 2.62, 0.141, 108, 92, SOLUTION STRUCTURE OF THE SECOND FN3 DOMAIN OF HUMAN SORLA/LR11
299, 2yuxA, 0.6014, 2.53, 0.133, 120, 90, SOLUTION STRUCTURE OF 3RD FIBRONECTIN TYPE THREE DOMAIN OF SLOW TYPE MYOSIN-BINDING PROTEIN C
300, 1ebaB, 0.6014, 2.92, 0.100, 207, 90, COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN INACTIVE PEPTIDE [EMP33] CONTAINS 35-DIBROMOTYROSINE IN POSITION 4 (DENOTED DBY)
301, 6k7oH, 0.6012, 2.85, 0.054, 225, 92, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
302, 4dohD, 0.6012, 2.43, 0.033, 193, 90, IL20/IL201/IL20R2 TERNARY COMPLEX
303, 2edxA, 0.6012, 2.80, 0.109, 134, 92, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR- TYPE TYROSINE-PROTEIN PHOSPHATASE F
304, 2ca4A, 0.6012, 2.41, 0.093, 373, 86, SULFITE DEHYDROGENASE FROM STARKEYA NOVELLA MUTANT
305, 1j0jA, 0.6012, 2.37, 0.034, 588, 89, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE
306, 6e3lD, 0.6010, 2.32, 0.080, 202, 87, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
307, 4nzdC, 0.6010, 2.80, 0.121, 210, 91, INTERLEUKIN 21 RECEPTOR
308, 2kbgA, 0.6010, 2.47, 0.055, 102, 91, SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE-III MODULE OF NCAM2
309, 4qqvC, 0.6008, 2.59, 0.144, 402, 90, EXTRACELLULAR DOMAINS OF MOUSE IL-3 BETA RECEPTOR
310, 3t1wA, 0.6008, 2.67, 0.133, 368, 90, STRUCTURE OF THE FOUR-DOMAIN FRAGMENT FN7B89 OF ONCOFETAL FIBRONECTIN
311, 5f7uA, 0.6006, 2.65, 0.022, 1059, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PENTASACCHARIDE SUBSTRATE
312, 2e7hA, 0.6006, 2.45, 0.124, 109, 89, SOLUTION STRUCTURE OF THE SECOND FN3 DOMAIN FROM HUMAN EPHRIN TYPE-B RECEPTOR 4
313, 6i6xB, 0.6005, 2.76, 0.066, 597, 91, NEW IRREVERSIBLE A-L-IDURONIDASE INHIBITORS AND ACTIVITY-BASED PROBES 
314, 5utkB, 0.6004, 2.54, 0.080, 280, 88, CRYSTAL STRUCTURE OF THE MEMBRANE PROXIMAL THREE FIBRONECTIN TYPE III (FNIII) DOMAINS OF TIE2 (TIE2[FNIIIA-C])
315, 4kmqA, 0.6004, 2.66, 0.022, 1029, 90, 1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN LMO2446 FROM LISTERIA MONOCYTOGENES EGD-E
316, 2ibgA, 0.6004, 3.07, 0.053, 214, 94, CRYSTAL STRUCTURE OF HEDGEHOG BOUND TO THE FNIII DOMAINS OF IHOG
317, 3n1fC, 0.6003, 2.34, 0.057, 94, 88, CRYSTAL STRUCTURE OF IHHN BOUND TO CDOFN3
318, 3prxD, 0.6000, 3.11, 0.053, 1215, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
319, 3prxB, 0.5999, 2.96, 0.064, 1215, 94, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
320, 5e53C, 0.5998, 2.79, 0.064, 292, 94, CRYSTAL STRUCTURE OF CHICKEN CNTN1 FN1-FN3 DOMAINS
321, 3lqmA, 0.5998, 2.53, 0.056, 201, 89, STRUCTURE OF THE IL-10R2 COMMON CHAIN
322, 6iaaB, 0.5997, 2.62, 0.163, 804, 92, HROBO2 ECTODOMAIN 
323, 4qqvA, 0.5997, 2.86, 0.152, 399, 92, EXTRACELLULAR DOMAINS OF MOUSE IL-3 BETA RECEPTOR
324, 4kwuA, 0.5997, 2.65, 0.022, 1030, 90, 1.9 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF UNCHARACTERIZED PROTEIN LMO2446 FROM LISTERIA MONOCYTOGENES EGD-E IN COMPLEX WITH ALPHA-D- GLUCOSE BETA-D-GLUCOSE MAGNESIUM AND CALCIUM
325, 4v33B, 0.5996, 2.70, 0.110, 315, 91, CRYSTAL STRUCTURE OF THE PUTATIVE POLYSACCHARIDE DEACETYLASE BA0330 FROM BACILLUS ANTHRACIS
326, 4jzjD, 0.5996, 2.82, 0.084, 251, 95, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
327, 2edyA, 0.5996, 2.57, 0.167, 103, 90, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR- TYPE TYROSINE-PROTEIN PHOSPHATASE F
328, 3kgrB, 0.5995, 2.32, 0.093, 97, 86, CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
329, 3kgrC, 0.5994, 2.38, 0.092, 99, 87, CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
330, 3hbgA, 0.5994, 2.48, 0.114, 353, 88, STRUCTURE OF RECOMBINANT CHICKEN LIVER SULFITE OXIDASE MUTANT C185S
331, 1j0hA, 0.5993, 2.38, 0.034, 588, 89, CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS NEOPULLULANASE
332, 3pddA, 0.5992, 2.42, 0.093, 190, 86, STRUCTURES OF CLOSTRIDIUM THERMOCELLUM CBHA FIBRONECTIN(III)-LIKE MODULES
333, 5mybB, 0.5990, 2.60, 0.090, 191, 89, HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 2 AND 3 IN SPACE GROUP P21
334, 4pbxA, 0.5990, 2.28, 0.149, 568, 87, CRYSTAL STRUCTURE OF THE SIX N-TERMINAL DOMAINS OF HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGMA
335, 1jrhI, 0.5990, 2.44, 0.080, 95, 87, COMPLEX (ANTIBODY/ANTIGEN)
336, 5hpoA, 0.5989, 2.55, 0.034, 1030, 89, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH MALTOPENTAOSE
337, 2b7dT, 0.5988, 2.48, 0.045, 149, 88, FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION PRECLINICAL PHARMACOKINETICS PHARMACODYNAMICS AND EFFICACY IN A BABOON THROMBOSIS MODEL
338, 1jpsT, 0.5987, 2.63, 0.023, 200, 88, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
339, 6iaaC, 0.5985, 2.63, 0.163, 804, 92, HROBO2 ECTODOMAIN 
340, 2ibgC, 0.5985, 3.09, 0.053, 213, 94, CRYSTAL STRUCTURE OF HEDGEHOG BOUND TO THE FNIII DOMAINS OF IHOG
341, 1j0kA, 0.5985, 2.39, 0.034, 588, 89, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE
342, 1eerB, 0.5985, 3.07, 0.098, 213, 92, CRYSTAL STRUCTURE OF HUMAN ERYTHROPOIETIN COMPLEXED TO ITS RECEPTOR AT 1.9 ANGSTROMS
343, 2ibgD, 0.5984, 3.09, 0.053, 213, 94, CRYSTAL STRUCTURE OF HEDGEHOG BOUND TO THE FNIII DOMAINS OF IHOG
344, 4nzdB, 0.5983, 2.95, 0.120, 208, 92, INTERLEUKIN 21 RECEPTOR
345, 3rp1A, 0.5983, 2.28, 0.106, 96, 85, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
346, 5hxmA, 0.5982, 2.69, 0.022, 1030, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH PANOSE
347, 6e3kD, 0.5981, 2.41, 0.091, 203, 88, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
348, 4u3hA, 0.5980, 2.18, 0.141, 100, 85, CRYSTAL STRUCTURE OF FN3CON
349, 4hd5A, 0.5980, 2.67, 0.066, 315, 91, CRYSTAL STRUCTURE OF BC0361 A POLYSACCHARIDE DEACETYLASE FROM BACILLUS CEREUS
350, 1ahwC, 0.5979, 2.61, 0.034, 200, 88, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
351, 3lzfH, 0.5978, 2.86, 0.044, 216, 91, CRYSTAL STRUCTURE OF FAB 2D1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ
352, 2dmkA, 0.5978, 2.53, 0.125, 127, 88, THE SOLUTION STRUCTURE OF THE FN3 DOMAIN OF HUMAN MIDLINE 2 PROTEIN
353, 5e4qA, 0.5977, 2.58, 0.097, 275, 93, CRYSTAL STRUCTURE OF MOUSE CNTN3 FN1-FN3 DOMAINS
354, 2gysB, 0.5977, 2.93, 0.109, 406, 92, 2.7 A STRUCTURE OF THE EXTRACELLULAR DOMAINS OF THE HUMAN BETA COMMON RECEPTOR INVOLVED IN IL-3 IL-5 AND GM-CSF SIGNALLING
355, 1j9cT, 0.5977, 2.58, 0.045, 210, 89, CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
356, 5k3xB, 0.5976, 2.72, 0.124, 345, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78K MUTANT FROM SINORHIZOBIUM MELILOTI
357, 5i0dB, 0.5976, 2.64, 0.022, 1030, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN
358, 2hftA, 0.5976, 2.68, 0.045, 205, 89, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR AT 1.7 ANGSTROMS RESOLUTION
359, 4iykA, 0.5974, 2.78, 0.097, 207, 93, CRYSTAL STRUCTURE OF A PUTATIVE CARBOHYDRATE BINDING PROTEIN (BACUNI_04699) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 2.00 A RESOLUTION
360, 2ibgB, 0.5974, 3.09, 0.053, 213, 94, CRYSTAL STRUCTURE OF HEDGEHOG BOUND TO THE FNIII DOMAINS OF IHOG
361, 2flbT, 0.5974, 2.50, 0.045, 151, 88, DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
362, 5i0dA, 0.5973, 2.68, 0.022, 1030, 90, CYCLOALTERNAN-FORMING ENZYME FROM LISTERIA MONOCYTOGENES IN COMPLEX WITH CYCLOALTERNAN
363, 4lsdF, 0.5972, 2.63, 0.114, 97, 88, MYOKINE STRUCTURE
364, 1f6fB, 0.5972, 2.71, 0.089, 195, 90, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN OVINE PLACENTAL LACTOGEN AND THE EXTRACELLULAR DOMAIN OF THE RAT PROLACTIN RECEPTOR
365, 1ebpA, 0.5972, 3.09, 0.109, 211, 92, COMPLEX BETWEEN THE EXTRACELLULAR DOMAIN OF ERYTHROPOIETIN (EPO) RECEPTOR [EBP] AND AN AGONIST PEPTIDE [EMP1]
366, 4lsdB, 0.5971, 2.56, 0.114, 93, 88, MYOKINE STRUCTURE
367, 4lsdA, 0.5971, 2.53, 0.114, 96, 88, MYOKINE STRUCTURE
368, 3kgrA, 0.5971, 2.39, 0.092, 99, 87, CRYSTAL STRUCTURE OF THE HUMAN LEUKOCYTE-ASSOCIATED IG-LIKE RECEPTOR-1 (LAIR-1)
369, 6i2xB, 0.5969, 3.18, 0.053, 951, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SMALL MOLECULE INHIBITOR AND CVF 
370, 2e3vB, 0.5969, 2.39, 0.125, 96, 88, CRYSTAL STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF NEURAL CELL ADHESION MOLECULE SPLICING ISOFORM FROM HUMAN MUSCLE CULTURE LAMBDA-4.4
371, 1x5fA, 0.5968, 3.00, 0.109, 120, 92, THE SOLUTION STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN
372, 5utkA, 0.5967, 2.58, 0.089, 289, 90, CRYSTAL STRUCTURE OF THE MEMBRANE PROXIMAL THREE FIBRONECTIN TYPE III (FNIII) DOMAINS OF TIE2 (TIE2[FNIIIA-C])
373, 5n47D, 0.5967, 2.64, 0.133, 280, 90, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
374, 1o5dT, 0.5967, 2.51, 0.045, 151, 88, DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
375, 5n47F, 0.5965, 2.64, 0.133, 277, 90, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
376, 5mzvC, 0.5965, 2.71, 0.043, 293, 92, IL-23:IL-23R:NB22E11 COMPLEX
377, 3hrzA, 0.5965, 3.15, 0.053, 614, 95, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
378, 5f7sA, 0.5964, 2.49, 0.045, 701, 88, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES
379, 4ypjB, 0.5964, 3.42, 0.090, 810, 100, X-RAY STRUCTURE OF THE MUTANT OF GLYCOSIDE HYDROLASE
380, 4q58C, 0.5964, 2.20, 0.070, 183, 86, CRYSTAL STRUCTURE OF THE PLECTIN 1A ACTIN-BINDING DOMAIN/INTEGRIN BETA 4 FRAGMENT COMPLEX
381, 2c26A, 0.5964, 2.58, 0.103, 250, 87, STRUCTURAL BASIS FOR THE PROMISCUOUS SPECIFICITY OF THE CARBOHYDRATE-BINDING MODULES FROM THE BETA-SANDWICH SUPER FAMILY
382, 5fucC, 0.5963, 2.96, 0.151, 199, 93, BIOPHYSICAL AND CELLULAR CHARACTERISATION OF A JUNCTIONAL EPITOPE ANTIBODY THAT LOCKS IL-6 AND GP80 TOGETHER IN A STABLE COMPLEX: IMPLICATIONS FOR NEW THERAPEUTIC STRATEGIES
383, 5ecjF, 0.5963, 2.22, 0.106, 93, 85, CRYSTAL STRUCTURE OF MONOBODY MB(S4) BOUND TO PRDM14 IN COMPLEX WITH MTGR1
384, 1lwrA, 0.5963, 2.75, 0.122, 96, 90, SOLUTION STRUCTURE OF THE NCAM FIBRONECTIN TYPE III MODULE 2
385, 4lsdC, 0.5961, 2.55, 0.114, 93, 88, MYOKINE STRUCTURE
386, 1lqsR, 0.5961, 2.79, 0.067, 207, 89, CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1
387, 5f7sB, 0.5960, 2.60, 0.046, 702, 87, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES
388, 4ypjA, 0.5960, 3.43, 0.090, 810, 100, X-RAY STRUCTURE OF THE MUTANT OF GLYCOSIDE HYDROLASE
389, 3og6B, 0.5959, 2.63, 0.067, 200, 90, THE CRYSTAL STRUCTURE OF HUMAN INTERFERON LAMBDA 1 COMPLEXED WITH ITS HIGH AFFINITY RECEPTOR IN SPACE GROUP P212121
390, 1p9mC, 0.5958, 3.05, 0.128, 201, 94, CRYSTAL STRUCTURE OF THE HEXAMERIC HUMAN IL-6/IL-6 ALPHA RECEPTOR/GP130 COMPLEX
391, 3pvmA, 0.5957, 2.72, 0.076, 1627, 92, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
392, 2flrT, 0.5957, 2.50, 0.034, 151, 88, NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS
393, 2erjG, 0.5956, 2.61, 0.091, 195, 88, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
394, 1owwA, 0.5955, 2.42, 0.090, 93, 89, SOLUTION STRUCTURE OF THE FIRST TYPE III MODULE OF HUMAN FIBRONECTIN DETERMINED BY 1H 15N NMR SPECTROSCOPY
395, 4ytgA, 0.5954, 2.66, 0.101, 417, 89, CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) MUTANT C351A IN COMPLEX WITH DIPEPTIDE MET-ARG.
396, 2r5oA, 0.5954, 3.11, 0.084, 167, 95, CRYSTAL STRUCTURE OF THE C-TERMINAL DOMAIN OF WZT
397, 1uj3C, 0.5953, 2.38, 0.023, 205, 87, CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
398, 4ytbA, 0.5952, 2.75, 0.088, 422, 91, CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) IN COMPLEX WITH DIPEPTIDE ASP-GLN.
399, 5uv8G, 0.5951, 2.70, 0.075, 265, 93, INTERLEUKIN-3 RECEPTOR COMPLEX
400, 1j0kB, 0.5951, 2.61, 0.044, 588, 91, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH ISOPANOSE
401, 6h16B, 0.5950, 2.82, 0.110, 119, 91, STRUCTURE OF LRP6 P3E3P4E4 IN COMPLEX WITH VHH L-P2-D07 
402, 4i18C, 0.5950, 3.02, 0.086, 188, 93, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
403, 1ea9D, 0.5950, 2.52, 0.056, 583, 90, CYCLOMALTODEXTRINASE
404, 4obsA, 0.5949, 2.72, 0.067, 594, 90, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE IN THE P212121 FORM
405, 2aerT, 0.5949, 2.55, 0.034, 192, 88, CRYSTAL STRUCTURE OF BENZAMIDINE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX.
406, 1p9mA, 0.5949, 2.82, 0.087, 298, 92, CRYSTAL STRUCTURE OF THE HEXAMERIC HUMAN IL-6/IL-6 ALPHA RECEPTOR/GP130 COMPLEX
407, 6hn5F, 0.5947, 2.63, 0.099, 323, 91, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  UPPER  MEMBRANE-DISTAL PART 
408, 5e53B, 0.5947, 2.80, 0.064, 296, 94, CRYSTAL STRUCTURE OF CHICKEN CNTN1 FN1-FN3 DOMAINS
409, 3n1gD, 0.5947, 2.48, 0.056, 99, 89, CRYSTAL STRUCTURE OF DHHN BOUND TO BOCFN3
410, 4cdgC, 0.5945, 2.73, 0.067, 122, 90, CRYSTAL STRUCTURE OF THE BLOOM S SYNDROME HELICASE BLM IN COMPLEX WITH NANOBODY
411, 1smaB, 0.5945, 2.58, 0.077, 588, 91, CRYSTAL STRUCTURE OF A MALTOGENIC AMYLASE
412, 1smaA, 0.5945, 2.58, 0.077, 588, 91, CRYSTAL STRUCTURE OF A MALTOGENIC AMYLASE
413, 5wa0A, 0.5944, 2.71, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
414, 1ahwF, 0.5944, 2.84, 0.034, 200, 89, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
415, 4pw3D, 0.5943, 2.71, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
416, 4pw3A, 0.5943, 2.71, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
417, 3pvmB, 0.5943, 3.14, 0.053, 1225, 95, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
418, 2puqT, 0.5943, 2.53, 0.045, 190, 88, CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR
419, 1gviB, 0.5943, 2.61, 0.077, 588, 91, THERMUS MALTOGENIC AMYLASE IN COMPLEX WITH BETA-CD
420, 4pw3C, 0.5942, 2.71, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
421, 4pw3B, 0.5942, 2.71, 0.124, 363, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT FROM SINORHIZOBIUM MELILOTI
422, 3hs0A, 0.5942, 3.12, 0.053, 613, 94, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
423, 6iaaA, 0.5941, 2.80, 0.183, 804, 93, HROBO2 ECTODOMAIN 
424, 5o4uF, 0.5941, 3.13, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
425, 5k3xA, 0.5941, 2.70, 0.124, 343, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78K MUTANT FROM SINORHIZOBIUM MELILOTI
426, 4yt9A, 0.5941, 2.46, 0.115, 418, 87, CRYSTAL STRUCTURE OF PORPHYROMONAS GINGIVALIS PEPTIDYLARGININE DEIMINASE (PPAD) SUBSTRATE-UNBOUND.
427, 4pw9A, 0.5941, 2.75, 0.124, 363, 89, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX FORMED BETWEEN A SULFITE DEHYDROGENASE AND A C-TYPE CYTOCHROME FROM SINORHIZOBIUM MELILOTI
428, 1j0jB, 0.5941, 2.61, 0.044, 588, 91, CRYSTAL STRUCTURE OF NEOPULLULANASE E357Q COMPLEX WITH MALTOTETRAOSE
429, 5uj6B, 0.5940, 3.21, 0.072, 840, 97, CRYSTAL STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE
430, 4larH, 0.5940, 2.83, 0.088, 117, 91, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
431, 5o4uL, 0.5939, 3.20, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
432, 5e55B, 0.5938, 2.67, 0.088, 307, 91, CRYSTAL STRUCTURE OF MOUSE CNTN6 FN1-FN3 DOMAINS
433, 4zmaT, 0.5938, 2.72, 0.057, 198, 88, CRYSTAL STRUCTURE OF A FVIIA-TRYPSIN CHIMERA (ST) IN COMPLEX WITH SOLUBLE TISSUE FACTOR
434, 4lsdD, 0.5938, 2.56, 0.114, 93, 88, MYOKINE STRUCTURE
435, 4cdgD, 0.5938, 2.74, 0.067, 122, 90, CRYSTAL STRUCTURE OF THE BLOOM S SYNDROME HELICASE BLM IN COMPLEX WITH NANOBODY
436, 1x5iA, 0.5938, 2.67, 0.080, 126, 88, THE SOLUTION STRUCTURE OF THE FOURTH FIBRONECTIN TYPE III DOMAIN OF HUMAN NEOGENIN
437, 4y5yF, 0.5934, 3.11, 0.076, 206, 92, DIABODY 330 COMPLEX WITH EPOR
438, 5i0fB, 0.5933, 2.53, 0.045, 729, 88, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH COVALENT INTERMEDIATE
439, 5fn8A, 0.5933, 2.40, 0.045, 178, 88, CRYSTAL STRUCTURE OF RAT CD45 EXTRACELLULAR REGION DOMAINS D3-D4
440, 1wfoA, 0.5933, 2.77, 0.099, 130, 91, THE EIGHTH FN3 DOMAIN OF HUMAN SIDEKICK-2
441, 5wa0C, 0.5932, 2.76, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
442, 5fn8B, 0.5932, 2.41, 0.045, 178, 88, CRYSTAL STRUCTURE OF RAT CD45 EXTRACELLULAR REGION DOMAINS D3-D4
443, 3v9fA, 0.5932, 3.18, 0.118, 731, 93, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE PUTATIVE HYBRID TWO COMPONENT SYSTEM BT3049 FROM B. THETAIOTAOMICRON
444, 2eefA, 0.5932, 2.50, 0.102, 156, 88, SOLUTION STRUCTURE OF THE CBM_21 DOMAIN FROM HUMAN PROTEIN PHOSPHATASE 1 REGULATORY (INHIBITOR) SUBUNIT 3B
445, 1y6mR, 0.5932, 2.60, 0.067, 204, 90, CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
446, 6ce7B, 0.5931, 2.74, 0.079, 659, 89, INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH ONE INSULIN MOLECULE
447, 3km9B, 0.5931, 3.03, 0.074, 1459, 94, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
448, 6cebA, 0.5930, 2.77, 0.089, 682, 90, INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES - C1 SYMMETRY
449, 1egjA, 0.5930, 2.60, 0.080, 101, 87, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
450, 5e7lA, 0.5929, 2.72, 0.098, 302, 92, CRYSTAL STRUCTURE OF MOUSE CNTN2 FN1-FN3 DOMAINS
451, 4x7eC, 0.5929, 2.81, 0.088, 121, 91, CRYSTAL STRUCTURE OF NOROVIRUS GII.10 P DOMAIN IN COMPLEX WITH NANO-85
452, 1wzmA, 0.5929, 2.50, 0.111, 585, 90, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469K
453, 4x7eD, 0.5928, 2.81, 0.088, 120, 91, CRYSTAL STRUCTURE OF NOROVIRUS GII.10 P DOMAIN IN COMPLEX WITH NANO-85
454, 3v9fD, 0.5928, 3.18, 0.118, 731, 93, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE PUTATIVE HYBRID TWO COMPONENT SYSTEM BT3049 FROM B. THETAIOTAOMICRON
455, 3pvmD, 0.5928, 3.01, 0.064, 1225, 94, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
456, 5wa0D, 0.5927, 2.72, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
457, 2mfnA, 0.5927, 2.50, 0.102, 184, 88, SOLUTION NMR STRUCTURE OF LINKED CELL ATTACHMENT MODULES OF MOUSE FIBRONECTIN CONTAINING THE RGD AND SYNERGY REGIONS 10 STRUCTURES
458, 4go6B, 0.5926, 2.81, 0.088, 165, 91, CRYSTAL STRUCTURE OF HCF-1 SELF-ASSOCIATION SEQUENCE 1
459, 2b8oT, 0.5926, 2.66, 0.034, 191, 88, CRYSTAL STRUCTURE OF GLU-GLY-ARG-CHLOROMETHYL KETONE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX
460, 3hs0F, 0.5925, 3.03, 0.064, 617, 94, COBRA VENOM FACTOR (CVF) IN COMPLEX WITH HUMAN FACTOR B
461, 1y6kR, 0.5925, 2.62, 0.067, 205, 90, CRYSTAL STRUCTURE OF HUMAN IL-10 COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
462, 1wk0A, 0.5925, 2.77, 0.066, 137, 91, SOLUTION STRUCTURE OF FIBRONECTIN TYPE III DOMAIN DERIVED FROM HUMAN KIAA0970 PROTEIN
463, 1ujtA, 0.5925, 2.82, 0.077, 120, 91, SOLUTION STRUCTURE OF THE SECOND FIBRONECTIN TYPE III DOMAIN OF HUMAN KIAA1568 PROTEIN
464, 6fpvB, 0.5924, 2.86, 0.055, 121, 91, A LLAMA-DERIVED JBP1-TARGETING NANOBODY 
465, 5o4uE, 0.5924, 3.22, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
466, 5dmyC, 0.5923, 3.27, 0.051, 855, 98, BETA-GALACTOSIDASE - CONSTRUCT 33-930
467, 4mkmA, 0.5923, 3.62, 0.091, 290, 99, REPEAT DOMAINS 1  and 2 OF CLOSTRIDIUM PERFRINGENS CPE0147
468, 3elaT, 0.5923, 2.55, 0.034, 191, 88, CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR
469, 2d2oA, 0.5923, 2.44, 0.112, 585, 89, STRUCTURE OF A COMPLEX OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 WITH MALTOHEXAOSE DEMONSTRATES THE IMPORTANT ROLE OF AROMATIC RESIDUES AT THE REDUCING END OF THE SUBSTRATE BINDING CLEFT
470, 2aeiT, 0.5923, 2.46, 0.034, 195, 87, CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR AND 2-[[6-[3-(AMINOIMINOMETHYL)PHENOXY]-35-DIFLURO-4-[(1-METHYL-3- PHENYLPROPYL)AMINO]-2-PYRIDINYL]OXY]-BENZOIC ACID
471, 1x5zA, 0.5923, 2.41, 0.159, 115, 88, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D ISOFORM 4 VARIANT
472, 5e52A, 0.5922, 3.00, 0.135, 294, 96, CRYSTAL STRUCTURE OF HUMAN CNTN5 FN1-FN3 DOMAINS
473, 3pjlA, 0.5922, 3.05, 0.063, 157, 95, THE CRYSTAL STRUCTURE OF TP34 BOUND TO CO (II) ION AT PH 7.5
474, 3klsA, 0.5922, 2.86, 0.075, 1622, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
475, 2firT, 0.5922, 2.49, 0.034, 191, 87, CRYSTAL STRUCTURE OF DFPR-VIIA/STF
476, 3klsB, 0.5921, 2.86, 0.075, 1478, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SSL7
477, 5dmyA, 0.5920, 3.08, 0.052, 855, 97, BETA-GALACTOSIDASE - CONSTRUCT 33-930
478, 3th3T, 0.5920, 2.54, 0.023, 154, 87, MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
479, 6h04A, 0.5919, 3.18, 0.063, 1219, 95, CLOSED CONFORMATION OF THE MEMBRANE ATTACK COMPLEX 
480, 5nstB, 0.5919, 2.43, 0.080, 336, 87, HUMAN MONOCLONAL ANTIBODY WITH A LAIR1 INSERTION
481, 4ploB, 0.5919, 2.74, 0.112, 192, 89, CRYSTAL STRUCTURE OF CHICKEN NETRIN-1 (LN-LE3) IN COMPLEX WITH MOUSE DCC (FN4-5)
482, 3bpoC, 0.5919, 2.71, 0.056, 286, 90, CRYSTAL STRUCTURE OF THE IL13-IL4R-IL13RA TERNARY COMPLEX
483, 5wa0B, 0.5918, 2.74, 0.124, 365, 89, CRYSTAL STRUCTURE OF THE SULFITE DEHYDROGENASE SORT R78Q MUTANT FROM SINORHIZOBIUM MELILOTI
484, 5dmyB, 0.5918, 3.27, 0.051, 858, 98, BETA-GALACTOSIDASE - CONSTRUCT 33-930
485, 4x7cC, 0.5918, 2.80, 0.067, 116, 90, CRYSTAL STRUCTURE OF SAGA-2006 GII.4 P DOMAIN IN COMPLEX WITH NANO-85
486, 6i2xC, 0.5917, 2.88, 0.065, 648, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SMALL MOLECULE INHIBITOR AND CVF 
487, 5t5wA, 0.5917, 2.45, 0.080, 198, 87, STRUCTURE OF AN AFFINITY MATURED LAMBDA-IFN/IFN-LAMBDAR1/IL-10RBETA RECEPTOR COMPLEX
488, 2x10A, 0.5917, 2.70, 0.122, 476, 90, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN
489, 4a5wA, 0.5916, 3.08, 0.053, 1528, 94, CRYSTAL STRUCTURE OF C5B6
490, 3th4T, 0.5916, 2.48, 0.034, 191, 87, MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
491, 1vfuA, 0.5916, 2.55, 0.111, 585, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 AMYLASE 2/GAMMA-CYCLODEXTRIN COMPLEX
492, 1tfhB, 0.5916, 2.68, 0.045, 182, 88, EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
493, 5uj6A, 0.5915, 3.24, 0.072, 838, 97, CRYSTAL STRUCTURE OF BACTEROIDES UNIFORMIS BETA-GLUCURONIDASE
494, 5t99A, 0.5915, 3.22, 0.021, 757, 97, CRYSTAL STRUCTURE OF BUGH2AWT IN COMPLEX WITH GALACTOISOFAGOMINE
495, 4iblT, 0.5915, 2.48, 0.034, 198, 87, RUBIDIUM SITES IN BLOOD COAGULATION FACTOR VIIA
496, 2rb8A, 0.5915, 2.42, 0.093, 93, 86, HIGH RESOLUTION DESIGN OF A PROTEIN LOOP
497, 1jibA, 0.5915, 2.43, 0.112, 585, 89, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE.
498, 1j7vR, 0.5915, 2.62, 0.067, 205, 90, HUMAN IL-10 / IL-10R1 COMPLEX
499, 1gviA, 0.5915, 2.62, 0.077, 588, 91, THERMUS MALTOGENIC AMYLASE IN COMPLEX WITH BETA-CD
500, 5iusA, 0.5914, 3.07, 0.054, 117, 93, CRYSTAL STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH HIGH AFFINITY PD-1 MUTANT
501, 3qhzH, 0.5914, 2.90, 0.055, 221, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
502, 5i0gB, 0.5913, 2.54, 0.045, 730, 88, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH CYCLOALTERNAN
503, 4nwnT, 0.5913, 3.54, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
504, 4lsdH, 0.5913, 2.65, 0.114, 93, 88, MYOKINE STRUCTURE
505, 5t98A, 0.5912, 3.23, 0.021, 756, 97, CRYSTAL STRUCTURE OF BUGH2AWT
506, 1vfoA, 0.5912, 2.43, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/BETA-CYCLODEXTRIN COMPLEX
507, 6fpvA, 0.5911, 2.87, 0.099, 122, 91, A LLAMA-DERIVED JBP1-TARGETING NANOBODY 
508, 6b24D, 0.5911, 2.35, 0.116, 96, 86, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80Y MUTANT
509, 5x83A, 0.5911, 2.71, 0.112, 94, 89, STRUCTURE OF DCC FN456 DOMAINS
510, 5w06T, 0.5911, 2.39, 0.023, 198, 86, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
511, 5hnpB, 0.5911, 3.09, 0.063, 166, 95, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
512, 4lsdE, 0.5911, 2.66, 0.114, 93, 88, MYOKINE STRUCTURE
513, 4go6D, 0.5911, 2.98, 0.087, 171, 92, CRYSTAL STRUCTURE OF HCF-1 SELF-ASSOCIATION SEQUENCE 1
514, 6d8gB, 0.5910, 3.24, 0.072, 831, 97, D341A D367A CALCIUM BINDING MUTANT OF BACTEROIDES UNIFORMIS BETA- GLUCURONIDASE 2 
515, 5x83C, 0.5910, 2.71, 0.101, 95, 89, STRUCTURE OF DCC FN456 DOMAINS
516, 5o4uK, 0.5909, 3.19, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
517, 5mtjB, 0.5909, 2.47, 0.115, 96, 87, YES1-SH2 IN COMPLEX WITH MONOBODY MB(YES_1)
518, 3th2T, 0.5909, 2.50, 0.034, 198, 87, MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
519, 2o6fA, 0.5909, 3.03, 0.053, 157, 95, STRUCTURE OF METAL- FREE RTP34 FROM TREPONEMA PALLIDUM
520, 1vb9A, 0.5909, 2.42, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT
521, 6d50B, 0.5908, 3.26, 0.072, 840, 97, BACTEROIDES UNIFORMS BETA-GLUCURONIDASE 2 BOUND TO D-GLUCARO-1;5- LACTONE 
522, 6d50A, 0.5908, 3.25, 0.072, 837, 97, BACTEROIDES UNIFORMS BETA-GLUCURONIDASE 2 BOUND TO D-GLUCARO-1;5- LACTONE 
523, 4mqtB, 0.5908, 3.10, 0.086, 121, 93, STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO AND ALLOSTERIC MODULATOR LY2119620
524, 2c4xA, 0.5908, 2.82, 0.102, 246, 88, STRUCTURAL BASIS FOR THE PROMISCUOUS SPECIFICITY OF THE CARBOHYDRATE-BINDING MODULES FROM THE BETA-SANDWICH SUPER FAMILY
525, 2a2qT, 0.5908, 2.50, 0.034, 191, 87, COMPLEX OF ACTIVE-SITE INHIBITED HUMAN COAGULATION FACTOR VIIA WITH HUMAN SOLUBLE TISSUE FACTOR IN THE PRESENCE OF CA2+ MG2+ NA+ AND ZN2+
526, 1jl8A, 0.5908, 2.42, 0.112, 585, 89, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH BETA-CYCLODEXTRIN BASED ON A CO- CRYSTALLIZATION WITH METHYL BETA-CYCLODEXTRIN
527, 6k7oB, 0.5907, 2.98, 0.054, 225, 92, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
528, 6hyfB, 0.5907, 2.75, 0.090, 100, 89, CRYSTAL STRUCTURE OF THE THIRD FNIII DOMAIN FROM RAT BETA4 INTEGRIN; A BINDING SITE FOR PERIAXIN 
529, 4yfgA, 0.5907, 2.51, 0.112, 481, 89, CRYSTAL STRUCTURE OF PTP DELTA MEA3/MEB MINUS VARIANT IG1-FN1
530, 3pdgA, 0.5907, 2.14, 0.134, 91, 82, STRUCTURES OF CLOSTRIDIUM THERMOCELLUM CBHA FIBRONECTIN(III)-LIKE MODULES
531, 6h03A, 0.5906, 3.16, 0.063, 1223, 95, struct.pdbx_descriptor              
532, 5es4G, 0.5906, 3.40, 0.072, 883, 97, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
533, 3km9A, 0.5906, 2.89, 0.075, 1459, 93, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH THE C-TERMINAL BETA-GRASP DOMAIN OF SSL7
534, 1nd0B, 0.5906, 2.94, 0.078, 222, 90, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
535, 6h41A, 0.5905, 3.59, 0.058, 309, 104, STRUCTURE OF THE COMPLEX OF THE IL-5 INHIBITORY PEPTIDE AF17121 BOUND TO THE IL-5 RECEPTOR IL-5RALPHA 
536, 5iusB, 0.5905, 3.04, 0.075, 115, 93, CRYSTAL STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH HIGH AFFINITY PD-1 MUTANT
537, 4nwnF, 0.5905, 3.37, 0.050, 157, 100, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
538, 1yzzB, 0.5905, 2.90, 0.110, 115, 91, HUMANIZED CABAN33 AT ROOM TEMPERATURE
539, 1wzkA, 0.5905, 2.43, 0.112, 585, 89, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT D465N
540, 5oc7C, 0.5904, 2.26, 0.118, 92, 85, CRYSTAL STRUCTURE OF THE PLECKSTRIN-HOMOLOGY DOMAIN OF BCR-ABL IN COMPLEX WITH MONOBODY MB(BCR-PH_4).
541, 5oc7B, 0.5904, 2.22, 0.119, 89, 84, CRYSTAL STRUCTURE OF THE PLECKSTRIN-HOMOLOGY DOMAIN OF BCR-ABL IN COMPLEX WITH MONOBODY MB(BCR-PH_4).
542, 5o4uB, 0.5904, 3.22, 0.061, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
543, 4lasH, 0.5904, 2.85, 0.088, 117, 91, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
544, 3qazf, 0.5904, 3.00, 0.022, 196, 92, IL-2 MUTANT D10 TERNARY COMPLEX
545, 3pjnA, 0.5904, 3.05, 0.063, 158, 95, THE CRYSTAL STRUCTURE OF TP34 BOUND TO ZN(II) ION AT PH 7.5
546, 3k6sE, 0.5904, 3.11, 0.064, 884, 94, STRUCTURE OF INTEGRIN ALPHAXBETA2 ECTODOMAIN
547, 1jf6A, 0.5904, 2.43, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE MUTANT F286Y
548, 6d8gA, 0.5903, 3.25, 0.072, 832, 97, D341A D367A CALCIUM BINDING MUTANT OF BACTEROIDES UNIFORMIS BETA- GLUCURONIDASE 2 
549, 5t99B, 0.5903, 3.28, 0.031, 756, 98, CRYSTAL STRUCTURE OF BUGH2AWT IN COMPLEX WITH GALACTOISOFAGOMINE
550, 6ed1B, 0.5902, 3.20, 0.103, 860, 97, BACTEROIDES DOREI BETA-GLUCURONIDASE 
551, 5o4uD, 0.5902, 3.19, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
552, 4plnD, 0.5902, 2.77, 0.078, 204, 90, CRYSTAL STRUCTURE OF CHICKEN NETRIN-1 (LN-LE3) COMPLEXED WITH MOUSE NEOGENIN (FN4-5)
553, 3gkzA, 0.5902, 2.84, 0.088, 233, 91, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE
554, 1nd0D, 0.5902, 2.94, 0.078, 222, 90, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
555, 1c8pA, 0.5901, 2.76, 0.101, 102, 89, NMR STRUCTURE OF THE LIGAND BINDING DOMAIN OF THE COMMON BETA-CHAIN IN THE GM-CSF IL-3 AND IL-5 RECEPTORS
556, 4yfdA, 0.5900, 2.51, 0.124, 491, 89, CRYSTAL STRUCTURE PTP DELTA IG1-FN2 IN COMPLEX WITH IL-1RACP
557, 3lzrB, 0.5900, 3.42, 0.060, 158, 100, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.73 A AT PH 9 AND MANGANESE PEAK WAVELENGTH (1.893 A)
558, 2d2oB, 0.5900, 2.58, 0.111, 585, 90, STRUCTURE OF A COMPLEX OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 2 WITH MALTOHEXAOSE DEMONSTRATES THE IMPORTANT ROLE OF AROMATIC RESIDUES AT THE REDUCING END OF THE SUBSTRATE BINDING CLEFT
559, 1y6nR, 0.5900, 2.64, 0.067, 202, 90, CRYSTAL STRUCTURE OF EPSTEIN-BARR VIRUS IL-10 MUTANT (A87I) COMPLEXED WITH THE SOLUBLE IL-10R1 CHAIN
560, 1vb9B, 0.5900, 2.58, 0.111, 585, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE II (TVA II) COMPLEXED WITH TRANSGLYCOSYLATED PRODUCT
561, 1nd0F, 0.5900, 2.94, 0.078, 222, 90, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
562, 3d48R, 0.5899, 3.13, 0.096, 195, 94, CRYSTAL STRUCTURE OF A PROLACTIN RECEPTOR ANTAGONIST BOUND TO THE EXTRACELLULAR DOMAIN OF THE PROLACTIN RECEPTOR
563, 2f9bT, 0.5899, 2.48, 0.045, 149, 88, DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS
564, 1nd0H, 0.5899, 2.94, 0.078, 222, 90, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
565, 6ed1A, 0.5898, 3.22, 0.103, 860, 97, BACTEROIDES DOREI BETA-GLUCURONIDASE 
566, 3a6oA, 0.5898, 2.46, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ACARBOSE COMPLEX
567, 3k72C, 0.5897, 3.11, 0.064, 882, 94, STRUCTURE OF INTEGRIN ALPHAX BETA2
568, 3k72A, 0.5897, 3.12, 0.064, 884, 94, STRUCTURE OF INTEGRIN ALPHAX BETA2
569, 3frpA, 0.5897, 3.07, 0.053, 602, 94, CRYSTAL STRUCTURE OF COBRA VENOM FACTOR A CO-FACTOR FOR C3- AND C5 CONVERTASE CVFBB
570, 6bzyH, 0.5896, 3.05, 0.077, 214, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
571, 5o4uN, 0.5896, 3.27, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
572, 5da4A, 0.5896, 3.04, 0.087, 123, 92, STRUCTURE OF A NANOBODY RECOGNIZING THE FUMARATE TRANSPORTER SLC26DG
573, 4nn5C, 0.5896, 2.27, 0.070, 183, 86, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1A
574, 3zl4H, 0.5896, 2.99, 0.077, 231, 91, ANTIBODY STRUCTURAL ORGANIZATION: ROLE OF KAPPA -  LAMBDA CHAIN CONSTANT DOMAIN SWITCH IN CATALYTIC FUNCTIONALITY
575, 3rrqA, 0.5896, 2.92, 0.067, 108, 90, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN PD-1
576, 3k71E, 0.5896, 3.11, 0.064, 882, 94, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
577, 3fl7A, 0.5896, 2.79, 0.101, 482, 89, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 ECTODOMAIN
578, 3a6oB, 0.5896, 2.57, 0.111, 585, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ACARBOSE COMPLEX
579, 1wfnA, 0.5896, 2.76, 0.099, 119, 91, THE FOURTH FN3 DOMAIN OF HUMAN SIDEKICK-2
580, 5da4B, 0.5895, 2.98, 0.088, 123, 91, STRUCTURE OF A NANOBODY RECOGNIZING THE FUMARATE TRANSPORTER SLC26DG
581, 4x7dD, 0.5895, 2.87, 0.088, 121, 91, CRYSTAL STRUCTURE OF 2012 NSW GII.4 P DOMAIN IN COMPLEX WITH NANO-85
582, 3k71C, 0.5895, 3.11, 0.064, 884, 94, STRUCTURE OF INTEGRIN ALPHAX BETA2 ECTODOMAIN
583, 4nwnB, 0.5894, 3.53, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
584, 4jn2H, 0.5894, 2.80, 0.066, 225, 91, AN ANTIDOTE FOR DABIGATRAN
585, 2geeA, 0.5894, 2.71, 0.100, 188, 90, CRYSTAL STRUCTURE OF HUMAN TYPE III FIBRONECTIN EXTRADOMAIN B AND DOMAIN 8
586, 5t98B, 0.5893, 3.29, 0.031, 755, 98, CRYSTAL STRUCTURE OF BUGH2AWT
587, 5i0eB, 0.5893, 2.68, 0.046, 703, 87, CYCLOALTERNAN-DEGRADING ENZYME FROM TRUEPERELLA PYOGENES IN COMPLEX WITH ISOMALTOSE
588, 5eh1A, 0.5893, 3.11, 0.043, 209, 93, CRYSTAL STRUCTURE OF THE EXTRACELLULAR PART OF RECEPTOR 2 OF HUMAN INTERFERON GAMMA
589, 4gqpH, 0.5893, 2.85, 0.088, 229, 91, STRUCTURE BASED DESIGN OF SUB-NANOMOLAR AFFINITY ANTI-METHAMPHETAMINE SINGLE CHAIN ANTIBODIES.
590, 4gh7D, 0.5893, 2.64, 0.044, 278, 90, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
591, 2xwbA, 0.5893, 3.25, 0.042, 640, 95, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
592, 2ic2B, 0.5893, 2.77, 0.088, 111, 91, CRYSTAL STRUCTURE OF THE FIRST FNIII DOMAIN OF IHOG
593, 1vfuB, 0.5893, 2.43, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 AMYLASE 2/GAMMA-CYCLODEXTRIN COMPLEX
594, 5lknA, 0.5892, 2.74, 0.132, 103, 91, NMR SOLUTION STRUCTURE OF HUMAN FNIII DOMAIN 2 OF NCAM
595, 4nwnN, 0.5892, 3.54, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
596, 4mj4A, 0.5892, 2.78, 0.067, 603, 90, HUMAN IDURONIDASE APO STRUCTURE P21 FORM
597, 4i18R, 0.5892, 2.80, 0.089, 205, 90, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
598, 3lzqB, 0.5892, 3.42, 0.060, 159, 100, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.41 A AT PH 9
599, 4nwnR, 0.5891, 3.54, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
600, 3t4aD, 0.5891, 3.36, 0.042, 633, 96, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
601, 3lzlB, 0.5891, 3.42, 0.060, 158, 100, CRYSTAL STRUCTURE ANALYSIS OF THE AS-SOLATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.45 A AT PH 9.0
602, 5mwnE, 0.5890, 2.98, 0.087, 119, 92, STRUCTURE OF THE EAEC T6SS COMPONENT TSSK N-TERMINAL DOMAIN IN COMPLEX WITH LLAMA NANOBODIES NBK18 AND NBK27
603, 2b39A, 0.5890, 3.21, 0.042, 1610, 95, STRUCTURE OF MAMMALIAN C3 WITH AN INTACT THIOESTER AT 3A RESOLUTION
604, 1tfhA, 0.5890, 2.77, 0.034, 202, 89, EXTRACELLULAR DOMAIN OF HUMAN TISSUE FACTOR
605, 3t4aA, 0.5889, 3.36, 0.042, 633, 96, STRUCTURE OF A TRUNCATED FORM OF STAPHYLOCOCCAL COMPLEMENT INHIBITOR B BOUND TO HUMAN C3C AT 3.4 ANGSTROM RESOLUTION
606, 6b24C, 0.5888, 2.39, 0.116, 96, 86, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80Y MUTANT
607, 5o4uH, 0.5888, 3.31, 0.040, 207, 99, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
608, 5i0vB, 0.5888, 3.35, 0.061, 157, 99, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER OXIDIZING CONDITIONS
609, 5da4C, 0.5888, 3.05, 0.098, 123, 92, STRUCTURE OF A NANOBODY RECOGNIZING THE FUMARATE TRANSPORTER SLC26DG
610, 4eiuA, 0.5888, 2.88, 0.152, 238, 92, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACUNI_03093) FROM BACTEROIDES UNIFORMIS ATCC 8492 AT 1.90 A RESOLUTION
611, 3mx0C, 0.5888, 2.79, 0.112, 406, 89, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
612, 3k2mD, 0.5888, 2.58, 0.090, 101, 89, CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX
613, 4k0vA, 0.5887, 2.59, 0.056, 514, 90, STRUCTURAL BASIS FOR ANGIOPOIETIN-1 MEDIATED SIGNALING INITIATION
614, 3v9fC, 0.5887, 3.26, 0.118, 731, 93, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE PUTATIVE HYBRID TWO COMPONENT SYSTEM BT3049 FROM B. THETAIOTAOMICRON
615, 1yc8B, 0.5887, 2.84, 0.100, 112, 90, CABAN33- Y37V/E44G/R45L TRIPLE MUTANT
616, 1wzlA, 0.5887, 2.43, 0.112, 585, 89, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L
617, 1lqsS, 0.5886, 2.64, 0.067, 206, 90, CRYSTAL STRUCTURE OF HUMAN CYTOMEGALOVIRUS IL-10 BOUND TO SOLUBLE HUMAN IL-10R1
618, 1ji2A, 0.5886, 2.43, 0.112, 585, 89, IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2
619, 4nwnH, 0.5885, 3.44, 0.060, 157, 100, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
620, 1j0iB, 0.5885, 2.66, 0.044, 588, 91, CRYSTAL STRUCTURE OF NEOPULLULANASE COMPLEX WITH PANOSE
621, 5nstD, 0.5884, 2.44, 0.080, 322, 87, HUMAN MONOCLONAL ANTIBODY WITH A LAIR1 INSERTION
622, 4wtxA, 0.5884, 2.71, 0.088, 97, 91, CRYSTAL STRUCTURE OF THE FOURTH FNIII DOMAIN OF INTEGRIN BETA4
623, 4mqsB, 0.5884, 3.06, 0.054, 121, 93, STRUCTURE OF ACTIVE HUMAN M2 MUSCARINIC ACETYLCHOLINE RECEPTOR BOUND TO THE AGONIST IPEROXO
624, 2ekjA, 0.5884, 2.46, 0.125, 105, 88, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN COLLAGEN ALPHA-1(XX) CHAIN
625, 1bvzA, 0.5884, 2.45, 0.112, 585, 89, ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R- 47
626, 3v9fB, 0.5883, 3.26, 0.118, 731, 93, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE PUTATIVE HYBRID TWO COMPONENT SYSTEM BT3049 FROM B. THETAIOTAOMICRON
627, 3qazH, 0.5883, 2.94, 0.033, 196, 91, IL-2 MUTANT D10 TERNARY COMPLEX
628, 3lzoA, 0.5883, 3.44, 0.060, 159, 100, CRYSTAL STRUCTURE ANALYSIS OF THE COPPER-RECONSTITUTED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 10.0
629, 3baeH, 0.5883, 2.93, 0.078, 219, 90, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
630, 2q7nA, 0.5883, 2.82, 0.055, 480, 91, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)
631, 2a74A, 0.5883, 3.27, 0.042, 630, 95, HUMAN COMPLEMENT COMPONENT C3C
632, 1jf6B, 0.5883, 2.58, 0.111, 585, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE MUTANT F286Y
633, 6ch8Q, 0.5882, 2.97, 0.066, 228, 91, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
634, 4nwnP, 0.5882, 3.53, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
635, 3pjnB, 0.5882, 3.09, 0.063, 157, 95, THE CRYSTAL STRUCTURE OF TP34 BOUND TO ZN(II) ION AT PH 7.5
636, 2votA, 0.5882, 3.15, 0.031, 837, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
637, 1vfmB, 0.5882, 2.44, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX
638, 6df3H, 0.5881, 2.53, 0.034, 190, 89, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF IL-24 WITH SOLUBLE RECEPTORS IL-22RA AND IL-20RB 
639, 4gh7B, 0.5881, 2.85, 0.132, 275, 91, CRYSTAL STRUCTURE OF ANTICALIN N7A IN COMPLEX WITH ONCOFETAL FIBRONECTIN FRAGMENT FN7B8
640, 3qazT, 0.5881, 2.92, 0.033, 196, 91, IL-2 MUTANT D10 TERNARY COMPLEX
641, 3pjlB, 0.5881, 3.15, 0.062, 157, 96, THE CRYSTAL STRUCTURE OF TP34 BOUND TO CO (II) ION AT PH 7.5
642, 6bx5C, 0.5880, 2.41, 0.116, 97, 86, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S12
643, 5es4E, 0.5880, 3.14, 0.064, 884, 94, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
644, 3teuA, 0.5880, 2.46, 0.148, 98, 88, CRYSTAL STRUCTURE OF FIBCON
645, 3rp1D, 0.5880, 2.27, 0.082, 97, 85, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
646, 6gjqH, 0.5879, 2.85, 0.067, 121, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
647, 6ed1C, 0.5879, 3.22, 0.093, 860, 97, BACTEROIDES DOREI BETA-GLUCURONIDASE 
648, 3lzoB, 0.5879, 3.45, 0.060, 159, 100, CRYSTAL STRUCTURE ANALYSIS OF THE COPPER-RECONSTITUTED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 10.0
649, 1fnfA, 0.5879, 2.43, 0.138, 368, 87, FRAGMENT OF HUMAN FIBRONECTIN ENCOMPASSING TYPE-III REPEATS 7 THROUGH 10
650, 5i0wB, 0.5878, 3.37, 0.061, 157, 99, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER REDUCING CONDITIONS
651, 5ecjE, 0.5878, 2.26, 0.106, 93, 85, CRYSTAL STRUCTURE OF MONOBODY MB(S4) BOUND TO PRDM14 IN COMPLEX WITH MTGR1
652, 4nwnD, 0.5878, 3.39, 0.050, 157, 100, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
653, 4fxtI, 0.5878, 2.81, 0.097, 189, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
654, 3gm0A, 0.5877, 2.87, 0.088, 237, 91, ANTI-METHAMPHETAMINE SINGLE CHAIN FV IN COMPLEX WITH MDMA
655, 6jbtF, 0.5876, 3.15, 0.086, 111, 93, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
656, 5o4uP, 0.5876, 3.32, 0.040, 207, 99, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
657, 5o4uJ, 0.5876, 3.30, 0.040, 207, 99, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
658, 4yg8A, 0.5876, 2.46, 0.069, 276, 87, CRYSTAL STRUCTURE OF THE CHS5-CHS6 EXOMER CARGO ADAPTOR COMPLEX
659, 2o6eA, 0.5876, 3.26, 0.062, 158, 97, STRUCTURE OF NATIVE RTP34 FROM TREPONEMA PALLIDUM FROM ZINC-SOAKED CRYSTALS
660, 2je8A, 0.5876, 3.17, 0.052, 837, 96, STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON
661, 5hx2A, 0.5875, 2.42, 0.080, 1030, 87, IN VITRO ASSEMBLED STAR-SHAPED HUBLESS T4 BASEPLATE
662, 2vl4A, 0.5875, 3.18, 0.052, 836, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
663, 2b39B, 0.5875, 3.22, 0.042, 1610, 95, STRUCTURE OF MAMMALIAN C3 WITH AN INTACT THIOESTER AT 3A RESOLUTION
664, 1vfoB, 0.5875, 2.57, 0.111, 585, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/BETA-CYCLODEXTRIN COMPLEX
665, 1jibB, 0.5875, 2.60, 0.111, 585, 90, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH MALTOTETRAOSE BASED ON A CRYSTAL SOAKED WITH MALTOHEXAOSE.
666, 1f58H, 0.5875, 3.03, 0.055, 228, 91, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 24-RESIDUE PEPTIDE (RESIDUES 308-333 OF HIV-1 GP120 (MN ISOLATE) WITH ALA TO AIB SUBSTITUTION AT POSITION 323
667, 5o4uM, 0.5874, 3.29, 0.051, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
668, 4nwnL, 0.5874, 3.56, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
669, 2vo5A, 0.5874, 3.18, 0.052, 833, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
670, 1jf5A, 0.5874, 2.45, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2 MUTANT F286A
671, 1bvzB, 0.5874, 2.45, 0.112, 585, 89, ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R- 47
672, 4plnC, 0.5873, 2.80, 0.078, 205, 90, CRYSTAL STRUCTURE OF CHICKEN NETRIN-1 (LN-LE3) COMPLEXED WITH MOUSE NEOGENIN (FN4-5)
673, 3lzpA, 0.5873, 3.43, 0.060, 159, 100, CRYSTAL STRUCTURE ANALYSIS OF THE  AS-ISOLATED  P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 9.0
674, 3hhsA, 0.5873, 3.93, 0.067, 668, 104, CRYSTAL STRUCTURE OF MANDUCA SEXTA PROPHENOLOXIDASE
675, 3csbA, 0.5873, 2.62, 0.122, 464, 90, CRYSTAL STRUCTURE OF MONOBODY YSX1/MALTOSE BINDING PROTEIN FUSION COMPLEX
676, 3bkjH, 0.5873, 2.93, 0.078, 224, 90, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
677, 2vr4A, 0.5873, 3.15, 0.031, 835, 96, TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE
678, 2o6eB, 0.5873, 3.15, 0.062, 157, 96, STRUCTURE OF NATIVE RTP34 FROM TREPONEMA PALLIDUM FROM ZINC-SOAKED CRYSTALS
679, 1wzmB, 0.5873, 2.42, 0.112, 585, 89, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469K
680, 1ji2B, 0.5873, 2.45, 0.112, 585, 89, IMPROVED X-RAY STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2
681, 6h7lC, 0.5872, 2.86, 0.067, 120, 90, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST DOBUTAMINE AND NANOBODY NB6B9 
682, 6b2bD, 0.5872, 2.47, 0.115, 96, 87, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83M MUTANT
683, 5ud9H, 0.5872, 3.03, 0.065, 227, 92, CRYSTAL STRUCTURE OF 354BG18 FAB
684, 5kbnC, 0.5872, 2.40, 0.128, 96, 86, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT
685, 5hnoB, 0.5872, 3.13, 0.042, 168, 95, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
686, 3qazI, 0.5872, 2.27, 0.095, 188, 84, IL-2 MUTANT D10 TERNARY COMPLEX
687, 3d0lB, 0.5872, 3.02, 0.066, 218, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671
688, 1jl8B, 0.5872, 2.49, 0.112, 585, 89, COMPLEX OF ALPHA-AMYLASE II (TVA II) FROM THERMOACTINOMYCES VULGARIS R-47 WITH BETA-CYCLODEXTRIN BASED ON A CO- CRYSTALLIZATION WITH METHYL BETA-CYCLODEXTRIN
689, 6b2dD, 0.5871, 2.45, 0.115, 96, 87, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 T114S MUTANT
690, 5jipB, 0.5871, 2.53, 0.080, 314, 87, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS SPORE CORTEX LYTIC ENZYME SLEM
691, 5i0wA, 0.5871, 3.44, 0.060, 159, 100, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER REDUCING CONDITIONS
692, 1qr4A, 0.5871, 2.51, 0.091, 175, 88, TWO FIBRONECTIN TYPE-III DOMAIN SEGMENT FROM CHICKEN TENASCIN
693, 6cmxA, 0.5870, 3.53, 0.059, 1300, 101, HUMAN TENEURIN 2 EXTRA-CELLULAR REGION 
694, 1wzkB, 0.5870, 2.45, 0.112, 585, 89, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT D465N
695, 5hnoC, 0.5869, 3.15, 0.042, 166, 95, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
696, 3bkmH, 0.5869, 2.94, 0.078, 224, 90, STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A P212121)
697, 2f58H, 0.5869, 3.05, 0.055, 228, 91, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
698, 6gjqF, 0.5868, 2.86, 0.067, 121, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
699, 4nwnX, 0.5868, 3.54, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
700, 4fxtL, 0.5868, 2.82, 0.097, 189, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
701, 4fxtD, 0.5868, 2.83, 0.097, 190, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
702, 3qazZ, 0.5868, 3.03, 0.022, 196, 92, IL-2 MUTANT D10 TERNARY COMPLEX
703, 3egsB, 0.5868, 3.01, 0.066, 216, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671 SOAKED IN AMMONIUM SULFATE
704, 1wzlB, 0.5868, 2.45, 0.112, 585, 89, THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE II (TVA II) MUTATNT R469L
705, 1ncwH, 0.5868, 2.99, 0.077, 222, 91, CATIONIC CYCLIZATION ANTIBODY 4C6 IN COMPLEX WITH BENZOIC ACID
706, 5xj3C, 0.5867, 2.78, 0.033, 115, 92, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
707, 5i0vA, 0.5867, 3.44, 0.060, 159, 100, IRON AND COPPER-BOUND P19 FROM CAMPYLOBACTER JEJUNI UNDER OXIDIZING CONDITIONS
708, 3qazW, 0.5867, 2.93, 0.033, 196, 91, IL-2 MUTANT D10 TERNARY COMPLEX
709, 3lznA, 0.5867, 3.44, 0.060, 158, 100, CRYSTAL STRUCTURE ANALYSIS OF THE APO P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.59 A AT PH 9
710, 1vfmA, 0.5867, 2.45, 0.112, 585, 89, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2/ALPHA-CYCLODEXTRIN COMPLEX
711, 1jf5B, 0.5867, 2.58, 0.111, 585, 90, CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA- AMYLASE 2 MUTANT F286A
712, 6h7lD, 0.5866, 2.86, 0.067, 120, 90, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST DOBUTAMINE AND NANOBODY NB6B9 
713, 6h3uI, 0.5866, 3.17, 0.054, 122, 92, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
714, 6b2aD, 0.5866, 2.46, 0.115, 96, 87, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80M MUTANT
715, 6b2aC, 0.5866, 2.46, 0.115, 96, 87, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80M MUTANT
716, 5komD, 0.5866, 2.45, 0.115, 96, 87, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83I MUTANT
717, 5o4uA, 0.5865, 3.21, 0.082, 207, 97, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
718, 4nwnV, 0.5865, 3.58, 0.069, 157, 101, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
719, 3qazK, 0.5865, 3.04, 0.022, 196, 92, IL-2 MUTANT D10 TERNARY COMPLEX
720, 3lzpB, 0.5865, 3.38, 0.061, 158, 99, CRYSTAL STRUCTURE ANALYSIS OF THE  AS-ISOLATED  P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.65 A AT PH 9.0
721, 6iblD, 0.5864, 2.85, 0.067, 120, 90, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
722, 5dwuB, 0.5864, 2.85, 0.103, 181, 87, BETA COMMON RECEPTOR IN COMPLEX WITH A FAB
723, 4lhjB, 0.5864, 2.92, 0.066, 120, 91, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH5)
724, 4j2qA, 0.5864, 3.21, 0.124, 340, 97, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
725, 6bx5D, 0.5863, 2.22, 0.107, 95, 84, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S12
726, 4jn1H, 0.5863, 3.01, 0.065, 225, 92, AN ANTIDOTE FOR DABIGATRAN
727, 4hs6H, 0.5863, 3.06, 0.065, 215, 92, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
728, 2qkiD, 0.5863, 3.42, 0.042, 632, 96, HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN
729, 2i07A, 0.5863, 3.16, 0.043, 630, 94, HUMAN COMPLEMENT COMPONENT C3B
730, 1rukH, 0.5863, 3.00, 0.077, 222, 91, CRYSTAL STRUCTURE (C) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1
731, 6bzwG, 0.5862, 3.01, 0.056, 219, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
732, 5o4uI, 0.5862, 3.22, 0.041, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
733, 4fxtG, 0.5862, 2.83, 0.097, 194, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
734, 3qwqB, 0.5862, 2.33, 0.118, 100, 85, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH AN ADNECTIN
735, 3lzlA, 0.5862, 3.44, 0.060, 157, 100, CRYSTAL STRUCTURE ANALYSIS OF THE AS-SOLATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.45 A AT PH 9.0
736, 3droB, 0.5862, 2.94, 0.067, 216, 90, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN GROWN IN AMMONIUM SULFATE
737, 2wbkA, 0.5862, 3.20, 0.052, 837, 96, STRUCTURE OF THE MICHAELIS COMPLEX OF BETA-MANNOSIDASE MAN2A PROVIDES INSIGHT INTO THE CONFORMATIONAL ITINERARY OF MANNOSIDE HYDROLYSIS
738, 1yc8A, 0.5862, 3.00, 0.076, 116, 92, CABAN33- Y37V/E44G/R45L TRIPLE MUTANT
739, 6gjqB, 0.5861, 2.87, 0.067, 121, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
740, 6b2dC, 0.5861, 2.47, 0.115, 96, 87, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 T114S MUTANT
741, 5hnoA, 0.5861, 3.15, 0.053, 164, 95, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
742, 4fxtK, 0.5861, 2.87, 0.097, 191, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
743, 3qazi, 0.5861, 3.04, 0.022, 196, 92, IL-2 MUTANT D10 TERNARY COMPLEX
744, 3f58H, 0.5861, 3.08, 0.055, 228, 91, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
745, 3drtB, 0.5861, 3.01, 0.066, 216, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 SCRAMBLEDFP-MPER SCRHYB3K CONSTRUCT GIGAFGLLGFLAAGSKK-AHX-K656NEQELLELDKWASLWN671
746, 2qkiA, 0.5861, 3.25, 0.043, 631, 94, HUMAN C3C IN COMPLEX WITH THE INHIBITOR COMPSTATIN
747, 1j0hB, 0.5861, 2.70, 0.044, 588, 91, CRYSTAL STRUCTURE OF BACILLUS STEAROTHERMOPHILUS NEOPULLULANASE
748, 5hnpA, 0.5860, 3.14, 0.063, 161, 95, THE STRUCTURE OF THE KDO-CAPPED SACCHARIDE BINDING SUBUNIT OF THE O-12 SPECIFIC ABC TRANSPORTER WZT
749, 3aazH, 0.5860, 3.10, 0.077, 229, 91, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
750, 2p8mB, 0.5860, 3.03, 0.066, 217, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN IN NEW CRYSTAL FORM
751, 2o6dB, 0.5860, 3.17, 0.062, 157, 96, STRUCTURE OF NATIVE RTP34 FROM TREPONEMA PALLIDUM
752, 6h7kD, 0.5859, 2.94, 0.077, 120, 91, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
753, 5vcoB, 0.5859, 2.99, 0.078, 215, 90, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
754, 5o4uO, 0.5859, 3.31, 0.040, 207, 99, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
755, 4pp2B, 0.5859, 2.99, 0.078, 215, 90, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
756, 4ni6A, 0.5859, 3.47, 0.115, 138, 96, REPEAT DOMAIN 1 OF CLOSTRIDIUM PERFRINGENS CPE0147
757, 4fxtN, 0.5859, 2.83, 0.097, 186, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
758, 4fxtA, 0.5859, 2.83, 0.097, 191, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
759, 3ifoH, 0.5859, 3.13, 0.065, 216, 92, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
760, 3fn9B, 0.5859, 3.32, 0.073, 672, 96, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
761, 1rupH, 0.5859, 2.99, 0.066, 222, 91, CRYSTAL STRUCTURE (G) OF NATIVE CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT APS BEAMLINE 19-ID
762, 1g1yB, 0.5859, 2.47, 0.112, 585, 89, CRYSTAL STRUCTURE OF ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47 AND BETA-CYCLODEXTRIN COMPLEX
763, 1ea9C, 0.5859, 2.62, 0.078, 583, 90, CYCLOMALTODEXTRINASE
764, 1bj8A, 0.5859, 2.97, 0.110, 109, 91, THIRD N-TERMINAL DOMAIN OF GP130 NMR MINIMIZED AVERAGE STRUCTURE
765, 6qtlD, 0.5858, 3.05, 0.054, 118, 92, CAFFEINE RECOGNIZING NANOBODY 
766, 4jmhA, 0.5858, 2.76, 0.101, 200, 89, CRYSTAL STRUCTURE OF SYNTHETIC PROTEIN IN COMPLEX WITH DOUBLE PY PEPTIDE
767, 3qhfH, 0.5858, 2.93, 0.044, 225, 90, CRYSTAL STRUCTURE OF FAB DEL2D1 A DELETION VARIANT OF ANTI-INFLUENZA ANTIBODY 2D1
768, 3fn9D, 0.5858, 3.32, 0.073, 666, 96, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
769, 3drqB, 0.5857, 3.03, 0.066, 216, 91, CRYSTAL STRUCTURE OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH THE GP41 FP-MPER HYB3K CONSTRUCT 514GIGALFLGFLGAAGS528KK-AHX-655KNEQELLELDKWASLWN671 SOAKED IN PEG/2- PROPANOL SOLUTION
770, 2o6fB, 0.5857, 3.17, 0.062, 157, 96, STRUCTURE OF METAL- FREE RTP34 FROM TREPONEMA PALLIDUM
771, 6bx4C, 0.5856, 2.48, 0.115, 96, 87, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S9
772, 6b2bC, 0.5856, 2.49, 0.115, 96, 87, CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83M MUTANT
773, 4g6aH, 0.5856, 2.98, 0.056, 221, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
774, 3lzqA, 0.5856, 3.45, 0.060, 157, 100, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.41 A AT PH 9
775, 5xj3L, 0.5855, 2.88, 0.032, 115, 93, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
776, 5n48D, 0.5855, 2.57, 0.091, 93, 88, STRUCTURE OF ANTICALIN N9B IN COMPLEX WITH EXTRA-DOMAIN B OF HUMAN ONCOFETAL FIBRONECTIN
777, 3lzrA, 0.5855, 3.44, 0.060, 158, 100, CRYSTAL STRUCTURE ANALYSIS OF MANGANESE TREATED P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 2.73 A AT PH 9 AND MANGANESE PEAK WAVELENGTH (1.893 A)
778, 5vcoD, 0.5854, 3.07, 0.077, 219, 91, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
779, 4pp2D, 0.5854, 3.07, 0.077, 219, 91, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
780, 4mmxC, 0.5854, 2.47, 0.138, 93, 87, INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN
781, 3idiB, 0.5854, 3.02, 0.066, 217, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ALDKWNQ
782, 2vtfA, 0.5854, 2.63, 0.103, 616, 87, X-RAY CRYSTAL STRUCTURE OF THE ENDO-BETA-N- ACETYLGLUCOSAMINIDASE FROM ARTHROBACTER PROTOPHORMIAE E173Q MUTANT REVEALS A TIM BARREL CATALYTIC DOMAIN AND TWO ANCILLARY DOMAINS
783, 2a74D, 0.5854, 3.25, 0.042, 633, 95, HUMAN COMPLEMENT COMPONENT C3C
784, 1ogpD, 0.5854, 2.38, 0.094, 388, 85, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
785, 5fo9A, 0.5853, 3.17, 0.043, 642, 94, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH CR1 (CCP15-17)
786, 4fxtM, 0.5853, 2.84, 0.097, 193, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
787, 6k7oF, 0.5852, 3.17, 0.043, 225, 93, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
788, 6ehgA, 0.5852, 3.15, 0.043, 638, 94, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
789, 6bzvE, 0.5852, 2.98, 0.056, 218, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
790, 5xj3I, 0.5852, 2.88, 0.032, 115, 93, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
791, 5komC, 0.5852, 2.48, 0.115, 96, 87, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F83I MUTANT
792, 4fxtH, 0.5852, 2.89, 0.096, 194, 94, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
793, 1ogpC, 0.5852, 2.38, 0.094, 388, 85, THE CRYSTAL STRUCTURE OF PLANT SULFITE OXIDASE PROVIDES INSIGHT INTO SULFITE OXIDATION IN PLANTS AND ANIMALS
794, 1mfnA, 0.5852, 2.51, 0.102, 184, 88, SOLUTION NMR STRUCTURE OF LINKED CELL ATTACHMENT MODULES OF MOUSE FIBRONECTIN CONTAINING THE RGD AND SYNERGY REGIONS 20 STRUCTURES
795, 6h7oC, 0.5851, 2.95, 0.077, 120, 91, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND WEAK PARTIAL AGONIST CYANOPINDOLOL AND NANOBODY NB6B9 
796, 5jpmA, 0.5851, 3.72, 0.040, 651, 100, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
797, 5iv5Z, 0.5851, 2.33, 0.093, 1004, 86, 
798, 5iv5WA, 0.5851, 2.33, 0.093, 1004, 86, 
799, 5iv5TB, 0.5851, 2.33, 0.093, 1004, 86, 
800, 5iv5QC, 0.5851, 2.33, 0.093, 1004, 86, 
801, 5iv5ND, 0.5851, 2.33, 0.093, 1004, 86, 
802, 5iv5C, 0.5851, 2.33, 0.093, 1004, 86, 
803, 4q66A, 0.5851, 2.36, 0.058, 226, 86, STRUCTURE OF EXOMER BOUND TO ARF1.
804, 4fxtE, 0.5851, 2.83, 0.097, 200, 93, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
805, 3ifnH, 0.5851, 2.97, 0.055, 215, 91, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-40:12A11) COMPLEX
806, 2vjxA, 0.5851, 3.15, 0.042, 836, 95, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
807, 1cf1D, 0.5851, 3.31, 0.125, 368, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
808, 5myaA, 0.5850, 2.86, 0.033, 292, 91, HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 1-3 IN SPACE GROUP C2
809, 4ocxH, 0.5850, 3.01, 0.067, 210, 90, FAB COMPLEX WITH METHOTREXATE
810, 2pr4H, 0.5850, 3.03, 0.066, 218, 91, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
811, 2f5aH, 0.5850, 3.03, 0.066, 228, 91, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5
812, 2b5iB, 0.5850, 3.05, 0.022, 196, 92, CYTOKINE RECEPTOR COMPLEX
813, 6bzwA, 0.5849, 3.04, 0.056, 219, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
814, 6bx4D, 0.5849, 2.48, 0.115, 96, 87, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 WITH MONOBODY S9
815, 5m30E, 0.5849, 3.00, 0.087, 123, 92, STRUCTURE OF TSSK FROM T6SS EAEC IN COMPLEX WITH NANOBODY NB18
816, 4fxtF, 0.5849, 2.90, 0.096, 195, 94, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
817, 4fxtC, 0.5849, 2.89, 0.096, 189, 94, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
818, 6bzwC, 0.5848, 3.04, 0.056, 218, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
819, 3wcyA, 0.5848, 2.75, 0.080, 318, 88, MURINE IFNAR1 IN COMPLEX WITH INTERFERON-BETA
820, 3lznB, 0.5848, 3.43, 0.050, 158, 100, CRYSTAL STRUCTURE ANALYSIS OF THE APO P19 PROTEIN FROM CAMPYLOBACTER JEJUNI AT 1.59 A AT PH 9
821, 2a73A, 0.5848, 3.22, 0.042, 635, 95, HUMAN COMPLEMENT COMPONENT C3
822, 6cxyH, 0.5847, 3.08, 0.066, 210, 91, CRYSTAL STRUCTURE OF HUMAN E-CADHERIN BOUND BY MOUSE MONOCLONAL ANTIBODY FAB MAB-1_19A11 
823, 4fxtJ, 0.5847, 2.90, 0.096, 195, 94, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
824, 3ifoA, 0.5847, 3.14, 0.077, 216, 91, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
825, 5n47B, 0.5846, 2.54, 0.092, 183, 87, STRUCTURE OF ANTICALIN N7E IN COMPLEX WITH THE THREE-DOMAIN FRAGMENT FN7B8 OF HUMAN ONCOFETAL FIBRONECTIN
826, 5kbnD, 0.5846, 2.48, 0.115, 96, 87, THE CRYSTAL STRUCTURE OF FLUORIDE CHANNEL FLUC EC2 F80I MUTANT
827, 5es4C, 0.5846, 3.15, 0.074, 884, 95, RE-REFINEMENT OF INTEGRIN ALPHAXBETA2 ECTODOMAIN IN THE CLOSED/BENT CONFORMATION
828, 5b71D, 0.5846, 2.97, 0.088, 219, 91, CRYSTAL STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SKY59
829, 4x7cD, 0.5846, 2.81, 0.044, 119, 90, CRYSTAL STRUCTURE OF SAGA-2006 GII.4 P DOMAIN IN COMPLEX WITH NANO-85
830, 3bkcH, 0.5846, 2.94, 0.078, 224, 90, CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21 FORMB)
831, 2vjxB, 0.5846, 3.20, 0.031, 839, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
832, 6h3uH, 0.5845, 3.01, 0.067, 121, 90, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
833, 6gjqD, 0.5845, 2.93, 0.077, 121, 91, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODY T27 
834, 5xwtA, 0.5845, 2.27, 0.118, 382, 85, CRYSTAL STRUCTURE OF PTPDELTA IG1-FN1 IN COMPLEX WITH SALM5 LRR-IG 
835, 4ztpH, 0.5845, 2.98, 0.077, 223, 91, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
836, 2vqtA, 0.5845, 3.13, 0.042, 836, 95, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
837, 4nwnJ, 0.5844, 3.47, 0.060, 157, 100, COMPUTATIONALLY DESIGNED TWO-COMPONENT SELF-ASSEMBLING TETRAHEDRAL CAGE T32-28
838, 3rp1B, 0.5844, 2.39, 0.081, 97, 86, CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP
839, 3idnB, 0.5844, 3.05, 0.066, 215, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(PAF)WAS
840, 1ayrC, 0.5844, 3.23, 0.125, 368, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
841, 1ayrA, 0.5844, 3.23, 0.125, 368, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
842, 4hc1M, 0.5843, 3.03, 0.055, 220, 91, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
843, 2erjF, 0.5843, 2.94, 0.033, 201, 91, CRYSTAL STRUCTURE OF THE HETEROTRIMERIC INTERLEUKIN-2 RECEPTOR IN COMPLEX WITH INTERLEUKIN-2
844, 1rumH, 0.5843, 3.15, 0.065, 222, 92, CRYSTAL STRUCTURE (F) OF H2O2-SOAKED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 8.5 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9-1.
845, 6bzvG, 0.5842, 2.96, 0.056, 221, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
846, 4ocyH, 0.5842, 3.05, 0.067, 210, 90, FAB FOR METHOTREXATE (UNBOUND APO)
847, 4kgjA, 0.5842, 2.80, 0.067, 595, 89, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 5-FLUORO- ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE
848, 3qazF, 0.5842, 2.39, 0.094, 186, 85, IL-2 MUTANT D10 TERNARY COMPLEX
849, 3qazC, 0.5842, 2.29, 0.107, 188, 84, IL-2 MUTANT D10 TERNARY COMPLEX
850, 3besR, 0.5842, 2.90, 0.044, 250, 91, STRUCTURE OF A POXVIRUS IFNGBP/IFNG COMPLEX
851, 2vr4B, 0.5842, 3.23, 0.052, 841, 96, TRANSITION-STATE MIMICRY IN MANNOSIDE HYDROLYSIS: CHARACTERISATION OF TWENTY SIX INHIBITORS AND INSIGHT INTO BINDING FROM LINEAR FREE ENERGY RELATIONSHIPS AND 3-D STRUCTURE
852, 2vquB, 0.5842, 3.23, 0.052, 840, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
853, 6h7jC, 0.5841, 2.79, 0.067, 119, 89, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST ISOPRENALINE AND NANOBODY NB80 
854, 6e3kE, 0.5841, 2.63, 0.080, 213, 88, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
855, 5mwnD, 0.5841, 2.89, 0.132, 119, 91, STRUCTURE OF THE EAEC T6SS COMPONENT TSSK N-TERMINAL DOMAIN IN COMPLEX WITH LLAMA NANOBODIES NBK18 AND NBK27
856, 5fo7A, 0.5841, 3.12, 0.043, 637, 94, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B AT 2.8 ANGSTROM RESOLUTION
857, 4nn6C, 0.5841, 2.10, 0.072, 163, 83, CYTOKINE RECEPTOR COMPLEX - CRYSTAL FORM 1B
858, 3b4nB, 0.5841, 2.53, 0.071, 314, 85, CRYSTAL STRUCTURE ANALYSIS OF PECTATE LYASE PELI FROM ERWINIA CHRYSANTHEMI
859, 2vmfB, 0.5841, 3.23, 0.052, 840, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
860, 2vl4B, 0.5841, 3.22, 0.052, 841, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
861, 6h7oD, 0.5840, 3.09, 0.076, 121, 92, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND WEAK PARTIAL AGONIST CYANOPINDOLOL AND NANOBODY NB6B9 
862, 6gkdS, 0.5840, 2.88, 0.100, 123, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
863, 6bzwE, 0.5840, 3.03, 0.056, 219, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
864, 3moaH, 0.5840, 3.10, 0.066, 236, 91, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE
865, 2vmfA, 0.5840, 3.14, 0.042, 835, 95, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
866, 6i60B, 0.5839, 2.99, 0.065, 886, 92, STRUCTURE OF ALPHA-L-RHAMNOSIDASE FROM DICTYOGLUMUS THERMOPHILUM 
867, 3idgB, 0.5839, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWD
868, 3e0gA, 0.5839, 2.84, 0.055, 479, 91, STRUCTURE OF THE LEUKEMIA INHIBITORY FACTOR RECEPTOR (LIF-R) DOMAINS D1-D5
869, 1fg9D, 0.5839, 2.63, 0.092, 205, 87, 3:1 COMPLEX OF INTERFERON-GAMMA RECEPTOR WITH INTERFERON- GAMMA DIMER
870, 4ogxH, 0.5838, 3.12, 0.065, 216, 92, CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.4 ANGSTROM RESOLUTION
871, 4m7lT, 0.5838, 2.28, 0.024, 194, 84, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
872, 1u95B, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDHWAS
873, 1u93B, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG EQDKW- [DAP]-S (CYCLIC)
874, 1u92B, 0.5838, 3.06, 0.066, 224, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG E-[DAP]- DKWQS (CYCLIC)
875, 1u91B, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ANALOG ENDKW- [DAP]-S (CYCLIC)
876, 1u8qB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELEKWAS
877, 1u8pB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ECDKWCS
878, 1u8oB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKHAS
879, 1u8nB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKFAS
880, 1u8mB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKYAS
881, 1u8lB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE DLDRWAS
882, 1u8jB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAG
883, 1u8iB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWAN
884, 1u8hB, 0.5838, 3.06, 0.066, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ALDKWAS
885, 4gayH, 0.5837, 3.04, 0.056, 212, 90, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
886, 2f5bH, 0.5837, 3.05, 0.066, 231, 91, CRYSTAL STRUCTURE OF FAB  FROM THE HIV-1 NEUTRALIZING ANTIBODY 2F5 IN COMPLEX WITH ITS GP41 EPITOPE
887, 1g1yA, 0.5837, 2.61, 0.111, 585, 90, CRYSTAL STRUCTURE OF ALPHA-AMYLASE II (TVAII) FROM THERMOACTINOMYCES VULGARIS R-47 AND BETA-CYCLODEXTRIN COMPLEX
888, 6h7kC, 0.5836, 2.88, 0.078, 119, 90, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
889, 4lxoA, 0.5836, 2.69, 0.100, 184, 90, CRYSTAL STRUCTURE OF 910FN3-ELEGANTIN CHIMERA
890, 4lsdG, 0.5836, 2.72, 0.114, 93, 88, MYOKINE STRUCTURE
891, 4fxtB, 0.5836, 2.91, 0.096, 191, 94, CRYSTAL STRUCTURE OF A DUF3823 FAMILY PROTEIN (BACOVA_02663) FROM BACTEROIDES OVATUS ATCC 8483 AT 2.77 A RESOLUTION
892, 3tesB, 0.5836, 2.48, 0.080, 94, 87, CRYSTAL STRUCTURE OF TENCON
893, 1c5dH, 0.5836, 3.03, 0.089, 214, 90, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
894, 5l2hA, 0.5835, 2.60, 0.091, 97, 88, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
895, 5i17H, 0.5835, 2.67, 0.079, 212, 89, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20
896, 4ztoI, 0.5835, 3.11, 0.065, 221, 92, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
897, 4pirI, 0.5835, 2.85, 0.099, 124, 91, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
898, 3modH, 0.5835, 3.10, 0.066, 237, 91, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
899, 3mobH, 0.5835, 3.11, 0.066, 233, 91, CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 11 AA GP41 MPER-DERIVED PEPTIDE
900, 3d0vB, 0.5835, 3.06, 0.066, 221, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LLELDKWASLW
901, 5l2hC, 0.5834, 2.60, 0.091, 97, 88, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
902, 5jipA, 0.5834, 2.59, 0.080, 317, 87, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM PERFRINGENS SPORE CORTEX LYTIC ENZYME SLEM
903, 4hc1H, 0.5834, 3.06, 0.055, 220, 91, CRYSTAL STRUCTURE OF A LOOP DELETED MUTANT OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB 10G3
904, 4gagH, 0.5834, 3.08, 0.055, 212, 91, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
905, 3idmB, 0.5834, 3.03, 0.077, 227, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(NRG)WAS
906, 2vquA, 0.5834, 3.14, 0.042, 836, 95, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
907, 2votB, 0.5834, 3.24, 0.052, 839, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
908, 1u8kB, 0.5834, 3.05, 0.066, 228, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASL
909, 5kqvF, 0.5833, 2.83, 0.099, 592, 91, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
910, 5iv7YA, 0.5833, 2.28, 0.093, 1004, 86, 
911, 5iv7S, 0.5833, 2.28, 0.093, 1004, 86, 
912, 5iv7OB, 0.5833, 2.28, 0.093, 1004, 86, 
913, 5iv7IA, 0.5833, 2.28, 0.093, 1004, 86, 
914, 5iv7EC, 0.5833, 2.28, 0.093, 1004, 86, 
915, 5iv7C, 0.5833, 2.28, 0.093, 1004, 86, 
916, 4u4bA, 0.5833, 2.65, 0.094, 326, 85, CRYSTAL STRUCTURE OF PECTATE LYASE PEL3 FROM PECTOBACTERIUM CAROTOVORUM WITH ONE MONOMER IN THE A.U.
917, 3tesA, 0.5833, 2.52, 0.070, 94, 86, CRYSTAL STRUCTURE OF TENCON
918, 3qazN, 0.5833, 3.05, 0.022, 195, 92, IL-2 MUTANT D10 TERNARY COMPLEX
919, 3b8yA, 0.5833, 2.37, 0.071, 304, 84, CRYSTAL STRUCTURE OF PECTATE LYASE PELI FROM ERWINIA CHRYSANTHEMI IN COMPLEX WITH TETRAGALACTURONIC ACID
920, 2pw1B, 0.5833, 3.06, 0.066, 221, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWNSL
921, 6apxB, 0.5832, 2.49, 0.103, 92, 87, CRYSTAL STRUCTURE OF HUMAN DUAL SPECIFICITY PHOSPHATASE 1 CATALYTIC DOMAIN (C258S) AS A MALTOSE BINDING PROTEIN FUSION IN COMPLEX WITH THE MONOBODY YSX1
922, 4pozD, 0.5832, 3.10, 0.077, 215, 91, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
923, 3bgaB, 0.5832, 3.43, 0.092, 980, 98, CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482
924, 3b4nA, 0.5832, 2.50, 0.071, 314, 85, CRYSTAL STRUCTURE ANALYSIS OF PECTATE LYASE PELI FROM ERWINIA CHRYSANTHEMI
925, 2p8pB, 0.5832, 3.05, 0.066, 221, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE LELDKWASLW[N-AC]
926, 2djuA, 0.5832, 2.59, 0.135, 106, 89, SOLUTION STRUCTURES OF THE FN3 DOMAIN OF HUMAN RECEPTOR- TYPE TYROSINE-PROTEIN PHOSPHATASE F
927, 2vqtB, 0.5831, 3.25, 0.052, 839, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
928, 2je8B, 0.5831, 3.23, 0.052, 841, 96, STRUCTURE OF A BETA-MANNOSIDASE FROM BACTEROIDES THETAIOTAOMICRON
929, 6bzvA, 0.5830, 2.95, 0.056, 218, 90, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
930, 2hkaA, 0.5830, 2.89, 0.054, 130, 92, CRYSTAL STRUCTURE OF BOVINE NPC2 AND CHOLESTEROL SULFATE COMPLEX
931, 6qtlE, 0.5829, 2.99, 0.109, 118, 92, CAFFEINE RECOGNIZING NANOBODY 
932, 6k7oD, 0.5829, 3.08, 0.076, 225, 92, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
933, 6i60A, 0.5829, 3.03, 0.065, 883, 92, STRUCTURE OF ALPHA-L-RHAMNOSIDASE FROM DICTYOGLUMUS THERMOPHILUM 
934, 6h7jD, 0.5829, 2.96, 0.077, 120, 91, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST ISOPRENALINE AND NANOBODY NB80 
935, 5yy3A, 0.5829, 3.86, 0.088, 577, 102, CRYSTAL STRUCTURE OF ASQI 
936, 5mhrK, 0.5829, 2.90, 0.100, 122, 90, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
937, 5dfzE, 0.5829, 2.66, 0.080, 113, 88, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
938, 3s98A, 0.5829, 2.27, 0.153, 267, 85, HUMAN IFNAR1
939, 3ezjD, 0.5829, 2.95, 0.088, 120, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY
940, 1tjhH, 0.5829, 3.10, 0.066, 236, 91, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 11MER EPITOPE
941, 1qr4B, 0.5829, 2.58, 0.091, 175, 88, TWO FIBRONECTIN TYPE-III DOMAIN SEGMENT FROM CHICKEN TENASCIN
942, 1fakT, 0.5829, 2.76, 0.046, 183, 87, HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
943, 5o4uC, 0.5828, 3.12, 0.082, 207, 97, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
944, 4lvnC, 0.5828, 2.88, 0.089, 216, 90, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX
945, 3ezjF, 0.5828, 2.96, 0.088, 120, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY
946, 2q7nC, 0.5828, 2.87, 0.066, 480, 91, CRYSTAL STRUCTURE OF LEUKEMIA INHIBITORY FACTOR IN COMPLEX WITH LIF RECEPTOR (DOMAINS 1-5)
947, 2pw2B, 0.5828, 3.06, 0.066, 221, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELDKWKSL
948, 2p8lB, 0.5828, 3.06, 0.066, 222, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 IN COMPLEX WITH GP41 PEPTIDE ELLELDKWASLWN
949, 2edbA, 0.5828, 2.98, 0.132, 116, 91, SOLUTION STRUCTURE OF THE FOURTH FIBRONECTIN TYPE III DOMAIN OF HUMAN NETRIN RECEPTOR DCC
950, 6iblC, 0.5827, 2.89, 0.078, 119, 90, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY NB80 
951, 5o4uG, 0.5827, 3.27, 0.041, 207, 98, THE FLAGELLIN OF PYROCOCCUS FURIOSUS
952, 5m30D, 0.5827, 3.02, 0.087, 119, 92, STRUCTURE OF TSSK FROM T6SS EAEC IN COMPLEX WITH NANOBODY NB18
953, 3rvtD, 0.5827, 3.04, 0.066, 222, 91, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
954, 6i6jC, 0.5826, 2.93, 0.088, 121, 91, CRYSTAL STRUCTURE OF THE KDEL RECEPTOR BOUND TO SYNTHETIC NANOBODY. 
955, 6gkdJ, 0.5826, 2.91, 0.100, 123, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
956, 4idlA, 0.5826, 2.78, 0.100, 123, 90, LOW MELTING TEMPERATURE ANTI-CHOLERA TOXIN LLAMA VHH DOMAIN
957, 3aazA, 0.5826, 3.05, 0.077, 228, 91, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
958, 2j88H, 0.5826, 2.96, 0.056, 162, 89, HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT
959, 2iqaH, 0.5826, 3.02, 0.077, 221, 91, PFA2 FAB FRAGMENT MONOCLINIC APO FORM
960, 6h7mD, 0.5825, 2.97, 0.077, 120, 91, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST SALBUTAMOL AND NANOBODY NB6B9 
961, 6cf2A, 0.5825, 2.94, 0.088, 116, 91, CRYSTAL STRUCTURE OF HIV-1 REV (RESIDUES 1-93)-RNA APTAMER COMPLEX 
962, 5vxjD, 0.5825, 2.95, 0.099, 118, 91, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
963, 5o04C, 0.5825, 2.81, 0.079, 121, 89, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-26 AND NANO-85
964, 4lvoC, 0.5825, 2.80, 0.079, 214, 89, CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2
965, 4ldoB, 0.5825, 2.85, 0.067, 120, 90, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO ADRENALINE AND AN ENGINEERED NANOBODY
966, 3go1H, 0.5825, 3.13, 0.076, 222, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN
967, 2winG, 0.5825, 3.15, 0.043, 638, 94, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
968, 2winE, 0.5825, 3.15, 0.043, 638, 94, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
969, 2winC, 0.5825, 3.15, 0.043, 638, 94, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
970, 2winA, 0.5825, 3.15, 0.043, 638, 94, C3 CONVERTASE (C3BBB) STABILIZED BY SCIN
971, 2iceD, 0.5825, 3.18, 0.043, 630, 94, CRIG BOUND TO C3C
972, 1yc7A, 0.5825, 2.97, 0.044, 116, 91, CABAN33 VHH FRAGMENT AGAINST VSG
973, 6qtlG, 0.5823, 3.07, 0.054, 119, 92, CAFFEINE RECOGNIZING NANOBODY 
974, 5m2wB, 0.5823, 2.83, 0.133, 119, 90, STRUCTURE OF NANOBODY NB18 RAISED AGAINST TSSK FROM E. COLI T6SS
975, 5a1aD, 0.5823, 3.01, 0.074, 1022, 95, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
976, 5a1aC, 0.5823, 3.01, 0.074, 1022, 95, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
977, 5a1aB, 0.5823, 3.01, 0.074, 1022, 95, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
978, 5a1aA, 0.5823, 3.01, 0.074, 1022, 95, 2.2 A RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE IN COMPLEX WITH A CELL-PERMEANT INHIBITOR
979, 4pirJ, 0.5823, 2.84, 0.099, 124, 91, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
980, 3pe9C, 0.5823, 2.41, 0.096, 90, 83, STRUCTURES OF CLOSTRIDIUM THERMOCELLUM CBHA FIBRONECTIN(III)-LIKE MODULES
981, 6e3lI, 0.5822, 2.63, 0.080, 213, 88, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
982, 5mwnF, 0.5822, 2.92, 0.132, 120, 91, STRUCTURE OF THE EAEC T6SS COMPONENT TSSK N-TERMINAL DOMAIN IN COMPLEX WITH LLAMA NANOBODIES NBK18 AND NBK27
983, 4mauH, 0.5822, 3.12, 0.044, 212, 91, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
984, 3idjB, 0.5822, 3.07, 0.066, 229, 91, CRYSTAL STRUCTURE OF THE HIV-1 CROSS NEUTRALIZING MONOCLONAL ANTIBODY 2F5 FAB  FRAGMENT IN COMPLEX WITH GP41 PEPTIDE ANALOG ELD(ORN)WAS
985, 1zanH, 0.5822, 3.11, 0.088, 216, 91, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
986, 1rulH, 0.5822, 2.93, 0.079, 221, 89, CRYSTAL STRUCTURE (D) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 5.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
987, 5a43D, 0.5821, 2.48, 0.116, 95, 86, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
988, 3qt2A, 0.5821, 3.52, 0.049, 307, 102, STRUCTURE OF A CYTOKINE LIGAND-RECEPTOR COMPLEX
989, 3mx0A, 0.5821, 2.77, 0.101, 406, 89, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
990, 2ywyC, 0.5821, 2.76, 0.125, 113, 88, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
991, 1sjxA, 0.5821, 2.98, 0.109, 119, 92, THREE-DIMENSIONAL STRUCTURE OF A LLAMA VHH DOMAIN OE7 BINDING THE CELL WALL PROTEIN MALF1
992, 1ruaH, 0.5821, 3.10, 0.067, 221, 90, CRYSTAL STRUCTURE (B) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 11-1.
993, 1jtoA, 0.5821, 2.83, 0.079, 132, 89, DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
994, 5yy2A, 0.5820, 3.92, 0.097, 569, 103, CRYSTAL STRUCTURE OF ASQI WITH ZN 
995, 2vo5B, 0.5820, 3.26, 0.052, 841, 96, STRUCTURAL AND BIOCHEMICAL EVIDENCE FOR A BOAT-LIKE TRANSITION STATE IN BETA-MANNOSIDASES
996, 1cf1C, 0.5820, 3.33, 0.124, 380, 97, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
997, 5ggrZ, 0.5819, 3.01, 0.088, 117, 91, PD-1 IN COMPLEX WITH NIVOLUMAB FAB
998, 5ggrY, 0.5819, 3.05, 0.098, 118, 92, PD-1 IN COMPLEX WITH NIVOLUMAB FAB
999, 1cf1A, 0.5819, 3.32, 0.124, 373, 97, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1000, 5dc0A, 0.5818, 2.34, 0.118, 91, 85, CRYSTAL STRUCTURE OF MONOBODY GG3/ABL1 SH2 DOMAIN COMPLEX
1001, 4rfoH, 0.5818, 3.22, 0.076, 214, 92, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48U1
1002, 1tjiH, 0.5818, 3.11, 0.066, 236, 91, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 17MER EPITOPE
1003, 1ru9H, 0.5818, 2.99, 0.078, 221, 90, CRYSTAL STRUCTURE (A) OF U.V.-IRRADIATED CATIONIC CYCLIZATION ANTIBODY 4C6 FAB AT PH 4.6 WITH A DATA SET COLLECTED IN-HOUSE.
1004, 6h7nC, 0.5817, 2.97, 0.077, 120, 91, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST XAMOTEROL AND NANOBODY NB6B9 
1005, 5n48B, 0.5817, 2.66, 0.101, 92, 89, STRUCTURE OF ANTICALIN N9B IN COMPLEX WITH EXTRA-DOMAIN B OF HUMAN ONCOFETAL FIBRONECTIN
1006, 4qkxB, 0.5817, 2.84, 0.067, 120, 90, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO A COVALENT AGONIST AND AN ENGINEERED NANOBODY
1007, 3qzbA, 0.5816, 3.24, 0.034, 131, 89, CRYSTAL STRUCTURE OF A PUTATIVE SUPEROXIDE REDUCTASE (TM0658) FROM THERMOTOGA MARITIMA AT 1.10 A RESOLUTION
1008, 3ezjH, 0.5816, 2.96, 0.088, 120, 91, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY
1009, 1c5dB, 0.5816, 3.02, 0.089, 215, 90, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
1010, 6bzuC, 0.5815, 3.06, 0.055, 218, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1011, 4no0D, 0.5815, 2.40, 0.105, 192, 86, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1
1012, 6h7mC, 0.5814, 2.98, 0.077, 120, 91, ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST SALBUTAMOL AND NANOBODY NB6B9 
1013, 6gkdP, 0.5814, 2.92, 0.100, 123, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
1014, 6gkdM, 0.5814, 2.91, 0.100, 124, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
1015, 4y5yC, 0.5814, 2.95, 0.102, 195, 88, DIABODY 330 COMPLEX WITH EPOR
1016, 3w11C, 0.5814, 3.12, 0.077, 118, 91, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
1017, 3k2mC, 0.5814, 2.70, 0.100, 101, 90, CRYSTAL STRUCTURE OF MONOBODY HA4/ABL1 SH2 DOMAIN COMPLEX
1018, 1f8tH, 0.5814, 3.07, 0.056, 220, 90, FAB (LNKB-2) OF MONOCLONAL ANTIBODY CRYSTAL STRUCTURE
1019, 6byeB, 0.5813, 3.21, 0.116, 861, 95, CRYSTAL STRUCTURE OF THE GH2 EXO-BETA-MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI IN COMPLEX WITH MANNOSE 
1020, 5vxjB, 0.5813, 2.87, 0.089, 119, 90, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
1021, 5t5wB, 0.5813, 2.99, 0.078, 188, 90, STRUCTURE OF AN AFFINITY MATURED LAMBDA-IFN/IFN-LAMBDAR1/IL-10RBETA RECEPTOR COMPLEX
1022, 5gniB, 0.5813, 2.94, 0.088, 198, 91, THE CRYSTAL STRUCTURE OF PECAM-1 IGL1-2 TRANS-HOMOPHILIC DIMER
1023, 5czxH, 0.5813, 2.96, 0.077, 215, 91, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB
1024, 3pe9A, 0.5813, 2.48, 0.096, 90, 83, STRUCTURES OF CLOSTRIDIUM THERMOCELLUM CBHA FIBRONECTIN(III)-LIKE MODULES
1025, 3eyuH, 0.5813, 3.12, 0.099, 218, 91, PFA1 FAB FRAGMENT COMPLEXED WITH ROR2(518-525)
1026, 2d9qB, 0.5813, 2.96, 0.110, 299, 91, CRYSTAL STRUCTURE OF THE HUMAN GCSF-RECEPTOR SIGNALING COMPLEX
1027, 6gkdG, 0.5812, 2.97, 0.110, 122, 91, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
1028, 6e3lE, 0.5812, 2.66, 0.080, 213, 88, INTERFERON GAMMA SIGNALLING COMPLEX WITH IFNGR1 AND IFNGR2 
1029, 6chbQ, 0.5812, 2.97, 0.077, 227, 91, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
1030, 6bzvC, 0.5812, 3.09, 0.055, 218, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1031, 5ggvY, 0.5812, 2.95, 0.043, 119, 92, CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB
1032, 4mj2A, 0.5812, 2.87, 0.078, 595, 90, CRYSTAL STRUCTURE OF APO-IDURONIDASE IN THE R3 FORM
1033, 3tesC, 0.5812, 2.54, 0.070, 94, 86, CRYSTAL STRUCTURE OF TENCON
1034, 3qazR, 0.5812, 2.38, 0.094, 188, 85, IL-2 MUTANT D10 TERNARY COMPLEX
1035, 3qazE, 0.5812, 3.00, 0.033, 196, 91, IL-2 MUTANT D10 TERNARY COMPLEX
1036, 1nc4B, 0.5812, 3.09, 0.100, 218, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
1037, 6h3jC, 0.5811, 3.45, 0.020, 397, 101, STRUCTURAL SNAPSHOTS OF THE TYPE 9 PROTEIN TRANSLOCON PLUG-COMPLEX 
1038, 5gztB, 0.5811, 2.47, 0.034, 1134, 88, CRYSTAL STRUCTURE OF CHITINASE CHIW FROM PAENIBACILLUS SP. STR. FPU-7 REVEALS A NOVEL TYPE OF BACTERIAL CELL-SURFACE-EXPRESSED MULTI- MODULAR ENZYME MACHINERY
1039, 5d1zF, 0.5811, 3.17, 0.098, 223, 92, ISDB NEAT1 BOUND BY CLONE D4-10
1040, 5a43C, 0.5811, 2.54, 0.115, 95, 87, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
1041, 4pjaG, 0.5811, 2.74, 0.056, 196, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
1042, 4lxoB, 0.5811, 2.63, 0.090, 184, 89, CRYSTAL STRUCTURE OF 910FN3-ELEGANTIN CHIMERA
1043, 4kh2A, 0.5811, 2.88, 0.067, 595, 90, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH 2-DEOXY-2- FLUORO-ALPHA-L-IDOPYRANOSYLURONIC ACID FLUORIDE
1044, 4f37F, 0.5811, 3.20, 0.076, 225, 92, STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER S DISEASE A PEPTIDE
1045, 4a2mA, 0.5811, 3.03, 0.121, 741, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1046, 3fn9A, 0.5811, 3.45, 0.071, 672, 98, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1047, 6h71D, 0.5810, 2.95, 0.066, 121, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-94 
1048, 5jtwA, 0.5810, 3.63, 0.050, 651, 100, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
1049, 4ldeB, 0.5810, 2.96, 0.077, 120, 91, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO BI167107 AND AN ENGINEERED NANOBODY
1050, 5vxjF, 0.5809, 2.90, 0.100, 118, 90, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
1051, 4ldlB, 0.5809, 2.92, 0.044, 120, 91, STRUCTURE OF BETA2 ADRENOCEPTOR BOUND TO HYDROXYBENZYLISOPROTERENOL AND AN ENGINEERED NANOBODY
1052, 2wiiA, 0.5809, 3.46, 0.052, 640, 97, COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4
1053, 1uc6A, 0.5809, 3.22, 0.172, 109, 93, SOLUTION STRUCTURE OF THE CARBOXYL TERMINAL DOMAIN OF THE CILIARY NEUROTROPHIC FACTOR RECEPTOR
1054, 1s5iH, 0.5809, 3.13, 0.056, 220, 90, FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2 CRYSTAL STRUCTURE
1055, 5jpmD, 0.5808, 3.77, 0.060, 651, 100, STRUCTURE OF THE COMPLEX OF HUMAN COMPLEMENT C4 WITH MASP-2 REBUILT USING IMDFF
1056, 4ogaC, 0.5808, 3.12, 0.077, 118, 91, INSULIN IN COMPLEX WITH SITE 1 OF THE HUMAN INSULIN RECEPTOR
1057, 3sddD, 0.5808, 3.10, 0.088, 238, 91, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
1058, 6qtlB, 0.5807, 3.08, 0.054, 119, 92, CAFFEINE RECOGNIZING NANOBODY 
1059, 6h70D, 0.5807, 3.09, 0.076, 126, 92, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-62 AND 2- FUCOSYLLACTOSE (2FL) 
1060, 6bzuE, 0.5807, 3.06, 0.055, 192, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1061, 6bzuA, 0.5807, 3.20, 0.043, 217, 92, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1062, 4zypN, 0.5807, 2.96, 0.044, 213, 90, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
1063, 4obrA, 0.5807, 2.82, 0.067, 595, 89, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH ALPHA-L- IDURONIC ACID
1064, 4a2lC, 0.5807, 3.02, 0.121, 749, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1065, 3qazc, 0.5807, 3.07, 0.022, 196, 92, IL-2 MUTANT D10 TERNARY COMPLEX
1066, 2p1yA, 0.5807, 3.28, 0.033, 231, 92, 1.B2.D9 A BISPECIFIC ALPHA/BETA TCR
1067, 6gkdB, 0.5806, 2.97, 0.110, 126, 91, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND G3A 
1068, 5t9gD, 0.5806, 3.38, 0.052, 811, 97, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
1069, 5l2hB, 0.5806, 2.60, 0.102, 98, 88, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
1070, 6mtsH, 0.5805, 3.13, 0.099, 224, 91, CRYSTAL STRUCTURE OF VRC43.03 FAB 
1071, 5nnsA, 0.5805, 2.70, 0.067, 225, 89, CRYSTAL STRUCTURE OF HILPMO9B 
1072, 4jlrA, 0.5805, 3.19, 0.033, 215, 92, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
1073, 3wkyA, 0.5805, 3.70, 0.078, 654, 102, CRYSTAL STRUCTURE OF HEMOLYMPH TYPE PROPHENOLOXIDASE (PROPOB) FROM CRUSTACEAN
1074, 3levH, 0.5805, 3.06, 0.066, 237, 91, HIV-1 ANTIBODY 2F5 IN COMPLEX WITH EPITOPE SCAFFOLD ES2
1075, 6h72D, 0.5804, 2.93, 0.077, 120, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-94 AND 2- FUCOSYLLACTOSE (2FL) 
1076, 6h6zD, 0.5804, 2.98, 0.110, 126, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-62 
1077, 5drxH, 0.5804, 2.97, 0.077, 220, 91, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
1078, 4w2qC, 0.5804, 3.01, 0.088, 117, 91, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1079, 4apqD, 0.5804, 3.04, 0.111, 240, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
1080, 3tnmH, 0.5804, 3.12, 0.076, 221, 92, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
1081, 1nc4D, 0.5804, 3.00, 0.111, 215, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
1082, 6gjsC, 0.5803, 2.96, 0.109, 117, 92, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T4 
1083, 2agjH, 0.5803, 3.08, 0.067, 225, 90, CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY
1084, 1tjgH, 0.5803, 3.10, 0.066, 236, 91, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 2F5 IN COMPLEX WITH A GP41 7MER EPITOPE
1085, 5gniA, 0.5802, 3.12, 0.087, 196, 92, THE CRYSTAL STRUCTURE OF PECAM-1 IGL1-2 TRANS-HOMOPHILIC DIMER
1086, 5dhvA, 0.5802, 2.97, 0.088, 123, 91, HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES
1087, 4zxbA, 0.5802, 3.15, 0.077, 214, 91, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
1088, 4ei0A, 0.5802, 3.01, 0.112, 293, 89, CRYSTAL STRUCTURE OF A DUF4466 FAMILY PROTEIN (PARMER_03218) FROM PARABACTEROIDES MERDAE ATCC 43184 AT 2.00 A RESOLUTION
1089, 3rvvD, 0.5802, 3.16, 0.054, 216, 92, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
1090, 3bquB, 0.5802, 3.06, 0.066, 214, 91, CRYSTAL STRUCTURE OF THE 2F5 FAB -3H6 FAB COMPLEX
1091, 2iq9H, 0.5802, 3.16, 0.088, 221, 91, PFA2 FAB FRAGMENT TRICLINIC APO FORM
1092, 1yzzA, 0.5802, 2.86, 0.078, 114, 90, HUMANIZED CABAN33 AT ROOM TEMPERATURE
1093, 6do1D, 0.5801, 3.04, 0.088, 126, 91, STRUCTURE OF NANOBODY-STABILIZED ANGIOTENSIN II TYPE 1 RECEPTOR BOUND TO S1I8 
1094, 5t9aD, 0.5801, 3.39, 0.052, 811, 97, CRYSTAL STRUCTURE OF BUGH2CWT
1095, 5jpnA, 0.5801, 2.92, 0.110, 651, 91, STRUCTURE OF HUMAN COMPLEMENT C4 REBUILT USING IMDFF
1096, 5d1zD, 0.5801, 3.17, 0.098, 230, 92, ISDB NEAT1 BOUND BY CLONE D4-10
1097, 4l4tG, 0.5801, 2.73, 0.056, 193, 89, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
1098, 4b50A, 0.5801, 3.12, 0.054, 122, 92, CRYSTAL STRUCTURE OF THE HIV-1 GP41 MPER-SPECIFIC LLAMA VHH 2H10
1099, 3u9pK, 0.5801, 3.07, 0.088, 200, 91, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
1100, 2ipuH, 0.5801, 3.07, 0.088, 223, 91, PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE
1101, 6ch7Q, 0.5800, 3.07, 0.076, 231, 92, XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
1102, 5vphD, 0.5800, 3.18, 0.054, 214, 92, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
1103, 5mhrP, 0.5800, 2.76, 0.101, 213, 89, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1104, 3ugxA, 0.5800, 3.23, 0.125, 369, 96, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1105, 3rvxD, 0.5800, 3.18, 0.054, 214, 92, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
1106, 2xwjE, 0.5800, 3.65, 0.051, 640, 99, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1107, 5u4mB, 0.5799, 3.13, 0.098, 129, 92, RTA-V1C7-G29R-NO_SALT
1108, 2xwjA, 0.5799, 3.65, 0.051, 640, 99, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1109, 2r0wH, 0.5799, 3.18, 0.088, 217, 91, PFA2 FAB COMPLEXED WITH ABETA1-8
1110, 5vpgD, 0.5798, 3.16, 0.054, 218, 92, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
1111, 5l2hD, 0.5798, 2.63, 0.091, 96, 88, CRYSTAL STRUCTURE OF W26A MUTANT OF ANTI-EGFR CENTYRIN P54AR4-83V2
1112, 4hs6B, 0.5798, 3.07, 0.077, 214, 91, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
1113, 4fe9A, 0.5798, 3.86, 0.069, 446, 102, CRYSTAL STRUCTURE OF SUSF FROM BACTEROIDES THETAIOTAOMICRON
1114, 4a2mC, 0.5798, 3.04, 0.121, 743, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1115, 3rvwD, 0.5798, 3.16, 0.054, 218, 92, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
1116, 2xwbC, 0.5798, 3.65, 0.051, 640, 99, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTORS B AND D
1117, 1melA, 0.5798, 2.86, 0.079, 132, 89, CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME
1118, 1jtpA, 0.5798, 3.02, 0.088, 135, 91, DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
1119, 5xkuC, 0.5797, 3.02, 0.066, 219, 91, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
1120, 5t9aB, 0.5797, 3.40, 0.052, 812, 97, CRYSTAL STRUCTURE OF BUGH2CWT
1121, 4kglA, 0.5797, 2.89, 0.067, 595, 90, CRYSTAL STRUCTURE OF HUMAN ALPHA-L-IDURONIDASE COMPLEX WITH [2R3R4R 5S]-2-CARBOXY-345-TRIHYDROXY-PIPERIDINE
1122, 3qt2B, 0.5797, 3.67, 0.049, 307, 102, STRUCTURE OF A CYTOKINE LIGAND-RECEPTOR COMPLEX
1123, 2xwjG, 0.5797, 3.65, 0.051, 640, 99, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1124, 2xwjC, 0.5797, 3.65, 0.051, 640, 99, CRYSTAL STRUCTURE OF COMPLEMENT C3B IN COMPLEX WITH FACTOR B
1125, 1nc2D, 0.5797, 3.02, 0.111, 215, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
1126, 6c5wC, 0.5796, 2.92, 0.089, 117, 90, CRYSTAL STRUCTURE OF THE MITOCHONDRIAL CALCIUM UNIPORTER 
1127, 5m30F, 0.5796, 2.94, 0.132, 122, 91, STRUCTURE OF TSSK FROM T6SS EAEC IN COMPLEX WITH NANOBODY NB18
1128, 3fn9C, 0.5796, 3.47, 0.071, 673, 98, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1129, 3b83H, 0.5796, 2.67, 0.068, 94, 88, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1130, 1n6qH, 0.5796, 3.05, 0.066, 225, 91, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX N)
1131, 5u1rB, 0.5795, 2.74, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1132, 5t9gA, 0.5795, 3.39, 0.052, 810, 97, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
1133, 3ld8C, 0.5795, 3.19, 0.044, 210, 91, STRUCTURE OF JMJD6 AND FAB FRAGMENTS
1134, 3eysH, 0.5795, 3.06, 0.088, 215, 91, PFA1 FAB FRAGMENT COMPLEXED WITH PYRO-GLU3-A-BETA (3-8)
1135, 2ywyA, 0.5795, 2.78, 0.114, 113, 88, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1136, 1efxD, 0.5795, 2.70, 0.057, 197, 88, STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3
1137, 1aifB, 0.5795, 3.05, 0.098, 218, 92, ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1138, 6do1C, 0.5794, 2.96, 0.088, 125, 91, STRUCTURE OF NANOBODY-STABILIZED ANGIOTENSIN II TYPE 1 RECEPTOR BOUND TO S1I8 
1139, 5u72D, 0.5794, 2.72, 0.056, 198, 89, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1140, 5myaB, 0.5794, 2.76, 0.045, 191, 89, HOMODIMERIZATION OF TIE2 FIBRONECTIN-LIKE DOMAINS 1-3 IN SPACE GROUP C2
1141, 5dhyH, 0.5794, 2.96, 0.099, 117, 91, HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES
1142, 4pirH, 0.5794, 2.90, 0.109, 124, 92, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
1143, 4gajH, 0.5794, 2.89, 0.056, 209, 89, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)
1144, 4ei0B, 0.5794, 3.03, 0.112, 294, 89, CRYSTAL STRUCTURE OF A DUF4466 FAMILY PROTEIN (PARMER_03218) FROM PARABACTEROIDES MERDAE ATCC 43184 AT 2.00 A RESOLUTION
1145, 2iqaB, 0.5794, 2.98, 0.077, 220, 91, PFA2 FAB FRAGMENT MONOCLINIC APO FORM
1146, 1f4hD, 0.5794, 3.09, 0.083, 1021, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1147, 5fn6A, 0.5793, 2.52, 0.068, 252, 88, CRYSTAL STRUCTURE OF HUMAN CD45 EXTRACELLULAR REGION DOMAINS D1-D3
1148, 4xamB, 0.5793, 3.62, 0.100, 651, 100, COMPLEMENT COMPONENT C4B
1149, 4hjjH, 0.5793, 3.12, 0.077, 341, 91, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
1150, 4a2mD, 0.5793, 3.05, 0.121, 745, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1151, 3iy5B, 0.5793, 2.93, 0.088, 122, 91, VARIABLE DOMAINS OF THE MOUSE FAB (1AIF) FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 16 COMPLEX
1152, 1vesB, 0.5793, 3.00, 0.100, 113, 90, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1153, 1aifH, 0.5793, 2.93, 0.088, 218, 91, ANTI-IDIOTYPIC FAB 409.5.3 (IGG2A) FAB FROM MOUSE
1154, 6hn5E, 0.5792, 3.23, 0.106, 584, 94, LEUCINE-ZIPPERED HUMAN INSULIN RECEPTOR ECTODOMAIN WITH SINGLE BOUND INSULIN -  UPPER  MEMBRANE-DISTAL PART 
1155, 4ztoH, 0.5792, 3.15, 0.076, 221, 92, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
1156, 4xamA, 0.5792, 3.63, 0.100, 651, 100, COMPLEMENT COMPONENT C4B
1157, 4jlrH, 0.5792, 3.22, 0.033, 215, 92, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
1158, 3g9vC, 0.5792, 2.58, 0.046, 176, 87, CRYSTAL STRUCTURE OF A SOLUBLE DECOY RECEPTOR IL-22BP BOUND TO INTERLEUKIN-22
1159, 32c2B, 0.5792, 3.16, 0.055, 218, 91, STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
1160, 6bygA, 0.5791, 3.26, 0.115, 856, 96, CRYSTAL STRUCTURE OF THE NUCLEOPHILE MUTANT (E575A) OF THE GH2 EXO- BETA-MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI 
1161, 5u16E, 0.5791, 2.73, 0.056, 185, 89, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1162, 5mhrR, 0.5791, 2.77, 0.101, 213, 89, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1163, 5dhzH, 0.5791, 2.96, 0.099, 117, 91, HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES
1164, 4pirG, 0.5791, 2.89, 0.099, 124, 91, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
1165, 3ew3C, 0.5791, 2.80, 0.091, 181, 88, THE 1:2 COMPLEX BETWEEN A NTERMINAL ELONGATED PROLACTIN AND THE EXTRA CELLULAR DOMAIN OF THE RAT PROLACTIN RECEPTOR
1166, 2p1yC, 0.5791, 3.31, 0.033, 231, 92, 1.B2.D9 A BISPECIFIC ALPHA/BETA TCR
1167, 2o6dA, 0.5791, 3.43, 0.041, 158, 98, STRUCTURE OF NATIVE RTP34 FROM TREPONEMA PALLIDUM
1168, 1c12B, 0.5791, 3.11, 0.055, 220, 91, INSIGHT IN ODORANT PERCEPTION: THE CRYSTAL STRUCTURE AND BINDING CHARACTERISTICS OF ANTIBODY FRAGMENTS DIRECTED AGAINST THE MUSK ODORANT TRASEOLIDE
1169, 5truc, 0.5790, 2.80, 0.033, 115, 91, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
1170, 5kf4A, 0.5790, 2.55, 0.116, 99, 86, CRYSTAL STRUCTURE OF FN3 DOMAIN (RESIDUES P368-P466) OF HUMAN COLLAGEN XX
1171, 5dezB, 0.5790, 3.34, 0.111, 528, 90, CRYSTAL STRUCTURE OF ACMNPV CHITINASE A
1172, 4g6aC, 0.5790, 2.98, 0.056, 220, 89, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
1173, 4a2mB, 0.5790, 3.06, 0.121, 750, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1174, 6k7oR, 0.5789, 2.56, 0.070, 94, 86, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
1175, 4yc2H, 0.5789, 3.07, 0.077, 220, 91, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32.
1176, 4v40A, 0.5789, 3.08, 0.083, 1021, 96, 
1177, 3qi9D, 0.5789, 3.04, 0.111, 239, 90, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
1178, 3ixtH, 0.5789, 3.06, 0.044, 213, 91, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
1179, 3ixtA, 0.5789, 3.06, 0.044, 212, 91, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
1180, 2r0zH, 0.5789, 3.18, 0.099, 216, 91, PFA1 FAB COMPLEXED WITH GRIPI PEPTIDE FRAGMENT
1181, 1j8kA, 0.5789, 2.64, 0.125, 94, 88, NMR STRUCTURE OF THE FIBRONECTIN EDA DOMAIN NMR 20 STRUCTURES
1182, 5uqyH, 0.5788, 3.01, 0.066, 220, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1183, 5dhyA, 0.5788, 2.98, 0.088, 117, 91, HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES
1184, 5dhvH, 0.5788, 2.97, 0.088, 117, 91, HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES
1185, 6k7oA, 0.5787, 2.58, 0.070, 94, 86, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
1186, 6gjsB, 0.5787, 3.02, 0.110, 122, 91, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T4 
1187, 5u17B, 0.5787, 2.73, 0.056, 195, 89, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1188, 4lcwG, 0.5787, 2.75, 0.056, 188, 89, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
1189, 3iflH, 0.5787, 3.09, 0.054, 214, 92, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12A11) COMPLEX
1190, 1vesA, 0.5787, 2.91, 0.112, 113, 89, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1191, 5t9aA, 0.5786, 3.41, 0.052, 811, 97, CRYSTAL STRUCTURE OF BUGH2CWT
1192, 4pj5G, 0.5786, 2.74, 0.056, 190, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
1193, 3vdaB, 0.5786, 3.07, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
1194, 3s9dD, 0.5786, 2.91, 0.080, 186, 87, BINARY COMPLEX BETWEEN IFNA2 AND IFNAR2
1195, 1tenA, 0.5786, 2.28, 0.084, 89, 83, STRUCTURE OF A FIBRONECTIN TYPE III DOMAIN FROM TENASCIN PHASED BY MAD ANALYSIS OF THE SELENOMETHIONYL PROTEIN
1196, 6k7oQ, 0.5785, 2.63, 0.069, 94, 87, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
1197, 5k8aV, 0.5785, 3.11, 0.033, 222, 91, NIST FAB
1198, 3wihB, 0.5785, 2.62, 0.174, 88, 86, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
1199, 2wbkB, 0.5785, 3.34, 0.052, 840, 96, STRUCTURE OF THE MICHAELIS COMPLEX OF BETA-MANNOSIDASE MAN2A PROVIDES INSIGHT INTO THE CONFORMATIONAL ITINERARY OF MANNOSIDE HYDROLYSIS
1200, 5w0pD, 0.5784, 3.18, 0.116, 773, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1201, 5kjrH, 0.5784, 3.16, 0.076, 218, 92, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1.
1202, 5czxC, 0.5784, 3.11, 0.087, 214, 92, CRYSTAL STRUCTURE OF NOTCH3 NRR IN COMPLEX WITH 20358 FAB
1203, 5ae6B, 0.5784, 3.66, 0.041, 766, 98, THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A ( BXL1) IN COMPLEX WITH 4-THIOXYLOBIOSE
1204, 4v45P, 0.5784, 3.07, 0.073, 1018, 96, 
1205, 4v45O, 0.5784, 3.07, 0.073, 1018, 96, 
1206, 4v45N, 0.5784, 3.07, 0.073, 1018, 96, 
1207, 4v45M, 0.5784, 3.07, 0.073, 1018, 96, 
1208, 4v45L, 0.5784, 3.07, 0.073, 1018, 96, 
1209, 4v45K, 0.5784, 3.07, 0.073, 1018, 96, 
1210, 4v45J, 0.5784, 3.07, 0.073, 1018, 96, 
1211, 4v45I, 0.5784, 3.07, 0.073, 1018, 96, 
1212, 4v45H, 0.5784, 3.07, 0.073, 1018, 96, 
1213, 4v45G, 0.5784, 3.07, 0.073, 1018, 96, 
1214, 4v45F, 0.5784, 3.07, 0.073, 1018, 96, 
1215, 4v45E, 0.5784, 3.07, 0.073, 1018, 96, 
1216, 4v45D, 0.5784, 3.08, 0.073, 1018, 96, 
1217, 4v45C, 0.5784, 3.07, 0.073, 1018, 96, 
1218, 4v45B, 0.5784, 3.07, 0.073, 1018, 96, 
1219, 4v45A, 0.5784, 3.07, 0.073, 1018, 96, 
1220, 1a21B, 0.5784, 2.66, 0.034, 197, 87, TISSUE FACTOR (TF) FROM RABBIT
1221, 6ck8A, 0.5783, 3.20, 0.043, 124, 92, CRYSTAL STRUCTURE OF ANTI-INFLUENZA SINGLE-DOMAIN LLAMA ANTIBODY SD38 
1222, 3p0gB, 0.5783, 2.86, 0.033, 121, 90, STRUCTURE OF A NANOBODY-STABILIZED ACTIVE STATE OF THE BETA2 ADRENOCEPTOR
1223, 3ezjB, 0.5783, 2.84, 0.089, 120, 90, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF THE SECRETIN GSPD FROM ETEC DETERMINED WITH THE ASSISTANCE OF A NANOBODY
1224, 2zwlT, 0.5783, 2.39, 0.036, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH HIGHLY SELECTIVE PEPTIDE INHIBITOR
1225, 2hwzH, 0.5783, 3.10, 0.044, 227, 91, FAB FRAGMENT OF HUMANIZED ANTI-VIRAL ANTIBODY MEDI-493 (SYNAGIS TM)
1226, 1wssT, 0.5783, 2.39, 0.048, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPTIDE-MIMETIC INHIBITOR THAT HAS TWO CHARGED GROUPS IN P2 AND P4
1227, 6h72C, 0.5782, 2.96, 0.066, 121, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-94 AND 2- FUCOSYLLACTOSE (2FL) 
1228, 6ewaH, 0.5782, 2.46, 0.115, 188, 87, CRYSTAL STRUCTURE OF HLA-A2 IN COMPLEX WITH LILRB1 
1229, 6bzuG, 0.5782, 3.14, 0.055, 220, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1230, 5uqyD, 0.5782, 3.01, 0.066, 218, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1231, 5t9gC, 0.5782, 3.40, 0.052, 811, 97, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
1232, 4i77H, 0.5782, 3.07, 0.056, 219, 90, LEBRIKIZUMAB FAB BOUND TO IL-13
1233, 4a2lB, 0.5782, 3.06, 0.121, 744, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1234, 3wihA, 0.5782, 2.49, 0.143, 88, 84, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
1235, 3tesD, 0.5782, 2.57, 0.070, 94, 86, CRYSTAL STRUCTURE OF TENCON
1236, 6h70C, 0.5781, 3.02, 0.110, 126, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-62 AND 2- FUCOSYLLACTOSE (2FL) 
1237, 6ed1D, 0.5781, 3.25, 0.103, 860, 97, BACTEROIDES DOREI BETA-GLUCURONIDASE 
1238, 5u2vG, 0.5781, 2.76, 0.056, 193, 89, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1239, 5axgA, 0.5781, 3.30, 0.086, 583, 93, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS
1240, 4nqeG, 0.5781, 2.75, 0.056, 189, 89, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
1241, 4nqdG, 0.5781, 2.75, 0.056, 190, 89, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
1242, 3vdaC, 0.5781, 3.08, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
1243, 3b2uF, 0.5781, 3.19, 0.076, 215, 92, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1244, 2hmiD, 0.5781, 3.09, 0.055, 220, 91, HIV-1 REVERSE TRANSCRIPTASE/FRAGMENT OF FAB 28/DNA COMPLEX
1245, 2ck2B, 0.5781, 2.51, 0.081, 96, 86, STRUCTURE OF CORE-SWAPPED MUTANT OF FIBRONECTIN
1246, 2arjB, 0.5781, 3.13, 0.077, 212, 91, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
1247, 1wv7T, 0.5781, 2.56, 0.047, 191, 85, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE
1248, 1wqvT, 0.5781, 2.39, 0.048, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D- THR-MET-P-AMINOBENZAMIDINE
1249, 1a21A, 0.5781, 2.76, 0.045, 194, 88, TISSUE FACTOR (TF) FROM RABBIT
1250, 6h71C, 0.5780, 2.95, 0.066, 121, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-94 
1251, 5n9bA, 0.5780, 2.73, 0.068, 244, 88, CRYSTAL STRUCTURE OF UNLIGANDED HUMAN IL-17RA 
1252, 4v40K, 0.5780, 3.06, 0.083, 1021, 96, 
1253, 3scmD, 0.5780, 3.06, 0.111, 239, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1254, 6k7oP, 0.5779, 2.58, 0.070, 94, 86, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
1255, 5t9aC, 0.5779, 3.41, 0.052, 811, 97, CRYSTAL STRUCTURE OF BUGH2CWT
1256, 2w9dH, 0.5779, 2.81, 0.101, 215, 89, STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY   AT 1.57 A RESOLUTION.
1257, 1g4mA, 0.5779, 3.22, 0.160, 356, 94, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1258, 6chbI, 0.5778, 3.09, 0.076, 227, 92, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
1259, 5uqyP, 0.5778, 3.02, 0.066, 211, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1260, 5drxA, 0.5778, 3.04, 0.066, 216, 91, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
1261, 4hlzK, 0.5778, 3.00, 0.088, 200, 91, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
1262, 4fxgD, 0.5778, 3.67, 0.101, 651, 99, COMPLEMENT C4 IN COMPLEX WITH MASP-2
1263, 3vg0H, 0.5778, 3.17, 0.077, 219, 91, ANTIBODY FAB FRAGMENT
1264, 1n5yH, 0.5778, 3.07, 0.066, 225, 91, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1265, 6qtlC, 0.5777, 2.92, 0.099, 119, 91, CAFFEINE RECOGNIZING NANOBODY 
1266, 6grqA, 0.5777, 2.76, 0.080, 536, 88, PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN 
1267, 6ewoH, 0.5777, 2.46, 0.115, 176, 87, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RTF PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 
1268, 6chbJ, 0.5777, 2.92, 0.078, 227, 90, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND IOMA 
1269, 5z9sA, 0.5777, 3.38, 0.074, 765, 94, FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF A BETA-GLUCOSIDASE INVOLVED IN SAPONIN METABOLISM FROM INTESTINAL BACTERIA
1270, 5jtwD, 0.5777, 3.73, 0.050, 651, 100, CRYSTAL STRUCTURE OF COMPLEMENT C4B RE-REFINED USING IMDFF
1271, 5dhxL, 0.5777, 2.99, 0.110, 227, 91, HIV-1 REV NTD DIMERS WITH VARIABLE CROSSING ANGLES
1272, 4u49B, 0.5777, 2.61, 0.094, 318, 85, CRYSTAL STRUCTURE OF PECTATE LYASE PEL3 FROM PECTOBACTERIUM CAROTOVORUM WITH TWO MONOMERS IN THE A.U
1273, 4a2lF, 0.5777, 3.05, 0.121, 749, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1274, 3o41A, 0.5777, 3.15, 0.055, 217, 91, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
1275, 2iptH, 0.5777, 3.06, 0.088, 223, 91, PFA1 FAB FRAGMENT
1276, 1zvoD, 0.5777, 3.20, 0.110, 512, 91, SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
1277, 1zvoC, 0.5777, 3.20, 0.110, 512, 91, SEMI-EXTENDED SOLUTION STRUCTURE OF HUMAN MYELOMA IMMUNOGLOBULIN D DETERMINED BY CONSTRAINED X-RAY SCATTERING
1278, 1qd0A, 0.5777, 3.03, 0.110, 128, 91, CAMELID HEAVY CHAIN VARIABLE DOMAINS PROVIDE EFFICIENT COMBINING SITES TO HAPTENS
1279, 6gjuB, 0.5776, 3.04, 0.109, 118, 92, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES T2A AND T4 
1280, 5tkkH, 0.5776, 2.97, 0.067, 213, 89, STRUCTURE OF MOUSE VACCINATION-ELICITED HIV NEUTRALIZING ANTIBODY VFP5.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1281, 5kvmC, 0.5776, 2.28, 0.133, 95, 83, EXTRACELLULAR REGION OF MOUSE GPR56/ADGRG1 IN COMPLEX WITH FN3 MONOBODY
1282, 4v40L, 0.5776, 3.09, 0.073, 1021, 96, 
1283, 4pjfE, 0.5776, 2.77, 0.067, 197, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
1284, 4l4vG, 0.5776, 2.76, 0.056, 188, 89, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
1285, 3w2dH, 0.5776, 3.19, 0.055, 223, 91, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL EENTEROTOXIN B IN COMPLEX WITH A NOVEL NEUTRALIZATION MONOCLONAL ANTIBODY FAB FRAGMENT
1286, 3b9eA, 0.5776, 3.82, 0.103, 581, 97, CRYSTAL STRUCTURE OF INACTIVE MUTANT E315M CHITINASE A FROM VIBRIO HARVEYI
1287, 3b83C, 0.5776, 2.67, 0.057, 99, 87, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1288, 2ipuG, 0.5776, 3.04, 0.088, 219, 91, PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE
1289, 6drvD, 0.5775, 3.11, 0.072, 1024, 97, BETA-GALACTOSIDASE 
1290, 6drvC, 0.5775, 3.11, 0.072, 1024, 97, BETA-GALACTOSIDASE 
1291, 6drvB, 0.5775, 3.11, 0.072, 1024, 97, BETA-GALACTOSIDASE 
1292, 6drvA, 0.5775, 3.11, 0.072, 1024, 97, BETA-GALACTOSIDASE 
1293, 6bycA, 0.5775, 3.25, 0.116, 861, 95, CRYSTAL STRUCTURE OF THE GH2 EXO-BETA-MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI 
1294, 5u64B, 0.5775, 3.09, 0.055, 127, 91, CAMEL NANOBODY VHH-28
1295, 5o32E, 0.5775, 3.66, 0.051, 640, 99, THE STRUCTURE OF COMPLEMENT COMPLEX
1296, 5axhA, 0.5775, 3.40, 0.084, 586, 95, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE
1297, 4l4tD, 0.5775, 2.76, 0.056, 200, 89, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
1298, 4duvB, 0.5775, 2.99, 0.074, 1018, 94, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
1299, 5t9gB, 0.5774, 3.45, 0.051, 810, 98, CRYSTAL STRUCTURE OF BUGH2CWT IN COMPLEX WITH GALACTOISOFAGOMINE
1300, 5o05C, 0.5774, 2.85, 0.067, 116, 89, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-42
1301, 5k8aF, 0.5774, 3.10, 0.033, 222, 91, NIST FAB
1302, 4ofpB, 0.5774, 2.82, 0.068, 194, 88, CRYSTAL STRUCTURE OF SYG-2 D3-D4
1303, 4llaB, 0.5774, 2.57, 0.047, 198, 86, CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
1304, 3x2dH, 0.5774, 3.06, 0.066, 226, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1305, 3v6oD, 0.5774, 3.20, 0.077, 215, 91, LEPTIN RECEPTOR-ANTIBODY COMPLEX
1306, 3qrgH, 0.5774, 3.15, 0.056, 219, 90, CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
1307, 3ob8B, 0.5774, 3.10, 0.063, 1024, 95, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1308, 1j5oH, 0.5774, 3.12, 0.055, 220, 91, CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE- PRIMER
1309, 1igiH, 0.5774, 2.83, 0.090, 217, 89, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1310, 6h6zC, 0.5773, 3.03, 0.110, 126, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-62 
1311, 5truC, 0.5773, 2.92, 0.033, 114, 92, STRUCTURE OF THE FIRST-IN-CLASS CHECKPOINT INHIBITOR IPILIMUMAB BOUND TO HUMAN CTLA-4
1312, 5gzoH, 0.5773, 3.02, 0.100, 214, 90, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1313, 4duxC, 0.5773, 3.01, 0.074, 1015, 94, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
1314, 4a2lA, 0.5773, 3.06, 0.121, 747, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1315, 3fzuC, 0.5773, 3.02, 0.110, 214, 91, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
1316, 2ij0E, 0.5773, 2.81, 0.067, 118, 89, STRUCTURAL BASIS OF T CELL SPECIFICITY AND ACTIVATION BY THE BACTERIAL SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN-1
1317, 1wtgT, 0.5773, 2.40, 0.048, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE
1318, 6ch9Q, 0.5772, 3.09, 0.065, 231, 92, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
1319, 5z1aA, 0.5772, 3.22, 0.063, 655, 95, THE CRYSTAL STRUCTURE OF BACTEROIDES FRAGILIS BETA-GLUCURONIDASE IN COMPLEX WITH URONIC ISOFAGOMINE 
1320, 5xj3F, 0.5772, 2.95, 0.032, 115, 93, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
1321, 5w0pC, 0.5772, 3.20, 0.116, 849, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1322, 4v40G, 0.5772, 3.07, 0.073, 1021, 96, 
1323, 3sdaD, 0.5772, 3.13, 0.088, 239, 91, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1324, 2zzuT, 0.5772, 2.58, 0.047, 191, 85, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5- (3-CARBOXYBENZYLOXY)-TRP-GLN-P-AMINOBENZAMIDINE
1325, 2gi7A, 0.5772, 2.66, 0.070, 182, 86, CRYSTAL STRUCTURE OF HUMAN PLATELET GLYCOPROTEIN VI (GPVI)
1326, 1r0aH, 0.5772, 3.14, 0.077, 225, 91, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLY TETHERED TO DNA TEMPLATE-PRIMER SOLVED TO 2.8 ANGSTROMS
1327, 1jtoB, 0.5772, 2.89, 0.079, 132, 89, DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
1328, 5o32A, 0.5771, 3.66, 0.051, 640, 99, THE STRUCTURE OF COMPLEMENT COMPLEX
1329, 5b71B, 0.5771, 3.08, 0.098, 222, 92, CRYSTAL STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH SKY59
1330, 3vdcB, 0.5771, 3.08, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
1331, 3o45A, 0.5771, 3.15, 0.055, 220, 91, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
1332, 3cfdH, 0.5771, 3.16, 0.056, 220, 90, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
1333, 2zp0T, 0.5771, 2.41, 0.036, 191, 84, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH BENZYLSULFONAMIDE-D- ILE-GLN-P-AMINOBENZAMIDINE
1334, 1g0xA, 0.5771, 2.53, 0.092, 192, 87, CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF LIR-1 (ILT2)
1335, 5iieH, 0.5770, 3.18, 0.066, 219, 91, STRUCTURE OF THE UNLIGANDED ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3
1336, 5eivB, 0.5770, 2.61, 0.081, 181, 86, CRYSTAL STRUCTURE OF COMPLEX OF OSTEOCLAST-ASSOCIATED IMMUNOGLOBULIN- LIKE RECEPTOR (OSCAR) AND A SYNTHETIC COLLAGEN CONSENSUS PEPTIDE
1337, 5axgB, 0.5770, 3.31, 0.086, 584, 93, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS
1338, 5a7mB, 0.5770, 3.64, 0.041, 765, 98, THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)
1339, 4f37H, 0.5770, 3.14, 0.077, 225, 91, STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER S DISEASE A PEPTIDE
1340, 3ob8A, 0.5770, 3.10, 0.063, 1024, 95, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1341, 1wunT, 0.5770, 2.57, 0.047, 191, 85, HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE
1342, 6cpgB, 0.5769, 2.25, 0.133, 89, 83, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) IN COMPLEX WITH INHIBITING MONOBODY AND AT9283 IN AN INACTIVE CONFORMATION 
1343, 6apqA, 0.5769, 2.80, 0.101, 119, 89, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B
1344, 5wt9G, 0.5769, 2.94, 0.078, 109, 90, COMPLEX STRUCTURE OF PD-1 AND NIVOLUMAB-FAB
1345, 5iieA, 0.5769, 3.19, 0.066, 210, 91, STRUCTURE OF THE UNLIGANDED ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3
1346, 5c2bH, 0.5769, 3.10, 0.076, 130, 92, ANTI-CXCL13 PARENTAL SCFV - 3B4
1347, 4nqdD, 0.5769, 2.76, 0.056, 200, 89, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
1348, 4kknA, 0.5769, 2.88, 0.033, 117, 91, CRYSTAL STRUCTURE OF BOVINE CTLA-4 PSI-NYSGRC-012704
1349, 3t08C, 0.5769, 3.07, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
1350, 6b3sF, 0.5768, 3.23, 0.076, 214, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
1351, 5uqyL, 0.5768, 3.03, 0.066, 222, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1352, 5u72B, 0.5768, 2.76, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1353, 4nqeD, 0.5768, 2.81, 0.056, 200, 89, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
1354, 4l4vD, 0.5768, 2.80, 0.056, 200, 89, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
1355, 4hlzG, 0.5768, 3.15, 0.076, 223, 92, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
1356, 3sdcD, 0.5768, 3.07, 0.111, 239, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
1357, 6ck8B, 0.5767, 3.22, 0.043, 124, 92, CRYSTAL STRUCTURE OF ANTI-INFLUENZA SINGLE-DOMAIN LLAMA ANTIBODY SD38 
1358, 5vxjH, 0.5767, 3.02, 0.099, 119, 91, 2.50 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JMK-E3
1359, 5u6qD, 0.5767, 2.80, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1360, 5dezA, 0.5767, 3.48, 0.121, 528, 91, CRYSTAL STRUCTURE OF ACMNPV CHITINASE A
1361, 4j2qB, 0.5767, 3.23, 0.125, 346, 96, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1362, 4gs7B, 0.5767, 2.84, 0.034, 192, 89, STRUCTURE OF THE INTERLEUKIN-15 QUATERNARY COMPLEX
1363, 3x2dD, 0.5767, 3.06, 0.077, 226, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1364, 5d7jG, 0.5766, 2.74, 0.056, 196, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
1365, 4w2pA, 0.5766, 2.97, 0.089, 126, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
1366, 4r4nN, 0.5766, 2.99, 0.089, 219, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
1367, 4pj5D, 0.5766, 2.77, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
1368, 3v6oC, 0.5766, 3.21, 0.077, 219, 91, LEPTIN RECEPTOR-ANTIBODY COMPLEX
1369, 3t2pC, 0.5766, 3.03, 0.084, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
1370, 3t2pB, 0.5766, 3.08, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
1371, 3mpcB, 0.5766, 2.56, 0.070, 96, 86, THE CRYSTAL STRUCTURE OF A FN3-LIKE PROTEIN FROM CLOSTRIDIUM THERMOCELLUM
1372, 3klhD, 0.5766, 3.08, 0.066, 225, 91, CRYSTAL STRUCTURE OF AZT-RESISTANT HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST-TRANSLOCATION AZTMP-TERMINATED DNA (COMPLEX P)
1373, 3as1A, 0.5766, 3.75, 0.103, 570, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - W275G MUTANT COMPLEX STRUCTURE WITH CHELERYTHRINE
1374, 2g2rH, 0.5766, 3.06, 0.077, 219, 91, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
1375, 1orsB, 0.5766, 3.23, 0.055, 221, 91, X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB
1376, 1kenT, 0.5766, 3.28, 0.054, 219, 92, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
1377, 1etzH, 0.5766, 3.08, 0.055, 228, 91, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
1378, 1dl7H, 0.5766, 2.98, 0.091, 112, 88, THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE
1379, 6fxnF, 0.5765, 2.96, 0.079, 220, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1380, 6b3sJ, 0.5765, 3.23, 0.076, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
1381, 5u16G, 0.5765, 2.80, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1382, 5g56A, 0.5765, 2.66, 0.069, 703, 87, THE TETRA-MODULAR CELLULOSOMAL ARABINOXYLANASE CTXYL5A STRUCTURE AS REVEALED BY X-RAY CRYSTALLOGRAPHY
1383, 4pjfG, 0.5765, 2.76, 0.067, 190, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
1384, 3vd3C, 0.5765, 3.16, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
1385, 3rkdH, 0.5765, 3.14, 0.066, 218, 91, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1386, 3i3bC, 0.5765, 3.08, 0.083, 1011, 96, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
1387, 3b2uN, 0.5765, 3.23, 0.076, 218, 92, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1388, 2hkaC, 0.5765, 2.99, 0.053, 130, 94, CRYSTAL STRUCTURE OF BOVINE NPC2 AND CHOLESTEROL SULFATE COMPLEX
1389, 1t03H, 0.5765, 3.09, 0.066, 225, 91, HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIR TERMINATED TEMPLATE-PRIMER (COMPLEX P)
1390, 6erxD, 0.5764, 2.99, 0.078, 215, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1391, 6b3sH, 0.5764, 3.23, 0.076, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
1392, 6b3sC, 0.5764, 3.22, 0.076, 213, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NECITUMUMAB (FAB11F8) IN COMPLEX WITH DOMAIN III FROM A CETUXIMAB RESISTANT VARIANT OF EGFR (SEGFRD3-S468R)
1393, 5x5xH, 0.5764, 2.79, 0.090, 216, 89, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OSTEOCALCIN C-TERMINAL PEPTIDE ANTIBODY KTM219
1394, 5u4lB, 0.5764, 3.41, 0.063, 131, 95, RTA-V1C7_G29R-HIGH-SALT
1395, 5n7eA, 0.5764, 2.37, 0.119, 93, 84, CRYSTAL STRUCTURE OF THE DBL-HOMOLOGY DOMAIN OF BCR-ABL IN COMPLEX WITH MONOBODY MB(BCR-DH_4).
1396, 4v44P, 0.5764, 3.21, 0.072, 1018, 97, 
1397, 4v44O, 0.5764, 3.21, 0.072, 1018, 97, 
1398, 4v44N, 0.5764, 3.21, 0.072, 1018, 97, 
1399, 4v44M, 0.5764, 3.21, 0.072, 1018, 97, 
1400, 4v44L, 0.5764, 3.21, 0.072, 1018, 97, 
1401, 4v44K, 0.5764, 3.21, 0.072, 1018, 97, 
1402, 4v44J, 0.5764, 3.21, 0.072, 1018, 97, 
1403, 4v44I, 0.5764, 3.21, 0.072, 1018, 97, 
1404, 4v44H, 0.5764, 3.21, 0.072, 1018, 97, 
1405, 4v44G, 0.5764, 3.21, 0.072, 1018, 97, 
1406, 4v44F, 0.5764, 3.21, 0.072, 1018, 97, 
1407, 4v44E, 0.5764, 3.21, 0.072, 1018, 97, 
1408, 4v44D, 0.5764, 3.21, 0.072, 1018, 97, 
1409, 4v44C, 0.5764, 3.21, 0.072, 1018, 97, 
1410, 4v44B, 0.5764, 3.21, 0.072, 1018, 97, 
1411, 4v44A, 0.5764, 3.21, 0.072, 1018, 97, 
1412, 4v40H, 0.5764, 3.14, 0.072, 1021, 97, 
1413, 4ofkB, 0.5764, 2.70, 0.069, 104, 87, CRYSTAL STRUCTURE OF SYG-2 D4
1414, 1jz5B, 0.5764, 3.08, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
1415, 5mhrN, 0.5763, 2.80, 0.101, 214, 89, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1416, 5axhB, 0.5763, 3.31, 0.086, 587, 93, CRYSTAL STRUCTURE OF THERMOPHILIC DEXTRANASE FROM THERMOANAEROBACTER PSEUDETHANOLICUS D312G MUTANT IN COMPLEX WITH ISOMALTOHEXAOSE
1417, 4n90F, 0.5763, 3.09, 0.088, 214, 91, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
1418, 3vd9C, 0.5763, 3.08, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
1419, 3t09B, 0.5763, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
1420, 3l5nA, 0.5763, 3.19, 0.043, 634, 94, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT COMPONENT C3B
1421, 1jz5C, 0.5763, 3.08, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
1422, 1igjD, 0.5763, 2.87, 0.090, 217, 89, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1423, 6qn7H, 0.5762, 3.18, 0.066, 223, 91, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B4HC-B13LC 
1424, 6qn7A, 0.5762, 3.17, 0.066, 221, 91, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B4HC-B13LC 
1425, 5w0pB, 0.5762, 3.20, 0.116, 802, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1426, 5u2vE, 0.5762, 2.80, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1427, 5ndxA, 0.5762, 2.67, 0.091, 606, 88, THE BACTERIAL ORTHOLOGUE OF HUMAN A-L-IDURONIDASE DOES NOT NEED N- GLYCAN POST-TRANSLATIONAL MODIFICATIONS TO BE CATALYTICALLY COMPETENT: CRYSTALLOGRAPHY AND QM/MM INSIGHTS INTO MUCOPOLYSACCHARIDOSIS I 
1428, 5kf4D, 0.5762, 2.57, 0.128, 97, 86, CRYSTAL STRUCTURE OF FN3 DOMAIN (RESIDUES P368-P466) OF HUMAN COLLAGEN XX
1429, 4llvA, 0.5762, 2.91, 0.066, 127, 91, THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV
1430, 3va2C, 0.5762, 3.68, 0.039, 307, 102, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-5 IN COMPLEX WITH ITS ALPHA RECEPTOR
1431, 3t0dC, 0.5762, 3.08, 0.074, 1015, 95, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
1432, 1jyvB, 0.5762, 3.09, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
1433, 6fxnD, 0.5761, 3.02, 0.078, 215, 90, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1434, 6dbeA, 0.5761, 2.79, 0.079, 115, 89, CRYSTAL STRUCTURE OF VHH R330 
1435, 4n90D, 0.5761, 3.05, 0.088, 218, 91, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
1436, 4brvD, 0.5761, 3.30, 0.100, 124, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1437, 3cfeH, 0.5761, 3.17, 0.056, 219, 90, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
1438, 3as3A, 0.5761, 3.74, 0.103, 567, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - W275G MUTANT COMPLEX STRUCTURE WITH 2-(IMIDAZOLIN- 2-YL)-5-ISOTHIOCYANATOBENZOFURAN
1439, 6qtlA, 0.5760, 2.99, 0.098, 119, 92, CAFFEINE RECOGNIZING NANOBODY 
1440, 6byeA, 0.5760, 3.30, 0.126, 861, 95, CRYSTAL STRUCTURE OF THE GH2 EXO-BETA-MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI IN COMPLEX WITH MANNOSE 
1441, 4pirF, 0.5760, 3.01, 0.044, 122, 91, X-RAY STRUCTURE OF THE MOUSE SEROTONIN 5-HT3 RECEPTOR
1442, 4lcwD, 0.5760, 2.77, 0.056, 200, 89, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
1443, 4duvC, 0.5760, 3.03, 0.084, 1018, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
1444, 3p2tA, 0.5760, 2.80, 0.068, 194, 88, CRYSTAL STRUCTURE OF LEUKOCYTE IG-LIKE RECEPTOR LILRB4 (ILT3/LIR- 5/CD85K)
1445, 1nepA, 0.5760, 3.06, 0.053, 130, 94, CRYSTAL STRUCTURE ANALYSIS OF THE BOVINE NPC2 (NIEMANN-PICK C2) PROTEIN
1446, 1etzB, 0.5760, 3.23, 0.043, 228, 92, THE THREE-DIMENSIONAL STRUCTURE OF AN ANTI-SWEETENER FAB NC10.14 SHOWS THE EXTENT OF STRUCTURAL DIVERSITY IN ANTIGEN RECOGNITION BY IMMUNOGLOBULINS
1447, 5w0pA, 0.5759, 3.19, 0.116, 847, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1448, 5o8fL, 0.5759, 2.97, 0.055, 124, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE
1449, 5o8fK, 0.5759, 2.98, 0.055, 125, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE
1450, 5k8aB, 0.5759, 2.95, 0.044, 222, 90, NIST FAB
1451, 5jhdI, 0.5759, 3.09, 0.066, 203, 91, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
1452, 3vdbB, 0.5759, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
1453, 1zmyA, 0.5759, 2.90, 0.100, 132, 90, CABBCII-10 VHH FRAMEWORK WITH CDR LOOPS OF CABLYS3 GRAFTED ON IT AND IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1454, 6gk4E, 0.5758, 3.06, 0.110, 122, 91, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T8 
1455, 5o8fO, 0.5758, 2.97, 0.055, 125, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE
1456, 4xrcH, 0.5758, 3.26, 0.076, 217, 92, ANTIBODY HEMAGGLUTININ COMPLEXES
1457, 4gfxA, 0.5758, 3.28, 0.063, 151, 95, CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF TXNIP
1458, 4fxgA, 0.5758, 3.57, 0.102, 651, 98, COMPLEMENT C4 IN COMPLEX WITH MASP-2
1459, 4a2lE, 0.5758, 3.07, 0.121, 744, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1460, 3b8sB, 0.5758, 3.69, 0.093, 567, 97, CRYSTAL STRUCTURE OF WILD-TYPE CHITINASE A FROM VIBRIO HARVEYI
1461, 1zvhA, 0.5758, 2.96, 0.044, 124, 91, CRYSTAL STUCTURE OF THE VHH DOMAIN D2-L24 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
1462, 5o05D, 0.5757, 3.16, 0.033, 114, 91, GII.10 VIETNAM 026 NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANOBODY NANO-42
1463, 5gzoC, 0.5757, 3.12, 0.110, 214, 91, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1464, 4yueH, 0.5757, 3.05, 0.110, 223, 91, MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT
1465, 4r4nW, 0.5757, 3.05, 0.089, 219, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
1466, 4brjA, 0.5757, 3.33, 0.100, 124, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS T24K
1467, 3x2dP, 0.5757, 3.04, 0.077, 226, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1468, 3t09C, 0.5757, 3.16, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
1469, 3qwoH, 0.5757, 3.08, 0.044, 220, 91, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
1470, 3i3dB, 0.5757, 3.10, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
1471, 3g5zB, 0.5757, 3.10, 0.078, 217, 90, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
1472, 3dypB, 0.5757, 3.09, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
1473, 2w9eH, 0.5757, 2.78, 0.079, 215, 89, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
1474, 1jz3B, 0.5757, 3.09, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
1475, 1cicD, 0.5757, 3.23, 0.066, 218, 91, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
1476, 6e9iH, 0.5756, 3.06, 0.078, 265, 90, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
1477, 6dbeB, 0.5756, 2.82, 0.080, 113, 88, CRYSTAL STRUCTURE OF VHH R330 
1478, 5o8fM, 0.5756, 2.98, 0.055, 124, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE
1479, 4v40B, 0.5756, 3.32, 0.092, 1021, 98, 
1480, 3t0bB, 0.5756, 3.09, 0.074, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
1481, 3t08B, 0.5756, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
1482, 3jbc7, 0.5756, 3.03, 0.054, 129, 92, COMPLEX OF POLIOVIRUS WITH VHH PVSP29F
1483, 1sujA, 0.5756, 3.36, 0.134, 363, 97, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1484, 1p6fA, 0.5756, 2.73, 0.069, 188, 87, STRUCTURE OF THE HUMAN NATURAL CYTOTOXICITY RECEPTOR NKP46
1485, 6fxnQ, 0.5755, 2.90, 0.079, 215, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1486, 6etiF, 0.5755, 3.04, 0.056, 118, 90, STRUCTURE OF INHIBITOR-BOUND ABCG2 
1487, 6etiD, 0.5755, 3.04, 0.056, 118, 90, STRUCTURE OF INHIBITOR-BOUND ABCG2 
1488, 6e9iC, 0.5755, 3.06, 0.078, 259, 90, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
1489, 6be4H, 0.5755, 3.12, 0.066, 217, 91, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)
1490, 5swsD, 0.5755, 3.16, 0.044, 198, 91, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
1491, 5nivB, 0.5755, 3.07, 0.056, 213, 90, CRYSTAL STRUCTURE OF 5D3 FAB
1492, 4r7dA, 0.5755, 3.16, 0.088, 218, 91, FAB HU 15C1
1493, 3t0aC, 0.5755, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
1494, 3bgaA, 0.5755, 3.56, 0.090, 983, 100, CRYSTAL STRUCTURE OF BETA-GALACTOSIDASE FROM BACTEROIDES THETAIOTAOMICRON VPI-5482
1495, 2vq1F, 0.5755, 3.14, 0.055, 211, 91, ANTI TRIMERIC LEWIS X FAB54-5C10-A
1496, 1px3B, 0.5755, 3.09, 0.083, 1009, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
1497, 1hn1A, 0.5755, 3.21, 0.072, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1498, 6db7I, 0.5754, 3.03, 0.089, 233, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
1499, 5vplD, 0.5754, 3.09, 0.077, 216, 91, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
1500, 4w2oE, 0.5754, 2.92, 0.089, 118, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1501, 4bk8A, 0.5754, 3.31, 0.100, 123, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS
1502, 3t0aB, 0.5754, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
1503, 2vtfB, 0.5754, 2.51, 0.081, 616, 86, X-RAY CRYSTAL STRUCTURE OF THE ENDO-BETA-N- ACETYLGLUCOSAMINIDASE FROM ARTHROBACTER PROTOPHORMIAE E173Q MUTANT REVEALS A TIM BARREL CATALYTIC DOMAIN AND TWO ANCILLARY DOMAINS
1504, 1dp0B, 0.5754, 3.09, 0.083, 1011, 96, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
1505, 1ayrB, 0.5754, 3.29, 0.125, 363, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1506, 6oe4B, 0.5753, 3.04, 0.111, 225, 90, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
1507, 6j71B, 0.5753, 3.45, 0.097, 233, 93, HUA21-SCFV IN COMPLEX WITH THE EXTRACELLULAR DOMAIN(ECD) OF HER2 
1508, 4zwjB, 0.5753, 3.31, 0.115, 673, 96, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1509, 4ofkA, 0.5753, 2.82, 0.080, 103, 88, CRYSTAL STRUCTURE OF SYG-2 D4
1510, 4k3dI, 0.5753, 3.15, 0.067, 217, 90, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
1511, 4a2lD, 0.5753, 3.08, 0.121, 745, 91, STRUCTURE OF THE PERIPLASMIC DOMAIN OF THE HEPARIN AND HEPARAN SULPHATE SENSING HYBRID TWO COMPONENT SYSTEM BT4663 IN APO AND LIGAND BOUND FORMS
1512, 3vd4C, 0.5753, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
1513, 3t0bC, 0.5753, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
1514, 3rkdD, 0.5753, 3.11, 0.066, 218, 91, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY
1515, 3ob8C, 0.5753, 3.17, 0.062, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1516, 3j7hD, 0.5753, 3.24, 0.093, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
1517, 1f4hA, 0.5753, 3.18, 0.073, 1021, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1518, 1ayrD, 0.5753, 3.29, 0.125, 363, 96, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1519, 6gjuC, 0.5752, 2.92, 0.099, 120, 91, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES T2A AND T4 
1520, 6ck8C, 0.5752, 3.20, 0.033, 124, 92, CRYSTAL STRUCTURE OF ANTI-INFLUENZA SINGLE-DOMAIN LLAMA ANTIBODY SD38 
1521, 6be3H, 0.5752, 3.09, 0.066, 217, 91, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE (GLCNAC)
1522, 5t4zH, 0.5752, 3.19, 0.066, 227, 91, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
1523, 5dgyA, 0.5752, 3.22, 0.116, 833, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1524, 5df0B, 0.5752, 3.20, 0.112, 528, 89, CRYSTAL STRUCTURE OF ACMNPV CHITINASE A IN COMPLEX WITH CHITOTRIO- THIAZOLINE DITHIOAMIDE
1525, 4zwjA, 0.5752, 3.22, 0.116, 833, 95, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1526, 4qrpD, 0.5752, 2.73, 0.091, 203, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1527, 4llvC, 0.5752, 3.08, 0.076, 127, 92, THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV
1528, 4brvC, 0.5752, 3.31, 0.100, 124, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1529, 3vdcC, 0.5752, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
1530, 3j7hC, 0.5752, 3.24, 0.093, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
1531, 3j7hB, 0.5752, 3.24, 0.093, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
1532, 3j7hA, 0.5752, 3.24, 0.093, 1022, 97, STRUCTURE OF BETA-GALACTOSIDASE AT 3.2-A RESOLUTION OBTAINED BY CRYO- ELECTRON MICROSCOPY
1533, 1jz2B, 0.5752, 3.09, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
1534, 1gigH, 0.5752, 3.14, 0.077, 221, 91, REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A MURINE IGG1 LAMBDA ANTIBODY
1535, 1f4hB, 0.5752, 3.08, 0.073, 1021, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1536, 6apbH, 0.5751, 3.13, 0.044, 219, 91, CRYSTAL STRUCTURE OF NON-NEUTRALIZING INFANT ANTIBODY ADI-14359 IN COMPLEX WITH POSTFUSION RSV F GLYCOPROTEIN
1537, 4duwB, 0.5751, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
1538, 4cucA, 0.5751, 3.41, 0.041, 847, 98, UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE BGAA.
1539, 3vd4B, 0.5751, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
1540, 3qq9H, 0.5751, 3.13, 0.055, 214, 91, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
1541, 3qq9D, 0.5751, 3.08, 0.056, 212, 90, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
1542, 3obaB, 0.5751, 3.17, 0.062, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1543, 3iapD, 0.5751, 3.18, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
1544, 3g9vA, 0.5751, 2.41, 0.047, 173, 85, CRYSTAL STRUCTURE OF A SOLUBLE DECOY RECEPTOR IL-22BP BOUND TO INTERLEUKIN-22
1545, 3b8sA, 0.5751, 3.79, 0.103, 567, 97, CRYSTAL STRUCTURE OF WILD-TYPE CHITINASE A FROM VIBRIO HARVEYI
1546, 2amuA, 0.5751, 3.30, 0.022, 132, 90, CRYSTAL STRUCTURE OF A PUTATIVE SUPEROXIDE REDUCTASE (TM0658) FROM THERMOTOGA MARITIMA AT 2.00 A RESOLUTION
1547, 1t4kD, 0.5751, 3.13, 0.066, 217, 91, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
1548, 6fxnM, 0.5750, 2.96, 0.079, 215, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1549, 6ch8D, 0.5750, 3.06, 0.088, 235, 91, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
1550, 5v7uH, 0.5750, 3.15, 0.088, 216, 91, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-22.1 FAB
1551, 4yc2B, 0.5750, 3.21, 0.065, 223, 93, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 FROM E. COLI IN COMPLEX WITH THE ANTIBODY A32.
1552, 4qrpJ, 0.5750, 2.74, 0.080, 203, 88, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1553, 4cu6A, 0.5750, 3.53, 0.040, 847, 99, UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE BGAA
1554, 3t2qC, 0.5750, 3.10, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
1555, 3obaA, 0.5750, 3.17, 0.062, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1556, 3o41H, 0.5750, 3.09, 0.055, 220, 91, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
1557, 1g4rA, 0.5750, 3.24, 0.140, 353, 93, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1558, 6qtlH, 0.5749, 3.06, 0.055, 117, 91, CAFFEINE RECOGNIZING NANOBODY 
1559, 6fxnO, 0.5749, 2.77, 0.068, 215, 88, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1560, 6e9iA, 0.5749, 3.08, 0.078, 267, 90, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
1561, 5o8fN, 0.5749, 2.98, 0.055, 124, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25 AND PREGNANOLONE
1562, 5kf4B, 0.5749, 2.70, 0.148, 99, 88, CRYSTAL STRUCTURE OF FN3 DOMAIN (RESIDUES P368-P466) OF HUMAN COLLAGEN XX
1563, 5gxbB, 0.5749, 3.06, 0.120, 132, 92, CRYSTAL STRUCTURE OF A LACY/NANOBODY COMPLEX
1564, 4zypJ, 0.5749, 3.22, 0.043, 213, 92, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
1565, 4w2pC, 0.5749, 3.01, 0.089, 120, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
1566, 4jmgA, 0.5749, 2.75, 0.090, 197, 89, CRYSTAL STRUCTURE OF THE SYNTHETIC PROTEIN IN COMPLEX WITH PY PEPTIDE
1567, 3rvuD, 0.5749, 3.02, 0.067, 221, 90, STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP
1568, 3obaD, 0.5749, 3.17, 0.062, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1569, 3o45H, 0.5749, 3.09, 0.055, 220, 91, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
1570, 3cfeB, 0.5749, 3.40, 0.054, 219, 92, CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10
1571, 6oe5B, 0.5748, 3.26, 0.043, 213, 92, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
1572, 6ml8H, 0.5748, 3.10, 0.108, 227, 93, CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY 
1573, 6grtB, 0.5748, 2.53, 0.092, 594, 87, PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN 
1574, 6dxuB, 0.5748, 3.39, 0.093, 803, 97, CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) 
1575, 5t4zA, 0.5748, 3.10, 0.067, 218, 90, STRUCTURE OF THE ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3 WITH FREE MAN9 GLYCAN
1576, 5b8cF, 0.5748, 3.31, 0.054, 116, 93, HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV
1577, 4v41P, 0.5748, 3.26, 0.103, 1018, 97, 
1578, 4v41O, 0.5748, 3.26, 0.103, 1018, 97, 
1579, 4v41N, 0.5748, 3.26, 0.103, 1018, 97, 
1580, 4v41M, 0.5748, 3.26, 0.103, 1018, 97, 
1581, 4v41L, 0.5748, 3.26, 0.103, 1018, 97, 
1582, 4v41K, 0.5748, 3.26, 0.103, 1018, 97, 
1583, 4v41J, 0.5748, 3.26, 0.103, 1018, 97, 
1584, 4v41I, 0.5748, 3.26, 0.103, 1018, 97, 
1585, 4v41H, 0.5748, 3.26, 0.103, 1018, 97, 
1586, 4v41G, 0.5748, 3.26, 0.103, 1018, 97, 
1587, 4v41F, 0.5748, 3.26, 0.103, 1018, 97, 
1588, 4v41E, 0.5748, 3.26, 0.103, 1018, 97, 
1589, 4v41D, 0.5748, 3.26, 0.103, 1018, 97, 
1590, 4v41C, 0.5748, 3.26, 0.103, 1018, 97, 
1591, 4v41B, 0.5748, 3.26, 0.103, 1018, 97, 
1592, 4v41A, 0.5748, 3.26, 0.103, 1018, 97, 
1593, 4v40E, 0.5748, 3.25, 0.103, 1021, 97, 
1594, 4nenA, 0.5748, 3.29, 0.074, 1063, 95, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
1595, 4j1uD, 0.5748, 3.01, 0.056, 210, 89, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
1596, 3vdbC, 0.5748, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
1597, 3t0dB, 0.5748, 3.11, 0.083, 1015, 96, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
1598, 3as0A, 0.5748, 3.76, 0.103, 570, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - W275G MUTANT COMPLEX STRUCTURE WITH SANGUINARINE
1599, 1jyxD, 0.5748, 3.11, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
1600, 1hysD, 0.5748, 3.09, 0.066, 220, 91, CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH A POLYPURINE TRACT RNA:DNA
1601, 1g7mB, 0.5748, 3.37, 0.043, 116, 92, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92V)
1602, 6eerC, 0.5747, 3.76, 0.059, 776, 102, STRUCTURE OF GLYCINE-BOUND GOXA FROM PSEUDOALTEROMONAS LUTEOVIOLACEA 
1603, 6cvmD, 0.5747, 3.26, 0.093, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
1604, 6bcsA, 0.5747, 2.89, 0.067, 196, 89, LILRB2 D1D2 DOMAINS COMPLEXED WITH BENZAMIDINE 
1605, 5ufvA, 0.5747, 2.99, 0.112, 227, 89, CRYSTAL STRUCTURE OF A CELLULOSE-ACTIVE POLYSACCHARIDE MONOOXYGENASE FROM M. THERMOPHILA (MTPMO3*)
1606, 5j3hC, 0.5747, 3.13, 0.078, 116, 90, HUMAN INSULIN RECEPTOR DOMAINS L1-CR IN COMPLEX WITH PEPTIDE S519C16 AND 83-7 FV
1607, 4w2oA, 0.5747, 2.91, 0.089, 118, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1608, 3ob8D, 0.5747, 3.14, 0.062, 1024, 96, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS IN COMPLEX WITH GALACTOSE
1609, 1jttA, 0.5747, 3.08, 0.077, 133, 91, DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
1610, 6df3L, 0.5746, 2.83, 0.090, 199, 89, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF IL-24 WITH SOLUBLE RECEPTORS IL-22RA AND IL-20RB 
1611, 6cvmC, 0.5746, 3.26, 0.093, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
1612, 6cvmB, 0.5746, 3.26, 0.093, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
1613, 6cvmA, 0.5746, 3.26, 0.093, 1021, 97, ATOMIC RESOLUTION CRYO-EM STRUCTURE OF BETA-GALACTOSIDASE 
1614, 6c61A, 0.5746, 2.65, 0.091, 206, 88, MHC-INDEPENDENT T-CELL RECEPTOR B12A 
1615, 5v7pD, 0.5746, 2.56, 0.118, 95, 85, ATOMIC STRUCTURE OF THE EUKARYOTIC INTRAMEMBRANE RAS METHYLTRANSFERASE ICMT (ISOPRENYLCYSTEINE CARBOXYL METHYLTRANSFERASE) IN COMPLEX WITH A MONOBODY
1616, 5swzN, 0.5746, 3.12, 0.055, 201, 91, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1617, 4n90H, 0.5746, 3.18, 0.076, 215, 92, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
1618, 4duwC, 0.5746, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
1619, 4dk6B, 0.5746, 3.09, 0.099, 127, 91, STRUCTURE OF EDITOSOME PROTEIN
1620, 4cu7A, 0.5746, 3.61, 0.030, 848, 100, UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE BGAA
1621, 3vd9B, 0.5746, 3.11, 0.083, 1016, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
1622, 1t4kB, 0.5746, 3.14, 0.066, 217, 91, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
1623, 1jrhH, 0.5746, 3.16, 0.077, 180, 91, COMPLEX (ANTIBODY/ANTIGEN)
1624, 1iaiI, 0.5746, 2.97, 0.099, 218, 91, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
1625, 6mtrH, 0.5745, 3.07, 0.111, 221, 90, CRYSTAL STRUCTURE OF VRC43.01 FAB 
1626, 5drwA, 0.5745, 2.97, 0.078, 218, 90, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL183
1627, 4kdtB, 0.5745, 2.87, 0.056, 128, 90, STRUCTURE OF AN EARLY NATIVE-LIKE INTERMEDIATE OF BETA2-MICROGLOBULIN AMYLOIDOSIS
1628, 4duxB, 0.5745, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
1629, 3sepB, 0.5745, 3.12, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
1630, 3cfdB, 0.5745, 3.25, 0.055, 219, 91, PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN
1631, 6erxF, 0.5744, 2.93, 0.067, 220, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1632, 6c83C, 0.5744, 2.19, 0.134, 87, 82, STRUCTURE OF AURORA A (122-403) BOUND TO INHIBITORY MONOBODY MB2 AND AMPPCP 
1633, 5d7jA, 0.5744, 2.78, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
1634, 5b8cC, 0.5744, 3.32, 0.065, 116, 93, HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV
1635, 4i0cD, 0.5744, 2.96, 0.079, 127, 89, THE STRUCTURE OF THE CAMELID ANTIBODY CABHUL5 IN COMPLEX WITH HUMAN LYSOZYME
1636, 4hs8H, 0.5744, 3.10, 0.099, 225, 91, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
1637, 4grwH, 0.5744, 3.12, 0.033, 123, 91, STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
1638, 2g2rB, 0.5744, 3.06, 0.077, 219, 91, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
1639, 2arwA, 0.5744, 3.23, 0.152, 103, 92, THE SOLUTION STRUCTURE OF THE MEMBRANE PROXIMAL CYTOKINE RECEPTOR DOMAIN OF THE HUMAN INTERLEUKIN-6 RECEPTOR
1640, 5weqB, 0.5743, 3.21, 0.054, 219, 92, THE CRYSTAL STRUCTURE OF A MR78 MUTANT 
1641, 4xnmH, 0.5743, 3.27, 0.076, 217, 92, ANTIBODY INFLUENZA H5 COMPLEX
1642, 4x7tA, 0.5743, 3.29, 0.054, 222, 92, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
1643, 4v40O, 0.5743, 3.27, 0.103, 1021, 97, 
1644, 4rx4A, 0.5743, 2.98, 0.090, 222, 89, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120
1645, 4krnA, 0.5743, 3.19, 0.043, 126, 92, NANOBODY/VHH DOMAIN EGA1
1646, 3sepC, 0.5743, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
1647, 3arzA, 0.5743, 3.78, 0.103, 567, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH 2-(IMIDAZOLIN-2-YL)-5- ISOTHIOCYANATOBENZOFURAN
1648, 1igjB, 0.5743, 2.93, 0.090, 217, 89, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1649, 6erxO, 0.5742, 2.78, 0.068, 215, 88, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1650, 5dlmH, 0.5742, 3.11, 0.089, 216, 90, COMPLEX OF INFLUENZA M2E AND ANTIBODY
1651, 4pj7G, 0.5742, 2.79, 0.056, 199, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
1652, 4duvD, 0.5742, 3.18, 0.083, 1018, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
1653, 3t2qB, 0.5742, 3.11, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
1654, 3moqA, 0.5742, 2.96, 0.112, 126, 89, AMYLOID BETA(18-41) PEPTIDE FUSION WITH NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1655, 3l7eH, 0.5742, 3.19, 0.077, 216, 91, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
1656, 3czjD, 0.5742, 3.18, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
1657, 3b83G, 0.5742, 2.69, 0.057, 99, 87, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1658, 3b2vH, 0.5742, 3.10, 0.077, 217, 91, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1659, 3b2uC, 0.5742, 3.26, 0.065, 213, 92, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1660, 1x5xA, 0.5742, 3.02, 0.109, 109, 92, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE-III DOMAIN OF HUMAN FIBRONECTIN TYPE III DOMAIN CONTAINING PROTEIN 3
1661, 1g4mB, 0.5742, 3.41, 0.144, 357, 97, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1662, 4x7sH, 0.5741, 3.11, 0.066, 222, 91, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
1663, 4rx4H, 0.5741, 3.06, 0.089, 217, 90, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120
1664, 4cu8A, 0.5741, 3.60, 0.030, 848, 100, UNRAVELLING THE MULTIPLE FUNCTIONS OF THE ARCHITECTURALLY INTRICATE STREPTOCOCCUS PNEUMONIAE BETA-GALACTOSIDASE BGAA
1665, 3vfgH, 0.5741, 3.22, 0.110, 217, 91, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
1666, 3g5vB, 0.5741, 3.07, 0.078, 200, 90, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
1667, 6qtlF, 0.5740, 3.04, 0.088, 119, 91, CAFFEINE RECOGNIZING NANOBODY 
1668, 4pj7E, 0.5740, 2.80, 0.056, 199, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
1669, 4jguB, 0.5740, 2.65, 0.095, 95, 84, CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY-DISEASE-LIKE DOMAIN 2B AT 1.4 ANGSTROM RESOLUTION IN THE PRESENCE OF CALCIUM
1670, 3we6A, 0.5740, 2.83, 0.144, 212, 90, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT
1671, 3t09A, 0.5740, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
1672, 3b9aA, 0.5740, 3.72, 0.104, 567, 96, CRYSTAL STRUCTURE OF VIBRIO HARVEYI CHITINASE A COMPLEXED WITH HEXASACCHARIDE
1673, 2o6cB, 0.5740, 3.14, 0.064, 154, 94, STRUCTURE OF SELENOMETHIONYL RTP34 FROM TREPONEMA PALLIDUM
1674, 2ialA, 0.5740, 2.72, 0.069, 196, 87, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1675, 6erxQ, 0.5739, 2.91, 0.079, 215, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1676, 6cpgE, 0.5739, 2.16, 0.134, 88, 82, STRUCTURE OF DEPHOSPHORYLATED AURORA A (122-403) IN COMPLEX WITH INHIBITING MONOBODY AND AT9283 IN AN INACTIVE CONFORMATION 
1677, 5whkL, 0.5739, 3.20, 0.097, 212, 93, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY DX-2507 BOUND TO FCRN- B2M
1678, 5ovwL, 0.5739, 3.11, 0.044, 126, 90, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1679, 4ckdD, 0.5739, 3.24, 0.072, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
1680, 4ckdC, 0.5739, 3.24, 0.072, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
1681, 3vd5C, 0.5739, 3.23, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
1682, 3t0bD, 0.5739, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
1683, 3t09D, 0.5739, 3.12, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) GALACTONOLACTONE COMPLEX
1684, 3pnwW, 0.5739, 3.22, 0.088, 220, 91, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
1685, 3mpcA, 0.5739, 2.54, 0.070, 96, 86, THE CRYSTAL STRUCTURE OF A FN3-LIKE PROTEIN FROM CLOSTRIDIUM THERMOCELLUM
1686, 2xzaH, 0.5739, 3.06, 0.078, 211, 90, CRYSTAL STRUCTURE OF RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
1687, 1qlrB, 0.5739, 3.05, 0.066, 209, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
1688, 1f4aD, 0.5739, 3.24, 0.072, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
1689, 1f4aC, 0.5739, 3.24, 0.072, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
1690, 6h6yG, 0.5738, 3.10, 0.099, 115, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-7 
1691, 6a4kK, 0.5738, 3.20, 0.087, 230, 92, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
1692, 5ubyH, 0.5738, 3.17, 0.077, 228, 91, FAB STRUCTURE OF ANTI-HIV-1 GP120 MAB 1A8
1693, 5m14C, 0.5738, 3.24, 0.043, 127, 93, SYNTHETIC NANOBODY IN COMPLEX WITH MBP
1694, 5j56B, 0.5738, 3.19, 0.109, 129, 92, RTA-V1C7
1695, 4m7jH, 0.5738, 3.20, 0.089, 219, 90, CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
1696, 4ckdB, 0.5738, 3.24, 0.072, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
1697, 4ckdA, 0.5738, 3.24, 0.072, 1021, 97, MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4.
1698, 3vd5A, 0.5738, 3.26, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
1699, 3sepD, 0.5738, 3.12, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
1700, 3ifpC, 0.5738, 3.13, 0.055, 216, 91, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
1701, 3arrA, 0.5738, 3.84, 0.103, 567, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH PENTOXIFYLLINE
1702, 2ic2A, 0.5738, 2.70, 0.092, 101, 87, CRYSTAL STRUCTURE OF THE FIRST FNIII DOMAIN OF IHOG
1703, 1f4aB, 0.5738, 3.24, 0.072, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
1704, 1f4aA, 0.5738, 3.24, 0.072, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (NCS CONSTRAINED MONOMER- ORTHORHOMBIC)
1705, 5ufvC, 0.5737, 3.02, 0.112, 227, 89, CRYSTAL STRUCTURE OF A CELLULOSE-ACTIVE POLYSACCHARIDE MONOOXYGENASE FROM M. THERMOPHILA (MTPMO3*)
1706, 5swzI, 0.5737, 3.17, 0.055, 186, 91, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1707, 4yzfG, 0.5737, 3.28, 0.043, 223, 92, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
1708, 4ywgI, 0.5737, 3.01, 0.089, 226, 90, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
1709, 4rs1B, 0.5737, 2.94, 0.054, 267, 92, CRYSTAL STRUCTURE OF RECEPTOR-CYTOKINE COMPLEX
1710, 4k3dH, 0.5737, 3.17, 0.067, 262, 90, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
1711, 2j6eI, 0.5737, 3.14, 0.077, 220, 91, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
1712, 1nc2B, 0.5737, 3.13, 0.100, 218, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
1713, 4fzeH, 0.5736, 2.99, 0.078, 221, 90, CRYSTAL STRUCTURE OF N26_I1 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
1714, 3t2pD, 0.5736, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
1715, 3moqC, 0.5736, 2.93, 0.101, 126, 89, AMYLOID BETA(18-41) PEPTIDE FUSION WITH NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1716, 2qbwA, 0.5736, 2.78, 0.112, 189, 89, THE CRYSTAL STRUCTURE OF PDZ-FIBRONECTIN FUSION PROTEIN
1717, 2ij0C, 0.5736, 2.85, 0.056, 118, 89, STRUCTURAL BASIS OF T CELL SPECIFICITY AND ACTIVATION BY THE BACTERIAL SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN-1
1718, 1vfbB, 0.5736, 3.09, 0.056, 116, 90, BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
1719, 6mamA, 0.5735, 2.98, 0.100, 226, 90, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
1720, 6feqF, 0.5735, 3.05, 0.056, 118, 90, STRUCTURE OF INHIBITOR-BOUND ABCG2 
1721, 6feqD, 0.5735, 3.05, 0.056, 118, 90, STRUCTURE OF INHIBITOR-BOUND ABCG2 
1722, 5w6cH, 0.5735, 3.24, 0.076, 225, 92, UCA FAB (UNBOUND) FROM 6649 LINEAGE
1723, 4kdtA, 0.5735, 2.89, 0.056, 129, 90, STRUCTURE OF AN EARLY NATIVE-LIKE INTERMEDIATE OF BETA2-MICROGLOBULIN AMYLOIDOSIS
1724, 4duxD, 0.5735, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
1725, 4duxA, 0.5735, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH L-RIBOSE
1726, 3lh2O, 0.5735, 3.24, 0.087, 110, 92, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
1727, 3ifpH, 0.5735, 3.04, 0.067, 222, 90, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
1728, 2ck2A, 0.5735, 2.78, 0.114, 94, 88, STRUCTURE OF CORE-SWAPPED MUTANT OF FIBRONECTIN
1729, 2a0lF, 0.5735, 3.35, 0.044, 116, 91, CRYSTAL STRUCTURE OF KVAP-33H1 FV COMPLEX
1730, 6eynD, 0.5734, 3.06, 0.066, 194, 91, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
1731, 5jrpH, 0.5734, 3.19, 0.065, 220, 92, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MR78 FAB
1732, 5e94D, 0.5734, 3.11, 0.044, 224, 90, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
1733, 5d5mG, 0.5734, 2.77, 0.056, 198, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
1734, 4w2oG, 0.5734, 2.96, 0.089, 118, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1735, 3vd9A, 0.5734, 3.07, 0.084, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
1736, 3moqD, 0.5734, 2.96, 0.112, 126, 89, AMYLOID BETA(18-41) PEPTIDE FUSION WITH NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1737, 3b2uW, 0.5734, 3.38, 0.065, 216, 93, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1738, 3as2A, 0.5734, 3.79, 0.093, 570, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - W275G MUTANT COMPLEX STRUCTURE WITH PROPENTOFYLLINE
1739, 5vxrH, 0.5733, 3.14, 0.067, 207, 90, THE ANTIGEN-BINDING FRAGMENT OF MAB24 IN COMPLEX WITH A PEPTIDE FROM HEPATITIS C VIRUS E2 EPITOPE I (412-423)
1740, 4ybhA, 0.5733, 3.23, 0.098, 302, 92, CRYSTAL STRUCTURE OF THE HUMAN RAGE ECTODOMAIN (VC1C2 FRAGMENT) IN COMPLEX WITH HUMAN S100A6
1741, 4duwD, 0.5733, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
1742, 4duwA, 0.5733, 3.07, 0.084, 1015, 95, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE
1743, 3w13C, 0.5733, 3.05, 0.067, 116, 89, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHACT PEPTIDE(693-719) AND FAB 83-7
1744, 3vdaD, 0.5733, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
1745, 3t2qD, 0.5733, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
1746, 3t0dA, 0.5733, 3.07, 0.084, 1015, 95, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
1747, 3i3eD, 0.5733, 3.19, 0.083, 1011, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
1748, 3b9kH, 0.5733, 3.11, 0.078, 214, 90, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
1749, 3b83E, 0.5733, 2.75, 0.067, 99, 89, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1750, 3arsA, 0.5733, 3.78, 0.103, 567, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - APO STRUCTURE OF MUTANT W275G
1751, 2vq1B, 0.5733, 3.21, 0.055, 213, 91, ANTI TRIMERIC LEWIS X FAB54-5C10-A
1752, 1ollA, 0.5733, 3.00, 0.045, 188, 88, EXTRACELLULAR REGION OF THE HUMAN RECEPTOR NKP46
1753, 1dp0D, 0.5733, 3.18, 0.083, 1011, 96, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
1754, 5swzD, 0.5732, 3.19, 0.055, 198, 91, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1755, 5m14D, 0.5732, 3.13, 0.065, 127, 92, SYNTHETIC NANOBODY IN COMPLEX WITH MBP
1756, 4v40I, 0.5732, 3.28, 0.093, 1021, 97, 
1757, 4nzrH, 0.5732, 3.40, 0.109, 228, 92, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB
1758, 4m1gH, 0.5732, 3.24, 0.077, 216, 91, STRUCTURE OF MURINE IGG2A A27D7-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 1.6 ANGSTROMS
1759, 4g6mH, 0.5732, 3.29, 0.087, 220, 92, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
1760, 3t08D, 0.5732, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
1761, 2ajuH, 0.5732, 3.20, 0.066, 219, 91, CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB 
1762, 2a0lD, 0.5732, 3.34, 0.044, 116, 91, CRYSTAL STRUCTURE OF KVAP-33H1 FV COMPLEX
1763, 1ay1H, 0.5732, 3.22, 0.044, 213, 91, ANTI TAQ FAB TP7
1764, 6ieaH, 0.5731, 3.13, 0.066, 210, 91, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
1765, 6f0yA, 0.5731, 3.33, 0.062, 172, 97, RTT109 PEPTIDE BOUND TO ASF1
1766, 6e9uA, 0.5731, 3.05, 0.067, 262, 90, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-7 
1767, 6c5iH, 0.5731, 3.17, 0.078, 216, 90, UNLIGANDED S25-5 FAB 
1768, 5hcgH, 0.5731, 3.34, 0.087, 332, 92, CRYSTAL STRUCTURE OF FREE-CODV.
1769, 5e94B, 0.5731, 3.22, 0.044, 224, 91, ANTIBODY-BOUND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR EXTRACELLULAR DOMAIN
1770, 5d5mE, 0.5731, 2.79, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
1771, 5c0rH, 0.5731, 3.08, 0.120, 222, 92, CRYSTAL STRUCTURE OF A GENERATION 3 INFLUENZA HEMAGGLUTININ STABILIZED STEM COMPLEXED WITH THE BROADLY NEUTRALIZING ANTIBODY C179
1772, 4ywgH, 0.5731, 3.22, 0.087, 210, 92, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
1773, 3vd4D, 0.5731, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
1774, 3moqB, 0.5731, 2.95, 0.112, 126, 89, AMYLOID BETA(18-41) PEPTIDE FUSION WITH NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
1775, 3artA, 0.5731, 3.78, 0.113, 570, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - W275G MUTANT COMPLEX STRUCTURE WITH DEQUALINIUM
1776, 2lfgA, 0.5731, 3.26, 0.086, 113, 93, SOLUTION STRUCTURE OF THE HUMAN PROLACTIN RECEPTOR ECD DOMAIN D2
1777, 1hn1B, 0.5731, 3.27, 0.093, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1778, 1dqdH, 0.5731, 3.22, 0.055, 221, 91, CRYSTAL STRUCTURE OF FAB HGR-2 F6 A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR
1779, 1cbvH, 0.5731, 3.00, 0.078, 219, 90, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE- DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE- FAB COMPLEX
1780, 4fp8K, 0.5730, 3.03, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
1781, 3vd9D, 0.5730, 3.13, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH IPTG
1782, 3t0dD, 0.5730, 3.14, 0.083, 1015, 96, E.COLI (LACZ) BETA-GALACTOSIDASE (S796T) IN COMPLEX WITH GALACTONOLACTONE
1783, 3b9dA, 0.5730, 3.73, 0.104, 567, 96, CRYSTAL STRUCTURE OF VIBRIO HARVEYI CHITINASE A COMPLEXED WITH PENTASACCHARIDE
1784, 3b2uJ, 0.5730, 3.13, 0.077, 217, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1785, 2vtcB, 0.5730, 2.85, 0.022, 228, 90, THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 61 MEMBER CEL61B FROM THE HYPOCREA JECORINA.
1786, 6fytI, 0.5729, 3.26, 0.043, 124, 92, STRUCTURE OF H1 (A/SOLOMON ISLANDS/3/06) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH SD38 
1787, 5ukrH, 0.5729, 3.29, 0.043, 221, 92, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB IN COMPLEX WITH A GP120 CORE
1788, 4w2oC, 0.5729, 2.92, 0.090, 118, 89, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY B COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1789, 3vdbD, 0.5729, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
1790, 3ifpA, 0.5729, 2.98, 0.056, 216, 90, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
1791, 3cx5J, 0.5729, 3.27, 0.043, 127, 92, STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
1792, 2vtcA, 0.5729, 2.85, 0.022, 228, 90, THE STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 61 MEMBER CEL61B FROM THE HYPOCREA JECORINA.
1793, 2virB, 0.5729, 3.18, 0.077, 221, 91, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1794, 6qn8J, 0.5728, 3.17, 0.077, 227, 91, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1795, 6qn8C, 0.5728, 3.07, 0.067, 226, 90, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
1796, 6mvgA, 0.5728, 3.21, 0.064, 637, 94, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
1797, 6h6yE, 0.5728, 3.11, 0.055, 117, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-7 
1798, 5wttH, 0.5728, 3.22, 0.044, 214, 91, STRUCTURE OF THE 093G9 FAB IN COMPLEX WITH THE EPITOPE PEPTIDE
1799, 4u6tA, 0.5728, 2.61, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A AT 1.76 ANGSTROM RESOLUTION
1800, 4q66D, 0.5728, 2.37, 0.060, 171, 84, STRUCTURE OF EXOMER BOUND TO ARF1.
1801, 4ofpD, 0.5728, 2.81, 0.069, 197, 87, CRYSTAL STRUCTURE OF SYG-2 D3-D4
1802, 3ifpE, 0.5728, 2.98, 0.056, 216, 90, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:12B4) COMPLEX
1803, 3dymC, 0.5728, 3.23, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
1804, 2p1yG, 0.5728, 2.85, 0.034, 217, 88, 1.B2.D9 A BISPECIFIC ALPHA/BETA TCR
1805, 6n48B, 0.5727, 3.02, 0.077, 120, 91, STRUCTURE OF BETA2 ADRENERGIC RECEPTOR BOUND TO BI167107; NANOBODY 6B9; AND A POSITIVE ALLOSTERIC MODULATOR 
1806, 6dxuC, 0.5727, 3.42, 0.082, 806, 97, CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) 
1807, 6bynM, 0.5727, 2.48, 0.118, 96, 85, CRYSTAL STRUCTURE OF WDR5-MB(S4) MONOBODY COMPLEX 
1808, 6a4kI, 0.5727, 3.19, 0.087, 230, 92, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
1809, 4pjeE, 0.5727, 2.74, 0.057, 189, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
1810, 4pjaE, 0.5727, 2.74, 0.057, 188, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
1811, 3vdaA, 0.5727, 3.15, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T)
1812, 3vd4A, 0.5727, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D) IN COMPLEX WITH IPTG
1813, 3l7eB, 0.5727, 3.19, 0.088, 215, 91, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
1814, 3i3bB, 0.5727, 3.24, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
1815, 3dgcS, 0.5727, 2.80, 0.124, 207, 89, STRUCTURE OF IL-22/IL-22R1
1816, 1ohqB, 0.5727, 3.07, 0.089, 119, 90, CRYSTAL STRUCTURE OF HEL4 A SOLUBLE HUMAN VH ANTIBODY DOMAIN RESISTANT TO AGGREGATION
1817, 6iutH, 0.5726, 2.93, 0.079, 219, 89, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY AVFLUIGG01 
1818, 6db7H, 0.5726, 3.11, 0.088, 234, 91, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1334 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
1819, 5mhrM, 0.5726, 2.76, 0.102, 119, 88, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1820, 5b8cL, 0.5726, 3.00, 0.056, 113, 90, HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV
1821, 4yzfK, 0.5726, 3.14, 0.044, 223, 91, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
1822, 3t2qA, 0.5726, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH GALACTONOLACTONE
1823, 3t0aD, 0.5726, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
1824, 3p2dB, 0.5726, 3.30, 0.124, 352, 97, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1825, 3eakB, 0.5726, 3.21, 0.098, 127, 92, NBBCII10 HUMANIZED (FGLA MUTANT)
1826, 2xzcH, 0.5726, 3.07, 0.078, 211, 90, CRYSTAL STRUCTURE OF PHOSPHONATE-MODIFIED RECOMBINANT A.17 ANTIBODY FAB FRAGMENT
1827, 6a4kH, 0.5725, 3.22, 0.087, 230, 92, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
1828, 5ufvE, 0.5725, 2.88, 0.090, 227, 89, CRYSTAL STRUCTURE OF A CELLULOSE-ACTIVE POLYSACCHARIDE MONOOXYGENASE FROM M. THERMOPHILA (MTPMO3*)
1829, 5ou7D, 0.5725, 2.04, 0.086, 178, 81, CRYSTAL STRUCTURE OF THE GLYCOPROTEIN VI LOOP TRUNCATION MUTANT PAVS- PAPYKN 
1830, 5jdsB, 0.5725, 3.21, 0.043, 127, 92, CRYSTAL STRUCTURE OF PD-L1 COMPLEXED WITH A NANOBODY AT 1.7 ANGSTRON RESOLUTION
1831, 5hbtD, 0.5725, 3.27, 0.077, 219, 91, COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1
1832, 5gs0H, 0.5725, 3.21, 0.067, 116, 90, CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY
1833, 4xrcB, 0.5725, 3.30, 0.076, 215, 92, ANTIBODY HEMAGGLUTININ COMPLEXES
1834, 4v40P, 0.5725, 3.33, 0.092, 1021, 98, 
1835, 4brvA, 0.5725, 3.36, 0.111, 124, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1836, 3vdcA, 0.5725, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
1837, 3g5yB, 0.5725, 3.09, 0.078, 210, 90, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
1838, 3b83A, 0.5725, 2.73, 0.067, 95, 89, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
1839, 2n1kA, 0.5725, 2.79, 0.102, 106, 88, STRUCTURE OF THE THIRD TYPE III DOMAIN FROM HUMAN FIBRONECTIN
1840, 1jyvA, 0.5725, 3.26, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
1841, 1g7hB, 0.5725, 3.09, 0.056, 116, 90, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A)
1842, 5u1rD, 0.5724, 2.83, 0.056, 199, 89, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1843, 4v40J, 0.5724, 3.35, 0.102, 1021, 98, 
1844, 4v40C, 0.5724, 3.26, 0.093, 1021, 97, 
1845, 4dohR, 0.5724, 2.67, 0.057, 204, 88, IL20/IL201/IL20R2 TERNARY COMPLEX
1846, 3vdbA, 0.5724, 3.15, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH GALACTONOLACTONE
1847, 3ks0K, 0.5724, 3.10, 0.044, 214, 90, CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
1848, 2w1nA, 0.5724, 2.69, 0.068, 228, 88, COHESIN AND FIBRONECTIN TYPE-III DOUBLE MODULE CONSTRUCT FROM THE CLOSTRIDIUM PERFRINGENS GLYCOSIDE HYDROLASE GH84C
1849, 2o6cA, 0.5724, 3.21, 0.053, 155, 95, STRUCTURE OF SELENOMETHIONYL RTP34 FROM TREPONEMA PALLIDUM
1850, 2ajvH, 0.5724, 3.25, 0.066, 219, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH COCAINE
1851, 5fo8A, 0.5723, 3.87, 0.050, 639, 101, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH MCP (CCP1-4)
1852, 4udtA, 0.5723, 2.85, 0.057, 202, 88, T CELL RECEPTOR (TRAV22TRBV7-9) STRUCTURE
1853, 4grlC, 0.5723, 3.11, 0.078, 191, 90, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
1854, 4brvB, 0.5723, 3.36, 0.111, 124, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM IGNICOCCUS HOSPITALIS E23A
1855, 3obaC, 0.5723, 3.24, 0.062, 1024, 97, STRUCTURE OF THE BETA-GALACTOSIDASE FROM KLUYVEROMYCES LACTIS
1856, 3eakA, 0.5723, 3.22, 0.098, 127, 92, NBBCII10 HUMANIZED (FGLA MUTANT)
1857, 3dymA, 0.5723, 3.26, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
1858, 1qlrD, 0.5723, 3.06, 0.066, 209, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ
1859, 1px4C, 0.5723, 3.19, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
1860, 6mvgC, 0.5722, 3.31, 0.063, 637, 95, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
1861, 5xcuD, 0.5722, 3.20, 0.065, 165, 92, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1862, 5ojmK, 0.5722, 3.09, 0.055, 123, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25
1863, 4of5B, 0.5722, 3.31, 0.098, 214, 92, REFINEMENT OF RAGE-DNA COMPLEX IN 3S59 WITHOUT DNA
1864, 3b2uT, 0.5722, 3.17, 0.088, 216, 91, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1865, 1hn1D, 0.5722, 3.24, 0.072, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1866, 1f90H, 0.5722, 3.27, 0.056, 220, 90, FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
1867, 5tp3A, 0.5721, 3.22, 0.077, 125, 91, CRYSTAL STRUCTURE OF THE RSV-NEUTRALIZING SINGLE-DOMAIN ANTIBODY F- VHH-4
1868, 5swzS, 0.5721, 3.20, 0.055, 203, 91, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1869, 5ovwK, 0.5721, 3.08, 0.044, 126, 90, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1870, 5ojmN, 0.5721, 3.10, 0.055, 123, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25
1871, 5ojmM, 0.5721, 3.09, 0.055, 123, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25
1872, 5ggsZ, 0.5721, 3.07, 0.077, 113, 91, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
1873, 4yzfI, 0.5721, 3.31, 0.043, 223, 92, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
1874, 4oi9A, 0.5721, 2.94, 0.080, 378, 87, CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT SPACE GROUP P21
1875, 4hgkD, 0.5721, 2.94, 0.135, 104, 89, SHARK IGNAR VARIABLE DOMAIN
1876, 3vdcD, 0.5721, 3.14, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH IPTG
1877, 3pnwK, 0.5721, 3.24, 0.088, 218, 91, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
1878, 3i3eC, 0.5721, 3.26, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
1879, 3b2uH, 0.5721, 3.37, 0.075, 217, 93, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1880, 3aruA, 0.5721, 3.78, 0.113, 570, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - W275G MUTANT COMPLEX STRUCTURE WITH PENTOXIFYLLINE
1881, 2x89A, 0.5721, 2.96, 0.044, 128, 91, STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
1882, 1hn1C, 0.5721, 3.26, 0.103, 1011, 97, E. COLI (LAC Z) BETA-GALACTOSIDASE (ORTHORHOMBIC)
1883, 6erxH, 0.5720, 2.93, 0.079, 216, 89, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
1884, 5ufvD, 0.5720, 3.01, 0.112, 227, 89, CRYSTAL STRUCTURE OF A CELLULOSE-ACTIVE POLYSACCHARIDE MONOOXYGENASE FROM M. THERMOPHILA (MTPMO3*)
1885, 5bopC, 0.5720, 3.08, 0.066, 123, 91, CRYSTAL STRUCTURE OF THE ARTIFICIAL NANOBODY OCTARELLINV.1 COMPLEX
1886, 5a16C, 0.5720, 3.40, 0.043, 226, 93, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
1887, 3t08A, 0.5720, 3.15, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A) IPTG COMPLEX
1888, 3sepA, 0.5720, 3.15, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796A)
1889, 3i3dC, 0.5720, 3.27, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
1890, 2pxyA, 0.5720, 2.79, 0.045, 114, 88, CRYSTAL STRUCTURES OF IMMUNE RECEPTOR COMPLEXES
1891, 1kiqB, 0.5720, 3.20, 0.066, 116, 91, FV MUTANT Y(B 101)F (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1892, 1jyvC, 0.5720, 3.18, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
1893, 1fdlH, 0.5720, 3.24, 0.066, 218, 91, CRYSTALLOGRAPHIC REFINEMENT OF THE THREE-DIMENSIONAL STRUCTURE OF THE FAB D1.3-LYSOZYME COMPLEX AT 2.5- ANGSTROMS RESOLUTION
1894, 6qv0F, 0.5719, 2.97, 0.077, 124, 91, STRUCTURE OF ATP-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
1895, 5gruL, 0.5719, 3.15, 0.067, 228, 90, STRUCTURE OF MONO-SPECIFIC DIABODY
1896, 5d7kD, 0.5719, 2.69, 0.046, 197, 87, STRUCTURE OF MR1-REACTIVE MAV36 TCR
1897, 4wemB, 0.5719, 3.26, 0.152, 121, 92, CO-COMPLEX STRUCTURE OF THE F4 FIMBRIAL ADHESIN FAEG VARIANT AC WITH LLAMA SINGLE DOMAIN ANTIBODY V1
1898, 3oskB, 0.5719, 2.73, 0.034, 123, 89, CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
1899, 3mckH, 0.5719, 3.21, 0.088, 226, 91, CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
1900, 3lhpL, 0.5719, 3.19, 0.088, 111, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
1901, 3iapB, 0.5719, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
1902, 3hujE, 0.5719, 2.73, 0.057, 199, 87, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1903, 3fzuH, 0.5719, 2.99, 0.121, 217, 91, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
1904, 3dymB, 0.5719, 3.19, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
1905, 2hh0H, 0.5719, 3.09, 0.110, 217, 91, STRUCTURE OF AN ANTI-PRP FAB P-CLONE IN COMPLEX WITH ITS COGNATE BOVINE PEPTIDE EPITOPE.
1906, 2d03H, 0.5719, 3.15, 0.089, 212, 90, CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB
1907, 1p84J, 0.5719, 3.17, 0.055, 127, 91, HDBT INHIBITED YEAST CYTOCHROME BC1 COMPLEX
1908, 1jz8A, 0.5719, 3.19, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
1909, 1jz4B, 0.5719, 3.19, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
1910, 1dvfB, 0.5719, 3.25, 0.066, 116, 91, IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
1911, 5ovwI, 0.5718, 3.08, 0.044, 126, 90, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
1912, 5ojmO, 0.5718, 3.10, 0.055, 123, 91, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25
1913, 5bzdD, 0.5718, 3.12, 0.088, 226, 91, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1914, 4v40D, 0.5718, 3.21, 0.103, 1021, 97, 
1915, 4lptB, 0.5718, 2.73, 0.105, 98, 86, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
1916, 3pnwH, 0.5718, 3.25, 0.088, 218, 91, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
1917, 3mv13, 0.5718, 3.27, 0.103, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
1918, 3dypC, 0.5718, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
1919, 2x7lG, 0.5718, 3.09, 0.120, 220, 92, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1920, 2x7lC, 0.5718, 3.09, 0.120, 220, 92, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1921, 2vitB, 0.5718, 3.16, 0.077, 221, 91, INFLUENZA VIRUS HEMAGGLUTININ MUTANT WITH THR 155 REPLACED BY ILE COMPLEXED WITH A NEUTRALIZING ANTIBODY
1922, 1jz6C, 0.5718, 3.20, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
1923, 5yhlH, 0.5717, 2.95, 0.089, 223, 90, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1924, 5fhxH, 0.5717, 3.39, 0.087, 340, 92, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
1925, 4grwI, 0.5717, 3.13, 0.033, 123, 91, STRUCTURE OF A COMPLEX OF HUMAN IL-23 WITH 3 NANOBODIES (LLAMA VHHS)
1926, 2j6eH, 0.5717, 3.43, 0.065, 216, 93, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
1927, 2ianN, 0.5717, 2.78, 0.069, 198, 87, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
1928, 1q72H, 0.5717, 3.16, 0.109, 220, 92, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
1929, 1kcsH, 0.5717, 3.17, 0.078, 217, 90, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
1930, 1jz4C, 0.5717, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
1931, 1jz2D, 0.5717, 3.34, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
1932, 1dp0C, 0.5717, 3.20, 0.093, 1011, 97, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
1933, 6qv0E, 0.5716, 2.96, 0.077, 124, 91, STRUCTURE OF ATP-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
1934, 5ywyH, 0.5716, 2.95, 0.089, 223, 90, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1935, 4xnqH, 0.5716, 3.23, 0.099, 217, 91, ANTIBODY HEMAGGLUTININ COMPLEXES
1936, 4xedA, 0.5716, 2.90, 0.138, 96, 87, PKD DOMAIN OF M14-LIKE PEPTIDASE FROM THERMOPLASMATALES ARCHAEON SCGC AB-540-F20
1937, 4p2cJ, 0.5716, 3.04, 0.111, 127, 90, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
1938, 4krmH, 0.5716, 3.33, 0.043, 124, 92, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
1939, 3t0aA, 0.5716, 3.15, 0.083, 1015, 96, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T)
1940, 3mv03, 0.5716, 3.29, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
1941, 3mv02, 0.5716, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
1942, 3cmgA, 0.5716, 3.35, 0.072, 661, 97, CRYSTAL STRUCTURE OF PUTATIVE BETA-GALACTOSIDASE FROM BACTEROIDES FRAGILIS
1943, 3cjjA, 0.5716, 3.23, 0.098, 219, 92, CRYSTAL STRUCTURE OF HUMAN RAGE LIGAND-BINDING DOMAIN
1944, 3b2uQ, 0.5716, 3.39, 0.075, 217, 93, CRYSTAL STRUCTURE OF ISOLATED DOMAIN III OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
1945, 2x7lJ, 0.5716, 3.10, 0.120, 220, 92, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1946, 1zxqA, 0.5716, 2.96, 0.076, 192, 92, THE CRYSTAL STRUCTURE OF ICAM-2
1947, 1nfdF, 0.5716, 3.17, 0.109, 222, 92, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
1948, 1jz4A, 0.5716, 3.28, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
1949, 1jyxB, 0.5716, 3.25, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
1950, 1g7iB, 0.5716, 3.10, 0.056, 116, 90, CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3 (VLW92F)
1951, 6mvhB, 0.5715, 3.31, 0.084, 638, 95, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
1952, 5k59E, 0.5715, 3.33, 0.076, 210, 92, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1953, 5bv7H, 0.5715, 3.26, 0.065, 222, 92, CRYSTAL STRUCTURE OF HUMAN LCAT (L4F N5D) IN COMPLEX WITH FAB OF AN AGONISTIC ANTIBODY
1954, 4u6tB, 0.5715, 2.62, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A AT 1.76 ANGSTROM RESOLUTION
1955, 4mayC, 0.5715, 3.13, 0.078, 191, 90, CRYSTAL STRUCTURE OF AN IMMUNE COMPLEX
1956, 3se4C, 0.5715, 3.17, 0.068, 190, 88, HUMAN IFNW-IFNAR TERNARY COMPLEX
1957, 3pnwQ, 0.5715, 3.25, 0.088, 218, 91, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
1958, 3i3eA, 0.5715, 3.28, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
1959, 2x7lH, 0.5715, 3.10, 0.120, 220, 92, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
1960, 2visB, 0.5715, 3.16, 0.077, 221, 91, INFLUENZA VIRUS HEMAGGLUTININ (ESCAPE) MUTANT WITH THR 131 REPLACED BY ILE COMPLEXED WITH A NEUTRALIZING ANTIBODY
1961, 1px3C, 0.5715, 3.21, 0.103, 1007, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
1962, 1kirB, 0.5715, 3.23, 0.066, 116, 91, FV MUTANT Y(A 50)S (VL DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
1963, 6d0nC, 0.5714, 2.46, 0.118, 90, 85, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; V319G MUTANT 
1964, 5u17D, 0.5714, 2.88, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1965, 5tp3B, 0.5714, 3.21, 0.077, 125, 91, CRYSTAL STRUCTURE OF THE RSV-NEUTRALIZING SINGLE-DOMAIN ANTIBODY F- VHH-4
1966, 5e0qA, 0.5714, 3.08, 0.110, 126, 91, CRYSTAL STRUCTURE OF THE NUP98 C-TERMINAL DOMAIN BOUND TO NANOBODY TP377
1967, 4yzfE, 0.5714, 3.27, 0.055, 223, 91, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
1968, 4w2qE, 0.5714, 2.98, 0.079, 116, 89, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
1969, 4s1dO, 0.5714, 2.97, 0.143, 213, 91, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
1970, 4r7dI, 0.5714, 3.22, 0.099, 218, 91, FAB HU 15C1
1971, 4r7dC, 0.5714, 3.22, 0.088, 210, 91, FAB HU 15C1
1972, 4nehA, 0.5714, 3.31, 0.074, 1084, 95, AN INTERNAL LIGAND-BOUND METASTABLE STATE OF A LEUKOCYTE INTEGRIN AXB2
1973, 4llvL, 0.5714, 3.20, 0.088, 108, 91, THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV
1974, 4aq1B, 0.5714, 3.14, 0.099, 124, 91, STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6
1975, 3u9uC, 0.5714, 3.21, 0.055, 215, 91, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479
1976, 3mv12, 0.5714, 3.28, 0.103, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
1977, 3muz1, 0.5714, 3.13, 0.073, 1011, 96, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
1978, 3muy3, 0.5714, 3.28, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
1979, 3iapC, 0.5714, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
1980, 3gc3A, 0.5714, 3.24, 0.140, 329, 93, CRYSTAL STRUCTURE OF ARRESTIN2S AND CLATHRIN
1981, 1rfdH, 0.5714, 3.16, 0.109, 220, 92, ANTI-COCAINE ANTIBODY M82G2
1982, 1jz3C, 0.5714, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
1983, 1jz3A, 0.5714, 3.20, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
1984, 1jynC, 0.5714, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
1985, 6mamE, 0.5713, 3.01, 0.078, 235, 90, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
1986, 5adoH, 0.5713, 2.98, 0.080, 211, 88, CRYSTAL STRUCTURE OF THE PARAOXON-MODIFIED A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT
1987, 4zypK, 0.5713, 3.20, 0.043, 213, 92, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
1988, 4pjeG, 0.5713, 2.79, 0.057, 197, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
1989, 3x2dL, 0.5713, 3.12, 0.077, 226, 91, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
1990, 3w12C, 0.5713, 3.07, 0.067, 116, 89, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2 ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
1991, 3u9uA, 0.5713, 3.19, 0.055, 219, 91, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN ERBB4/HER4 IN COMPLEX WITH THE FAB FRAGMENT OF MAB1479
1992, 3pnwN, 0.5713, 3.25, 0.088, 226, 91, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
1993, 3pnwE, 0.5713, 3.25, 0.099, 226, 91, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
1994, 3arvA, 0.5713, 3.83, 0.103, 575, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH SANGUINARINE
1995, 3arpA, 0.5713, 3.83, 0.103, 574, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH DEQUALINIUM
1996, 2ak1H, 0.5713, 3.35, 0.065, 219, 92, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH BENZOIC ACID
1997, 1jyxC, 0.5713, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
1998, 6nn3H, 0.5712, 3.19, 0.066, 121, 91, STRUCTURE OF PARVOVIRUS B19 DECORATED WITH FAB MOLECULES FROM A HUMAN ANTIBODY 
1999, 6b6lA, 0.5712, 3.54, 0.072, 716, 97, THE CRYSTAL STRUCTURE OF GLYCOSYL HYDROLASE FAMILY 2 (GH2) MEMBER FROM BACTEROIDES CELLULOSILYTICUS DSM 14838
2000, 5ojmL, 0.5712, 2.96, 0.056, 123, 90, STRUCTURE OF A CHIMAERIC BETA3-ALPHA5 GABAA RECEPTOR IN COMPLEX WITH NANOBODY NB25
2001, 5j11C, 0.5712, 2.62, 0.058, 190, 86, STRUCTURE OF HUMAN TSLP IN COMPLEX WITH TSLPR AND IL-7RALPHA
2002, 5a16G, 0.5712, 3.27, 0.043, 226, 92, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2003, 4z7wG, 0.5712, 3.24, 0.067, 191, 90, T316 COMPLEX
2004, 4r7fA, 0.5712, 3.82, 0.050, 390, 101, CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN (PARMER_01801) FROM PARABACTEROIDES MERDAE ATCC 43184 AT 2.30 A RESOLUTION
2005, 4r4bF, 0.5712, 3.08, 0.089, 220, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
2006, 4irzH, 0.5712, 3.07, 0.078, 217, 90, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
2007, 4fqro, 0.5712, 3.07, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2008, 2x7lA, 0.5712, 3.10, 0.120, 220, 92, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
2009, 2ajxH, 0.5712, 3.22, 0.066, 219, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH TRANSITION STATE ANALOG
2010, 1tvdA, 0.5712, 2.86, 0.079, 116, 89, VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN
2011, 1jz8C, 0.5712, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
2012, 1jywC, 0.5712, 3.19, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
2013, 1a2yB, 0.5712, 3.21, 0.066, 116, 91, HEN EGG WHITE LYSOZYME D18A MUTANT IN COMPLEX WITH MOUSE MONOCLONAL ANTIBODY D1.3
2014, 6quzF, 0.5711, 3.09, 0.065, 124, 92, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
2015, 6n6bK, 0.5711, 3.27, 0.077, 221, 91, THE COMPLEX CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/MINNESOTA/11/2010 WITH B10 ANTIBODY. 
2016, 6d0jC, 0.5711, 2.47, 0.118, 90, 85, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER 
2017, 6bliJ, 0.5711, 3.01, 0.101, 220, 89, RSV G PEPTIDE BOUND TO FAB CB002.5
2018, 5y9jH, 0.5711, 2.83, 0.080, 218, 88, BAFF IN COMPLEX WITH BELIMUMAB
2019, 5j1sC, 0.5711, 3.25, 0.087, 123, 92, TORSINA-LULL1 COMPLEX H. SAPIENS BOUND TO VHH-BS2
2020, 5dlmI, 0.5711, 3.05, 0.090, 214, 89, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2021, 4ogyH, 0.5711, 3.01, 0.099, 219, 91, CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.1 ANGSTROM RESOLUTION
2022, 3vd7B, 0.5711, 3.19, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
2023, 3mckB, 0.5711, 3.36, 0.087, 226, 92, CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705
2024, 3dypA, 0.5711, 3.26, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
2025, 2ajsH, 0.5711, 3.21, 0.066, 219, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH HEPTAETHYLENE GLYCOL
2026, 1nfdH, 0.5711, 3.17, 0.109, 222, 92, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2027, 1mvfA, 0.5711, 3.01, 0.110, 126, 91, MAZE ADDICTION ANTIDOTE
2028, 5m15C, 0.5710, 3.26, 0.043, 127, 93, SYNTHETIC NANOBODY IN COMPLEX WITH MBP
2029, 4w2pB, 0.5710, 2.99, 0.100, 122, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
2030, 4p2yA, 0.5710, 3.11, 0.099, 301, 91, CRYSTAL STRUCTURE OF THE HUMAN RAGE ECTODOMAIN (FRAGMENT VC1C2) IN COMPLEX WITH MOUSE S100A6
2031, 3w14F, 0.5710, 2.78, 0.090, 580, 89, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
2032, 3t2oC, 0.5710, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
2033, 3lh2L, 0.5710, 3.25, 0.087, 110, 92, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
2034, 3gd1C, 0.5710, 3.27, 0.146, 345, 96, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
2035, 2x7lE, 0.5710, 3.10, 0.120, 220, 92, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
2036, 2hkaB, 0.5710, 3.06, 0.053, 130, 95, CRYSTAL STRUCTURE OF BOVINE NPC2 AND CHOLESTEROL SULFATE COMPLEX
2037, 1zvyA, 0.5710, 3.22, 0.055, 125, 91, CRYSTAL STRUCTURE OF THE VHH D3-L11 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
2038, 1tvdB, 0.5710, 2.99, 0.078, 116, 90, VARIABLE DOMAIN OF T CELL RECEPTOR DELTA CHAIN
2039, 1kipB, 0.5710, 3.19, 0.066, 116, 91, FV MUTANT Y(B 32)A (VH DOMAIN) OF MOUSE MONOCLONAL ANTIBODY D1.3 COMPLEXED WITH HEN EGG WHITE LYSOZYME
2040, 1jz2C, 0.5710, 3.25, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
2041, 1jywA, 0.5710, 3.20, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
2042, 1jynA, 0.5710, 3.20, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
2043, 1hq4B, 0.5710, 3.21, 0.056, 216, 90, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
2044, 1dp0A, 0.5710, 3.26, 0.072, 1011, 97, E. COLI BETA-GALACTOSIDASE AT 1.7 ANGSTROM
2045, 6d0kC, 0.5709, 2.47, 0.118, 90, 85, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; E118Q MUTANT 
2046, 5myoD, 0.5709, 3.00, 0.089, 219, 90, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
2047, 5j12C, 0.5709, 2.60, 0.070, 189, 86, CYTOKINE RECEPTOR COMPLEX
2048, 4yk4C, 0.5709, 3.07, 0.111, 220, 90, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2049, 4xnmB, 0.5709, 3.30, 0.087, 216, 92, ANTIBODY INFLUENZA H5 COMPLEX
2050, 4r7dM, 0.5709, 3.28, 0.088, 201, 91, FAB HU 15C1
2051, 4pjhE, 0.5709, 2.79, 0.068, 192, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
2052, 4krmL, 0.5709, 3.30, 0.043, 124, 92, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
2053, 4hgkC, 0.5709, 2.95, 0.135, 104, 89, SHARK IGNAR VARIABLE DOMAIN
2054, 3w14E, 0.5709, 2.77, 0.090, 580, 89, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14
2055, 3t2oA, 0.5709, 3.21, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
2056, 3muy2, 0.5709, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
2057, 3dymD, 0.5709, 3.26, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418E)
2058, 3b83D, 0.5709, 2.78, 0.079, 91, 89, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
2059, 1px4A, 0.5709, 3.20, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
2060, 1melB, 0.5709, 3.00, 0.079, 132, 89, CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME
2061, 1f4hC, 0.5709, 3.28, 0.072, 1021, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (ORTHORHOMBIC)
2062, 6oe4E, 0.5708, 3.10, 0.124, 225, 89, PREFUSION RSV F MONOMER BOUND BY NEUTRALIZING ANTIBODY CR9501 
2063, 5df0A, 0.5708, 3.05, 0.114, 528, 88, CRYSTAL STRUCTURE OF ACMNPV CHITINASE A IN COMPLEX WITH CHITOTRIO- THIAZOLINE DITHIOAMIDE
2064, 5b8cI, 0.5708, 3.05, 0.067, 113, 90, HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV
2065, 4z7wE, 0.5708, 3.23, 0.067, 199, 90, T316 COMPLEX
2066, 4i3rH, 0.5708, 3.17, 0.077, 228, 91, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
2067, 3prxC, 0.5708, 3.17, 0.099, 1626, 91, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
2068, 3pl6C, 0.5708, 3.14, 0.078, 191, 90, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
2069, 3muy1, 0.5708, 3.26, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
2070, 3dyoC, 0.5708, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
2071, 3dlqR, 0.5708, 2.94, 0.112, 201, 89, CRYSTAL STRUCTURE OF THE IL-22/IL-22R1 COMPLEX
2072, 1hq4D, 0.5708, 3.21, 0.056, 216, 90, STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4
2073, 6qn8H, 0.5707, 3.04, 0.078, 227, 90, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
2074, 6db6H, 0.5707, 3.03, 0.100, 226, 90, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 311-11D IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
2075, 6d7gD, 0.5707, 3.22, 0.033, 198, 92, STRUCTURE OF 5F3 TCR IN COMPLEX WITH HLA-A2/MART-1 
2076, 5z87B, 0.5707, 3.54, 0.065, 755, 93, STRUCTURAL OF A NOVEL B-GLUCOSIDASE EMGH1 AT 2.3 ANGSTROM FROM ERYTHROBACTER MARINUS 
2077, 4fqrs, 0.5707, 3.06, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2078, 3vd3B, 0.5707, 3.28, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
2079, 3tf7G, 0.5707, 3.13, 0.056, 224, 90, 42F3 QL9/H2-LD COMPLEX
2080, 3iaqC, 0.5707, 3.18, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
2081, 3arwA, 0.5707, 3.83, 0.103, 575, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH CHELERYTHRINE
2082, 2ibzX, 0.5707, 3.18, 0.055, 127, 91, YEAST CYTOCHROME BC1 COMPLEX WITH STIGMATELLIN
2083, 1jz6B, 0.5707, 3.21, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
2084, 1jz5A, 0.5707, 3.19, 0.082, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
2085, 1ezvX, 0.5707, 3.13, 0.055, 127, 91, STRUCTURE OF THE YEAST CYTOCHROME BC1 COMPLEX CO- CRYSTALLIZED WITH AN ANTIBODY FV-FRAGMENT
2086, 1dvfD, 0.5707, 3.16, 0.078, 121, 90, IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
2087, 1dn0D, 0.5707, 3.06, 0.077, 217, 91, STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
2088, 6d7jD, 0.5706, 3.44, 0.082, 787, 97, THE CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) WITH GLYCEROL IN ACTIVE-SITE 
2089, 5hvfB, 0.5706, 2.99, 0.122, 118, 90, CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH AN INHIBITORY NANOBODY (VHH-I83)
2090, 3vd5B, 0.5706, 3.21, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
2091, 3qhtD, 0.5706, 2.67, 0.105, 93, 86, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-1 BOUND TO YEAST SUMO
2092, 2z91A, 0.5706, 3.00, 0.057, 207, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2093, 2pyeE, 0.5706, 2.73, 0.081, 242, 86, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
2094, 2p5wE, 0.5706, 2.75, 0.070, 242, 86, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2095, 1px3A, 0.5706, 3.21, 0.103, 1010, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
2096, 1jvkA, 0.5706, 3.12, 0.065, 215, 92, THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
2097, 6miyC, 0.5705, 2.88, 0.080, 200, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
2098, 6mamC, 0.5705, 3.17, 0.077, 233, 91, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2099, 6bliG, 0.5705, 2.99, 0.112, 220, 89, RSV G PEPTIDE BOUND TO FAB CB002.5
2100, 6bliA, 0.5705, 3.03, 0.101, 220, 89, RSV G PEPTIDE BOUND TO FAB CB002.5
2101, 5utzB, 0.5705, 3.29, 0.088, 219, 91, HUMAN IL-2/FAB COMPLEX 
2102, 5u6qB, 0.5705, 2.78, 0.057, 195, 88, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2103, 5e95B, 0.5705, 2.61, 0.129, 92, 85, CRYSTAL STRUCTURE OF MB(NS1)/H-RAS COMPLEX
2104, 5dumH, 0.5705, 3.10, 0.077, 219, 91, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 65C6
2105, 4rwyH, 0.5705, 3.10, 0.077, 227, 91, CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC131 IN COMPLEX WITH HIV-1 CLADE B YU2 GP120
2106, 4krmB, 0.5705, 3.16, 0.055, 124, 91, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
2107, 4je4B, 0.5705, 2.64, 0.116, 93, 86, CRYSTAL STRUCTURE OF MONOBODY NSA1/SHP2 N-SH2 DOMAIN COMPLEX
2108, 4janA, 0.5705, 3.19, 0.100, 218, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
2109, 4fqrc, 0.5705, 3.08, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2110, 4dzbA, 0.5705, 2.82, 0.056, 196, 89, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
2111, 3vd7A, 0.5705, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
2112, 3t2pA, 0.5705, 3.29, 0.093, 1014, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D) IN COMPLEX WITH IPTG
2113, 3t2oB, 0.5705, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
2114, 3pnwT, 0.5705, 3.16, 0.089, 225, 90, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2115, 3lh2N, 0.5705, 3.29, 0.087, 110, 92, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
2116, 3ks0H, 0.5705, 3.11, 0.044, 211, 90, CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4
2117, 3i3eB, 0.5705, 3.26, 0.072, 1010, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A)
2118, 3i3bA, 0.5705, 3.20, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
2119, 1px4B, 0.5705, 3.19, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
2120, 1dn0B, 0.5705, 3.18, 0.077, 216, 91, STRUCTURE OF THE FAB FRAGMENT FROM A HUMAN IGM COLD AGGLUTININ
2121, 5utzH, 0.5704, 3.16, 0.089, 223, 90, HUMAN IL-2/FAB COMPLEX 
2122, 5ovwH, 0.5704, 3.12, 0.089, 126, 90, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
2123, 5mhrI, 0.5704, 3.12, 0.098, 213, 92, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2124, 5d7iG, 0.5704, 2.84, 0.056, 198, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2125, 4yblB, 0.5704, 3.20, 0.065, 222, 92, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32
2126, 4fxkA, 0.5704, 3.45, 0.104, 651, 96, HUMAN COMPLEMENT C4
2127, 4fnlI, 0.5704, 3.06, 0.099, 233, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
2128, 3qhtC, 0.5704, 2.58, 0.094, 93, 85, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-1 BOUND TO YEAST SUMO
2129, 3p2dA, 0.5704, 3.38, 0.124, 354, 97, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
2130, 3muz3, 0.5704, 3.22, 0.093, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
2131, 3mj8H, 0.5704, 3.28, 0.067, 211, 90, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2132, 3gd1E, 0.5704, 3.41, 0.144, 300, 97, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
2133, 3czjC, 0.5704, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
2134, 2z8vC, 0.5704, 3.17, 0.099, 116, 91, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
2135, 1cf8H, 0.5704, 3.21, 0.056, 218, 90, CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
2136, 1bvkE, 0.5704, 3.14, 0.100, 116, 90, HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
2137, 6quzE, 0.5703, 3.09, 0.065, 124, 92, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH SYBODY SB_TM35 
2138, 6mvhA, 0.5703, 3.32, 0.084, 639, 95, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
2139, 6mdtD, 0.5703, 3.04, 0.078, 240, 90, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P63 SPACE GROUP 
2140, 6h6yF, 0.5703, 3.12, 0.111, 115, 90, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-7 
2141, 6erxM, 0.5703, 2.85, 0.080, 215, 88, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2142, 5kn5D, 0.5703, 3.27, 0.098, 215, 92, TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859
2143, 4w2qG, 0.5703, 3.14, 0.077, 117, 91, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
2144, 4s1dC, 0.5703, 2.84, 0.144, 212, 90, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
2145, 4geiA, 0.5703, 3.22, 0.053, 144, 94, N-TERMINAL DOMAIN OF VDUP-1
2146, 4fqrg, 0.5703, 3.06, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2147, 3vd5D, 0.5703, 3.27, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S)
2148, 3tyfC, 0.5703, 2.86, 0.057, 197, 88, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2149, 3l5wH, 0.5703, 3.14, 0.077, 223, 91, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2150, 3l5wB, 0.5703, 3.20, 0.077, 221, 91, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2151, 3czjB, 0.5703, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
2152, 2obgA, 0.5703, 3.01, 0.090, 457, 89, CRYSTAL STRUCTURE OF MONOBODY MBP-74/MALTOSE BINDING PROTEIN FUSION COMPLEX
2153, 1jz6A, 0.5703, 3.30, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
2154, 6oe5H, 0.5702, 3.08, 0.124, 225, 89, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
2155, 5eulV, 0.5702, 3.05, 0.033, 115, 90, STRUCTURE OF THE SECA-SECY COMPLEX WITH A TRANSLOCATING POLYPEPTIDE SUBSTRATE
2156, 4bz2H, 0.5702, 3.04, 0.121, 213, 91, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 2D73
2157, 3rzwB, 0.5702, 2.47, 0.083, 89, 84, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-9 BOUND TO HUMAN SUMO1
2158, 3prxA, 0.5702, 3.17, 0.099, 1626, 91, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF AND SSL7
2159, 3lh2M, 0.5702, 3.24, 0.088, 108, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
2160, 2xa8H, 0.5702, 3.22, 0.077, 219, 91, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
2161, 2j8uM, 0.5702, 3.12, 0.089, 237, 90, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2162, 1jz7C, 0.5702, 3.20, 0.104, 1010, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
2163, 7fabH, 0.5701, 3.21, 0.132, 209, 91, CRYSTAL STRUCTURE OF HUMAN IMMUNOGLOBULIN FRAGMENT FAB NEW REFINED AT 2.0 ANGSTROMS RESOLUTION
2164, 6mvfB, 0.5701, 3.48, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
2165, 6ewaD, 0.5701, 2.45, 0.116, 169, 86, CRYSTAL STRUCTURE OF HLA-A2 IN COMPLEX WITH LILRB1 
2166, 5x3jA, 0.5701, 2.04, 0.076, 718, 79, KFLA1895 D451A MUTANT IN COMPLEX WITH CYCLOBIS-(1->6)-ALPHA-NIGEROSYL
2167, 5vlvA, 0.5701, 3.20, 0.077, 125, 91, THE APO FORM OF THE TRICLOCARBAN-BINDING SINGLE DOMAIN CAMELID NANOBODY VHH T9 
2168, 4nqcG, 0.5701, 2.80, 0.057, 198, 88, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2169, 3vd7C, 0.5701, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
2170, 3mv01, 0.5701, 3.30, 0.103, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
2171, 3iy3B, 0.5701, 3.00, 0.133, 119, 90, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 8 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 8 COMPLEX
2172, 1kb9J, 0.5701, 3.18, 0.055, 127, 91, YEAST CYTOCHROME BC1 COMPLEX
2173, 1jz8B, 0.5701, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
2174, 1jywB, 0.5701, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
2175, 1bfoH, 0.5701, 3.16, 0.077, 216, 91, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
2176, 1axsB, 0.5701, 3.09, 0.099, 221, 91, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
2177, 6d7jA, 0.5700, 3.46, 0.082, 799, 97, THE CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) WITH GLYCEROL IN ACTIVE-SITE 
2178, 6bqoC, 0.5700, 2.58, 0.107, 95, 84, STRUCTURE OF A DUAL TOPOLOGY FLUORIDE CHANNEL WITH MONOBODY S8
2179, 5utzF, 0.5700, 3.06, 0.067, 222, 90, HUMAN IL-2/FAB COMPLEX 
2180, 5umnC, 0.5700, 3.07, 0.088, 238, 91, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2181, 5ou7C, 0.5700, 2.07, 0.086, 178, 81, CRYSTAL STRUCTURE OF THE GLYCOPROTEIN VI LOOP TRUNCATION MUTANT PAVS- PAPYKN 
2182, 5o1rI, 0.5700, 3.20, 0.099, 221, 91, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2183, 5m13B, 0.5700, 3.28, 0.098, 126, 92, SYNTHETIC NANOBODY IN COMPLEX WITH MBP
2184, 4ttgC, 0.5700, 3.21, 0.104, 1014, 96, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
2185, 4ofpC, 0.5700, 2.82, 0.080, 193, 88, CRYSTAL STRUCTURE OF SYG-2 D3-D4
2186, 4n9gM, 0.5700, 3.13, 0.132, 223, 91, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
2187, 4fqru, 0.5700, 3.07, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2188, 4fqrk, 0.5700, 3.07, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2189, 4fnlH, 0.5700, 3.08, 0.099, 232, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
2190, 3iaqA, 0.5700, 3.28, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
2191, 3dyoD, 0.5700, 3.36, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
2192, 3aryA, 0.5700, 3.84, 0.103, 575, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH 2-(IMIDAZOLIN-2-YL)-5- ISOTHIOCYANATOBENZOFURAN
2193, 2z8wD, 0.5700, 3.19, 0.099, 116, 91, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
2194, 2ialC, 0.5700, 2.81, 0.069, 195, 87, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2195, 1nbvH, 0.5700, 2.93, 0.090, 219, 89, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
2196, 1kenH, 0.5700, 3.42, 0.054, 221, 92, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION
2197, 1jz6D, 0.5700, 3.20, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTO- TETRAZOLE
2198, 6h06E, 0.5699, 2.94, 0.079, 215, 89, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
2199, 6a67H, 0.5699, 3.27, 0.076, 222, 92, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
2200, 5ovwJ, 0.5699, 3.13, 0.089, 126, 90, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
2201, 5d7iE, 0.5699, 2.85, 0.056, 200, 89, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2202, 4xt1C, 0.5699, 3.14, 0.055, 116, 91, STRUCTURE OF A NANOBODY-BOUND VIRAL GPCR BOUND TO HUMAN CHEMOKINE CX3CL1
2203, 4uojA, 0.5699, 3.52, 0.107, 917, 103, STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM
2204, 4s1dH, 0.5699, 2.94, 0.154, 216, 91, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
2205, 4fqra, 0.5699, 3.07, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2206, 3e1f2, 0.5699, 3.27, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
2207, 3arqA, 0.5699, 3.84, 0.103, 575, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH IDARUBICIN
2208, 1kyoU, 0.5699, 3.13, 0.055, 127, 91, YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C
2209, 1jynB, 0.5699, 3.22, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
2210, 1bfoF, 0.5699, 3.16, 0.077, 216, 91, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
2211, 1bfoD, 0.5699, 3.16, 0.077, 216, 91, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
2212, 1a7pH, 0.5699, 3.28, 0.077, 116, 91, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) ENGINEERED MUTANT PRO95L->SER ON VARIANT CHAIN L GLU81- >ASP AND CHAIN H LEU312->VAL
2213, 6obzH, 0.5698, 3.14, 0.099, 221, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2214, 5ukoH, 0.5698, 3.14, 0.089, 226, 90, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522IA FAB
2215, 5fykD, 0.5698, 3.31, 0.076, 242, 92, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE B JR-FL SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
2216, 4v40M, 0.5698, 3.29, 0.103, 1021, 97, 
2217, 4fqrm, 0.5698, 3.07, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2218, 4fqri, 0.5698, 3.08, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2219, 2ha1A, 0.5698, 2.97, 0.079, 201, 89, COMPLEX OF THE FIRST AND SECOND TYPE III DOMAINS OF HUMAN FIBRONECTIN IN SOLUTION
2220, 1kcvH, 0.5698, 3.18, 0.079, 217, 89, CRYSTAL STRUCTURE OF ANTIBODY PC282
2221, 1d6vH, 0.5698, 3.04, 0.078, 221, 90, CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
2222, 6mtqH, 0.5697, 3.06, 0.078, 221, 90, CRYSTAL STRUCTURE OF VRC42.N1 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
2223, 5kf4C, 0.5697, 2.51, 0.106, 96, 85, CRYSTAL STRUCTURE OF FN3 DOMAIN (RESIDUES P368-P466) OF HUMAN COLLAGEN XX
2224, 5k59H, 0.5697, 3.32, 0.076, 212, 92, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2225, 4zqkB, 0.5697, 3.14, 0.088, 106, 91, STRUCTURE OF THE COMPLEX OF HUMAN PROGRAMMED DEATH-1 (PD-1) AND ITS LIGAND PD-L1.
2226, 4y4fG, 0.5697, 2.87, 0.080, 202, 88, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
2227, 4v40N, 0.5697, 3.35, 0.102, 1021, 98, 
2228, 3whxA, 0.5697, 2.99, 0.133, 211, 90, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE1 COMPLEX
2229, 3se4A, 0.5697, 2.93, 0.102, 285, 88, HUMAN IFNW-IFNAR TERNARY COMPLEX
2230, 3e1f1, 0.5697, 3.27, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
2231, 3dyoB, 0.5697, 3.21, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
2232, 2p5eD, 0.5697, 2.90, 0.124, 194, 89, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2233, 1bfoB, 0.5697, 3.16, 0.077, 216, 91, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
2234, 6qgxB, 0.5696, 3.39, 0.087, 126, 92, CRYSTAL STRUCTURE OF E.COLI BAMA BETA-BARREL IN COMPLEX WITH NANOBODY F7 
2235, 6meiH, 0.5696, 2.99, 0.088, 228, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2236, 6h0eC, 0.5696, 3.08, 0.089, 218, 90, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2237, 6dfvA, 0.5696, 3.17, 0.089, 190, 90, MOUSE DIABETOGENIC TCR 8F10 
2238, 6bliD, 0.5696, 2.99, 0.112, 220, 89, RSV G PEPTIDE BOUND TO FAB CB002.5
2239, 6bdzH, 0.5696, 3.26, 0.088, 219, 91, ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB
2240, 5yfiH, 0.5696, 2.91, 0.089, 221, 90, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2241, 5xxlB, 0.5696, 3.49, 0.075, 731, 93, CRYSTAL STRUCTURE OF GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON
2242, 5m2wA, 0.5696, 2.82, 0.136, 117, 88, STRUCTURE OF NANOBODY NB18 RAISED AGAINST TSSK FROM E. COLI T6SS
2243, 5hvhC, 0.5696, 3.02, 0.122, 118, 90, CRYSTAL STRUCTURE OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR IN COMPLEX WITH TWO INHIBITORY NANOBODIES
2244, 5bmfH, 0.5696, 3.19, 0.089, 216, 90, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
2245, 4yblH, 0.5696, 3.20, 0.066, 214, 91, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32
2246, 4uojB, 0.5696, 3.52, 0.107, 917, 103, STRUCTURE OF FUNGAL BETA-MANNOSIDASE (GH2) FROM TRICHODERMA HARZIANUM
2247, 4u7kG, 0.5696, 2.60, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2248, 4r4nC, 0.5696, 3.04, 0.090, 219, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
2249, 4pjhG, 0.5696, 2.83, 0.068, 198, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
2250, 4pj9C, 0.5696, 2.83, 0.091, 190, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR
2251, 4p2cK, 0.5696, 2.96, 0.090, 120, 89, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
2252, 4nqcD, 0.5696, 2.77, 0.057, 185, 88, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2253, 4i8dB, 0.5696, 3.57, 0.084, 714, 95, CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI
2254, 4aq1D, 0.5696, 3.27, 0.088, 124, 91, STRUCTURE OF THE SBSB S-LAYER PROTEIN OF GEOBACILLUS STEAROTHERMOPHILUS PV72P2 IN COMPLEX WITH NANOBODY KB6
2255, 1jz2A, 0.5696, 3.36, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-F-GALACTOSYL- ENZYME INTERMEDIATE (ORTHORHOMBIC)
2256, 6mvgB, 0.5695, 3.31, 0.063, 636, 95, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM RUMINOCOCCUS GNAVUS 
2257, 6mlkH, 0.5695, 3.06, 0.067, 213, 89, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
2258, 6mf7H, 0.5695, 3.10, 0.056, 118, 89, STRUCTURE OF PARVOVIRUS B19 DECORATED WITH FAB MOLECULES FROM A HUMAN ANTIBODY 
2259, 6hcoF, 0.5695, 3.09, 0.056, 118, 90, CRYO-EM STRUCTURE OF THE ABCG2 E211Q MUTANT BOUND TO ESTRONE 3-SULFATE AND 5D3-FAB 
2260, 6hcoD, 0.5695, 3.09, 0.056, 118, 90, CRYO-EM STRUCTURE OF THE ABCG2 E211Q MUTANT BOUND TO ESTRONE 3-SULFATE AND 5D3-FAB 
2261, 6h0eH, 0.5695, 3.04, 0.089, 216, 90, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2262, 6dbdB, 0.5695, 3.00, 0.067, 114, 89, CRYSTAL STRUCTURE OF VHH R326 
2263, 6cbvH, 0.5695, 3.32, 0.098, 227, 92, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
2264, 6c5hH, 0.5695, 3.22, 0.089, 212, 90, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
2265, 5mhsN, 0.5695, 3.14, 0.078, 205, 90, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
2266, 4yr6D, 0.5695, 3.12, 0.055, 213, 91, FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE
2267, 4lgrB, 0.5695, 2.85, 0.068, 122, 88, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH3)
2268, 4i8dA, 0.5695, 3.57, 0.084, 711, 95, CRYSTAL STRUCTURE OF BETA-D-GLUCOSIDE GLUCOHYDROLASE FROM TRICHODERMA REESEI
2269, 4c56A, 0.5695, 2.82, 0.057, 192, 87, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
2270, 3nz8A, 0.5695, 3.02, 0.111, 217, 90, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
2271, 3cxhJ, 0.5695, 3.27, 0.043, 127, 92, STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
2272, 2wbjD, 0.5695, 2.97, 0.078, 270, 90, TCR COMPLEX
2273, 1i9eA, 0.5695, 2.93, 0.080, 115, 88, TCR DOMAIN
2274, 1i8lC, 0.5695, 2.83, 0.044, 118, 90, HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX
2275, 1fnsH, 0.5695, 3.25, 0.088, 220, 91, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN I546V MUTANT IN COMPLEX WITH THE FUNCTION BLOCKING FAB NMC4
2276, 6mvfD, 0.5694, 3.48, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
2277, 6bgtB, 0.5694, 3.36, 0.076, 210, 92, STRUCTURE OF TRASTUZUMAB FAB MUTANT IN COMPLEX WITH HER2 EXTRACELLULAR DOMAIN 
2278, 6b6lB, 0.5694, 3.53, 0.072, 715, 97, THE CRYSTAL STRUCTURE OF GLYCOSYL HYDROLASE FAMILY 2 (GH2) MEMBER FROM BACTEROIDES CELLULOSILYTICUS DSM 14838
2279, 5ggsY, 0.5694, 3.14, 0.088, 114, 91, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
2280, 5bopA, 0.5694, 3.08, 0.066, 123, 91, CRYSTAL STRUCTURE OF THE ARTIFICIAL NANOBODY OCTARELLINV.1 COMPLEX
2281, 4u7kF, 0.5694, 2.60, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2282, 4fqre, 0.5694, 3.07, 0.099, 238, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2283, 3muz2, 0.5694, 3.24, 0.093, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
2284, 3ikcB, 0.5694, 3.15, 0.077, 221, 91, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2285, 2jb5L, 0.5694, 2.95, 0.045, 211, 89, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-1
2286, 6mejH, 0.5693, 2.97, 0.088, 225, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2287, 6mcoD, 0.5693, 3.23, 0.077, 240, 91, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
2288, 6ieqD, 0.5693, 3.05, 0.078, 229, 90, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
2289, 6d0uH, 0.5693, 3.04, 0.099, 238, 91, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2290, 5wabA, 0.5693, 3.26, 0.066, 674, 91, CRYSTAL STRUCTURE OF BIFIDOBACTERIUM ADOLESCENTIS GH3 BETA-GLUCOSIDASE
2291, 5fehF, 0.5693, 2.88, 0.135, 229, 89, CRYSTAL STRUCTURE OF PCT64_35B A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY
2292, 4jm2A, 0.5693, 3.44, 0.108, 227, 93, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
2293, 3vd7D, 0.5693, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (N460S) IN COMPLEX WITH GALACTOTETRAZOLE
2294, 3se3A, 0.5693, 2.83, 0.103, 285, 87, HUMAN IFNA2-IFNAR TERNARY COMPLEX
2295, 3of6E, 0.5693, 3.22, 0.053, 104, 94, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
2296, 1tzhB, 0.5693, 3.09, 0.078, 222, 90, CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
2297, 1px3D, 0.5693, 3.37, 0.071, 1008, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A)
2298, 1jz3D, 0.5693, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL ENZYME INTERMEDIATE
2299, 1jyvD, 0.5693, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ONPG
2300, 1flrH, 0.5693, 3.03, 0.089, 216, 90, 4-4-20 FAB FRAGMENT
2301, 6obzA, 0.5692, 3.14, 0.099, 221, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2302, 5ovwG, 0.5692, 3.09, 0.078, 126, 90, NANOBODY-BOUND BTUF THE VITAMIN B12 BINDING PROTEIN IN ESCHERICHIA COLI
2303, 5njgE, 0.5692, 3.22, 0.044, 118, 91, STRUCTURE OF AN ABC TRANSPORTER: PART OF THE STRUCTURE THAT COULD BE BUILT DE NOVO
2304, 5njgC, 0.5692, 3.22, 0.044, 118, 91, STRUCTURE OF AN ABC TRANSPORTER: PART OF THE STRUCTURE THAT COULD BE BUILT DE NOVO
2305, 5nj3E, 0.5692, 3.22, 0.044, 208, 91, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
2306, 5nj3C, 0.5692, 3.22, 0.044, 208, 91, STRUCTURE OF AN ABC TRANSPORTER: COMPLETE STRUCTURE
2307, 4yk4Z, 0.5692, 3.05, 0.111, 223, 90, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2308, 4ttgB, 0.5692, 3.22, 0.104, 1014, 96, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
2309, 4dkaB, 0.5692, 3.16, 0.099, 127, 91, STRUCTURE OF EDITOSOME PROTEIN
2310, 3vd3A, 0.5692, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
2311, 3pnwB, 0.5692, 3.17, 0.089, 225, 90, CRYSTAL STRUCTURE OF THE TUDOR DOMAIN OF HUMAN TDRD3 IN COMPLEX WITH AN ANTI-TDRD3 FAB
2312, 3phoB, 0.5692, 3.03, 0.078, 216, 90, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2313, 3ijhB, 0.5692, 3.15, 0.077, 221, 91, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2314, 1za3H, 0.5692, 3.19, 0.055, 224, 91, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
2315, 1pkqB, 0.5692, 3.14, 0.088, 221, 91, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
2316, 6mvhC, 0.5691, 3.35, 0.084, 638, 95, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM ROSEBURIA HOMINIS 
2317, 6a67C, 0.5691, 3.28, 0.076, 222, 92, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
2318, 5um8D, 0.5691, 3.06, 0.078, 240, 90, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
2319, 3mv04, 0.5691, 3.28, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
2320, 3gm8A, 0.5691, 3.33, 0.073, 770, 96, CRYSTAL STRUCTURE OF A BETA-GLYCOSIDASE FROM BACTEROIDES VULGATUS
2321, 3cx5U, 0.5691, 3.17, 0.055, 127, 91, STRUCTURE OF COMPLEX III WITH BOUND CYTOCHROME C IN REDUCED STATE AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
2322, 2j8uF, 0.5691, 3.15, 0.089, 237, 90, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
2323, 2bmkB, 0.5691, 3.11, 0.088, 223, 91, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2324, 1jynD, 0.5691, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH LACTOSE
2325, 6mvfE, 0.5690, 3.49, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
2326, 6f0dA, 0.5690, 3.11, 0.043, 128, 92, CRYSTAL STRUCTURE OF A LLAMA VHH ANTIBODY BCD090-M2 AGAINST HUMAN ERBB3 IN SPACE GROUP P1 WITH CADMIUM IONS
2327, 6ch7D, 0.5690, 3.15, 0.077, 226, 91, XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
2328, 5utzJ, 0.5690, 3.30, 0.088, 218, 91, HUMAN IL-2/FAB COMPLEX 
2329, 5hcdB, 0.5690, 3.40, 0.097, 647, 93, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS MICROPLUS RACI2
2330, 4u6tC, 0.5690, 2.63, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A AT 1.76 ANGSTROM RESOLUTION
2331, 4fp8J, 0.5690, 3.10, 0.109, 238, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2332, 3iaqB, 0.5690, 3.20, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
2333, 3cxhU, 0.5690, 3.18, 0.055, 127, 91, STRUCTURE OF YEAST COMPLEX III WITH ISOFORM-2 CYTOCHROME C BOUND AND DEFINITION OF A MINIMAL CORE INTERFACE FOR ELECTRON TRANSFER.
2334, 2ajzH, 0.5690, 3.27, 0.066, 219, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH ECGONINE METHYL ESTER
2335, 1px4D, 0.5690, 3.27, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (G794A) WITH IPTG BOUND
2336, 1jz5D, 0.5690, 3.21, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH D-GALCTOPYRANOSYL-1- ON
2337, 1ex0B, 0.5690, 3.19, 0.065, 716, 92, HUMAN FACTOR XIII MUTANT W279F ZYMOGEN
2338, 5nltC, 0.5689, 3.10, 0.108, 225, 93, CVAA9A
2339, 5j75B, 0.5689, 2.82, 0.091, 233, 88, FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342
2340, 5gjtH, 0.5689, 3.03, 0.089, 211, 90, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
2341, 5f9oH, 0.5689, 3.16, 0.077, 220, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
2342, 5bzwB, 0.5689, 3.21, 0.099, 230, 91, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2343, 4jm4H, 0.5689, 3.44, 0.109, 229, 92, CRYSTAL STRUCTURE OF PGT 135 FAB
2344, 4eisB, 0.5689, 3.04, 0.056, 224, 90, STRUCTURAL BASIS FOR SUBSTRATE TARGETING AND CATALYSIS BY FUNGAL POLYSACCHARIDE MONOOXYGENASES (PMO-3)
2345, 3skjI, 0.5689, 3.17, 0.088, 228, 91, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
2346, 3nmsA, 0.5689, 3.88, 0.059, 641, 101, STAPHYLOCOCCAL COMPLEMENT INHIBITOR (SCIN) IN COMPLEX WITH HUMAN COMPLEMENT C3C
2347, 3muz4, 0.5689, 3.37, 0.071, 1011, 98, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH IPTG
2348, 3kbpD, 0.5689, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2349, 3effD, 0.5689, 3.27, 0.055, 219, 91, THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION
2350, 3dypD, 0.5689, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N)
2351, 2ap2B, 0.5689, 3.24, 0.088, 122, 91, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2352, 1t2qH, 0.5689, 3.32, 0.076, 217, 92, THE CRYSTAL STRUCTURE OF AN NNA7 FAB THAT RECOGNIZES AN N-TYPE BLOOD GROUP ANTIGEN
2353, 1rivH, 0.5689, 3.04, 0.111, 220, 90, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2354, 1jz8D, 0.5689, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE
2355, 1jz7B, 0.5689, 3.22, 0.104, 1010, 96, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
2356, 6okqA, 0.5688, 3.06, 0.100, 230, 90, CRYSTAL STRUCTURE OF THE SF12 FAB 
2357, 6mjaC, 0.5688, 2.89, 0.080, 200, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXO (JJ294) /INKTCR TERNARY COMPLEX 
2358, 5f7lD, 0.5688, 3.07, 0.077, 124, 91, BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH NANOBODY NB-ER14
2359, 4z5rB, 0.5688, 3.45, 0.065, 213, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2360, 4u7kC, 0.5688, 2.61, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2361, 4u7kB, 0.5688, 2.60, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2362, 4jegB, 0.5688, 2.50, 0.119, 93, 84, CRYSTAL STRUCTURE OF MONOBODY CS1/SHP2 C-SH2 DOMAIN COMPLEX
2363, 4fp8H, 0.5688, 3.10, 0.109, 238, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2364, 4duvA, 0.5688, 3.38, 0.071, 1019, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) 2-DEOXY-GALACTOSYL-ENZYME AND BIS-TRIS COMPLEX
2365, 4acqD, 0.5688, 3.33, 0.097, 1269, 93, ALPHA-2 MACROGLOBULIN
2366, 3ugxD, 0.5688, 3.34, 0.125, 348, 96, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
2367, 3t2oD, 0.5688, 3.38, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (S796D)
2368, 3skjH, 0.5688, 3.32, 0.076, 228, 92, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY
2369, 3mv14, 0.5688, 3.32, 0.103, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
2370, 3kbpB, 0.5688, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2371, 3czjA, 0.5688, 3.25, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460T) IN COMPLEX WITH D- GALCTOPYRANOSYL-1-ONE
2372, 3ch8A, 0.5688, 2.86, 0.112, 190, 89, THE CRYSTAL STRUCTURE OF PDZ-FIBRONECTIN FUSION PROTEIN
2373, 1jz4D, 0.5688, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE-TRAPPED 2-DEOXY- GALACTOSYL-ENZYME INTERMEDIATE (LOW BIS-TRIS)
2374, 1jyxA, 0.5688, 3.29, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH IPTG
2375, 1jywD, 0.5688, 3.38, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH PNPG
2376, 6ce9B, 0.5687, 2.91, 0.114, 562, 88, INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES
2377, 6ce9A, 0.5687, 2.91, 0.114, 562, 88, INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH TWO INSULIN MOLECULES
2378, 5nkqG, 0.5687, 2.48, 0.120, 88, 83, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2379, 5mp2D, 0.5687, 3.07, 0.033, 125, 91, XCPQN012 IN COMPLEX WITH VHH04
2380, 5e08H, 0.5687, 3.25, 0.088, 229, 91, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
2381, 4ttgA, 0.5687, 3.37, 0.082, 1014, 97, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
2382, 4qhmC, 0.5687, 3.21, 0.100, 217, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
2383, 4llaC, 0.5687, 2.54, 0.070, 198, 86, CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
2384, 4jrwB, 0.5687, 2.62, 0.119, 87, 84, CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE PKD DOMAIN 2 AT 1.6 ANGSTROM RESOLUTION
2385, 4fp8I, 0.5687, 3.10, 0.109, 238, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2386, 3kbpC, 0.5687, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2387, 3iu4H, 0.5687, 3.18, 0.067, 215, 90, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
2388, 3iaqD, 0.5687, 3.39, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (E416V)
2389, 3i3bD, 0.5687, 3.22, 0.072, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH D- GALACTOPYRANOSYL-1-ON
2390, 2uweF, 0.5687, 3.17, 0.089, 237, 90, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2391, 2i60R, 0.5687, 3.05, 0.089, 222, 90, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2392, 2cdeC, 0.5687, 3.00, 0.067, 192, 89, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2393, 2bmkH, 0.5687, 3.11, 0.088, 221, 91, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
2394, 6mvfF, 0.5686, 3.48, 0.083, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
2395, 6mnnA, 0.5686, 2.85, 0.034, 196, 88, 6236 TCR BOUND TO I-AB PADI4 
2396, 6f0dB, 0.5686, 3.11, 0.043, 128, 92, CRYSTAL STRUCTURE OF A LLAMA VHH ANTIBODY BCD090-M2 AGAINST HUMAN ERBB3 IN SPACE GROUP P1 WITH CADMIUM IONS
2397, 6dfiH, 0.5686, 3.20, 0.110, 220, 91, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII 
2398, 6az2C, 0.5686, 3.33, 0.054, 214, 92, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
2399, 5z87A, 0.5686, 3.57, 0.065, 756, 93, STRUCTURAL OF A NOVEL B-GLUCOSIDASE EMGH1 AT 2.3 ANGSTROM FROM ERYTHROBACTER MARINUS 
2400, 5eu7F, 0.5686, 3.04, 0.056, 227, 90, CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB
2401, 4ttgD, 0.5686, 3.38, 0.082, 1014, 97, BETA-GALACTOSIDASE (E. COLI) IN THE PRESENCE OF POTASSIUM CHLORIDE.
2402, 4rrpL, 0.5686, 3.26, 0.055, 214, 91, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
2403, 4j4pH, 0.5686, 3.16, 0.099, 224, 91, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
2404, 4cvuA, 0.5686, 3.65, 0.106, 913, 104, STRUCTURE OF FUNGAL BETA-MANNOSIDASE FROM GLYCOSIDE HYDROLASE FAMILY 2 OF TRICHODERMA HARZIANUM
2405, 3wfhA, 0.5686, 3.01, 0.133, 211, 90, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX
2406, 3qw9B, 0.5686, 3.35, 0.052, 166, 97, CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN
2407, 3kbpA, 0.5686, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2408, 2z8wC, 0.5686, 3.20, 0.099, 116, 91, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
2409, 2ajzB, 0.5686, 3.27, 0.066, 219, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH ECGONINE METHYL ESTER
2410, 1mamH, 0.5686, 3.41, 0.077, 217, 91, CRYSTAL STRUCTURE TO 2.45 A RESOLUTION OF A MONOCLONAL FAB SPECIFIC FOR THE BRUCELLA A CELL WALL POLYSACCHARIDE ANTIGEN
2411, 1kbpD, 0.5686, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2412, 1bafH, 0.5686, 3.28, 0.067, 217, 90, 2.9 ANGSTROMS RESOLUTION STRUCTURE OF AN ANTI-DINITROPHENYL-SPIN-LABEL MONOCLONAL ANTIBODY FAB FRAGMENT WITH BOUND HAPTEN
2413, 6iebE, 0.5685, 3.14, 0.067, 182, 90, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R15 
2414, 6dsiA, 0.5685, 3.06, 0.099, 229, 91, ANTI RECOMBINANT PROLACTIN RECEPTOR SCFV 
2415, 5hceB, 0.5685, 3.39, 0.098, 647, 92, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND RHIPICEPHALUS APPENDICULATUS RACI1
2416, 5eu7E, 0.5685, 3.06, 0.056, 228, 90, CRYSTAL STRUCTURE OF HIV-1 INTEGRASE CATALYTIC CORE IN COMPLEX WITH FAB
2417, 4dohE, 0.5685, 2.74, 0.057, 204, 88, IL20/IL201/IL20R2 TERNARY COMPLEX
2418, 3u48B, 0.5685, 3.33, 0.077, 742, 91, FROM SOIL TO STRUCTURE: A NOVEL DIMERIC FAMILY 3-BETA-GLUCOSIDASE ISOLATED FROM COMPOST USING METAGENOMIC ANALYSIS
2419, 3phqB, 0.5685, 3.12, 0.077, 213, 91, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2420, 3ijyB, 0.5685, 3.16, 0.077, 221, 91, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
2421, 3dyoA, 0.5685, 3.38, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (H418N) IN COMPLEX WITH IPTG
2422, 2cdeA, 0.5685, 2.82, 0.069, 192, 87, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2423, 1kyoJ, 0.5685, 3.17, 0.055, 127, 91, YEAST CYTOCHROME BC1 COMPLEX WITH BOUND SUBSTRATE CYTOCHROME C
2424, 1kbpC, 0.5685, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2425, 1jz7D, 0.5685, 3.37, 0.082, 1010, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
2426, 6iebH, 0.5684, 3.00, 0.079, 211, 89, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R15 
2427, 6h06A, 0.5684, 3.04, 0.089, 218, 90, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
2428, 6ewoD, 0.5684, 2.45, 0.106, 184, 85, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RTF PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 
2429, 5xxmB, 0.5684, 3.50, 0.075, 744, 93, CRYSTAL STRUCTURE OF GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH GLUCONOLACTONE
2430, 5xotD, 0.5684, 3.18, 0.022, 203, 91, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
2431, 5w6dD, 0.5684, 3.07, 0.078, 223, 90, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
2432, 5u02A, 0.5684, 3.24, 0.083, 355, 96, CRYSTAL STRUCTURE OF S. AUREUS TARS 217-571
2433, 5m15D, 0.5684, 3.18, 0.099, 125, 91, SYNTHETIC NANOBODY IN COMPLEX WITH MBP
2434, 5bjzD, 0.5684, 3.35, 0.087, 231, 92, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
2435, 5a40F, 0.5684, 2.33, 0.122, 88, 82, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2436, 5a16E, 0.5684, 3.31, 0.043, 226, 92, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2437, 4u7kD, 0.5684, 2.62, 0.119, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2438, 4r4nH, 0.5684, 3.09, 0.089, 219, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
2439, 4humB, 0.5684, 2.54, 0.151, 91, 86, MATE TRANSPORTER NORM-NG IN COMPLEX WITH ETHIDIUM AND MONOBODY
2440, 43c9B, 0.5684, 3.37, 0.075, 118, 93, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
2441, 3uajH, 0.5684, 3.14, 0.099, 219, 91, CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
2442, 3tyfA, 0.5684, 2.71, 0.057, 199, 87, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2443, 3t0bA, 0.5684, 3.38, 0.071, 1014, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (S796T) IPTG COMPLEX
2444, 3rzwA, 0.5684, 2.52, 0.083, 89, 84, CRYSTAL STRUCTURE OF THE MONOBODY YSMB-9 BOUND TO HUMAN SUMO1
2445, 3lb6D, 0.5684, 2.92, 0.044, 284, 90, THE STRUCTURE OF IL-13 IN COMPLEX WITH IL-13RALPHA2
2446, 3i3dD, 0.5684, 3.38, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
2447, 3fo0H, 0.5684, 3.26, 0.099, 214, 91, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
2448, 3arxA, 0.5684, 3.80, 0.103, 575, 97, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - COMPLEX STRUCTURE WITH PROPENTOFYLLINE
2449, 2z8vD, 0.5684, 3.19, 0.099, 116, 91, STRUCTURE OF AN IGNAR-AMA1 COMPLEX
2450, 2ianD, 0.5684, 2.82, 0.069, 198, 87, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2451, 6gk4B, 0.5683, 3.07, 0.111, 121, 90, HUMAN NBD1 OF CFTR IN COMPLEX WITH NANOBODIES D12 AND T8 
2452, 5wabB, 0.5683, 3.28, 0.055, 659, 91, CRYSTAL STRUCTURE OF BIFIDOBACTERIUM ADOLESCENTIS GH3 BETA-GLUCOSIDASE
2453, 4u6tD, 0.5683, 2.62, 0.143, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A AT 1.76 ANGSTROM RESOLUTION
2454, 4r4nT, 0.5683, 3.03, 0.101, 219, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
2455, 4q66G, 0.5683, 2.44, 0.060, 211, 83, STRUCTURE OF EXOMER BOUND TO ARF1.
2456, 4pjcG, 0.5683, 2.80, 0.068, 197, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
2457, 4p2cI, 0.5683, 3.06, 0.111, 120, 90, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
2458, 4gkzB, 0.5683, 2.78, 0.035, 241, 86, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
2459, 4cakA, 0.5683, 3.88, 0.050, 912, 101, THREE-DIMENSIONAL RECONSTRUCTION OF INTACT HUMAN INTEGRIN ALPHAIIBBETA3 IN A PHOSPHOLIPID BILAYER NANODISC
2460, 43c9D, 0.5683, 3.38, 0.075, 118, 93, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
2461, 3tfkC, 0.5683, 3.24, 0.055, 201, 91, 42F3-P4B10/H2-LD
2462, 3o3uN, 0.5683, 3.40, 0.097, 580, 93, CRYSTAL STRUCTURE OF HUMAN RECEPTOR FOR ADVANCED GLYCATION ENDPRODUCTS (RAGE)
2463, 3nn8A, 0.5683, 3.31, 0.087, 121, 92, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
2464, 3k80A, 0.5683, 3.17, 0.088, 124, 91, STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI
2465, 3b9kD, 0.5683, 3.14, 0.078, 214, 90, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
2466, 2po6C, 0.5683, 2.88, 0.057, 203, 88, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2467, 1kbpB, 0.5683, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2468, 1kbpA, 0.5683, 2.32, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2469, 6qn8A, 0.5682, 3.20, 0.077, 235, 91, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
2470, 6mnoA, 0.5682, 3.11, 0.033, 196, 90, 6235 TCR BOUND TO I-AB PADI4 
2471, 5xxlA, 0.5682, 3.53, 0.075, 745, 93, CRYSTAL STRUCTURE OF GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON
2472, 5wkoC, 0.5682, 3.20, 0.066, 225, 91, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2473, 5w3mE, 0.5682, 3.16, 0.056, 116, 90, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:1 FULL PARTICLE)
2474, 5hysC, 0.5682, 3.34, 0.054, 222, 92, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2475, 5cp7H, 0.5682, 2.92, 0.057, 212, 87, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
2476, 4p2cG, 0.5682, 2.96, 0.089, 121, 90, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
2477, 3revA, 0.5682, 3.04, 0.044, 201, 90, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
2478, 3okmB, 0.5682, 3.18, 0.088, 215, 91, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
2479, 3mj8B, 0.5682, 3.30, 0.067, 211, 90, CRYSTAL STRUCTURE OF HL4E10 FAB A HAMSTER AB STIMULATORY FOR GAMMADELTA T CELLS
2480, 3iapA, 0.5682, 3.35, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (E416Q)
2481, 3h3pM, 0.5682, 3.20, 0.088, 111, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
2482, 2xa3A, 0.5682, 3.20, 0.043, 127, 92, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING LLAMA VHH D7 AND ITS MODE OF HIV-1 GP120 INTERACTION
2483, 2uweM, 0.5682, 3.15, 0.089, 237, 90, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2484, 2p49B, 0.5682, 3.45, 0.110, 123, 91, COMPLEX OF A CAMELID SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A AT 1.4A RESOLUTION: NATIVE MONO_1 CRYSTAL FORM
2485, 1yylH, 0.5682, 3.22, 0.098, 229, 92, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2486, 1wc7B, 0.5682, 3.11, 0.088, 223, 91, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
2487, 6h06H, 0.5681, 2.95, 0.079, 216, 89, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
2488, 6dfqG, 0.5681, 2.88, 0.068, 167, 88, MOUSE DIABETOGENIC TCR I.29 
2489, 6dbdC, 0.5681, 2.89, 0.057, 111, 87, CRYSTAL STRUCTURE OF VHH R326 
2490, 6c5wE, 0.5681, 3.10, 0.055, 117, 91, CRYSTAL STRUCTURE OF THE MITOCHONDRIAL CALCIUM UNIPORTER 
2491, 4llaA, 0.5681, 2.68, 0.069, 198, 87, CRYSTAL STRUCTURE OF D3D4 DOMAIN OF THE LILRB2 MOLECULE
2492, 4jguA, 0.5681, 2.66, 0.095, 95, 84, CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY-DISEASE-LIKE DOMAIN 2B AT 1.4 ANGSTROM RESOLUTION IN THE PRESENCE OF CALCIUM
2493, 4edxH, 0.5681, 3.29, 0.066, 216, 91, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
2494, 3uajC, 0.5681, 3.14, 0.099, 220, 91, CRYSTAL STRUCTURE OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
2495, 3pp3H, 0.5681, 3.18, 0.088, 220, 91, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
2496, 3lhpM, 0.5681, 3.21, 0.088, 110, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
2497, 1tzhH, 0.5681, 3.27, 0.088, 217, 91, CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF
2498, 1kcuH, 0.5681, 3.25, 0.067, 217, 90, CRYSTAL STRUCTURE OF ANTIBODY PC287
2499, 1i8lD, 0.5681, 3.00, 0.044, 118, 91, HUMAN B7-1/CTLA-4 CO-STIMULATORY COMPLEX
2500, 1fe8J, 0.5681, 3.24, 0.100, 210, 90, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
2501, 6eyoI, 0.5680, 3.01, 0.077, 208, 91, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
2502, 5t3sD, 0.5680, 3.06, 0.078, 240, 90, HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022
2503, 5nltF, 0.5680, 3.11, 0.108, 223, 93, CVAA9A
2504, 5j1tC, 0.5680, 3.09, 0.078, 121, 90, TORSINADELTAE-LULL1 COMPLEX H. SAPIENS BOUND TO VHH-BS2
2505, 5hbvD, 0.5680, 3.33, 0.077, 219, 91, COMPLEX STRUCTURE OF FAB35 AND MOUSE NACHR ALPHA1
2506, 5gjsH, 0.5680, 3.21, 0.088, 211, 91, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
2507, 4u7kA, 0.5680, 2.60, 0.119, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2508, 4pjdE, 0.5680, 2.79, 0.057, 188, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
2509, 4ioiB, 0.5680, 3.23, 0.077, 220, 91, MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
2510, 4dk3B, 0.5680, 3.17, 0.099, 127, 91, STRUCTURE OF EDITOSOME PROTEIN
2511, 3vd3D, 0.5680, 3.25, 0.093, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (N460D)
2512, 3muy4, 0.5680, 3.33, 0.072, 1011, 97, E. COLI (LACZ) BETA-GALACTOSIDASE (R599A)
2513, 3i3dA, 0.5680, 3.37, 0.071, 1011, 98, E. COLI (LACZ) BETA-GALACTOSIDASE (M542A) IN COMPLEX WITH IPTG
2514, 3g5xD, 0.5680, 3.14, 0.078, 216, 90, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
2515, 2z91C, 0.5680, 3.01, 0.057, 203, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
2516, 2f53E, 0.5680, 3.05, 0.091, 243, 88, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
2517, 2cspA, 0.5680, 3.10, 0.118, 130, 93, SOLUTION STRUCTURE OF THE FNIII DOMAIN OF HUMAN RIM-BINDING PROTEIN 2
2518, 2arjH, 0.5680, 3.25, 0.087, 212, 92, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2519, 1jz7A, 0.5680, 3.37, 0.082, 1010, 97, E. COLI (LACZ) BETA-GALACTOSIDASE IN COMPLEX WITH GALACTOSE
2520, 6qnaH, 0.5679, 3.07, 0.090, 232, 89, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
2521, 6hnfA, 0.5679, 2.75, 0.068, 91, 88, STRUCTURE IN SOLUTION OF HUMAN FIBRONECTIN TYPE III-DOMAIN 14 
2522, 6fr7B, 0.5679, 2.93, 0.046, 241, 87, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2523, 6ce0D, 0.5679, 3.07, 0.078, 240, 90, CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM 
2524, 5hysH, 0.5679, 3.20, 0.066, 222, 91, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2525, 5f7lB, 0.5679, 2.97, 0.056, 121, 90, BLOOD GROUP ANTIGEN BINDING ADHESIN BABA OF HELICOBACTER PYLORI STRAIN 17875 IN COMPLEX WITH NANOBODY NB-ER14
2526, 4zffH, 0.5679, 3.27, 0.055, 211, 91, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2527, 4yr6A, 0.5679, 3.12, 0.055, 215, 91, FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE
2528, 4oiaB, 0.5679, 2.79, 0.081, 375, 86, CRYSTAL STRUCTURE OF ICAM-5 D1-D4 ECTODOMAIN FRAGMENT SPACE GROUP P4322
2529, 4m8qH, 0.5679, 3.07, 0.078, 125, 90, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
2530, 4m5yI, 0.5679, 3.36, 0.065, 224, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
2531, 4kbpC, 0.5679, 2.33, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2532, 3g5xB, 0.5679, 3.27, 0.077, 216, 91, ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR
2533, 2m26A, 0.5679, 2.96, 0.066, 126, 91, NMR STRUCTURE OF THE C-TERMINAL DOMAIN OF THE PROTEIN HCFC1 FROM MUS MUSCULUS
2534, 1za3B, 0.5679, 3.26, 0.066, 224, 91, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
2535, 1wcbH, 0.5679, 3.16, 0.077, 222, 91, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
2536, 1orqB, 0.5679, 3.29, 0.055, 219, 91, X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
2537, 1kxvD, 0.5679, 3.12, 0.110, 121, 91, CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE
2538, 1kc5H, 0.5679, 3.24, 0.067, 217, 90, CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE
2539, 6fxnH, 0.5678, 2.74, 0.069, 216, 87, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2540, 6eh8B, 0.5678, 2.78, 0.035, 241, 86, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2541, 5xxoA, 0.5678, 3.53, 0.075, 745, 93, CRYSTAL STRUCTURE OF MUTANT (D286N) GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH SOPHOROTRIOSE
2542, 5a16A, 0.5678, 3.30, 0.043, 226, 92, CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1
2543, 4zffA, 0.5678, 3.28, 0.055, 206, 91, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
2544, 4v40F, 0.5678, 3.38, 0.092, 1021, 98, 
2545, 4u7kH, 0.5678, 2.60, 0.119, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2546, 4r7nI, 0.5678, 3.37, 0.065, 218, 92, FAB C2E3
2547, 4j4pC, 0.5678, 3.18, 0.088, 222, 91, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
2548, 3ugxB, 0.5678, 3.38, 0.125, 352, 96, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
2549, 3sdxE, 0.5678, 2.86, 0.057, 196, 88, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2550, 2fjhH, 0.5678, 3.21, 0.099, 219, 91, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
2551, 1gguB, 0.5678, 3.16, 0.065, 707, 92, HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE
2552, 1bvkB, 0.5678, 3.15, 0.111, 116, 90, HUMANIZED ANTI-LYSOZYME FV COMPLEXED WITH LYSOZYME
2553, 6oc3A, 0.5677, 3.22, 0.110, 224, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2554, 5w6gH, 0.5677, 3.32, 0.076, 225, 92, HUMAN ANTIBODY 6649 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS
2555, 5ukpH, 0.5677, 3.24, 0.055, 220, 91, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.1 FAB
2556, 5kenQ, 0.5677, 3.12, 0.099, 121, 91, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6
2557, 4u7kE, 0.5677, 2.62, 0.119, 86, 84, CRYSTAL STRUCTURE OF THE CLOSTRIDIUM HISTOLYTICUM COLH COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN 2A IN THE PRESENCE OF CALCIUM AT 1.9 ANGSTROM RESOLUTION
2558, 4n9gA, 0.5677, 3.19, 0.099, 224, 91, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
2559, 4kbpA, 0.5677, 2.33, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2560, 4e0sA, 0.5677, 3.19, 0.098, 1552, 92, CRYSTAL STRUCTURE OF C5B-6
2561, 3u48A, 0.5677, 3.42, 0.087, 739, 92, FROM SOIL TO STRUCTURE: A NOVEL DIMERIC FAMILY 3-BETA-GLUCOSIDASE ISOLATED FROM COMPOST USING METAGENOMIC ANALYSIS
2562, 2vsdA, 0.5677, 2.88, 0.047, 93, 86, CRYSTAL STRUCTURE OF CHIR-AB1
2563, 1soxA, 0.5677, 2.70, 0.101, 463, 89, SULFITE OXIDASE FROM CHICKEN LIVER
2564, 1blnB, 0.5677, 3.30, 0.054, 218, 92, ANTI-P-GLYCOPROTEIN FAB MRK-16
2565, 6mj4C, 0.5676, 2.91, 0.080, 201, 88, CRYSTAL STRUCTURE OF MCD1D/INKTCR TERNARY COMPLEX BOUND TO GLYCOLIPID (XXW) 
2566, 6d7jB, 0.5676, 3.47, 0.082, 788, 97, THE CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) WITH GLYCEROL IN ACTIVE-SITE 
2567, 6cx9C, 0.5676, 2.91, 0.080, 201, 88, STRUCTURE OF ALPHA-GSA[16;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2568, 5nyxM, 0.5676, 3.03, 0.100, 223, 90, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2569, 5fk9A, 0.5676, 2.90, 0.056, 198, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN A F47A MUTANT IN COMPLEX WITH A T CELL RECEPTOR
2570, 5cezD, 0.5676, 3.06, 0.078, 240, 90, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM
2571, 4x7tH, 0.5676, 3.24, 0.077, 222, 91, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2572, 4r4hH, 0.5676, 3.21, 0.088, 220, 91, CRYSTAL STRUCTURE OF NON-NEUTRALIZING A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 ENV GP120
2573, 4kbpD, 0.5676, 2.33, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2574, 4kbpB, 0.5676, 2.33, 0.071, 424, 85, KIDNEY BEAN PURPLE ACID PHOSPHATASE
2575, 3sdxG, 0.5676, 2.87, 0.057, 196, 88, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2576, 3ijsB, 0.5676, 3.17, 0.077, 221, 91, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
2577, 3i2cL, 0.5676, 3.25, 0.086, 218, 93, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088
2578, 1yylR, 0.5676, 3.02, 0.089, 229, 90, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2579, 1moeB, 0.5676, 3.31, 0.086, 240, 93, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
2580, 6qnaA, 0.5675, 3.07, 0.090, 229, 89, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
2581, 6ocbH, 0.5675, 3.16, 0.099, 222, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
2582, 6mjqD, 0.5675, 3.22, 0.078, 240, 90, CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX 
2583, 6cx5C, 0.5675, 2.94, 0.068, 200, 88, STRUCTURE OF ALPHA-GSA[8;8P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2584, 6bnkG, 0.5675, 2.92, 0.080, 203, 88, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
2585, 6bnkC, 0.5675, 2.92, 0.080, 203, 88, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
2586, 5xxnB, 0.5675, 3.41, 0.076, 731, 92, CRYSTAL STRUCTURE OF MUTANT (D286N) BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH SOPHOROSE
2587, 5fhcA, 0.5675, 3.23, 0.055, 221, 91, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
2588, 4z5rU, 0.5675, 3.38, 0.076, 213, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2589, 4xnqB, 0.5675, 3.28, 0.099, 217, 91, ANTIBODY HEMAGGLUTININ COMPLEXES
2590, 4r7dK, 0.5675, 3.52, 0.075, 201, 93, FAB HU 15C1
2591, 4pjcE, 0.5675, 2.80, 0.068, 188, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
2592, 4dt2A, 0.5675, 2.32, 0.071, 426, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
2593, 4apqC, 0.5675, 3.12, 0.089, 196, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
2594, 3wifA, 0.5675, 3.06, 0.143, 211, 91, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT 9CL-PGF2BETA COMPLEX
2595, 3nn8F, 0.5675, 3.50, 0.064, 116, 94, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
2596, 3leyH, 0.5675, 3.21, 0.078, 217, 90, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN COMPLEX WITH HIV-1 GP41
2597, 3lexA, 0.5675, 3.20, 0.056, 212, 90, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
2598, 2x89C, 0.5675, 3.12, 0.043, 128, 92, STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
2599, 2h1pH, 0.5675, 3.39, 0.065, 220, 92, THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES
2600, 2ap2D, 0.5675, 3.21, 0.088, 122, 91, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2601, 2ajyH, 0.5675, 3.35, 0.066, 219, 91, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID
2602, 1nfdC, 0.5675, 2.94, 0.101, 203, 89, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2603, 6mvfC, 0.5674, 3.50, 0.073, 643, 96, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
2604, 6ewcH, 0.5674, 2.52, 0.116, 186, 86, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RLS PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 
2605, 5wduU, 0.5674, 3.07, 0.078, 242, 90, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
2606, 5ubzH, 0.5674, 3.27, 0.098, 222, 92, FAB STRUCTURE OF HIV GP120 SPECIFIC MAB 1E12
2607, 5ijkA, 0.5674, 2.94, 0.135, 213, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2608, 4s1dE, 0.5674, 2.95, 0.154, 214, 91, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
2609, 4jvpA, 0.5674, 3.34, 0.054, 131, 92, THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 ALPACA NANOBODY D03
2610, 4i0cC, 0.5674, 3.03, 0.068, 126, 88, THE STRUCTURE OF THE CAMELID ANTIBODY CABHUL5 IN COMPLEX WITH HUMAN LYSOZYME
2611, 4hukB, 0.5674, 2.53, 0.151, 91, 86, MATE TRANSPORTER NORM-NG IN COMPLEX WITH TPP AND MONOBODY
2612, 4dt2C, 0.5674, 2.32, 0.071, 426, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
2613, 3se9H, 0.5674, 3.32, 0.086, 225, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
2614, 3dvnB, 0.5674, 3.39, 0.087, 217, 92, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN
2615, 2qfpB, 0.5674, 2.28, 0.071, 424, 84, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
2616, 1riuH, 0.5674, 3.23, 0.098, 220, 92, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2617, 1mvuB, 0.5674, 3.09, 0.132, 121, 91, SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2618, 1lp9F, 0.5674, 3.05, 0.079, 237, 89, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
2619, 6mj6C, 0.5673, 2.74, 0.080, 200, 87, CRYSTAL STRUCTURE OF THE MCD1D/XXX (JJ166) /INKTCR TERNARY COMPLEX 
2620, 6miyG, 0.5673, 2.90, 0.080, 199, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
2621, 6ii4E, 0.5673, 3.28, 0.076, 220, 92, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4A-14 
2622, 5nyxO, 0.5673, 3.12, 0.099, 224, 91, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2623, 5nltD, 0.5673, 3.12, 0.108, 223, 93, CVAA9A
2624, 5lbsM, 0.5673, 3.23, 0.043, 112, 92, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2625, 5hysA, 0.5673, 3.27, 0.077, 222, 91, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2626, 4z5rZ, 0.5673, 3.39, 0.076, 117, 92, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
2627, 4r7nE, 0.5673, 3.38, 0.076, 218, 92, FAB C2E3
2628, 4r7dG, 0.5673, 3.37, 0.076, 190, 92, FAB HU 15C1
2629, 4qthH, 0.5673, 3.24, 0.109, 224, 92, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2630, 4pjdG, 0.5673, 2.80, 0.057, 197, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
2631, 4m5yH, 0.5673, 3.36, 0.065, 217, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING FAB 5J8
2632, 4hkzB, 0.5673, 3.23, 0.099, 221, 91, TRASTUZUMAB FAB COMPLEXED WITH PROTEIN L AND PROTEIN A FRAGMENTS
2633, 3utsI, 0.5673, 3.12, 0.078, 201, 90, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2634, 3to4D, 0.5673, 2.58, 0.047, 243, 85, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
2635, 3mv11, 0.5673, 3.33, 0.103, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (R599A) IN COMPLEX WITH GUANIDINIUM
2636, 2ny5H, 0.5673, 3.04, 0.089, 221, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T257S V275C S334A S375W Q428C A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
2637, 1n8zB, 0.5673, 3.24, 0.099, 220, 91, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
2638, 6mekB, 0.5672, 2.88, 0.089, 224, 90, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2639, 6medG, 0.5672, 3.05, 0.088, 222, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2640, 6eh9B, 0.5672, 2.79, 0.035, 241, 86, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2641, 5nltB, 0.5672, 3.11, 0.108, 226, 93, CVAA9A
2642, 5nltA, 0.5672, 3.12, 0.108, 223, 93, CVAA9A
2643, 5d2lO, 0.5672, 2.88, 0.023, 187, 88, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2644, 4p2cH, 0.5672, 3.05, 0.111, 120, 90, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
2645, 4lexH, 0.5672, 3.30, 0.065, 217, 92, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
2646, 3lexH, 0.5672, 3.20, 0.056, 212, 90, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
2647, 3fo2H, 0.5672, 3.15, 0.067, 214, 90, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2648, 2ianS, 0.5672, 2.91, 0.080, 198, 88, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2649, 1kcrH, 0.5672, 3.38, 0.077, 218, 91, CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
2650, 6hwrC, 0.5671, 2.32, 0.071, 423, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
2651, 6h0eE, 0.5671, 2.95, 0.090, 215, 89, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2652, 5xj4L, 0.5671, 3.24, 0.066, 113, 91, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
2653, 4x0kL, 0.5671, 3.55, 0.063, 226, 95, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
2654, 4r4nQ, 0.5671, 3.06, 0.101, 219, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
2655, 4qthA, 0.5671, 3.04, 0.111, 215, 90, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2656, 4hjgB, 0.5671, 3.24, 0.088, 221, 91, MEDITOPE-ENABLED TRASTUZUMAB
2657, 4fqrq, 0.5671, 3.13, 0.109, 238, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2658, 3zz1A, 0.5671, 3.62, 0.083, 713, 96, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE BGL1 FROM HYPOCREA JECORINA AT 2.1A RESOLUTION.
2659, 3v4pC, 0.5671, 3.93, 0.050, 581, 101, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2660, 3u4aB, 0.5671, 3.44, 0.087, 742, 92, FROM SOIL TO STRUCTURE: A NOVEL DIMERIC FAMILY 3-BETA-GLUCOSIDASE ISOLATED FROM COMPOST USING METAGENOMIC ANALYSIS
2661, 3qi9C, 0.5671, 3.11, 0.089, 196, 90, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
2662, 3he7C, 0.5671, 2.87, 0.080, 197, 88, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
2663, 3e1f4, 0.5671, 3.30, 0.093, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
2664, 2ny3D, 0.5671, 3.18, 0.099, 223, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E267C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2665, 6mvfA, 0.5670, 3.45, 0.074, 643, 95, CRYSTAL STRUCTURE OF FMN-BINDING BETA-GLUCURONIDASE FROM FACAELIBACTERIUM PRAUSNITZII L2-6 
2666, 6h15C, 0.5670, 3.14, 0.078, 123, 90, STRUCTURE OF LRP6 P3E3P4E4 IN COMPLEX WITH VHH L-P2-B10 
2667, 5m94B, 0.5670, 2.85, 0.102, 120, 88, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
2668, 5kn5A, 0.5670, 3.36, 0.109, 214, 92, TGFALPHA/EPIREGULIN COMPLEX WITH NEUTRALIZING ANTIBODY LY3016859
2669, 4r7nK, 0.5670, 3.39, 0.065, 218, 92, FAB C2E3
2670, 4npyH, 0.5670, 3.00, 0.091, 231, 88, CRYSTAL STRUCTURE OF GERMLINE FAB PGT121 A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2671, 4iiqA, 0.5670, 2.80, 0.045, 197, 88, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
2672, 4fqqB, 0.5670, 3.13, 0.067, 227, 90, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY PGT121-GL FAB
2673, 3r8bD, 0.5670, 3.18, 0.079, 114, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
2674, 3qh3C, 0.5670, 3.15, 0.089, 194, 90, THE CRYSTAL STRUCTURE OF TCR A6
2675, 2gk0B, 0.5670, 3.22, 0.089, 216, 90, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
2676, 2gjzB, 0.5670, 3.31, 0.099, 221, 91, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
2677, 2bjmH, 0.5670, 3.25, 0.098, 120, 92, SPE7:ANTHRONE COMPLEX
2678, 1fe8H, 0.5670, 3.23, 0.100, 210, 90, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
2679, 6qv1E, 0.5669, 2.93, 0.079, 115, 89, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH NANOBODY NB_TM1 
2680, 6cweC, 0.5669, 2.76, 0.069, 199, 87, STRUCTURE OF ALPHA-GSA[8;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2681, 6a96K, 0.5669, 3.10, 0.065, 125, 92, CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25 
2682, 5yxuA, 0.5669, 3.24, 0.066, 191, 91, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2683, 5utfD, 0.5669, 3.15, 0.088, 242, 91, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M Y177W N300M N302M T320L I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A
2684, 5nnsB, 0.5669, 2.91, 0.066, 225, 91, CRYSTAL STRUCTURE OF HILPMO9B 
2685, 5i0xB, 0.5669, 3.21, 0.053, 158, 94, COPPER-BOUND M90I VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
2686, 4r7nC, 0.5669, 3.39, 0.076, 218, 92, FAB C2E3
2687, 4krmF, 0.5669, 3.29, 0.044, 122, 91, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
2688, 2gjzH, 0.5669, 3.30, 0.099, 221, 91, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
2689, 1xfpA, 0.5669, 3.06, 0.078, 131, 90, CRYSTAL STRUCTURE OF THE CDR2 GERMLINE REVERSION MUTANT OF CAB-LYS3 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
2690, 6cxeC, 0.5668, 2.91, 0.080, 202, 88, STRUCTURE OF ALPHA-GSA[26;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2691, 6ch9D, 0.5668, 3.21, 0.077, 236, 91, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
2692, 5wkoI, 0.5668, 3.11, 0.078, 225, 90, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2693, 5ushH, 0.5668, 3.06, 0.089, 214, 90, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
2694, 5tjwK, 0.5668, 3.41, 0.110, 122, 91, INFLUENZA A VIRUS NUCLEOPROTEIN IN COMPLEX WITH INHIBITORY NANOBODY
2695, 5tihL, 0.5668, 3.18, 0.033, 212, 90, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
2696, 5nltE, 0.5668, 3.12, 0.108, 225, 93, CVAA9A
2697, 5kyhU, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2698, 5kyhT, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2699, 5kyhS, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2700, 5kyhR, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2701, 5kyhQ, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2702, 5kyhP, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2703, 5kyhO, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2704, 5kyhN, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2705, 5kyhM, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2706, 5kyhL, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2707, 5kyhK, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2708, 5kyhJ, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2709, 5kyhI, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2710, 5kyhH, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2711, 5kyhG, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2712, 5kyhF, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2713, 5kyhE, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2714, 5kyhD, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2715, 5kyhC, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2716, 5kyhB, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2717, 5kyhA, 0.5668, 3.62, 0.068, 242, 103, STRUCTURE OF IHO670 FLAGELLAR-LIKE FILAMENT
2718, 4pd4J, 0.5668, 3.20, 0.055, 127, 91, STRUCTURAL ANALYSIS OF ATOVAQUONE-INHIBITED CYTOCHROME BC1 COMPLEX REVEALS THE MOLECULAR BASIS OF ANTIMALARIAL DRUG ACTION
2719, 3vwkC, 0.5668, 2.70, 0.058, 194, 86, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2720, 3h3pL, 0.5668, 3.19, 0.088, 109, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
2721, 3eo0D, 0.5668, 3.21, 0.077, 220, 91, STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
2722, 2p5wD, 0.5668, 2.80, 0.125, 192, 88, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2723, 1mcsA, 0.5668, 3.17, 0.076, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
2724, 1fveB, 0.5668, 3.25, 0.110, 223, 91, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
2725, 6mekH, 0.5667, 2.90, 0.089, 222, 90, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2726, 6d7jC, 0.5667, 3.47, 0.082, 789, 97, THE CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) WITH GLYCEROL IN ACTIVE-SITE 
2727, 6d0uK, 0.5667, 3.11, 0.109, 238, 92, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2728, 5cl2B, 0.5667, 3.42, 0.062, 245, 96, CRYSTAL STRUCTURE OF SPO0M SPORULATION CONTROL PROTEIN FROM BACILLUS SUBTILIS.
2729, 4ybqD, 0.5667, 3.35, 0.098, 120, 92, RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM
2730, 4dsyD, 0.5667, 2.33, 0.071, 426, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
2731, 3eo0B, 0.5667, 3.20, 0.077, 220, 91, STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
2732, 6njmP, 0.5666, 3.15, 0.089, 215, 90, STRUCTURE OF A COMPLEX 
2733, 6c6xE, 0.5666, 3.35, 0.066, 215, 91, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
2734, 5xxmA, 0.5666, 3.37, 0.076, 749, 92, CRYSTAL STRUCTURE OF GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH GLUCONOLACTONE
2735, 5o2uD, 0.5666, 3.08, 0.112, 116, 89, LLAMA VHH IN COMPLEX WITH P24
2736, 5kqvE, 0.5666, 2.69, 0.103, 593, 87, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
2737, 5cp3A, 0.5666, 3.66, 0.064, 218, 94, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
2738, 5b4mC, 0.5666, 3.26, 0.065, 221, 92, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2739, 4xbpE, 0.5666, 3.20, 0.076, 225, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
2740, 4r7nG, 0.5666, 3.30, 0.077, 218, 91, FAB C2E3
2741, 4qhmG, 0.5666, 3.21, 0.100, 217, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
2742, 4pjxG, 0.5666, 2.82, 0.068, 198, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
2743, 4pjxE, 0.5666, 2.80, 0.068, 187, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
2744, 4pjbE, 0.5666, 2.80, 0.057, 188, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
2745, 4lnvA, 0.5666, 3.64, 0.031, 1276, 96, CRYSTAL STRUCTURE OF TEP1S
2746, 4hlzI, 0.5666, 3.01, 0.089, 221, 90, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2747, 3tnmA, 0.5666, 2.89, 0.092, 218, 87, CRYSTAL STRUCTURE OF A32 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY
2748, 3s9dB, 0.5666, 3.17, 0.080, 180, 88, BINARY COMPLEX BETWEEN IFNA2 AND IFNAR2
2749, 3dvgB, 0.5666, 3.27, 0.088, 221, 91, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU.3A8 BOUND TO K63-LINKED DI- UBIQUITIN
2750, 2ywyB, 0.5666, 2.90, 0.115, 103, 87, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2751, 2nxzD, 0.5666, 3.18, 0.099, 222, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
2752, 2hkfH, 0.5666, 3.06, 0.100, 210, 90, CRYSTAL STRUCTURE OF THE COMPLEX FAB M75- PEPTIDE
2753, 2dl2A, 0.5666, 2.93, 0.045, 197, 89, KILLER IMMUNOGLOBULIN RECEPTOR 2DL2
2754, 1lp9M, 0.5666, 3.03, 0.079, 237, 89, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
2755, 1hxmG, 0.5666, 3.35, 0.065, 206, 93, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2756, 1bvlC, 0.5666, 3.18, 0.100, 116, 90, HUMANIZED ANTI-LYSOZYME FV
2757, 6jbtH, 0.5665, 3.25, 0.120, 217, 92, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
2758, 6h6yH, 0.5665, 3.23, 0.099, 118, 91, GI.1 HUMAN NOROVIRUS PROTRUDING DOMAIN IN COMPLEX WITH NANO-7 
2759, 6eyoH, 0.5665, 3.04, 0.056, 204, 90, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
2760, 5wlgE, 0.5665, 3.13, 0.067, 243, 89, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
2761, 5vanB, 0.5665, 3.17, 0.111, 122, 90, CRYSTAL STRUCTURE OF BETA-KLOTHO
2762, 5umnE, 0.5665, 3.10, 0.099, 238, 91, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
2763, 5mtmB, 0.5665, 2.47, 0.155, 92, 84, MONOBODY MB(LCK_3) BOUND TO LCK-SH2 DOMAIN
2764, 4ybqC, 0.5665, 3.60, 0.084, 115, 95, RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM
2765, 4xceH, 0.5665, 3.21, 0.066, 223, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
2766, 4lnvC, 0.5665, 3.64, 0.031, 1276, 96, CRYSTAL STRUCTURE OF TEP1S
2767, 4kkzA, 0.5665, 2.33, 0.071, 424, 85, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
2768, 3v4pA, 0.5665, 3.90, 0.060, 582, 100, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
2769, 3tvmC, 0.5665, 2.75, 0.080, 200, 87, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
2770, 2qhrH, 0.5665, 3.41, 0.043, 222, 92, CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
2771, 1t66D, 0.5665, 3.13, 0.100, 220, 90, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
2772, 6oe6A, 0.5664, 2.70, 0.081, 127, 86, STRUCTURE OF A UNCHARACTERIZED PROTEIN FROM LEPTOSPIRA INTERROGANS SEROGROUP ICTEROHAEMORRHAGIAE SEROVAR COPENHAGENI (STRAIN FIOCRUZ L1- 130) 
2773, 5oclC, 0.5664, 3.05, 0.100, 117, 90, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
2774, 5n6uA, 0.5664, 3.18, 0.106, 811, 94, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
2775, 5gguH, 0.5664, 3.22, 0.088, 218, 91, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
2776, 5cl2A, 0.5664, 3.44, 0.084, 246, 95, CRYSTAL STRUCTURE OF SPO0M SPORULATION CONTROL PROTEIN FROM BACILLUS SUBTILIS.
2777, 4qhkM, 0.5664, 3.08, 0.089, 216, 90, UCA (UNBOUND) FROM CH103 LINEAGE
2778, 2z31A, 0.5664, 2.61, 0.047, 112, 86, CRYSTAL STRUCTURE OF IMMUNE RECEPTOR COMPLEX
2779, 1yymH, 0.5664, 3.22, 0.087, 229, 92, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2780, 1hilD, 0.5664, 3.31, 0.065, 213, 92, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
2781, 1eo8H, 0.5664, 3.19, 0.055, 217, 91, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2782, 1bqhH, 0.5664, 3.11, 0.088, 125, 91, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
2783, 1a7oH, 0.5664, 3.31, 0.077, 116, 91, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) R96L DELETION MUTANT ON VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
2784, 6qn8E, 0.5663, 3.07, 0.090, 226, 89, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
2785, 6medA, 0.5663, 3.00, 0.088, 219, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2786, 6h0eA, 0.5663, 3.14, 0.100, 215, 90, FAB DMCBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-23 
2787, 6d0uE, 0.5663, 3.12, 0.109, 238, 92, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2788, 5y9kH, 0.5663, 3.05, 0.078, 216, 90, STRUCTURE OF THE BELIMUMAB FAB FRAGMENT
2789, 5ug0D, 0.5663, 3.31, 0.087, 227, 92, HUMAN ANTIBODY H2897 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2790, 5ocyH, 0.5663, 3.34, 0.077, 211, 91, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-48-CIT 
2791, 5n6uD, 0.5663, 3.33, 0.105, 811, 95, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
2792, 5g15B, 0.5663, 2.42, 0.107, 88, 84, STRUCTURE AURORA A (122-403) BOUND TO ACTIVATING MONOBODY MB1 AND AMPPCP
2793, 4rrpK, 0.5663, 3.19, 0.089, 214, 90, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
2794, 4pjgE, 0.5663, 2.80, 0.057, 198, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
2795, 4fqrw, 0.5663, 3.14, 0.098, 238, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2796, 4dsyA, 0.5663, 2.33, 0.071, 425, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
2797, 3nz8H, 0.5663, 3.12, 0.121, 217, 91, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
2798, 3ijhD, 0.5663, 3.19, 0.077, 221, 91, STRUCTURE OF S67-27 IN COMPLEX WITH KO
2799, 3cu7B, 0.5663, 3.27, 0.098, 1481, 92, HUMAN COMPLEMENT COMPONENT 5
2800, 3cu7A, 0.5663, 3.27, 0.098, 1625, 92, HUMAN COMPLEMENT COMPONENT 5
2801, 2iamC, 0.5663, 2.91, 0.080, 198, 88, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2802, 2i5yR, 0.5663, 3.07, 0.089, 223, 90, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2803, 1rz8D, 0.5663, 3.21, 0.098, 228, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2804, 1nldH, 0.5663, 3.08, 0.102, 215, 88, FAB FRAGMENT OF A NEUTRALIZING ANTIBODY DIRECTED AGAINST AN EPITOPE OF GP41 FROM HIV-1
2805, 6f5gB, 0.5662, 3.15, 0.100, 127, 90, COMPLETE PCSK9 C-TER DOMAIN IN COMPLEX WITH VHH P.140 
2806, 6c5kA, 0.5662, 3.27, 0.100, 215, 90, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
2807, 5u7oD, 0.5662, 3.11, 0.077, 242, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
2808, 5tfyZ, 0.5662, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2809, 5tfyV, 0.5662, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2810, 5tfyU, 0.5662, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2811, 5tfyI, 0.5662, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2812, 5o2uB, 0.5662, 3.02, 0.114, 115, 88, LLAMA VHH IN COMPLEX WITH P24
2813, 5nyxH, 0.5662, 3.20, 0.087, 224, 92, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
2814, 5l2kD, 0.5662, 2.84, 0.067, 185, 89, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
2815, 4r7nM, 0.5662, 3.43, 0.087, 218, 92, FAB C2E3
2816, 4pjbG, 0.5662, 2.82, 0.057, 197, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
2817, 4lp4B, 0.5662, 3.27, 0.109, 212, 92, CRYSTAL STRUCTURE OF THE HUMAN RAGE VC1 FRAGMENT IN SPACE GROUP P62
2818, 4lp4A, 0.5662, 3.27, 0.109, 212, 92, CRYSTAL STRUCTURE OF THE HUMAN RAGE VC1 FRAGMENT IN SPACE GROUP P62
2819, 4dn3L, 0.5662, 3.35, 0.044, 214, 91, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
2820, 2x89B, 0.5662, 3.05, 0.066, 128, 91, STRUCTURE OF THE BETA2_MICROGLOBULIN INVOLVED IN AMYLOIDOGENESIS
2821, 1nfdA, 0.5662, 3.00, 0.100, 203, 90, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2822, 1ao7D, 0.5662, 3.09, 0.090, 115, 89, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR VIRAL PEPTIDE (TAX) AND HLA-A 0201
2823, 6qnaC, 0.5661, 3.11, 0.078, 227, 90, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
2824, 6ayzM, 0.5661, 3.45, 0.052, 152, 97, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
2825, 5wabC, 0.5661, 3.28, 0.066, 654, 91, CRYSTAL STRUCTURE OF BIFIDOBACTERIUM ADOLESCENTIS GH3 BETA-GLUCOSIDASE
2826, 5tfyY, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2827, 5tfyX, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2828, 5tfyW, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2829, 5tfyT, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2830, 5tfyS, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2831, 5tfyR, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2832, 5tfyQ, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2833, 5tfyP, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2834, 5tfyO, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2835, 5tfyN, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2836, 5tfyM, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2837, 5tfyL, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2838, 5tfyK, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2839, 5tfyJ, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2840, 5tfyH, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2841, 5tfyG, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2842, 5tfyF, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2843, 5tfyE, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2844, 5tfyD, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2845, 5tfyC, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2846, 5tfyB, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2847, 5tfyA, 0.5661, 3.51, 0.020, 164, 98, THE ARCHAEAL FLAGELLUM OF METHANOSPIRILLUM HUNGATEI STRAIN JF1.
2848, 4rgmC, 0.5661, 3.22, 0.120, 217, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
2849, 4odxA, 0.5661, 3.09, 0.078, 127, 90, 4E10 GERMLINE ENCODED PRECURSOR NO.7 IN COMPLEX WITH EPITOPE SCAFFOLD T117
2850, 4m62I, 0.5661, 3.10, 0.078, 126, 90, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
2851, 4lptE, 0.5661, 2.93, 0.090, 98, 89, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
2852, 4janH, 0.5661, 3.18, 0.100, 218, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
2853, 4dhlD, 0.5661, 2.33, 0.071, 423, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
2854, 4dhlA, 0.5661, 2.33, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
2855, 3sddC, 0.5661, 3.11, 0.089, 189, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
2856, 3qxvD, 0.5661, 3.14, 0.111, 124, 90, STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
2857, 1qokA, 0.5661, 3.15, 0.089, 226, 90, MFE-23 AN ANTI-CARCINOEMBRYONIC ANTIGEN SINGLE-CHAIN FV ANTIBODY
2858, 1oakH, 0.5661, 3.30, 0.088, 218, 91, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR (VWF) A1 DOMAIN IN COMPLEX WITH THE FUNCTION BLOCKING NMC-4 FAB
2859, 1lgvA, 0.5661, 3.25, 0.065, 213, 92, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
2860, 1ce1H, 0.5661, 3.18, 0.132, 220, 91, 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
2861, 6hwrD, 0.5660, 2.34, 0.071, 426, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
2862, 6hwrA, 0.5660, 2.33, 0.071, 424, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
2863, 6b9zB, 0.5660, 3.25, 0.088, 220, 91, TRASTUZUMAB FAB V3 
2864, 5vm0B, 0.5660, 3.23, 0.099, 127, 91, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T9 
2865, 5viyK, 0.5660, 3.34, 0.076, 227, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2866, 5n6uC, 0.5660, 3.34, 0.105, 811, 95, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
2867, 5jz7H, 0.5660, 3.30, 0.088, 128, 91, NGF IN COMPLEX WITH MEDI578 SCFV
2868, 5ivxE, 0.5660, 3.15, 0.044, 194, 90, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
2869, 5hccB, 0.5660, 3.42, 0.097, 647, 93, TERNARY COMPLEX OF HUMAN COMPLEMENT C5 WITH ORNITHODOROS MOUBATA OMCI AND DERMACENTOR ANDERSONI RACI3.
2870, 5dlmM, 0.5660, 3.57, 0.074, 217, 94, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2871, 4xwoU, 0.5660, 3.24, 0.066, 214, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
2872, 3wyrA, 0.5660, 2.61, 0.047, 189, 86, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL4
2873, 3vwjC, 0.5660, 2.76, 0.057, 193, 87, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
2874, 3c09H, 0.5660, 3.29, 0.130, 216, 92, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
2875, 3bdxB, 0.5660, 2.96, 0.056, 111, 90, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
2876, 2z93C, 0.5660, 3.03, 0.068, 201, 88, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C-ABCD
2877, 1ggiH, 0.5660, 3.04, 0.068, 215, 88, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
2878, 1a7qH, 0.5660, 3.21, 0.056, 116, 90, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) HIGH AFFINITY EXPRESSED VARIANT CONTAINING SER26L->GLY ILE29L->THR GLU81L->ASP THR97L->SER PRO240H->LEU ASP258H->ALA LYS281H->GLU ASN283H->ASP AND LEU312H->VAL
2879, 6qnaE, 0.5659, 3.11, 0.078, 228, 90, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
2880, 6gg0H, 0.5659, 3.14, 0.088, 123, 91, CRYO-EM STRUCTURE OF BK POLYOMAVIRUS LIKE PARTICLE IN COMPLEX WITH SINGLE CHAIN ANTIBODY SCFV41F17 
2881, 6dc7M, 0.5659, 3.57, 0.074, 218, 94, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
2882, 5wkoK, 0.5659, 3.20, 0.088, 225, 91, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
2883, 5wduH, 0.5659, 3.07, 0.078, 242, 90, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
2884, 5mzvD, 0.5659, 2.97, 0.045, 123, 89, IL-23:IL-23R:NB22E11 COMPLEX
2885, 4r7nA, 0.5659, 3.27, 0.077, 218, 91, FAB C2E3
2886, 4pjiG, 0.5659, 2.81, 0.057, 189, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
2887, 4oawB, 0.5659, 3.07, 0.077, 236, 91, FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
2888, 4evnK, 0.5659, 3.38, 0.076, 221, 92, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2889, 4dhlB, 0.5659, 2.34, 0.071, 425, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
2890, 3sdcC, 0.5659, 3.10, 0.089, 191, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
2891, 3m4eB, 0.5659, 3.63, 0.052, 293, 96, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
2892, 3bx7C, 0.5659, 3.03, 0.044, 120, 90, ENGINEERED HUMAN LIPOCALIN 2 (LCN2) IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HUMAN CTLA-4
2893, 1q9kB, 0.5659, 3.17, 0.077, 222, 91, S25-2 FAB UNLIGANDED 1
2894, 1fe8I, 0.5659, 3.12, 0.090, 210, 89, CRYSTAL STRUCTURE OF THE VON WILLEBRAND FACTOR A3 DOMAIN IN COMPLEX WITH A FAB FRAGMENT OF IGG RU5 THAT INHIBITS COLLAGEN BINDING
2895, 1beyH, 0.5659, 3.14, 0.132, 210, 91, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
2896, 6okpQ, 0.5658, 3.17, 0.088, 131, 91, B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074 
2897, 6okpO, 0.5658, 3.17, 0.088, 131, 91, B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074 
2898, 6okpM, 0.5658, 3.17, 0.088, 131, 91, B41 SOSIP.664 IN COMPLEX WITH THE SILENT-FACE ANTIBODY SF12 AND V3- TARGETING ANTIBODY 10-1074 
2899, 6hwrB, 0.5658, 2.34, 0.071, 425, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH ADENOSINE DIVANADATE 
2900, 6g46D, 0.5658, 2.34, 0.071, 423, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
2901, 6bygB, 0.5658, 3.27, 0.097, 858, 93, CRYSTAL STRUCTURE OF THE NUCLEOPHILE MUTANT (E575A) OF THE GH2 EXO- BETA-MANNANASE FROM XANTHOMONAS AXONOPODIS PV. CITRI 
2902, 5wobI, 0.5658, 3.27, 0.078, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
2903, 5j3dL, 0.5658, 3.23, 0.033, 215, 91, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
2904, 5hysE, 0.5658, 3.29, 0.077, 218, 91, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2905, 5eoqH, 0.5658, 3.26, 0.066, 217, 91, STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40
2906, 5a40G, 0.5658, 2.35, 0.122, 88, 82, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2907, 4xwoK, 0.5658, 3.15, 0.056, 216, 90, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
2908, 4rqsD, 0.5658, 3.06, 0.089, 223, 90, CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB
2909, 4ofpA, 0.5658, 2.94, 0.080, 197, 88, CRYSTAL STRUCTURE OF SYG-2 D3-D4
2910, 4oawD, 0.5658, 3.14, 0.098, 236, 92, FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
2911, 4krmJ, 0.5658, 3.24, 0.077, 124, 91, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
2912, 4kkzC, 0.5658, 2.33, 0.071, 423, 85, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
2913, 4fqcH, 0.5658, 3.37, 0.065, 227, 92, CRYSTAL STRUCTURE OF PGT121 FAB BOUND TO A COMPLEX-TYPE SIALYLATED N- GLYCAN
2914, 3r8bB, 0.5658, 3.20, 0.079, 114, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
2915, 3r0mA, 0.5658, 3.27, 0.054, 127, 92, CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12
2916, 3juyC, 0.5658, 3.22, 0.110, 236, 91, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
2917, 3e1f3, 0.5658, 3.24, 0.093, 1011, 97, E.COLI (LACZ) BETA-GALACTOSIDASE (H418E) IN COMPLEX WITH GALACTOSE
2918, 3csgA, 0.5658, 2.82, 0.091, 458, 88, CRYSTAL STRUCTURE OF MONOBODY YS1(MBP-74)/MALTOSE BINDING PROTEIN FUSION COMPLEX
2919, 3b5gB, 0.5658, 2.97, 0.056, 111, 90, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
2920, 2ywzA, 0.5658, 2.91, 0.056, 111, 89, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
2921, 2qfrB, 0.5658, 2.35, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE WITH BOUND SULFATE
2922, 1u0qB, 0.5658, 3.25, 0.066, 124, 91, STRUCTURE OF A LLAMA VHH DOMAIN RAISED AGAINST A CARBAZOLE MOLECULE
2923, 6oc3C, 0.5657, 3.24, 0.110, 221, 91, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
2924, 6bi2H, 0.5657, 3.24, 0.110, 222, 91, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
2925, 5w5zH, 0.5657, 3.11, 0.111, 209, 90, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY AT HIGH RESOLUTION 
2926, 5u3dB, 0.5657, 3.24, 0.088, 221, 91, STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT
2927, 5iw1E, 0.5657, 3.18, 0.044, 189, 90, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
2928, 5d1qC, 0.5657, 3.08, 0.133, 231, 90, ISDB NEAT2 BOUND BY CLONE D2-06
2929, 5b4mH, 0.5657, 3.12, 0.066, 221, 91, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2930, 4jrxD, 0.5657, 3.27, 0.033, 204, 92, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
2931, 4ht1H, 0.5657, 3.28, 0.110, 210, 91, HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
2932, 4gsdH, 0.5657, 3.23, 0.110, 222, 91, H5.3 FAB STRUCTURE
2933, 3tzvG, 0.5657, 3.08, 0.045, 201, 89, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
2934, 2qfpD, 0.5657, 2.34, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
2935, 2qfpA, 0.5657, 2.34, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
2936, 1yymR, 0.5657, 3.06, 0.089, 229, 90, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
2937, 1d5iH, 0.5657, 3.16, 0.077, 221, 91, UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
2938, 6nouA, 0.5656, 3.43, 0.043, 231, 93, AN SCFV DERIVED FROM IXEKIZUMAB 
2939, 6faxH, 0.5656, 3.05, 0.122, 216, 90, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
2940, 5jw5H, 0.5656, 3.24, 0.076, 224, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT
2941, 4pjgG, 0.5656, 2.79, 0.057, 188, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
2942, 4kkzB, 0.5656, 2.34, 0.071, 425, 85, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
2943, 4evnA, 0.5656, 3.34, 0.077, 221, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2944, 4dhlC, 0.5656, 2.34, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT MO07123
2945, 3sdaC, 0.5656, 3.13, 0.089, 196, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2946, 3ikcD, 0.5656, 3.05, 0.067, 221, 90, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
2947, 3b83F, 0.5656, 2.81, 0.080, 92, 88, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
2948, 1t66H, 0.5656, 3.12, 0.100, 220, 90, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
2949, 1jfqH, 0.5656, 3.06, 0.090, 220, 89, ANTIGEN-BINDING FRAGMENT OF THE MURINE ANTI-PHENYLARSONATE ANTIBODY 36-71 FAB 36-71
2950, 1d5bH, 0.5656, 3.03, 0.089, 221, 90, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
2951, 1bqhK, 0.5656, 2.94, 0.090, 125, 89, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
2952, 6g46B, 0.5655, 2.34, 0.071, 425, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
2953, 6dxuA, 0.5655, 3.48, 0.082, 774, 97, CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) 
2954, 6dfqA, 0.5655, 2.89, 0.068, 195, 88, MOUSE DIABETOGENIC TCR I.29 
2955, 6d0uC, 0.5655, 3.13, 0.109, 238, 92, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2956, 5uoeH, 0.5655, 3.29, 0.055, 119, 91, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
2957, 5uk4h, 0.5655, 3.23, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
2958, 5nkqE, 0.5655, 2.68, 0.106, 87, 85, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2959, 5lbsI, 0.5655, 3.21, 0.088, 122, 91, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2960, 5lbsH, 0.5655, 3.21, 0.088, 121, 91, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
2961, 5gs0D, 0.5655, 3.17, 0.088, 122, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY
2962, 5a40E, 0.5655, 2.73, 0.106, 90, 85, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
2963, 4r4bH, 0.5655, 3.18, 0.100, 220, 90, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
2964, 4n5eC, 0.5655, 3.18, 0.044, 199, 91, 42F3 TCR PCPA12/H-2LD COMPLEX
2965, 4lp5A, 0.5655, 3.39, 0.097, 302, 93, CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN RAGE EXTRACELLULAR DOMAIN (VC1C2 FRAGMENT)
2966, 4evnG, 0.5655, 3.34, 0.077, 221, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2967, 4dt2B, 0.5655, 2.35, 0.071, 426, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
2968, 3zyzA, 0.5655, 3.62, 0.062, 713, 96, CRYSTAL STRUCTURE OF A GLYCOSIDE HYDROLASE FAMILY 3 BETA-GLUCOSIDASE BGL1 FROM HYPOCREA JECORINA AT 2.1A RESOLUTION.
2969, 3utsD, 0.5655, 3.14, 0.078, 200, 90, 1E6-A*0201-ALWGPDPAAA COMPLEX MONOCLINIC
2970, 3qeqE, 0.5655, 3.11, 0.045, 243, 89, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2971, 3nn8C, 0.5655, 3.21, 0.098, 122, 92, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
2972, 2a6jB, 0.5655, 3.22, 0.099, 222, 91, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65
2973, 1wc7H, 0.5655, 3.16, 0.077, 223, 91, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
2974, 1h3pH, 0.5655, 3.17, 0.089, 214, 90, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
2975, 6njnK, 0.5654, 3.14, 0.089, 215, 90, STRUCTURE OF A COMPLEX 
2976, 6grtA, 0.5654, 2.64, 0.103, 593, 87, PAIRED IMMUNOGLOBULIN-LIKE RECEPTOR B (PIRB) OR LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B MEMBER 3 (LILRB3) FULL EXTRACELLULAR DOMAIN 
2977, 6c6zH, 0.5654, 2.90, 0.079, 224, 89, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
2978, 5tojD, 0.5654, 3.23, 0.066, 126, 91, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-4
2979, 5m94D, 0.5654, 2.86, 0.102, 120, 88, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
2980, 5kelM, 0.5654, 3.22, 0.087, 121, 92, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
2981, 5kelJ, 0.5654, 3.22, 0.087, 121, 92, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
2982, 5kelC, 0.5654, 3.22, 0.087, 121, 92, EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C2G4 AND C13C6
2983, 5cbeC, 0.5654, 3.00, 0.067, 127, 90, E10 IN COMPLEX WITH CXCL13
2984, 5bzdB, 0.5654, 3.10, 0.079, 229, 89, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2985, 4nkdA, 0.5654, 3.35, 0.109, 121, 92, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
2986, 4evnM, 0.5654, 3.39, 0.076, 221, 92, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2987, 4c56G, 0.5654, 2.84, 0.057, 198, 87, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
2988, 3r8bL, 0.5654, 3.19, 0.079, 114, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
2989, 3m3rB, 0.5654, 3.83, 0.061, 293, 98, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
2990, 3go1L, 0.5654, 2.90, 0.067, 209, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 268-D IN COMPLEX WITH V3 PEPTIDE MN
2991, 2z92A, 0.5654, 3.02, 0.068, 206, 88, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
2992, 1n4xL, 0.5654, 3.57, 0.064, 113, 94, STRUCTURE OF SCFV 1696 AT ACIDIC PH
2993, 1lhzA, 0.5654, 3.18, 0.065, 213, 92, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
2994, 6qv1F, 0.5653, 2.93, 0.079, 115, 89, STRUCTURE OF ATPGS-BOUND OUTWARD-FACING TM287/288 IN COMPLEX WITH NANOBODY NB_TM1 
2995, 6dfqC, 0.5653, 2.87, 0.103, 200, 87, MOUSE DIABETOGENIC TCR I.29 
2996, 5vm0A, 0.5653, 3.25, 0.088, 125, 91, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T9 
2997, 5uk4g, 0.5653, 3.24, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
2998, 5ueaA, 0.5653, 3.15, 0.056, 212, 90, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH HISTONE CHAPERONE ASF1
2999, 5sx5J, 0.5653, 3.23, 0.088, 207, 91, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
3000, 5myoB, 0.5653, 3.10, 0.110, 221, 91, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
3001, 5m01G, 0.5653, 3.19, 0.033, 188, 90, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
3002, 5jz7J, 0.5653, 3.42, 0.087, 128, 92, NGF IN COMPLEX WITH MEDI578 SCFV
3003, 5ggvH, 0.5653, 3.20, 0.088, 225, 91, CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB
3004, 4z5rM, 0.5653, 3.33, 0.099, 213, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3005, 4z5rK, 0.5653, 3.33, 0.099, 213, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3006, 4xceA, 0.5653, 3.22, 0.077, 225, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); C2 SPACE GROUP
3007, 4w2qA, 0.5653, 3.02, 0.056, 116, 90, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C COMPLEXED WITH NUCLEOPROTEIN C-TERMINAL DOMAIN
3008, 4r7dO, 0.5653, 3.33, 0.088, 209, 91, FAB HU 15C1
3009, 4onhA, 0.5653, 3.00, 0.067, 201, 89, CRYSTAL STRUCTURE OF DN6 TCR
3010, 4onfL, 0.5653, 3.68, 0.053, 218, 94, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
3011, 4jrwA, 0.5653, 2.60, 0.133, 87, 83, CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE PKD DOMAIN 2 AT 1.6 ANGSTROM RESOLUTION
3012, 4evnO, 0.5653, 3.34, 0.077, 221, 91, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3013, 4edwH, 0.5653, 3.31, 0.099, 215, 91, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
3014, 43caB, 0.5653, 3.30, 0.076, 117, 92, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
3015, 3tclA, 0.5653, 3.26, 0.077, 228, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3016, 3kxfN, 0.5653, 2.94, 0.034, 204, 89, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
3017, 3bikC, 0.5653, 3.30, 0.075, 118, 93, CRYSTAL STRUCTURE OF THE PD-1/PD-L1 COMPLEX
3018, 2cdeE, 0.5653, 2.78, 0.057, 192, 87, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
3019, 1evuA, 0.5653, 3.17, 0.065, 707, 92, HUMAN FACTOR XIII WITH CALCIUM BOUND IN THE ION SITE
3020, 6d0nD, 0.5652, 2.30, 0.110, 88, 82, CRYSTAL STRUCTURE OF A CLC-TYPE FLUORIDE/PROTON ANTIPORTER; V319G MUTANT 
3021, 6cwkA, 0.5652, 3.09, 0.066, 129, 91, ANTI-RTA VHH ANTIBODY 
3022, 6baeB, 0.5652, 3.29, 0.087, 223, 92, TRASTUZUMAB FAB V3 IN COMPLEX WITH CQFDLSTRRLKC 
3023, 5yaxA, 0.5652, 3.41, 0.077, 228, 91, CRYSTAL STRUCTURE OF A HUMAN NEUTRALIZING ANTIBODY BOUND TO A HBV PRES1 PEPTIDE
3024, 5kwyD, 0.5652, 3.08, 0.064, 132, 94, STRUCTURE OF HUMAN NPC1 MIDDLE LUMENAL DOMAIN BOUND TO NPC2
3025, 5gs0X, 0.5652, 3.34, 0.067, 114, 90, CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY
3026, 5f96H, 0.5652, 3.21, 0.088, 220, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
3027, 5bjzC, 0.5652, 3.25, 0.088, 228, 91, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
3028, 4z5rW, 0.5652, 3.33, 0.099, 213, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3029, 4z5rS, 0.5652, 3.33, 0.099, 213, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3030, 4tn9A, 0.5652, 2.48, 0.120, 86, 83, CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN AT 1.4 ANGSTROM RESOLUTION
3031, 4rgmH, 0.5652, 3.22, 0.120, 216, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
3032, 4qhmE, 0.5652, 3.22, 0.122, 217, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
3033, 4oi7A, 0.5652, 3.08, 0.100, 211, 90, RAGE RECOGNIZES NUCLEIC ACIDS AND PROMOTES INFLAMMATORY RESPONSES TO DNA
3034, 4nkdC, 0.5652, 3.25, 0.143, 121, 91, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3035, 4n0cC, 0.5652, 3.25, 0.054, 195, 92, 42F3 TCR PCPE3/H-2LD COMPLEX
3036, 4m3kB, 0.5652, 2.93, 0.091, 116, 88, STRUCTURE OF A SINGLE DOMAIN CAMELID ANTIBODY FRAGMENT CAB-H7S IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
3037, 4kkzD, 0.5652, 2.34, 0.071, 426, 85, THE CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH DIETHYLENE GLYCOL MONOVANADATE
3038, 4evnI, 0.5652, 3.39, 0.076, 221, 92, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3039, 3q6gI, 0.5652, 3.23, 0.089, 228, 90, CRYSTAL STRUCTURE OF FAB OF RHESUS MAB 2.5B SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
3040, 3ijsD, 0.5652, 3.19, 0.077, 221, 91, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3041, 3fo1B, 0.5652, 3.29, 0.099, 214, 91, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
3042, 2ywyD, 0.5652, 2.84, 0.115, 103, 87, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
3043, 2r2bB, 0.5652, 3.28, 0.054, 214, 92, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3044, 2gsiE, 0.5652, 3.39, 0.065, 215, 92, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3045, 1lo4L, 0.5652, 3.61, 0.074, 217, 94, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
3046, 1jsyA, 0.5652, 3.41, 0.146, 358, 96, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
3047, 6dezB, 0.5651, 3.22, 0.121, 210, 91, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
3048, 6cezH, 0.5651, 3.10, 0.146, 222, 89, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V2 FAB 16C2 IN COMPLEX WITH V2 PEPTIDE CONB 
3049, 5wduM, 0.5651, 3.09, 0.078, 242, 90, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
3050, 5sx4J, 0.5651, 3.25, 0.077, 205, 91, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
3051, 5n6uB, 0.5651, 3.20, 0.117, 811, 94, CRYSTAL STRUCTURE OF BETA-D-MANNOSIDASE FROM DICTYOGLOMUS THERMOPHILUM.
3052, 5h35F, 0.5651, 3.25, 0.066, 220, 91, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3053, 5gguA, 0.5651, 3.18, 0.088, 218, 91, CRYSTAL STRUCTURE OF TREMELIMUMAB FAB
3054, 4ybqE, 0.5651, 3.63, 0.084, 115, 95, RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM
3055, 4utaI, 0.5651, 3.15, 0.089, 211, 90, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
3056, 4r4nF, 0.5651, 3.01, 0.112, 219, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
3057, 4nylH, 0.5651, 3.23, 0.110, 212, 91, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3058, 4kroD, 0.5651, 3.28, 0.078, 213, 90, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
3059, 43caD, 0.5651, 3.28, 0.076, 117, 92, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
3060, 3t4yB, 0.5651, 3.28, 0.054, 222, 92, S25-2- KDO MONOSACCHARIDE COMPLEX
3061, 3r8bN, 0.5651, 3.19, 0.079, 112, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
3062, 3pjsB, 0.5651, 3.20, 0.088, 219, 91, MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL
3063, 3nn8D, 0.5651, 3.28, 0.109, 121, 92, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
3064, 3dvnH, 0.5651, 3.23, 0.099, 217, 91, CRYSTAL STRUCTURE OF K63-SPECIFIC FAB APU2.16 BOUND TO K63-LINKED DI- UBIQUITIN
3065, 2bveB, 0.5651, 3.16, 0.055, 118, 91, STRUCTURE OF THE N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH 2-PHENYL-PROP5AC
3066, 2ajuL, 0.5651, 3.34, 0.043, 216, 92, CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB 
3067, 1knoB, 0.5651, 3.29, 0.065, 220, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
3068, 6jfiH, 0.5650, 3.42, 0.086, 235, 93, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3069, 6jfhM, 0.5650, 3.42, 0.086, 235, 93, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3070, 6jfhH, 0.5650, 3.42, 0.086, 235, 93, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3071, 6jepH, 0.5650, 3.42, 0.086, 235, 93, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
3072, 6fr6B, 0.5650, 2.79, 0.035, 241, 86, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3073, 6cm3O, 0.5650, 3.22, 0.087, 127, 92, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3074, 6cm3M, 0.5650, 3.22, 0.087, 127, 92, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3075, 6cm3K, 0.5650, 3.22, 0.087, 127, 92, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3076, 6bahB, 0.5650, 3.30, 0.087, 223, 92, TRASTUZUMAB FAB V3 WITH 5-DIPHENYL MEDITOPE VARIANT 
3077, 6b14H, 0.5650, 3.28, 0.099, 225, 91, CRYSTAL STRUCTURE OF SPINACH RNA APTAMER IN COMPLEX WITH FAB BL3-6S97N
3078, 5uk4l, 0.5650, 3.25, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3079, 5m2mF, 0.5650, 3.18, 0.078, 127, 90, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
3080, 5gs0F, 0.5650, 3.19, 0.088, 122, 91, CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY
3081, 5dlmL, 0.5650, 3.59, 0.074, 217, 94, COMPLEX OF INFLUENZA M2E AND ANTIBODY
3082, 5cp7D, 0.5650, 2.93, 0.058, 204, 86, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3083, 4z5rQ, 0.5650, 3.33, 0.099, 213, 91, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
3084, 4xwoI, 0.5650, 3.33, 0.087, 220, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
3085, 4rgoH, 0.5650, 3.38, 0.076, 213, 92, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
3086, 4qhkO, 0.5650, 3.11, 0.077, 216, 91, UCA (UNBOUND) FROM CH103 LINEAGE
3087, 4evnC, 0.5650, 3.39, 0.076, 221, 92, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3088, 2iijA, 0.5650, 3.52, 0.031, 156, 97, STRUCTURE OF HUMAN ASF1A IN COMPLEX WITH HISTONE H3
3089, 2aepH, 0.5650, 3.26, 0.033, 143, 91, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
3090, 1fieA, 0.5650, 3.24, 0.065, 705, 93, RECOMBINANT HUMAN COAGULATION FACTOR XIII
3091, 6b3kH, 0.5649, 3.28, 0.099, 225, 91, CRYSTAL STRUCTURE OF MUTANT SPINACH RNA APTAMER IN COMPLEX WITH FAB BL3-6
3092, 6az2A, 0.5649, 3.27, 0.055, 213, 91, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
3093, 5uknH, 0.5649, 3.16, 0.089, 227, 90, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522UCA FAB
3094, 5uk4s, 0.5649, 3.24, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3095, 5n09H, 0.5649, 3.27, 0.098, 226, 92, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3096, 5ldnH, 0.5649, 3.16, 0.056, 218, 90, A VIRAL CAPSID:ANTIBODY COMPLEX
3097, 5lbsL, 0.5649, 3.19, 0.044, 111, 91, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
3098, 5a8hP, 0.5649, 3.21, 0.098, 229, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3099, 5a8hJ, 0.5649, 3.21, 0.098, 229, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3100, 5a8hD, 0.5649, 3.21, 0.098, 229, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3101, 5a7xL, 0.5649, 3.21, 0.098, 229, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3102, 5a7xH, 0.5649, 3.21, 0.098, 229, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3103, 5a7xD, 0.5649, 3.21, 0.098, 229, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3104, 4xbpA, 0.5649, 2.99, 0.078, 222, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
3105, 4r4bB, 0.5649, 3.39, 0.087, 220, 92, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
3106, 4q5zI, 0.5649, 3.28, 0.078, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
3107, 4pjiE, 0.5649, 2.79, 0.045, 198, 88, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3108, 4nylC, 0.5649, 3.21, 0.099, 213, 91, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3109, 4evnE, 0.5649, 3.39, 0.076, 221, 92, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3110, 3x3fH, 0.5649, 3.28, 0.099, 222, 91, TRAIL-R2 EXTRACELLULAR REGION COMPLEXED TO A FAB FRAGMENT FROM HUMAN AGONIST ANTIBODY KMTR2
3111, 3pjsD, 0.5649, 3.20, 0.088, 219, 91, MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL
3112, 3pgfH, 0.5649, 2.99, 0.090, 222, 89, CRYSTAL STRUCTURE OF MALTOSE BOUND MBP WITH A CONFORMATIONALLY SPECIFIC SYNTHETIC ANTIGEN BINDER (SAB)
3113, 3m4dG, 0.5649, 3.74, 0.041, 293, 98, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
3114, 3ldbC, 0.5649, 3.29, 0.065, 210, 92, STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
3115, 3gbmI, 0.5649, 3.44, 0.076, 213, 92, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3116, 2y72B, 0.5649, 2.60, 0.120, 85, 83, CRYSTAL STRUCTURE OF THE PKD DOMAIN OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 1.18 ANGSTROM RESOLUTION.
3117, 1yycA, 0.5649, 3.76, 0.090, 174, 100, SOLUTION STRUCTURE OF A PUTATIVE LATE EMBRYOGENESIS ABUNDANT (LEA) PROTEIN AT2G46140.1
3118, 1u0qA, 0.5649, 3.26, 0.077, 124, 91, STRUCTURE OF A LLAMA VHH DOMAIN RAISED AGAINST A CARBAZOLE MOLECULE
3119, 1rzkH, 0.5649, 3.21, 0.098, 229, 92, HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3120, 1i9iH, 0.5649, 3.30, 0.054, 220, 92, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3121, 1fvdB, 0.5649, 3.28, 0.110, 223, 91, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
3122, 6mjaD, 0.5648, 3.11, 0.067, 240, 89, CRYSTAL STRUCTURE OF THE MCD1D/XXO (JJ294) /INKTCR TERNARY COMPLEX 
3123, 6h02B, 0.5648, 3.16, 0.077, 123, 91, CRYSTAL STRUCTURE OF HUMAN MEDIATOR SUBUNIT MED23 
3124, 6ezwB, 0.5648, 3.20, 0.087, 128, 92, CRYSTAL STRUCTURE OF A LLAMA VHH ANTIBODY BCD090-M2 AGAINST HUMAN ERBB3 IN SPACE GROUP C2
3125, 6dbaA, 0.5648, 3.13, 0.044, 123, 91, CRYSTAL STRUCTURE OF VHH R303 
3126, 6crqI, 0.5648, 3.19, 0.088, 125, 91, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3127, 6cmoH, 0.5648, 2.88, 0.080, 230, 88, RHODOPSIN-GI COMPLEX 
3128, 4wenB, 0.5648, 3.22, 0.077, 121, 91, CO-COMPLEX STRUCTURE OF THE F4 FIMBRIAL ADHESIN FAEG VARIANT AC WITH LLAMA SINGLE DOMAIN ANTIBODY V2
3129, 4utaH, 0.5648, 3.14, 0.089, 221, 90, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8
3130, 4q5zS, 0.5648, 3.29, 0.067, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
3131, 4oi8B, 0.5648, 3.35, 0.098, 215, 92, RAGE IS A NUCLEIC ACID RECEPTOR THAT PROMOTES INFLAMMATORY RESPONSES TO DNA.
3132, 4ktdH, 0.5648, 3.23, 0.100, 217, 90, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE136 FROM NON-HUMAN PRIMATE
3133, 3r8qA, 0.5648, 2.87, 0.090, 271, 89, STRUCTURE OF FIBRONECTIN DOMAIN 12-14
3134, 3qcuH, 0.5648, 3.19, 0.077, 219, 91, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3135, 3juyB, 0.5648, 3.23, 0.110, 240, 91, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3136, 3juyA, 0.5648, 3.22, 0.110, 233, 91, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3137, 3ivkH, 0.5648, 3.33, 0.098, 224, 92, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3138, 2x1oB, 0.5648, 3.11, 0.055, 120, 91, GELSOLIN NANOBODY
3139, 2qfrA, 0.5648, 2.36, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE WITH BOUND SULFATE
3140, 2jixD, 0.5648, 3.44, 0.065, 216, 92, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3141, 6mkdA, 0.5647, 3.11, 0.033, 193, 90, 4699 TCR BOUND TO I-AB PADI4 
3142, 6g46C, 0.5647, 2.35, 0.071, 424, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
3143, 6g46A, 0.5647, 2.35, 0.071, 424, 85, RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH 2-(NAPHTHALEN- 1-YL)THIAZOLE-4-CARBOXYLIC ACID 
3144, 6ewcD, 0.5647, 2.52, 0.116, 186, 86, CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF RLS PHOSPHOPEPTIDE BOUND TO HLA-A2 IN COMPLEX WITH LILRB1 
3145, 5xwdH, 0.5647, 3.13, 0.078, 119, 90, CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD
3146, 5w1kI, 0.5647, 3.17, 0.089, 225, 90, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3147, 5vf6A, 0.5647, 3.42, 0.087, 226, 92, CRYSTAL STRUCTURE OF SINGLE CHAIN VARIABLE FRAGMENT (SCFV45).
3148, 5o1rH, 0.5647, 3.26, 0.110, 226, 91, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
3149, 5jw5A, 0.5647, 3.26, 0.076, 223, 92, STRUCTURE OF MEDI8852 FAB FRAGMENT
3150, 5ijkB, 0.5647, 3.03, 0.122, 211, 90, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
3151, 5cd3G, 0.5647, 3.31, 0.065, 220, 92, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
3152, 5c8jC, 0.5647, 3.41, 0.087, 230, 92, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
3153, 4xcnC, 0.5647, 3.25, 0.077, 228, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3154, 4tvpD, 0.5647, 3.08, 0.078, 242, 90, CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22
3155, 4qwwF, 0.5647, 3.08, 0.122, 219, 90, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
3156, 4hunB, 0.5647, 2.56, 0.151, 91, 86, MATE TRANSPORTER NORM-NG IN COMPLEX WITH R6G AND MONOBODY
3157, 4grmC, 0.5647, 2.91, 0.114, 187, 88, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
3158, 4g7yH, 0.5647, 3.39, 0.065, 212, 92, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
3159, 4dkaA, 0.5647, 3.22, 0.099, 127, 91, STRUCTURE OF EDITOSOME PROTEIN
3160, 3tzvA, 0.5647, 3.09, 0.045, 196, 89, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
3161, 3t65B, 0.5647, 3.29, 0.054, 222, 92, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
3162, 3mj9H, 0.5647, 3.41, 0.066, 210, 91, CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
3163, 2fjhB, 0.5647, 3.26, 0.099, 219, 91, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3164, 1wcbB, 0.5647, 3.17, 0.077, 224, 91, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
3165, 1mh5B, 0.5647, 3.15, 0.110, 172, 91, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3166, 1fnaA, 0.5647, 2.40, 0.120, 91, 83, CRYSTAL STRUCTURE OF THE TENTH TYPE III CELL ADHESION MODULE OF HUMAN FIBRONECTIN
3167, 1ct8D, 0.5647, 3.18, 0.077, 220, 91, CATALYTIC ANTIBODY 7C8 COMPLEX
3168, 6b7zE, 0.5646, 3.21, 0.110, 217, 91, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11 HEAVY CHAIN AND FAB H11 LIGHT CHAIN
3169, 6a6yA, 0.5646, 3.55, 0.041, 152, 98, CRYSTAL STRUCTURE OF ASF1 FROM PLASMODIUM FALCIPARUM 
3170, 5ushD, 0.5646, 3.18, 0.078, 216, 90, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
3171, 5uk4b, 0.5646, 3.25, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3172, 5t6pA, 0.5646, 3.53, 0.064, 216, 94, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3173, 5grxH, 0.5646, 3.21, 0.055, 231, 91, CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY
3174, 5cp7G, 0.5646, 3.64, 0.053, 218, 94, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3175, 4xbpC, 0.5646, 3.08, 0.066, 224, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
3176, 4rauB, 0.5646, 3.39, 0.076, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3177, 4qwwD, 0.5646, 3.08, 0.122, 225, 90, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
3178, 4qtiH, 0.5646, 3.11, 0.110, 218, 91, CRYSTAL STRUCTURE OF HUMAN UPAR IN COMPLEX WITH ANTI-UPAR FAB 8B12
3179, 4ftvD, 0.5646, 3.21, 0.089, 200, 90, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
3180, 4dk6A, 0.5646, 3.21, 0.088, 127, 91, STRUCTURE OF EDITOSOME PROTEIN
3181, 3syaA, 0.5646, 3.45, 0.060, 328, 100, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) IN COMPLEX WITH SODIUM AND PIP2
3182, 2uudL, 0.5646, 3.59, 0.064, 113, 94, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
3183, 2r23B, 0.5646, 3.28, 0.054, 222, 92, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3184, 2i5yH, 0.5646, 3.14, 0.088, 224, 91, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3185, 1yedH, 0.5646, 3.15, 0.111, 226, 90, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
3186, 1rz8B, 0.5646, 3.22, 0.087, 228, 92, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
3187, 1d5bB, 0.5646, 3.04, 0.089, 221, 90, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
3188, 1a7nH, 0.5646, 3.18, 0.056, 116, 90, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL
3189, 6q7iB, 0.5645, 3.72, 0.000, 768, 97, GH3 EXO-BETA-XYLOSIDASE (XLND) 
3190, 6fyuC, 0.5645, 2.97, 0.136, 122, 88, STRUCTURE OF H7(A/SHANGHAI/2/2013) INFLUENZA HEMAGGLUTININ IN COMPLEX SD36 
3191, 6dbaB, 0.5645, 2.97, 0.056, 123, 90, CRYSTAL STRUCTURE OF VHH R303 
3192, 5wb9H, 0.5645, 3.22, 0.077, 220, 91, CRYSTAL STRUCTURE OF CD4 BINDING SITE ANTIBODY N60P23 IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 CORE 
3193, 5wabD, 0.5645, 3.30, 0.055, 701, 91, CRYSTAL STRUCTURE OF BIFIDOBACTERIUM ADOLESCENTIS GH3 BETA-GLUCOSIDASE
3194, 5w3lE, 0.5645, 3.35, 0.077, 116, 91, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (4 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
3195, 5w3eE, 0.5645, 3.21, 0.067, 116, 90, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
3196, 5vl2F, 0.5645, 3.28, 0.043, 125, 92, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
3197, 5u7mD, 0.5645, 3.12, 0.077, 242, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
3198, 5nmvH, 0.5645, 3.27, 0.078, 221, 90, CRYSTAL STRUCTURE OF 2F22 FAB FRAGMENT AGAINST TFPI1
3199, 5jw4Q, 0.5645, 3.14, 0.088, 177, 91, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3200, 4ziuA, 0.5645, 3.20, 0.089, 639, 90, CRYSTAL STRUCTURE OF NATIVE ALPHA-2-MACROGLOBULIN FROM ESCHERICHIA COLI SPANNING THE RESIDUES FROM DOMAIN MG7 TO THE C-TERMINUS.
3201, 4dtgH, 0.5645, 3.25, 0.087, 221, 92, HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
3202, 4dsyC, 0.5645, 2.35, 0.071, 423, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
3203, 4d94A, 0.5645, 2.97, 0.034, 1274, 89, CRYSTAL STRUCTURE OF TEP1R
3204, 3gkwL, 0.5645, 3.55, 0.043, 199, 93, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
3205, 3anzP, 0.5645, 3.93, 0.061, 294, 99, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
3206, 2qfpC, 0.5645, 2.35, 0.071, 424, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH FLUORIDE
3207, 2p1yE, 0.5645, 2.87, 0.034, 217, 87, 1.B2.D9 A BISPECIFIC ALPHA/BETA TCR
3208, 2jccM, 0.5645, 3.10, 0.067, 237, 89, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
3209, 1dlfH, 0.5645, 3.06, 0.111, 120, 90, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 5.25
3210, 6miyD, 0.5644, 3.12, 0.067, 240, 89, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
3211, 6j5dL, 0.5644, 3.17, 0.033, 108, 90, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH LOUPING ILL VIRUS ENVELOPE PROTEIN DOMAIN III 
3212, 6bfqE, 0.5644, 3.17, 0.079, 210, 89, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3213, 5uk4n, 0.5644, 3.26, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3214, 5gksC, 0.5644, 3.32, 0.089, 200, 90, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY
3215, 5f1oB, 0.5644, 3.28, 0.099, 128, 91, HUMAN CD38 IN COMPLEX WITH NANOBODY MU551
3216, 5esaA, 0.5644, 3.13, 0.078, 213, 90, CRYSTAL STRUCTURE OF ANTI-HCV E2 ANTIBODY HC84-26
3217, 5c07I, 0.5644, 2.95, 0.080, 199, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
3218, 4zfgH, 0.5644, 3.28, 0.088, 215, 91, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
3219, 4w6xB, 0.5644, 3.22, 0.088, 125, 91, CO-COMPLEX STRUCTURE OF THE LECTIN DOMAIN OF F18 FIMBRIAL ADHESIN FEDF WITH INHIBITORY NANOBODY NBFEDF7
3220, 4r4fH, 0.5644, 3.22, 0.111, 219, 90, CRYSTAL STRUCTURE OF NON-NEUTRALIZING A32-LIKE ANTIBODY 2.2C IN COMPLEX WITH HIV-1 YU2 GP120
3221, 4hcrM, 0.5644, 3.16, 0.121, 217, 91, CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
3222, 4gftB, 0.5644, 3.14, 0.077, 125, 91, MALARIA INVASION MACHINERY PROTEIN-NANOBODY COMPLEX
3223, 3w0wE, 0.5644, 2.99, 0.080, 241, 87, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
3224, 3pjsA, 0.5644, 3.25, 0.022, 215, 91, MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL
3225, 3lrsH, 0.5644, 3.22, 0.098, 220, 92, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3226, 3juyD, 0.5644, 3.22, 0.110, 234, 91, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3227, 3eyoD, 0.5644, 3.29, 0.098, 218, 92, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3228, 2xwxB, 0.5644, 3.28, 0.100, 385, 90, VIBRIO CHOLERAE COLONIZATION FACTOR GBPA CRYSTAL STRUCTURE
3229, 2jccF, 0.5644, 3.10, 0.067, 237, 89, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
3230, 2ianI, 0.5644, 2.69, 0.070, 198, 86, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3231, 6n5eH, 0.5643, 3.28, 0.054, 225, 92, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
3232, 6mkrA, 0.5643, 3.13, 0.033, 195, 90, 5287 TCR BOUND TO IAB PADI4 
3233, 6c5kL, 0.5643, 3.61, 0.064, 219, 94, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
3234, 5uk4q, 0.5643, 3.11, 0.089, 125, 90, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3235, 5m00G, 0.5643, 3.21, 0.033, 187, 90, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
3236, 5jw4W, 0.5643, 3.08, 0.089, 223, 90, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3237, 5eorH, 0.5643, 3.18, 0.078, 214, 90, STRUCTURE OF THE MURINE ANTIBODY FAB 8E3 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 101-110
3238, 5c07D, 0.5643, 2.94, 0.080, 199, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA
3239, 4r7nQ, 0.5643, 3.26, 0.055, 218, 91, FAB C2E3
3240, 4r7dE, 0.5643, 3.29, 0.088, 209, 91, FAB HU 15C1
3241, 4o9hH, 0.5643, 3.01, 0.144, 200, 90, STRUCTURE OF INTERLEUKIN-6 IN COMPLEX WITH A CAMELID FAB FRAGMENT
3242, 4npyB, 0.5643, 3.11, 0.101, 228, 89, CRYSTAL STRUCTURE OF GERMLINE FAB PGT121 A PUTATIVE PRECURSOR OF THE BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3243, 4kfmA, 0.5643, 3.47, 0.060, 328, 100, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) IN COMPLEX WITH THE BETA-GAMMA G PROTEIN SUBUNITS
3244, 3qxwA, 0.5643, 3.36, 0.054, 124, 92, FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY
3245, 3k2uH, 0.5643, 3.30, 0.066, 215, 91, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
3246, 3hzvB, 0.5643, 3.20, 0.077, 220, 91, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
3247, 3h3pH, 0.5643, 3.07, 0.066, 125, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
3248, 3fn0H, 0.5643, 3.34, 0.065, 221, 92, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB Z13E1 IN COMPLEX WITH A 12-RESIDUE PEPTIDE CONTAINING THE Z13E1 EPITOPE ON GP41
3249, 1nezG, 0.5643, 2.89, 0.091, 122, 88, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
3250, 1a7rH, 0.5643, 3.24, 0.044, 116, 90, FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C IGG1 K) VARIANT CHAIN L GLU81->ASP
3251, 6dxuD, 0.5642, 3.47, 0.103, 800, 97, CRYSTAL STRUCTURE OF PARABACTEROIDES MERDAE BETA-GLUCURONIDASE (GUS) 
3252, 6b9yB, 0.5642, 3.31, 0.087, 223, 92, TRASTUZUMAB FAB V3 IN COMPLEX WITH 5-PHENYL MEDITOPE VARIANT 
3253, 5vvfH, 0.5642, 3.27, 0.087, 223, 92, CRYSTAL STRUCTURE OF 354BG1 FAB
3254, 5vl2H, 0.5642, 3.27, 0.043, 125, 92, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
3255, 5vl2A, 0.5642, 3.16, 0.044, 125, 91, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
3256, 5uoeT, 0.5642, 3.17, 0.033, 107, 90, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
3257, 5ueaH, 0.5642, 3.28, 0.055, 215, 91, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH HISTONE CHAPERONE ASF1
3258, 5t78A, 0.5642, 3.56, 0.064, 216, 94, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3259, 5sx5H, 0.5642, 3.26, 0.088, 207, 91, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
3260, 5sx4H, 0.5642, 3.31, 0.076, 210, 92, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
3261, 5jw4O, 0.5642, 3.08, 0.089, 223, 90, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3262, 5hggT, 0.5642, 3.36, 0.110, 127, 91, CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH A CAMELID-DERIVED ANTIBODY FRAGMENT
3263, 5ea0H, 0.5642, 3.24, 0.088, 214, 91, STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE
3264, 5c08I, 0.5642, 2.93, 0.091, 191, 88, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
3265, 4xcnA, 0.5642, 3.06, 0.056, 227, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3266, 4irjD, 0.5642, 3.03, 0.068, 239, 88, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
3267, 4i18L, 0.5642, 3.31, 0.033, 216, 92, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
3268, 3u46A, 0.5642, 3.30, 0.077, 225, 91, CH04H/CH02L P212121
3269, 3ra7I, 0.5642, 3.26, 0.065, 225, 92, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3270, 3qcvH, 0.5642, 3.29, 0.076, 219, 92, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
3271, 3p9wD, 0.5642, 3.12, 0.044, 121, 90, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3272, 3b5gA, 0.5642, 2.98, 0.056, 111, 90, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3273, 2ny1D, 0.5642, 3.23, 0.098, 223, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C T257S S334A S375W Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3274, 1ggiJ, 0.5642, 3.06, 0.068, 215, 88, CRYSTAL STRUCTURE OF AN HIV-1 NEUTRALIZING ANTIBODY 50.1 IN COMPLEX WITH ITS V3 LOOP PEPTIDE ANTIGEN
3275, 1fl6B, 0.5642, 3.21, 0.088, 219, 91, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
3276, 6q7iA, 0.5641, 3.73, 0.000, 769, 97, GH3 EXO-BETA-XYLOSIDASE (XLND) 
3277, 6nnfH, 0.5641, 3.28, 0.077, 227, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO VRC01 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.5 ANGSTROM 
3278, 6njlN, 0.5641, 3.21, 0.100, 215, 90, STRUCTURE OF A COMPLEX 
3279, 6mugH, 0.5641, 3.30, 0.077, 227, 91, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.8 ANGSTROM 
3280, 6j5fL, 0.5641, 3.16, 0.033, 108, 90, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN DOMAIN III 
3281, 6csyN, 0.5641, 3.12, 0.089, 122, 90, CRYSTAL STRUCTURE OF HUMAN BETA2 ADRENERGIC RECEPTOR BOUND TO SALMETEROL AND NB71 
3282, 5viyO, 0.5641, 3.35, 0.076, 227, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3283, 5viyM, 0.5641, 3.35, 0.076, 227, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3284, 5m2mD, 0.5641, 3.21, 0.067, 127, 90, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
3285, 5hggS, 0.5641, 3.31, 0.099, 128, 91, CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH A CAMELID-DERIVED ANTIBODY FRAGMENT
3286, 5h35A, 0.5641, 3.25, 0.066, 219, 91, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3287, 5gruH, 0.5641, 3.21, 0.055, 240, 91, STRUCTURE OF MONO-SPECIFIC DIABODY
3288, 5dzyE, 0.5641, 3.20, 0.079, 413, 89, PROTOCADHERIN BETA 8 EXTRACELLULAR CADHERIN DOMAINS 1-4
3289, 5d7lD, 0.5641, 2.91, 0.045, 187, 88, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
3290, 5cjxH, 0.5641, 3.35, 0.076, 227, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
3291, 5c8jA, 0.5641, 3.30, 0.099, 229, 91, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
3292, 4r4nJ, 0.5641, 3.06, 0.112, 219, 89, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120
3293, 4n0yH, 0.5641, 3.18, 0.099, 222, 91, STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526
3294, 4lptC, 0.5641, 3.09, 0.100, 97, 90, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
3295, 4lccA, 0.5641, 2.82, 0.045, 157, 88, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
3296, 4krlB, 0.5641, 3.30, 0.044, 122, 91, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 6.0
3297, 4i18H, 0.5641, 2.99, 0.090, 227, 89, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
3298, 4hg4N, 0.5641, 3.19, 0.078, 223, 90, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
3299, 3sobH, 0.5641, 3.24, 0.110, 222, 91, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
3300, 3pvmC, 0.5641, 3.29, 0.120, 1627, 92, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH CVF
3301, 3oskA, 0.5641, 3.05, 0.054, 121, 92, CRYSTAL STRUCTURE OF HUMAN CTLA-4 APO HOMODIMER
3302, 3jwoH, 0.5641, 2.83, 0.102, 220, 88, STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3303, 3jwdH, 0.5641, 2.83, 0.102, 220, 88, STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
3304, 3ivkA, 0.5641, 3.24, 0.088, 224, 91, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
3305, 3eyfB, 0.5641, 3.32, 0.087, 218, 92, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE
3306, 3dgcR, 0.5641, 2.91, 0.090, 202, 89, STRUCTURE OF IL-22/IL-22R1
3307, 3b9vC, 0.5641, 3.40, 0.109, 119, 92, CRYSTAL STRUCTURE OF AN AUTONOMOUS VH DOMAIN
3308, 2bfvL, 0.5641, 3.48, 0.074, 112, 94, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
3309, 1pkqG, 0.5641, 3.15, 0.110, 214, 91, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
3310, 1l7tH, 0.5641, 3.33, 0.054, 220, 92, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
3311, 1hzhH, 0.5641, 3.35, 0.130, 457, 92, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
3312, 1hxmA, 0.5641, 3.24, 0.065, 206, 92, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
3313, 6jbtL, 0.5640, 3.62, 0.053, 218, 94, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
3314, 6df2A, 0.5640, 3.08, 0.034, 215, 89, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
3315, 5uk4r, 0.5640, 3.27, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3316, 5uk4d, 0.5640, 3.17, 0.055, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3317, 5u6aB, 0.5640, 3.32, 0.087, 223, 92, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- PEG3-MEDITOPE
3318, 5u5mB, 0.5640, 3.32, 0.087, 223, 92, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- MEDITOPE
3319, 5u3pL, 0.5640, 3.20, 0.055, 214, 91, CRYSTAL STRUCTURE OF DH511.4 FAB
3320, 5jo4A, 0.5640, 3.19, 0.087, 221, 92, ANTIBODY FAB FRAGMENT COMPLEX
3321, 5c8jG, 0.5640, 3.30, 0.088, 229, 91, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
3322, 5c0cD, 0.5640, 2.94, 0.080, 200, 88, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA
3323, 4m3jA, 0.5640, 2.92, 0.102, 116, 88, STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-H7S SPECIFIC OF THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
3324, 4krmD, 0.5640, 3.22, 0.066, 124, 91, NANOBODY/VHH DOMAIN 7D12 IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR PH 3.5
3325, 4i18B, 0.5640, 3.32, 0.033, 215, 92, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
3326, 4i18A, 0.5640, 3.00, 0.090, 219, 89, CRYSTAL STRUCTURE OF HUMAN PROLACTIN RECEPTOR COMPLEXED WITH FAB FRAGMENT
3327, 3v6zA, 0.5640, 3.23, 0.099, 221, 91, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3328, 3u4bH, 0.5640, 3.29, 0.088, 227, 91, CH04H/CH02L FAB P4
3329, 3u46H, 0.5640, 3.30, 0.077, 228, 91, CH04H/CH02L P212121
3330, 3scmC, 0.5640, 3.12, 0.089, 191, 90, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
3331, 3qcuI, 0.5640, 3.13, 0.077, 219, 91, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (14:0)
3332, 3nn8G, 0.5640, 3.30, 0.109, 121, 92, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
3333, 3fo1H, 0.5640, 3.31, 0.099, 216, 91, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
3334, 3bdxA, 0.5640, 2.98, 0.056, 111, 90, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3335, 3anzJ, 0.5640, 3.66, 0.052, 294, 96, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
3336, 1um5H, 0.5640, 3.08, 0.132, 217, 91, CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
3337, 1qygH, 0.5640, 3.27, 0.098, 220, 92, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
3338, 1ggtB, 0.5640, 3.75, 0.050, 708, 101, THREE-DIMENSIONAL STRUCTURE OF A TRANSGLUTAMINASE: HUMAN BLOOD COAGULATION FACTOR XIII
3339, 1axsH, 0.5640, 3.18, 0.077, 221, 91, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
3340, 6mxtN, 0.5639, 3.12, 0.089, 122, 90, CRYSTAL STRUCTURE OF HUMAN BETA2 ADRENERGIC RECEPTOR BOUND TO SALMETEROL AND NB71 
3341, 6h15D, 0.5639, 3.17, 0.078, 123, 90, STRUCTURE OF LRP6 P3E3P4E4 IN COMPLEX WITH VHH L-P2-B10 
3342, 6fr8A, 0.5639, 3.28, 0.033, 202, 91, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3343, 6fabH, 0.5639, 3.17, 0.110, 222, 91, THREE-DIMENSIONAL STRUCTURE OF MURINE ANTI-P- AZOPHENYLARSONATE FAB 36-71. 1. X-RAY CRYSTALLOGRAPHY SITE-DIRECTED MUTAGENESIS AND MODELING OF THE COMPLEX WITH HAPTEN
3344, 6ddvA, 0.5639, 3.61, 0.064, 217, 94, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3345, 6ca6H, 0.5639, 3.01, 0.133, 226, 90, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
3346, 5xcuA, 0.5639, 3.16, 0.077, 171, 91, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
3347, 5wobS, 0.5639, 3.30, 0.067, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
3348, 5uk4t, 0.5639, 3.03, 0.067, 125, 89, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3349, 5ugyJ, 0.5639, 3.35, 0.130, 221, 92, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3350, 5j74B, 0.5639, 2.99, 0.089, 233, 90, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
3351, 5e2vH, 0.5639, 3.05, 0.057, 208, 87, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
3352, 5cd5C, 0.5639, 3.23, 0.066, 220, 91, CRYSTAL STRUCTURE OF AN IMMATURE VRC01-CLASS ANTIBODY DRVIA7 FROM A CHINESE DONOR BOUND TO CLADE A/E HIV-1 GP120 CORE
3353, 5a40H, 0.5639, 2.63, 0.106, 90, 85, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
3354, 4xcnH, 0.5639, 3.14, 0.077, 230, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3355, 4uv4H, 0.5639, 3.19, 0.110, 229, 91, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
3356, 4ouuL, 0.5639, 3.58, 0.064, 217, 94, ANTI-MT1-MMP MONOCLONAL ANTIBODY
3357, 3sypA, 0.5639, 3.50, 0.040, 305, 99, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) R201A MUTANT
3358, 3okeB, 0.5639, 3.21, 0.099, 217, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3359, 3hzkB, 0.5639, 3.19, 0.077, 222, 91, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3360, 1yc7B, 0.5639, 2.69, 0.070, 114, 86, CABAN33 VHH FRAGMENT AGAINST VSG
3361, 1hilB, 0.5639, 3.25, 0.099, 214, 91, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION
3362, 6cw3A, 0.5638, 3.02, 0.101, 222, 89, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
3363, 6bi2I, 0.5638, 3.26, 0.110, 212, 91, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
3364, 5v6lH, 0.5638, 3.19, 0.088, 220, 91, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
3365, 5uk4k, 0.5638, 3.24, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3366, 5tilG, 0.5638, 3.34, 0.066, 114, 91, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
3367, 5gkrA, 0.5638, 3.13, 0.090, 207, 89, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY IN COMPLEX WITH OLIGONUCLEOTIDE
3368, 4xc3H, 0.5638, 2.99, 0.078, 220, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE
3369, 4x0kH, 0.5638, 3.36, 0.109, 229, 92, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
3370, 4ouuA, 0.5638, 3.61, 0.053, 217, 94, ANTI-MT1-MMP MONOCLONAL ANTIBODY
3371, 4i3sH, 0.5638, 3.14, 0.089, 222, 90, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
3372, 4dk3A, 0.5638, 3.27, 0.120, 127, 92, STRUCTURE OF EDITOSOME PROTEIN
3373, 3v6zC, 0.5638, 3.23, 0.099, 221, 91, CRYSTAL STRUCTURE OF HEPATITIS B VIRUS E-ANTIGEN
3374, 3to4C, 0.5638, 3.18, 0.078, 190, 90, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
3375, 3ta3D, 0.5638, 2.92, 0.046, 239, 87, STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3376, 3qwoA, 0.5638, 3.23, 0.054, 220, 92, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3377, 3lrsE, 0.5638, 3.23, 0.098, 221, 92, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3378, 3j5mL, 0.5638, 3.11, 0.077, 225, 91, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3379, 3j5mH, 0.5638, 3.11, 0.077, 225, 91, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3380, 3j5mD, 0.5638, 3.11, 0.077, 225, 91, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3381, 2ny4D, 0.5638, 3.23, 0.098, 222, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E268C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
3382, 6fr6A, 0.5637, 3.22, 0.033, 202, 91, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3383, 6db5H, 0.5637, 3.22, 0.087, 228, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
3384, 5yxnA, 0.5637, 3.22, 0.055, 192, 91, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
3385, 5u5fB, 0.5637, 3.32, 0.087, 223, 92, MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (AC) CQFDA(PH)2STRRLRCGGSK
3386, 5t78C, 0.5637, 3.56, 0.064, 216, 94, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3387, 5nb5I, 0.5637, 3.10, 0.112, 214, 89, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
3388, 5jw4U, 0.5637, 3.08, 0.089, 223, 90, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3389, 5c8jE, 0.5637, 3.31, 0.099, 230, 91, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
3390, 5c0sH, 0.5637, 3.44, 0.076, 221, 92, CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261
3391, 4y16D, 0.5637, 3.04, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX
3392, 4xbpH, 0.5637, 2.88, 0.056, 224, 89, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLETHANOLAMINE (06:0 PE)
3393, 4tprH, 0.5637, 3.13, 0.100, 221, 90, STRUCTURE OF TAU5 ANTIBODY FAB FRAGMENT
3394, 4imlH, 0.5637, 3.21, 0.099, 234, 91, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
3395, 43c9F, 0.5637, 3.40, 0.086, 118, 93, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
3396, 3sgdI, 0.5637, 3.63, 0.043, 218, 94, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3397, 3rtqD, 0.5637, 2.91, 0.057, 239, 87, STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
3398, 3okoB, 0.5637, 3.23, 0.099, 219, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
3399, 3ntcH, 0.5637, 3.20, 0.099, 221, 91, CRYSTAL STRUCTURE OF KD-247 FAB AN ANTI-V3 ANTIBODY THAT INHIBITS HIV-1 ENTRY
3400, 3bdyH, 0.5637, 3.21, 0.078, 216, 90, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3401, 2mcpH, 0.5637, 3.27, 0.088, 222, 91, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
3402, 1rzjH, 0.5637, 3.23, 0.087, 229, 92, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3403, 1mcpH, 0.5637, 3.26, 0.088, 222, 91, PHOSPHOCHOLINE BINDING IMMUNOGLOBULIN FAB MC/PC603. AN X-RAY DIFFRACTION STUDY AT 2.7 ANGSTROMS
3404, 6mjqH, 0.5636, 2.91, 0.069, 239, 87, CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX 
3405, 6ii4H, 0.5636, 3.30, 0.109, 220, 92, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4A-14 
3406, 6h06C, 0.5636, 3.04, 0.100, 218, 90, FAB CBTAU-22.1 IN COMPLEX WITH TAU PEPTIDE V1088-5 
3407, 6ey6P, 0.5636, 3.16, 0.099, 130, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3408, 6ey6J, 0.5636, 3.16, 0.099, 130, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3409, 6eh9A, 0.5636, 3.20, 0.033, 202, 91, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3410, 6c6xC, 0.5636, 3.39, 0.066, 213, 91, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
3411, 5yotA, 0.5636, 3.53, 0.129, 754, 93, ISOPRIMEVEROSE-PRODUCING ENZYME FROM ASPERGILLUS ORYZAE IN COMPLEX WITH ISOPRIMEVEROSE 
3412, 5m95B, 0.5636, 2.90, 0.112, 120, 89, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
3413, 5hdoC, 0.5636, 3.24, 0.111, 125, 90, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
3414, 4xbgF, 0.5636, 3.22, 0.088, 212, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3415, 4xbeH, 0.5636, 3.18, 0.077, 216, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).
3416, 4wgwB, 0.5636, 2.90, 0.112, 120, 89, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
3417, 4wgvB, 0.5636, 2.90, 0.112, 120, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
3418, 4mxqC, 0.5636, 3.25, 0.044, 199, 91, 42F3 TCR PCPC5/H-2LD COMPLEX
3419, 4dsyB, 0.5636, 2.40, 0.082, 426, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC24201
3420, 43caH, 0.5636, 3.33, 0.076, 117, 92, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
3421, 3tvmH, 0.5636, 3.26, 0.078, 240, 90, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3422, 3nn8H, 0.5636, 3.63, 0.063, 116, 95, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
3423, 3h3bC, 0.5636, 3.53, 0.097, 234, 93, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI- ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN
3424, 3d39D, 0.5636, 3.21, 0.089, 200, 90, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
3425, 2gsiC, 0.5636, 3.56, 0.054, 215, 93, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3426, 2ajvL, 0.5636, 3.36, 0.043, 216, 92, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH COCAINE
3427, 1yehH, 0.5636, 3.16, 0.099, 222, 91, STRUCTURE OF IGG2A FAB FRAGMENT
3428, 1qseD, 0.5636, 3.25, 0.111, 200, 90, STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
3429, 1hxmC, 0.5636, 3.36, 0.065, 206, 93, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
3430, 6gs4H, 0.5635, 3.20, 0.100, 125, 90, CRYSTAL STRUCTURE OF PEPTIDE TRANSPORTER DTPA-NANOBODY IN COMPLEX WITH VALGANCICLOVIR 
3431, 6gffL, 0.5635, 3.31, 0.076, 214, 92, STRUCTURE OF GARP (LRRC32) IN COMPLEX WITH LATENT TGF-BETA1 AND MHG-8 FAB 
3432, 6fyuF, 0.5635, 2.97, 0.125, 122, 88, STRUCTURE OF H7(A/SHANGHAI/2/2013) INFLUENZA HEMAGGLUTININ IN COMPLEX SD36 
3433, 6crqD, 0.5635, 3.22, 0.088, 125, 91, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3434, 6c5hL, 0.5635, 3.62, 0.064, 216, 94, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
3435, 5uk4i, 0.5635, 3.26, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3436, 5uk4c, 0.5635, 3.26, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3437, 5udcE, 0.5635, 3.20, 0.056, 220, 90, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3438, 5tjdH, 0.5635, 2.96, 0.080, 218, 88, COMPUTER-BASED RATIONAL DESIGN OF IMPROVED FUNCTIONALITY FOR ANTIBODY CATALYSTS TOWARD ORGANOPHOSPHORUS COMPOUNDS 
3439, 5o7pB, 0.5635, 3.31, 0.109, 218, 92, HER3 IN COMPLEX WITH FAB MF3178 
3440, 5jxaH, 0.5635, 3.25, 0.089, 231, 90, CRYSTAL STRUCTURE OF LIGAND-FREE VRC03 ANTIGEN-BINDING FRAGMENT.
3441, 5iw1A, 0.5635, 3.20, 0.044, 189, 90, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
3442, 5g64I, 0.5635, 3.29, 0.066, 203, 91, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3443, 5dqjH, 0.5635, 3.25, 0.088, 222, 91, STRUCTURE OF UNLIGANDED S55-5 FAB
3444, 4ybqF, 0.5635, 3.41, 0.065, 119, 92, RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM
3445, 4hulB, 0.5635, 2.57, 0.163, 91, 86, MATE TRANSPORTER NORM-NG IN COMPLEX WITH CS+ AND MONOBODY
3446, 43c9H, 0.5635, 3.47, 0.075, 118, 93, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY
3447, 3tf7C, 0.5635, 3.17, 0.056, 232, 90, 42F3 QL9/H2-LD COMPLEX
3448, 3mmeC, 0.5635, 3.23, 0.098, 222, 92, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3449, 3lrsC, 0.5635, 3.24, 0.098, 228, 92, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3450, 3l5xH, 0.5635, 3.26, 0.033, 223, 90, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND H2L6 FAB
3451, 2ny6D, 0.5635, 3.23, 0.087, 222, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T123C T257S V275CS334A S375W Q428C G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3452, 2ny6C, 0.5635, 3.21, 0.022, 214, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T123C T257S V275CS334A S375W Q428C G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3453, 1pg7Z, 0.5635, 3.09, 0.089, 220, 90, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
3454, 1g9nH, 0.5635, 3.20, 0.098, 229, 92, HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3455, 6n5eG, 0.5634, 3.19, 0.088, 222, 91, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
3456, 6n5eE, 0.5634, 3.15, 0.066, 226, 91, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
3457, 6eqiB, 0.5634, 3.14, 0.055, 124, 91, STRUCTURE OF PINK1 BOUND TO UBIQUITIN
3458, 6dc8L, 0.5634, 3.57, 0.074, 218, 94, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3459, 6c5kB, 0.5634, 3.60, 0.074, 219, 94, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
3460, 6aruC, 0.5634, 3.26, 0.067, 212, 90, STRUCTURE OF CETUXIMAB FAB MUTANT IN COMPLEX WITH EGFR EXTRACELLULAR DOMAIN 
3461, 5mjeB, 0.5634, 3.09, 0.077, 124, 91, CRYSTAL STRUCTURE OF THE HIGB2 TOXIN IN COMPLEX WITH NB8
3462, 5drxB, 0.5634, 3.84, 0.062, 220, 96, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
3463, 4xvuI, 0.5634, 3.32, 0.054, 207, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3464, 4ktyB, 0.5634, 3.47, 0.074, 698, 95, FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND
3465, 4k3jH, 0.5634, 3.25, 0.088, 221, 91, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
3466, 4fabH, 0.5634, 3.19, 0.100, 216, 90, THREE-DIMENSIONAL STRUCTURE OF A FLUORESCEIN-FAB COMPLEX CRYSTALLIZED IN 2-METHYL-24-PENTANEDIOL
3467, 3v4vA, 0.5634, 3.91, 0.040, 582, 100, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
3468, 3ijyD, 0.5634, 3.20, 0.077, 220, 91, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3469, 3anzO, 0.5634, 3.86, 0.040, 295, 99, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
3470, 2uveA, 0.5634, 2.77, 0.114, 571, 88, STRUCTURE OF YERSINIA ENTEROCOLITICA FAMILY 28 EXOPOLYGALACTURONASE
3471, 2mmxA, 0.5634, 3.16, 0.079, 111, 89, NMR STUDY OF 6AJL2
3472, 1g9mL, 0.5634, 3.20, 0.033, 214, 91, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3473, 1g9mH, 0.5634, 3.24, 0.087, 229, 92, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3474, 1fl6H, 0.5634, 3.21, 0.088, 219, 91, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
3475, 1a6vJ, 0.5634, 3.13, 0.111, 120, 90, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
3476, 6q7jA, 0.5633, 3.73, 0.000, 769, 97, GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE 
3477, 6mufH, 0.5633, 3.30, 0.066, 226, 91, CRYSTAL STRUCTURE OF HIV-1 B41 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.4 ANGSTROM 
3478, 6jmrE, 0.5633, 3.16, 0.089, 215, 90, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3479, 6ehgC, 0.5633, 3.28, 0.066, 124, 91, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
3480, 6cx7D, 0.5633, 2.92, 0.057, 239, 87, STRUCTURE OF ALPHA-GSA[12;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3481, 5w1kO, 0.5633, 3.20, 0.100, 225, 90, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3482, 5uoeL, 0.5633, 3.18, 0.022, 108, 90, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
3483, 5uk4o, 0.5633, 3.26, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3484, 5mevH, 0.5633, 3.25, 0.110, 207, 91, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21
3485, 5menE, 0.5633, 3.06, 0.068, 240, 88, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
3486, 5dfvC, 0.5633, 2.89, 0.124, 214, 89, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
3487, 4z0bH, 0.5633, 3.43, 0.043, 222, 92, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OFLOXACIN ANTIBODY AND EXPLORATION ITS RECEPTOR BINDING SITE
3488, 4tvsa, 0.5633, 3.48, 0.065, 128, 93, LAP1(AA356-583) H.SAPIENS BOUND TO VHH-BS1
3489, 4rrpJ, 0.5633, 3.32, 0.088, 222, 91, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
3490, 4llvB, 0.5633, 3.28, 0.088, 111, 91, THE STRUCTURE OF THE UNBOUND FORM OF ANTI-HIV ANTIBODY 4E10 FV
3491, 3wyrB, 0.5633, 2.48, 0.047, 189, 85, CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR 2DL4
3492, 3h3pI, 0.5633, 3.24, 0.077, 126, 91, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
3493, 3dusD, 0.5633, 3.17, 0.066, 121, 91, CRYSTAL STRUCTURE OF SAG506-01 ORTHORHOMBIC TWINNED CRYSTAL 1
3494, 2xn9B, 0.5633, 3.05, 0.056, 242, 89, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
3495, 2mkwA, 0.5633, 3.04, 0.067, 111, 90, SOLUTION STRUCTURE OF 6AJL2 AND 6AJL2-R24G AMYLOIDOGENICS LIGHT CHAIN PROTEINS
3496, 2fjgH, 0.5633, 3.27, 0.088, 218, 91, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3497, 2dlfH, 0.5633, 3.05, 0.111, 120, 90, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75
3498, 1vfaB, 0.5633, 3.20, 0.044, 116, 90, BOUND WATER MOLECULES AND CONFORMATIONAL STABILIZATION HELP MEDIATE AN ANTIGEN-ANTIBODY ASSOCIATION
3499, 1rz7H, 0.5633, 3.26, 0.099, 219, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D
3500, 1n4xM, 0.5633, 3.69, 0.063, 113, 95, STRUCTURE OF SCFV 1696 AT ACIDIC PH
3501, 1j8hE, 0.5633, 2.83, 0.035, 241, 86, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
3502, 1ggcH, 0.5633, 3.25, 0.080, 215, 88, MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
3503, 6ey6L, 0.5632, 3.16, 0.099, 130, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3504, 6bf9C, 0.5632, 3.35, 0.065, 217, 92, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN
3505, 5uoeP, 0.5632, 3.20, 0.066, 118, 91, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
3506, 5uk4a, 0.5632, 3.27, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3507, 5uddO, 0.5632, 3.17, 0.056, 216, 90, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3508, 5tokE, 0.5632, 3.17, 0.089, 126, 90, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-L66
3509, 5m2mH, 0.5632, 3.24, 0.067, 127, 90, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
3510, 5cd3C, 0.5632, 3.18, 0.066, 220, 91, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
3511, 5brzE, 0.5632, 2.78, 0.058, 241, 86, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
3512, 4xvuC, 0.5632, 3.28, 0.088, 222, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3513, 4xbgH, 0.5632, 3.15, 0.077, 230, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3514, 4lriP, 0.5632, 2.99, 0.079, 222, 89, ANTI CMV FAB FRAGMENT
3515, 43caF, 0.5632, 3.35, 0.087, 117, 92, CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL
3516, 3qg7L, 0.5632, 3.62, 0.064, 216, 94, STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY
3517, 3pwpD, 0.5632, 3.13, 0.112, 200, 89, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
3518, 3mmeA, 0.5632, 3.24, 0.098, 235, 92, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3519, 3mbxH, 0.5632, 3.21, 0.089, 229, 90, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
3520, 3l7fB, 0.5632, 3.09, 0.045, 220, 89, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
3521, 3i02D, 0.5632, 3.22, 0.099, 212, 91, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3522, 3bdxC, 0.5632, 3.03, 0.056, 111, 90, CRYSTAL STRUCTURE OF THE UNSTABLE AND HIGHLY FIBRILLOGENIC PRO7SER MUTANT OF THE RECOMBINANT VARIABLE DOMAIN 6AJL2
3523, 3a0oB, 0.5632, 3.19, 0.057, 763, 88, CRYSTAL STRUCTURE OF ALGINATE LYASE FROM AGROBACTERIUM TUMEFACIENS C58
3524, 2znwB, 0.5632, 3.26, 0.044, 221, 90, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
3525, 2y72A, 0.5632, 2.60, 0.120, 85, 83, CRYSTAL STRUCTURE OF THE PKD DOMAIN OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 1.18 ANGSTROM RESOLUTION.
3526, 2nxyD, 0.5632, 3.23, 0.087, 227, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
3527, 2hfgH, 0.5632, 3.36, 0.087, 220, 92, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
3528, 2f54K, 0.5632, 2.97, 0.124, 206, 89, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
3529, 2ajsL, 0.5632, 3.34, 0.043, 216, 92, CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB  IN COMPLEX WITH HEPTAETHYLENE GLYCOL
3530, 1vdgA, 0.5632, 2.41, 0.096, 187, 83, CRYSTAL STRUCTURE OF LIR1.01 ONE OF THE ALLELES OF LIR1
3531, 6n4yE, 0.5631, 3.25, 0.044, 123, 91, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43 
3532, 6ii9M, 0.5631, 3.18, 0.067, 213, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
3533, 6b0nD, 0.5631, 3.35, 0.098, 171, 92, CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A 
3534, 5vxlB, 0.5631, 3.12, 0.100, 116, 90, 2.80 A RESOLUTION STRUCTURE OF IPAD FROM SHIGELLA FLEXNERI IN COMPLEX WITH SINGLE-DOMAIN ANTIBODY JPS-G3
3535, 5t6pC, 0.5631, 3.53, 0.064, 216, 94, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3536, 4y4kD, 0.5631, 3.03, 0.045, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX
3537, 4rzcH, 0.5631, 3.31, 0.132, 118, 91, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
3538, 4irzA, 0.5631, 3.91, 0.069, 592, 102, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
3539, 4g80G, 0.5631, 3.40, 0.065, 221, 92, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
3540, 4g80A, 0.5631, 3.40, 0.065, 221, 92, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
3541, 3rzcD, 0.5631, 2.92, 0.069, 239, 87, STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
3542, 3juyF, 0.5631, 3.21, 0.110, 234, 91, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3543, 2ny2D, 0.5631, 3.22, 0.087, 221, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C T257S S334A S375W G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
3544, 2gsiG, 0.5631, 3.54, 0.054, 215, 93, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3545, 1q9oD, 0.5631, 3.25, 0.077, 226, 91, S45-18 FAB UNLIGANDED
3546, 1om3K, 0.5631, 3.22, 0.088, 225, 91, FAB 2G12 UNLIGANDED
3547, 1ifhH, 0.5631, 3.31, 0.065, 219, 92, A DETAILED ANALYSIS OF THE FREE AND BOUND CONFORMATION OF AN ANTIBODY: X-RAY STRUCTURES OF ANTI-PEPTIDE FAB 17(SLASH)9 AND THREE DIFFERENT FAB-PEPTIDE COMPLEXES
3548, 1f13A, 0.5631, 3.79, 0.059, 722, 101, RECOMBINANT HUMAN CELLULAR COAGULATION FACTOR XIII
3549, 1bfvL, 0.5631, 3.51, 0.074, 113, 94, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
3550, 6okqF, 0.5630, 3.16, 0.088, 230, 91, CRYSTAL STRUCTURE OF THE SF12 FAB 
3551, 6dkpD, 0.5630, 3.22, 0.089, 192, 90, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
3552, 6db5I, 0.5630, 3.26, 0.087, 228, 92, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB TA6 IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM NY5 STRAIN 
3553, 6cx9D, 0.5630, 3.05, 0.068, 239, 88, STRUCTURE OF ALPHA-GSA[16;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3554, 6cuhB, 0.5630, 2.94, 0.080, 240, 87, CRYSTAL STRUCTURE OF THE UNLIGANDED BC8B TCR 
3555, 6ce7A, 0.5630, 3.34, 0.098, 528, 92, INSULIN RECEPTOR ECTODOMAIN IN COMPLEX WITH ONE INSULIN MOLECULE
3556, 6bnlH, 0.5630, 2.92, 0.057, 240, 87, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
3557, 5vhvB, 0.5630, 3.23, 0.065, 361, 92, PSEUDOMONAS FLUORESCENS ALKYLPURINE DNA GLYCOSYLASE ALKC BOUND TO DNA CONTAINING AN OXOCARBENIUM-INTERMEDIATE ANALOG
3558, 5vcjD, 0.5630, 3.03, 0.068, 239, 88, STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR
3559, 5uk4f, 0.5630, 3.27, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3560, 5m2iL, 0.5630, 3.02, 0.080, 121, 88, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
3561, 5jhlH, 0.5630, 2.96, 0.125, 216, 88, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
3562, 5cp7B, 0.5630, 2.90, 0.058, 214, 86, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3563, 5a8hR, 0.5630, 3.37, 0.076, 224, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3564, 5a8hL, 0.5630, 3.37, 0.076, 224, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3565, 5a8hF, 0.5630, 3.37, 0.076, 224, 92, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3566, 5a7xR, 0.5630, 3.37, 0.076, 224, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3567, 5a7xP, 0.5630, 3.37, 0.076, 224, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3568, 5a7xN, 0.5630, 3.37, 0.076, 224, 92, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
3569, 4zfoA, 0.5630, 3.16, 0.143, 215, 91, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
3570, 4xcyE, 0.5630, 3.03, 0.089, 223, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3571, 4r7nS, 0.5630, 3.29, 0.077, 218, 91, FAB C2E3
3572, 4q9qH, 0.5630, 3.28, 0.099, 225, 91, CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO BROMO-LIGAND ANALOG IN COMPLEX WITH FAB
3573, 4p9mH, 0.5630, 3.37, 0.076, 224, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB
3574, 4kzdH, 0.5630, 3.30, 0.099, 225, 91, CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FLUOROPHORE AND FAB
3575, 4aqoA, 0.5630, 2.64, 0.119, 86, 84, CRYSTAL STRUCTURE OF THE CALCIUM BOUND PKD-LIKE DOMAIN OF COLLAGENASE G FROM CLOSTRIDIUM HISTOLYTICUM AT 0.99 ANGSTROM RESOLUTION.
3576, 3qumC, 0.5630, 3.38, 0.043, 218, 92, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3577, 2hkhH, 0.5630, 2.99, 0.101, 209, 89, CRYSTAL STRUCTURE OF THE FAB M75
3578, 2gjjB, 0.5630, 3.41, 0.108, 234, 93, CRYSTAL STRUCTURE OF A SINGLE CHAIN ANTIBODY SCA21 AGAINST HER2/ERBB2
3579, 1pg7X, 0.5630, 3.06, 0.078, 220, 90, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
3580, 1nakI, 0.5630, 3.15, 0.068, 214, 88, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
3581, 6jfiK, 0.5629, 3.44, 0.086, 235, 93, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3582, 6jfhK, 0.5629, 3.44, 0.086, 235, 93, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
3583, 6jepK, 0.5629, 3.44, 0.086, 235, 93, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
3584, 6f2wB, 0.5629, 3.31, 0.099, 128, 91, BACTERIAL ASC TRANSPORTER CRYSTAL STRUCTURE IN OPEN TO IN CONFORMATION 
3585, 6ey6I, 0.5629, 3.17, 0.099, 129, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3586, 6dezH, 0.5629, 3.20, 0.132, 217, 91, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
3587, 6de7D, 0.5629, 3.22, 0.077, 205, 91, CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22 
3588, 6cxaD, 0.5629, 3.05, 0.068, 239, 88, STRUCTURE OF ALPHA-GSA[20;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3589, 6axpB, 0.5629, 3.24, 0.089, 220, 90, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
3590, 5ockH, 0.5629, 3.32, 0.077, 219, 91, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1 
3591, 5k8aH, 0.5629, 3.09, 0.044, 222, 90, NIST FAB
3592, 5j74A, 0.5629, 2.91, 0.091, 231, 88, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
3593, 4u49A, 0.5629, 2.62, 0.084, 311, 83, CRYSTAL STRUCTURE OF PECTATE LYASE PEL3 FROM PECTOBACTERIUM CAROTOVORUM WITH TWO MONOMERS IN THE A.U
3594, 4tn9B, 0.5629, 2.50, 0.120, 87, 83, CRYSTAL STRUCTURE OF CLOSTRIDIUM HISTOLYTICUM COLG COLLAGENASE POLYCYSTIC KIDNEY DISEASE-LIKE DOMAIN AT 1.4 ANGSTROM RESOLUTION
3595, 4p48A, 0.5629, 3.34, 0.118, 235, 93, THE STRUCTURE OF A CHICKEN ANTI-CARDIAC TROPONIN I SCFV
3596, 4m62H, 0.5629, 3.11, 0.078, 127, 90, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
3597, 4lmqH, 0.5629, 3.27, 0.110, 220, 91, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
3598, 4kzeH, 0.5629, 3.29, 0.099, 225, 91, CRYSTAL STRUCTURE OF AN RNA APTAMER IN COMPLEX WITH FAB
3599, 4glrH, 0.5629, 3.28, 0.110, 229, 91, STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235
3600, 4elkD, 0.5629, 2.97, 0.080, 242, 88, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
3601, 3qh3A, 0.5629, 2.95, 0.091, 194, 88, THE CRYSTAL STRUCTURE OF TCR A6
3602, 3lrsA, 0.5629, 3.24, 0.098, 221, 92, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3603, 3hzyB, 0.5629, 3.21, 0.077, 219, 91, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3604, 3hzmB, 0.5629, 3.21, 0.077, 225, 91, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3605, 3b83B, 0.5629, 2.84, 0.080, 92, 88, COMPUTER-BASED REDESIGN OF A BETA SANDWICH PROTEIN SUGGESTS THAT EXTENSIVE NEGATIVE DESIGN IS NOT REQUIRED FOR DE NOVO BETA SHEET DESIGN.
3606, 2vxqH, 0.5629, 3.10, 0.089, 213, 90, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
3607, 2nx5N, 0.5629, 2.87, 0.068, 188, 88, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
3608, 1tcrA, 0.5629, 2.95, 0.080, 202, 88, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
3609, 1frgH, 0.5629, 3.27, 0.065, 220, 92, CRYSTAL STRUCTURE SEQUENCE AND EPITOPE MAPPING OF A PEPTIDE COMPLEX OF AN ANTI-INFLUENZA HA PEPTIDE ANTIBODY FAB 26(SLASH)9: FINE-TUNING ANTIBODY SPECIFICITY
3610, 6okqD, 0.5628, 3.18, 0.088, 230, 91, CRYSTAL STRUCTURE OF THE SF12 FAB 
3611, 6ek2H, 0.5628, 3.38, 0.054, 227, 92, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT 10 
3612, 5uk4j, 0.5628, 3.28, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3613, 5u3kB, 0.5628, 3.26, 0.044, 199, 91, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 662- 683 PEPTIDE
3614, 5trpL, 0.5628, 3.70, 0.053, 217, 94, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
3615, 5aciA, 0.5628, 3.08, 0.087, 234, 92, X-RAY STRUCTURE OF LPMO
3616, 4yn1A, 0.5628, 2.99, 0.067, 261, 90, THE ATOMIC STRUCTURE OF ANOMALA CUPREA ENTOMOPOXVIRUS (ACEPV) FUSOLIN SPINDLES
3617, 4y7mB, 0.5628, 3.16, 0.111, 129, 90, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC
3618, 4y2dH, 0.5628, 2.93, 0.046, 239, 87, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
3619, 4xcnF, 0.5628, 3.23, 0.088, 214, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3620, 4x6cG, 0.5628, 2.82, 0.069, 201, 87, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
3621, 4q9rH, 0.5628, 3.30, 0.099, 223, 91, CRYSTAL STRUCTURE OF AN RNA APTAMER BOUND TO TRIFLUOROETHYL-LIGAND ANALOG IN COMPLEX WITH FAB
3622, 4irsD, 0.5628, 3.04, 0.068, 239, 88, STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
3623, 4g9fD, 0.5628, 3.09, 0.044, 204, 90, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
3624, 4dt2D, 0.5628, 2.37, 0.071, 426, 85, CRYSTAL STRUCTURE OF RED KIDNEY BEAN PURPLE ACID PHOSPHATASE IN COMPLEX WITH MAYBRIDGE FRAGMENT CC27209
3625, 4aeiL, 0.5628, 3.54, 0.064, 218, 94, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3626, 3ulvD, 0.5628, 3.22, 0.099, 224, 91, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
3627, 3ru8H, 0.5628, 3.21, 0.121, 225, 91, STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB
3628, 3ra7H, 0.5628, 3.32, 0.065, 225, 92, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3629, 2uylX, 0.5628, 3.60, 0.064, 216, 94, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3630, 2uylM, 0.5628, 3.60, 0.064, 216, 94, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3631, 2ojzI, 0.5628, 3.18, 0.089, 216, 90, ANTI-DNA ANTIBODY ED10
3632, 2ny0D, 0.5628, 3.23, 0.087, 222, 92, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C T257S V275C S334A S375W A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
3633, 2fjgB, 0.5628, 3.28, 0.088, 218, 91, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3634, 2cmrH, 0.5628, 3.14, 0.100, 204, 90, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY D5 FAB BOUND TO THE GP41 INNER-CORE MIMETIC 5-HELIX
3635, 1ct8B, 0.5628, 3.20, 0.077, 220, 91, CATALYTIC ANTIBODY 7C8 COMPLEX
3636, 6mjiD, 0.5627, 3.04, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXS (JJ304) /INKTCR TERNARY COMPLEX 
3637, 6mj6D, 0.5627, 3.04, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXX (JJ166) /INKTCR TERNARY COMPLEX 
3638, 6ca6B, 0.5627, 2.98, 0.135, 226, 89, CRYSTAL STRUCTURE OF PCT64_35S; A BROADLY NEUTRALIZING ANTI-HIV ANTIBODY. 
3639, 6bnkH, 0.5627, 2.93, 0.057, 239, 87, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
3640, 6bnkD, 0.5627, 2.93, 0.046, 239, 87, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
3641, 5uk4e, 0.5627, 3.17, 0.055, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
3642, 5ugyI, 0.5627, 3.36, 0.130, 221, 92, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3643, 5nkqF, 0.5627, 2.59, 0.107, 86, 84, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
3644, 5mp6P, 0.5627, 3.02, 0.067, 210, 90, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALIZING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE AT TWO ANGSTROM RESOLUTION.
3645, 5irbB, 0.5627, 3.65, 0.061, 314, 98, STRUCTURAL INSIGHT INTO HOST CELL SURFACE RETENTION OF A 1.5-MDA BACTERIAL ICE-BINDING ADHESIN
3646, 5i5kB, 0.5627, 3.30, 0.098, 1634, 92, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
3647, 5i5kA, 0.5627, 3.30, 0.098, 1632, 92, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
3648, 5hdoA, 0.5627, 3.02, 0.101, 126, 89, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
3649, 5fcuH, 0.5627, 3.33, 0.077, 217, 91, CRYSTAL STRUCTURE OF THE INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4
3650, 5e2wH, 0.5627, 3.03, 0.057, 208, 87, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
3651, 5bk2D, 0.5627, 3.24, 0.022, 216, 92, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH A PERISTERIC SYNTHETIC ANTIBODY
3652, 4xawH, 0.5627, 3.18, 0.077, 215, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA)
3653, 4rzcA, 0.5627, 3.32, 0.132, 119, 91, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
3654, 4r4bD, 0.5627, 3.18, 0.088, 220, 91, CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C
3655, 4nylA, 0.5627, 3.38, 0.076, 199, 92, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3656, 4lkxA, 0.5627, 3.29, 0.121, 214, 91, HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT
3657, 3uc0H, 0.5627, 3.19, 0.087, 215, 92, CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
3658, 3u0tD, 0.5627, 2.97, 0.079, 207, 89, FAB-ANTIBODY COMPLEX
3659, 3u0tB, 0.5627, 2.97, 0.079, 209, 89, FAB-ANTIBODY COMPLEX
3660, 3bquD, 0.5627, 3.12, 0.089, 217, 90, CRYSTAL STRUCTURE OF THE 2F5 FAB -3H6 FAB COMPLEX
3661, 2qqkH, 0.5627, 3.29, 0.088, 219, 91, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
3662, 2ny7H, 0.5627, 3.22, 0.121, 230, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
3663, 1nakH, 0.5627, 3.16, 0.068, 214, 88, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
3664, 1lmkA, 0.5627, 3.66, 0.074, 238, 95, THE STRUCTURE OF A BIVALENT DIABODY
3665, 1lhzB, 0.5627, 3.06, 0.077, 213, 91, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
3666, 1fveD, 0.5627, 3.29, 0.110, 223, 91, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
3667, 1ad9H, 0.5627, 3.15, 0.066, 219, 91, IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
3668, 6ey6K, 0.5626, 3.17, 0.099, 130, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3669, 6cbvL, 0.5626, 3.05, 0.034, 213, 89, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
3670, 6ca9B, 0.5626, 3.07, 0.122, 229, 90, CRYSTAL STRUCTURE OF FAB PCT64_LMCA (SAR); THE LEAST MUTATED COMMON ANCESTOR OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY LINEAGE PCT64 
3671, 6c6xA, 0.5626, 3.22, 0.078, 212, 90, CRYSTAL STRUCTURE OF MIDDLE-EAST RESPIRATORY SYNDROME (MERS) CORONAVIRUS NEUTRALIZING ANTIBODY JC57-14 ISOLATED FROM A VACCINATED RHESUS MACAQUE.
3672, 5xqwH, 0.5626, 3.32, 0.065, 210, 92, CATALYTIC ANTIBODY 7B9 
3673, 5vl2C, 0.5626, 3.30, 0.043, 126, 92, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
3674, 5vjqG, 0.5626, 3.01, 0.057, 206, 88, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3675, 5nmdC, 0.5626, 3.19, 0.089, 200, 90, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
3676, 5n88H, 0.5626, 3.24, 0.099, 126, 91, CRYSTAL STRUCTURE OF ANTIBODY BOUND TO VIRAL PROTEIN
3677, 5hdoB, 0.5626, 3.30, 0.055, 127, 91, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
3678, 4zakD, 0.5626, 3.04, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX
3679, 4xvuF, 0.5626, 3.19, 0.033, 216, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3680, 4imlA, 0.5626, 3.23, 0.099, 234, 91, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
3681, 4edxB, 0.5626, 3.34, 0.077, 216, 91, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911
3682, 3pjsC, 0.5626, 3.26, 0.022, 215, 91, MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL
3683, 3lexL, 0.5626, 3.51, 0.043, 219, 93, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
3684, 3juyE, 0.5626, 3.22, 0.110, 234, 91, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3685, 3jauH, 0.5626, 3.09, 0.067, 117, 90, THE CRYOEM MAP OF EV71 MATURE VIRON IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY D5
3686, 3fo1A, 0.5626, 3.63, 0.064, 216, 94, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
3687, 1n0xH, 0.5626, 3.35, 0.130, 222, 92, CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
3688, 1lo2Y, 0.5626, 3.30, 0.077, 220, 91, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
3689, 1b88A, 0.5626, 3.29, 0.056, 114, 90, V-ALPHA 2.6 MOUSE T CELL RECEPTOR (TCR) DOMAIN
3690, 6q7jB, 0.5625, 3.74, 0.000, 768, 97, GH3 EXO-BETA-XYLOSIDASE (XLND) IN COMPLEX WITH XYLOBIOSE AZIRIDINE ACTIVITY BASED PROBE 
3691, 6n7jA, 0.5625, 3.37, 0.087, 223, 92, BDBV223 FAB BOUND TO SYNTHETIC PEPTIDE OF BUNDIBUGYO VIRUS GLYCOPROTEIN STALK 
3692, 6midL, 0.5625, 3.09, 0.078, 110, 90, CRYO-EM STRUCTURE OF THE ZIKV VIRION IN COMPLEX WITH FAB FRAGMENTS OF THE POTENTLY NEUTRALIZING HUMAN MONOCLONAL ANTIBODY ZIKV-195 
3693, 6c6zC, 0.5625, 3.11, 0.099, 222, 91, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
3694, 5vlpH, 0.5625, 3.33, 0.065, 220, 92, PCSK9 COMPLEX WITH LDLR ANTAGONIST PEPTIDE AND FAB7G7
3695, 5ugyH, 0.5625, 3.25, 0.121, 221, 91, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3696, 5tdoD, 0.5625, 3.25, 0.121, 213, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
3697, 5jz7C, 0.5625, 3.16, 0.079, 128, 89, NGF IN COMPLEX WITH MEDI578 SCFV
3698, 5ifjG, 0.5625, 3.29, 0.054, 215, 92, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
3699, 4u05A, 0.5625, 3.38, 0.043, 130, 92, HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB) S74A VARIANT
3700, 4q5zW, 0.5625, 3.29, 0.078, 204, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
3701, 4nkdG, 0.5625, 3.28, 0.132, 121, 91, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3702, 3effA, 0.5625, 3.29, 0.033, 215, 91, THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION
3703, 3be1H, 0.5625, 3.25, 0.110, 213, 91, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
3704, 2otpB, 0.5625, 3.08, 0.046, 194, 87, CRYSTAL STRUCTURE OF IMMUNOGLOBULIN-LIKE TRANSCRIPT 1 (ILT1/LIR7/LILRA2)
3705, 2jb6A, 0.5625, 2.96, 0.045, 211, 89, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-2
3706, 2j8uL, 0.5625, 2.75, 0.069, 194, 87, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
3707, 2fx9I, 0.5625, 3.16, 0.077, 227, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
3708, 2e27L, 0.5625, 3.13, 0.045, 107, 89, CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
3709, 2cumA, 0.5625, 2.72, 0.080, 105, 87, THE SOLUTION STRUCTURE OF THE 33RD FIBRONECTIN TYPE III DOMAIN OF HUMAN TENASCIN-X
3710, 1mclA, 0.5625, 3.10, 0.076, 216, 92, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
3711, 1j05B, 0.5625, 3.25, 0.121, 121, 91, THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
3712, 1gc1L, 0.5625, 3.19, 0.033, 213, 91, HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
3713, 6ey6N, 0.5624, 3.17, 0.099, 129, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3714, 6crqJ, 0.5624, 3.22, 0.088, 125, 91, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3715, 6bnlD, 0.5624, 2.94, 0.057, 240, 87, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
3716, 5wkoG, 0.5624, 3.22, 0.088, 225, 91, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3717, 5wi9H, 0.5624, 3.30, 0.099, 217, 91, CRYSTAL STRUCTURE OF KL WITH AN AGONIST FAB 
3718, 5vl2E, 0.5624, 3.33, 0.043, 125, 92, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
3719, 5mp2C, 0.5624, 3.08, 0.033, 123, 90, XCPQN012 IN COMPLEX WITH VHH04
3720, 5lfrA, 0.5624, 3.52, 0.053, 310, 95, CRYSTAL STRUCTURE OF GLYCOSYLATED MYELIN-ASSOCIATED GLYCOPROTEIN (MAG) IG1-3
3721, 5k9qX, 0.5624, 3.30, 0.110, 231, 91, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3722, 5dqjA, 0.5624, 3.24, 0.088, 222, 91, STRUCTURE OF UNLIGANDED S55-5 FAB
3723, 4xwoO, 0.5624, 3.36, 0.087, 218, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
3724, 4xcyH, 0.5624, 3.07, 0.056, 224, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3725, 4w68A, 0.5624, 3.38, 0.054, 130, 92, CYTOPLASMICALLY PRODUCED HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) C22A/C99V VARIANT AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB)
3726, 4okvD, 0.5624, 3.65, 0.053, 218, 94, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
3727, 4odxH, 0.5624, 3.28, 0.087, 127, 92, 4E10 GERMLINE ENCODED PRECURSOR NO.7 IN COMPLEX WITH EPITOPE SCAFFOLD T117
3728, 4jkpH, 0.5624, 3.25, 0.044, 221, 91, RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES
3729, 4dzbB, 0.5624, 2.74, 0.080, 244, 87, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
3730, 3quzD, 0.5624, 2.76, 0.047, 239, 86, STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3731, 3p9wF, 0.5624, 3.16, 0.044, 122, 90, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3732, 3m4eE, 0.5624, 3.68, 0.052, 293, 97, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
3733, 3j3oH, 0.5624, 3.12, 0.078, 220, 90, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
3734, 3ffdA, 0.5624, 3.32, 0.043, 210, 92, STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY
3735, 3c09L, 0.5624, 3.14, 0.045, 211, 89, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3736, 2vq1E, 0.5624, 3.69, 0.074, 216, 94, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3737, 2uylV, 0.5624, 3.60, 0.064, 216, 94, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3738, 2pn5A, 0.5624, 2.98, 0.034, 1283, 89, CRYSTAL STRUCTURE OF TEP1R
3739, 2ol3B, 0.5624, 2.89, 0.058, 113, 86, CRYSTAL STRUCTURE OF BM3.3 SCFV TCR IN COMPLEX WITH PBM8-H-2KBM8 MHC CLASS I MOLECULE
3740, 2ocfD, 0.5624, 2.59, 0.129, 93, 85, HUMAN ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH ESTRADIOL AND THE E2 23 FN3 MONOBODY
3741, 1qrkB, 0.5624, 3.79, 0.050, 705, 101, HUMAN FACTOR XIII WITH STRONTIUM BOUND IN THE ION SITE
3742, 1lo2H, 0.5624, 3.31, 0.077, 220, 91, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY
3743, 1i9jH, 0.5624, 3.33, 0.054, 220, 92, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3744, 1fptH, 0.5624, 3.12, 0.078, 220, 90, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
3745, 6frbB, 0.5623, 2.78, 0.058, 240, 86, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3746, 6e56H, 0.5623, 3.08, 0.100, 229, 90, HUMAN ANTIBODY H2214 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/AICHI/2/1968 (X-31) (H3N2) 
3747, 6bgaD, 0.5623, 3.10, 0.044, 245, 90, 2B4 I-EK TCR-MHC COMPLEX WITH AFFINITY-ENHANCING VELCRO PEPTIDE 
3748, 5uddM, 0.5623, 3.16, 0.056, 221, 90, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3749, 5od8A, 0.5623, 3.24, 0.077, 230, 91, CRYSTAL STRUCTURE OF THE RA-ASSOCIATED MAB B2 (FAB FRAGMENT) 
3750, 5n09I, 0.5623, 3.29, 0.098, 226, 92, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3751, 5m95D, 0.5623, 2.91, 0.112, 120, 89, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
3752, 5jw4S, 0.5623, 3.18, 0.088, 223, 91, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3753, 5imoB, 0.5623, 3.27, 0.054, 125, 92, NANOBODY TARGETING MOUSE VSIG4 IN SPACEGROUP P3221
3754, 4xvuE, 0.5623, 3.38, 0.076, 222, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3755, 4xcfH, 0.5623, 3.01, 0.067, 218, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)
3756, 4xbgC, 0.5623, 3.18, 0.077, 226, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3757, 4wgwD, 0.5623, 2.91, 0.112, 120, 89, STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE
3758, 4wgvD, 0.5623, 2.91, 0.112, 120, 89, CRYSTAL STRUCTURE OF STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH NANOBODY
3759, 4tprL, 0.5623, 3.57, 0.064, 218, 94, STRUCTURE OF TAU5 ANTIBODY FAB FRAGMENT
3760, 4s10B, 0.5623, 3.32, 0.076, 126, 92, GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS
3761, 4oi7B, 0.5623, 3.42, 0.097, 215, 93, RAGE RECOGNIZES NUCLEIC ACIDS AND PROMOTES INFLAMMATORY RESPONSES TO DNA
3762, 4ocrH, 0.5623, 3.27, 0.077, 233, 91, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.01 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
3763, 4nylE, 0.5623, 3.21, 0.088, 162, 91, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3764, 4nghH, 0.5623, 2.88, 0.057, 228, 88, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 AND A TETHERED PHOSPHATE MOIETY.
3765, 4hcrH, 0.5623, 3.16, 0.121, 217, 91, CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659
3766, 4g80E, 0.5623, 3.29, 0.077, 221, 91, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
3767, 3mmeH, 0.5623, 3.25, 0.098, 235, 92, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3768, 2jb5H, 0.5623, 2.82, 0.080, 216, 88, FAB FRAGMENT IN COMPLEX WITH SMALL MOLECULE HAPTEN CRYSTAL FORM-1
3769, 1cfvL, 0.5623, 3.49, 0.074, 113, 94, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
3770, 6oe6B, 0.5622, 3.04, 0.080, 110, 87, STRUCTURE OF A UNCHARACTERIZED PROTEIN FROM LEPTOSPIRA INTERROGANS SEROGROUP ICTEROHAEMORRHAGIAE SEROVAR COPENHAGENI (STRAIN FIOCRUZ L1- 130) 
3771, 6njmM, 0.5622, 3.21, 0.000, 218, 91, STRUCTURE OF A COMPLEX 
3772, 6eh6B, 0.5622, 2.80, 0.058, 240, 86, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3773, 6e0cN, 0.5622, 3.29, 0.055, 229, 91, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
3774, 6cxfD, 0.5622, 3.05, 0.068, 239, 88, STRUCTURE OF ALPHA-GSA[26;P5P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3775, 6cx5D, 0.5622, 3.04, 0.068, 239, 88, STRUCTURE OF ALPHA-GSA[8;8P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3776, 6cqrE, 0.5622, 3.04, 0.080, 245, 88, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
3777, 5x5xL, 0.5622, 3.69, 0.053, 217, 95, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OSTEOCALCIN C-TERMINAL PEPTIDE ANTIBODY KTM219
3778, 5vcnF, 0.5622, 3.35, 0.087, 214, 92, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
3779, 5uddN, 0.5622, 3.15, 0.056, 221, 90, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3780, 5nlrA, 0.5622, 3.05, 0.076, 234, 92, AUXILIARY ACTIVITY 9
3781, 5m2mJ, 0.5622, 3.19, 0.067, 127, 90, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
3782, 5ifjJ, 0.5622, 3.08, 0.099, 219, 91, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
3783, 4xvuK, 0.5622, 3.29, 0.088, 216, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
3784, 4qf1A, 0.5622, 3.28, 0.099, 212, 91, CRYSTAL STRUCTURE OF UNLIGANDED CH59UA THE INFERRED UNMUTATED ANCESTOR OF THE RV144 ANTI-HIV ANTIBODY LINEAGE PRODUCING CH59
3785, 4pp1F, 0.5622, 3.35, 0.087, 214, 92, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
3786, 4m93H, 0.5622, 3.24, 0.079, 217, 89, UNLIGANDED 2 CRYSTAL STRUCTURE OF S25-26 FAB
3787, 4ij3C, 0.5622, 3.20, 0.067, 220, 90, OXIDOREDUCTASE FRAGMENT OF HUMAN QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTI- HUMAN QSOX1 ANTIBODY
3788, 4gkzA, 0.5622, 3.22, 0.033, 202, 91, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
3789, 4b5eA, 0.5622, 3.27, 0.066, 126, 91, CRYSTAL STRUCTURE OF AN AMYLOID-BETA BINDING SINGLE CHAIN ANTIBODY PS2-8
3790, 3fo2L, 0.5622, 3.61, 0.074, 216, 94, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
3791, 1yylQ, 0.5622, 3.23, 0.022, 214, 91, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3792, 1wftA, 0.5622, 3.30, 0.086, 123, 93, SOLUTION STRUCTURE OF C-TERMINAL FIBRONECTIN TYPE III DOMAIN OF MOUSE 1700129L13RIK PROTEIN
3793, 1rzjL, 0.5622, 3.22, 0.022, 214, 91, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3794, 1m7dA, 0.5622, 3.55, 0.065, 215, 93, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
3795, 1f6fC, 0.5622, 2.08, 0.089, 169, 79, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN OVINE PLACENTAL LACTOGEN AND THE EXTRACELLULAR DOMAIN OF THE RAT PROLACTIN RECEPTOR
3796, 6cugD, 0.5621, 2.77, 0.057, 186, 87, CRYSTAL STRUCTURE OF BC8B TCR-CD1B-PC COMPLEX 
3797, 5xcxA, 0.5621, 3.37, 0.076, 171, 92, CRYSTAL STRUCTURE OF TS2/16 FV-CLASP FRAGMENT
3798, 5x08H, 0.5621, 3.00, 0.078, 217, 90, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY 4E10 MUTANT NPRO WITH PEPTIDE BOUND
3799, 5gksA, 0.5621, 3.15, 0.090, 206, 89, CRYSTAL STRUCTURE OF SLE PATIENT-DERIVED ANTI-DNA ANTIBODY
3800, 4rauK, 0.5621, 3.33, 0.087, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3801, 4q2zA, 0.5621, 3.25, 0.088, 224, 91, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
3802, 4jm2D, 0.5621, 3.23, 0.087, 220, 92, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
3803, 3v6fH, 0.5621, 3.40, 0.065, 215, 92, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
3804, 3u79D, 0.5621, 3.22, 0.033, 110, 91, AL-103 Y32F Y96F
3805, 3tpkA, 0.5621, 3.18, 0.055, 120, 91, CRYSTAL STRUCTURE OF THE OLIGOMER-SPECIFIC KW1 ANTIBODY FRAGMENT
3806, 3qxwB, 0.5621, 3.43, 0.054, 124, 92, FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY
3807, 3p9wB, 0.5621, 3.25, 0.077, 123, 91, CRYSTAL STRUCTURE OF AN ENGINEERED HUMAN AUTONOMOUS VH DOMAIN IN COMPLEX WITH VEGF
3808, 3o8xD, 0.5621, 3.03, 0.045, 239, 88, RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
3809, 3mlyI, 0.5621, 3.26, 0.101, 230, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3810, 3g6jA, 0.5621, 3.49, 0.085, 642, 94, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
3811, 2uveB, 0.5621, 2.78, 0.114, 566, 88, STRUCTURE OF YERSINIA ENTEROCOLITICA FAMILY 28 EXOPOLYGALACTURONASE
3812, 1z7zI, 0.5621, 2.90, 0.023, 434, 88, CRYO-EM STRUCTURE OF HUMAN COXSACKIEVIRUS A21 COMPLEXED WITH FIVE DOMAIN ICAM-1KILIFI
3813, 1y18D, 0.5621, 3.24, 0.110, 226, 91, FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
3814, 1jtpB, 0.5621, 3.10, 0.066, 133, 91, DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
3815, 1bvlA, 0.5621, 3.36, 0.132, 116, 91, HUMANIZED ANTI-LYSOZYME FV
3816, 1a3rH, 0.5621, 3.13, 0.111, 212, 90, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
3817, 6f2gB, 0.5620, 3.29, 0.099, 131, 91, struct.pdbx_descriptor               Putative amino acid/polyamine transport protein; Nanobody 74  
3818, 6cm3T, 0.5620, 3.41, 0.076, 131, 92, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3819, 6cm3R, 0.5620, 3.41, 0.076, 131, 92, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3820, 6cm3P, 0.5620, 3.41, 0.076, 131, 92, BG505 SOSIP IN COMPLEX WITH SCD4; 17B; 8ANC195 
3821, 6bfqA, 0.5620, 3.21, 0.090, 210, 89, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3822, 5ou7B, 0.5620, 2.25, 0.074, 173, 81, CRYSTAL STRUCTURE OF THE GLYCOPROTEIN VI LOOP TRUNCATION MUTANT PAVS- PAPYKN 
3823, 5nhrL, 0.5620, 3.15, 0.056, 111, 90, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
3824, 5nhrB, 0.5620, 3.29, 0.066, 114, 91, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
3825, 5mhlB, 0.5620, 3.45, 0.074, 697, 94, FXIIIA IN COMPLEX WITH THE INHIBITOR MI0621
3826, 5jw4M, 0.5620, 3.18, 0.088, 223, 91, STRUCTURE OF MEDI8852 FAB FRAGMENT IN COMPLEX WITH H5 HA
3827, 5fylD, 0.5620, 3.27, 0.054, 242, 92, CRYSTAL STRUCTURE AT 3.7 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22
3828, 5eiiH, 0.5620, 3.34, 0.077, 225, 91, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
3829, 5ayuH, 0.5620, 3.11, 0.057, 113, 88, CRYSTAL STRUCTURE OF HYHEL-10 FV
3830, 5ae6A, 0.5620, 3.55, 0.042, 761, 95, THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A ( BXL1) IN COMPLEX WITH 4-THIOXYLOBIOSE
3831, 5adpH, 0.5620, 2.95, 0.070, 211, 86, CRYSTAL STRUCTURE OF THE A.17 ANTIBODY FAB FRAGMENT - LIGHT CHAIN S35R MUTANT
3832, 4zpvB, 0.5620, 3.15, 0.044, 212, 90, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 2)
3833, 4rrpH, 0.5620, 3.17, 0.067, 221, 90, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
3834, 4rrpG, 0.5620, 3.33, 0.088, 219, 91, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
3835, 4rauN, 0.5620, 3.31, 0.087, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3836, 4rauE, 0.5620, 3.32, 0.087, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3837, 4ps4H, 0.5620, 3.31, 0.044, 223, 91, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
3838, 4p9hH, 0.5620, 3.29, 0.065, 215, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2
3839, 4krpD, 0.5620, 3.27, 0.078, 213, 90, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
3840, 3tclH, 0.5620, 3.24, 0.089, 229, 90, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04
3841, 3qehE, 0.5620, 3.37, 0.087, 214, 92, CRYSTAL STRUCTURE OF HUMAN N12-I15 AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
3842, 3idyB, 0.5620, 3.43, 0.086, 229, 93, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
3843, 3c5zE, 0.5620, 2.82, 0.046, 201, 87, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3844, 2fjfD, 0.5620, 3.24, 0.044, 218, 91, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3845, 2coqA, 0.5620, 3.00, 0.079, 108, 89, STRUCTURE OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN FROM SHARKS
3846, 2b1hL, 0.5620, 3.08, 0.056, 215, 90, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
3847, 1x9qA, 0.5620, 3.18, 0.110, 231, 91, 4M5.3 ANTI-FLUORESCEIN SINGLE CHAIN ANTIBODY FRAGMENT (SCFV)
3848, 1jvkB, 0.5620, 2.91, 0.079, 214, 89, THREE-DIMENSIONAL STRUCTURE OF AN IMMUNOGLOBULIN LIGHT CHAIN DIMER ACTING AS A LETHAL AMYLOID PRECURSOR
3849, 6j5gL, 0.5619, 3.16, 0.033, 108, 90, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN 
3850, 6eh7B, 0.5619, 2.79, 0.058, 240, 86, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3851, 6e0pN, 0.5619, 3.26, 0.055, 229, 91, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
3852, 5wkoA, 0.5619, 3.25, 0.077, 225, 91, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3853, 5w2bH, 0.5619, 3.04, 0.090, 226, 89, CRYSTAL STRUCTURE OF C-TERMINAL DOMAIN OF EBOLA (RESTON) NUCLEOPROTEIN IN COMPLEX WITH FAB FRAGMENT 
3854, 5vgjL, 0.5619, 3.42, 0.043, 217, 92, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90 BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN
3855, 5vcnD, 0.5619, 3.36, 0.087, 213, 92, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
3856, 5ou7A, 0.5619, 2.25, 0.074, 173, 81, CRYSTAL STRUCTURE OF THE GLYCOPROTEIN VI LOOP TRUNCATION MUTANT PAVS- PAPYKN 
3857, 5nkwA, 0.5619, 3.09, 0.087, 234, 92, X-RAY CRYSTAL STRUCTURE OF AN AA9 LPMO
3858, 5menD, 0.5619, 2.75, 0.058, 200, 86, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
3859, 5kanH, 0.5619, 3.15, 0.111, 231, 90, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3860, 5h35I, 0.5619, 3.61, 0.064, 217, 94, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3861, 5en2A, 0.5619, 3.23, 0.099, 219, 91, MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES
3862, 5awnH, 0.5619, 3.17, 0.089, 219, 90, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB
3863, 4uaoC, 0.5619, 3.28, 0.098, 223, 92, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
3864, 4pp1D, 0.5619, 3.36, 0.087, 213, 92, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 5H8
3865, 4n9gH, 0.5619, 3.23, 0.110, 221, 91, CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9
3866, 4f57H, 0.5619, 3.30, 0.088, 225, 91, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L1 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
3867, 4dn4L, 0.5619, 3.37, 0.054, 213, 92, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A
3868, 3uyoD, 0.5619, 2.62, 0.106, 94, 85, CRYSTAL STRUCTURE OF MONOBODY SH13/ABL1 SH2 DOMAIN COMPLEX
3869, 3rugH, 0.5619, 2.90, 0.058, 236, 86, CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)
3870, 3npsB, 0.5619, 3.26, 0.088, 226, 91, CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3871, 3m2lE, 0.5619, 3.69, 0.052, 293, 97, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
3872, 3hr5J, 0.5619, 3.30, 0.099, 220, 91, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3873, 3c5zA, 0.5619, 2.82, 0.046, 202, 87, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
3874, 2uylA, 0.5619, 3.61, 0.064, 218, 94, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3875, 2ok0H, 0.5619, 3.14, 0.110, 216, 91, FAB ED10-DNA COMPLEX
3876, 2jixF, 0.5619, 3.36, 0.066, 216, 91, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3877, 2i60Q, 0.5619, 3.25, 0.022, 214, 91, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3878, 2bfvH, 0.5619, 3.23, 0.055, 119, 91, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
3879, 1q9wB, 0.5619, 3.23, 0.077, 226, 91, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
3880, 1nl0H, 0.5619, 3.25, 0.088, 216, 91, CRYSTAL STRUCTURE OF HUMAN FACTOR IX GLA DOMAIN IN COMPLEX OF AN INHIBITORY ANTIBODY 10C12
3881, 1kxqE, 0.5619, 2.94, 0.080, 120, 87, CAMELID VHH DOMAIN IN COMPLEX WITH PORCINE PANCREATIC ALPHA- AMYLASE
3882, 1kemH, 0.5619, 3.23, 0.077, 218, 91, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
3883, 1acyH, 0.5619, 3.28, 0.065, 221, 92, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
3884, 6cxeD, 0.5618, 3.06, 0.068, 239, 88, STRUCTURE OF ALPHA-GSA[26;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
3885, 6be2H, 0.5618, 3.14, 0.088, 217, 91, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598)
3886, 5viyJ, 0.5618, 3.27, 0.087, 223, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3887, 5viyH, 0.5618, 3.27, 0.087, 223, 92, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3888, 5tojF, 0.5618, 3.22, 0.066, 125, 91, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-4
3889, 5t5fH, 0.5618, 3.20, 0.077, 212, 91, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
3890, 5k9qS, 0.5618, 3.30, 0.110, 231, 91, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3891, 5k9qH, 0.5618, 3.29, 0.110, 228, 91, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3892, 5gzrM, 0.5618, 3.23, 0.121, 221, 91, ZIKA VIRUS E PROTEIN COMPLEXED WITH A NEUTRALIZING ANTIBODY Z23-FAB
3893, 5gzrH, 0.5618, 3.23, 0.121, 221, 91, ZIKA VIRUS E PROTEIN COMPLEXED WITH A NEUTRALIZING ANTIBODY Z23-FAB
3894, 5d7lG, 0.5618, 2.88, 0.046, 189, 87, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
3895, 5acjA, 0.5618, 3.06, 0.076, 234, 92, X-RAY STRUCTURE OF LPMO
3896, 4n0cG, 0.5618, 3.19, 0.066, 197, 91, 42F3 TCR PCPE3/H-2LD COMPLEX
3897, 3qhzI, 0.5618, 2.58, 0.048, 213, 83, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
3898, 3of6D, 0.5618, 2.95, 0.034, 100, 89, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3899, 3efdH, 0.5618, 3.40, 0.077, 215, 91, THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA
3900, 2znwA, 0.5618, 3.18, 0.057, 221, 88, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
3901, 2yk1H, 0.5618, 2.63, 0.155, 182, 84, STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
3902, 2r2eB, 0.5618, 3.26, 0.077, 221, 91, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3903, 2r1yB, 0.5618, 3.23, 0.077, 216, 91, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3904, 1yedB, 0.5618, 3.23, 0.099, 226, 91, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
3905, 1nqbA, 0.5618, 3.72, 0.074, 232, 95, TRIVALENT ANTIBODY FRAGMENT
3906, 1nd0C, 0.5618, 3.48, 0.043, 219, 92, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
3907, 1ktrL, 0.5618, 3.60, 0.064, 113, 94, CRYSTAL STRUCTURE OF THE ANTI-HIS TAG ANTIBODY 3D5 SINGLE- CHAIN FRAGMENT (SCFV) IN COMPLEX WITH A OLIGOHISTIDINE PEPTIDE
3908, 1iamA, 0.5618, 2.90, 0.023, 185, 88, STRUCTURE OF THE TWO AMINO-TERMINAL DOMAINS OF HUMAN INTERCELLULAR ADHESION MOLECULE-1 ICAM-1
3909, 1gc1H, 0.5618, 3.21, 0.098, 229, 92, HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
3910, 6mtmE, 0.5617, 3.04, 0.070, 237, 86, CRYSTAL STRUCTURE OF EM2 TCR IN COMPLEX WITH HLA-B*37:01-NP338 
3911, 6miyH, 0.5617, 3.05, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
3912, 6ey6M, 0.5617, 3.18, 0.099, 130, 91, C-TERMINAL PART (RESIDUES 315-516) OF PORM WITH THE LLAMA NANOBODY NB130
3913, 6ca7H, 0.5617, 3.27, 0.110, 232, 91, CRYSTAL STRUCTURE OF PCT64_13C; A STRAIN SPECIFIC ANTI-HIV ANTIBODY 
3914, 5wkoE, 0.5617, 3.22, 0.088, 225, 91, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
3915, 5uddK, 0.5617, 3.24, 0.055, 220, 91, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3916, 5ogiB, 0.5617, 3.42, 0.109, 233, 92, COMPLEX OF A BINDING PROTEIN AND HUMAN ADENOVIRUS C 5 HEXON
3917, 5oclF, 0.5617, 3.28, 0.088, 118, 91, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
3918, 5nmgE, 0.5617, 3.05, 0.057, 242, 88, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
3919, 5ig7A, 0.5617, 2.94, 0.101, 216, 89, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
3920, 5h35G, 0.5617, 3.61, 0.053, 217, 94, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3921, 5e2tH, 0.5617, 3.06, 0.057, 209, 87, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
3922, 5a7mA, 0.5617, 3.55, 0.042, 760, 95, THE STRUCTURE OF HYPOCREA JECORINA BETA-XYLOSIDASE XYL3A (BXL1)
3923, 4xc1H, 0.5617, 2.99, 0.078, 220, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE
3924, 4x6cE, 0.5617, 2.98, 0.057, 198, 88, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
3925, 4w2pD, 0.5617, 2.85, 0.071, 114, 85, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
3926, 4ut7L, 0.5617, 3.16, 0.055, 113, 91, CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3927, 4rauT, 0.5617, 3.33, 0.087, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3928, 4rauH, 0.5617, 3.33, 0.087, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
3929, 4p3dL, 0.5617, 3.63, 0.053, 218, 94, MT1-MMP:FAB COMPLEX (FORM II)
3930, 4aeiN, 0.5617, 3.61, 0.064, 217, 94, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3931, 3tt1H, 0.5617, 3.07, 0.100, 212, 90, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3932, 3quxD, 0.5617, 2.93, 0.046, 239, 87, STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3933, 3qdgD, 0.5617, 3.11, 0.090, 199, 89, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
3934, 3okdB, 0.5617, 3.23, 0.099, 218, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3935, 3lexB, 0.5617, 3.64, 0.043, 219, 94, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
3936, 3d3vD, 0.5617, 3.25, 0.089, 200, 90, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
3937, 3bgfC, 0.5617, 3.12, 0.034, 210, 89, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
3938, 2ncmA, 0.5617, 2.98, 0.057, 99, 87, NEURAL CELL ADHESION MOLECULE NMR 20 STRUCTURES
3939, 2b0sL, 0.5617, 3.14, 0.066, 215, 91, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
3940, 1yeeH, 0.5617, 3.20, 0.132, 222, 91, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.5)
3941, 1tzgI, 0.5617, 3.19, 0.077, 228, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
3942, 1hxmE, 0.5617, 3.39, 0.065, 206, 93, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
3943, 1ex0A, 0.5617, 3.27, 0.065, 705, 93, HUMAN FACTOR XIII MUTANT W279F ZYMOGEN
3944, 1clzL, 0.5617, 3.64, 0.074, 219, 94, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
3945, 6n8dD, 0.5616, 3.39, 0.109, 216, 92, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH NEUTRALIZING HUMAN ANTIBODY A1431 
3946, 6mnmA, 0.5616, 3.10, 0.034, 196, 89, 6256 TCR BOUND TO I-AB PADI4 
3947, 6medC, 0.5616, 3.01, 0.088, 226, 91, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3948, 6df1H, 0.5616, 3.31, 0.110, 220, 91, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
3949, 6db9H, 0.5616, 3.30, 0.099, 219, 91, STRUCTURAL BASIS FOR PROMISCUOUS BINDING AND ACTIVATION OF FLUOROGENIC DYES BY DIR2S RNA APTAMER 
3950, 6cw3C, 0.5616, 3.31, 0.065, 220, 92, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 2 
3951, 6c5jH, 0.5616, 3.07, 0.079, 218, 89, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 1) 
3952, 5xcsA, 0.5616, 3.20, 0.099, 168, 91, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
3953, 5wobM, 0.5616, 3.30, 0.067, 214, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
3954, 5vkjA, 0.5616, 2.59, 0.084, 312, 83, CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3
3955, 5tppH, 0.5616, 3.31, 0.110, 228, 91, CRYSTAL STRUCTURE OF DH270.5 (UNLIGANDED) FROM THE DH270 BROADLY NEUTRALIZING N332-GLYCAN DEPENDENT LINEAGE
3956, 5mhoB, 0.5616, 3.81, 0.059, 676, 101, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED2369
3957, 5k9qU, 0.5616, 3.20, 0.110, 231, 91, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3958, 5iwlA, 0.5616, 3.63, 0.053, 232, 94, CD47-DIABODY COMPLEX
3959, 5ifjA, 0.5616, 3.30, 0.054, 216, 92, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
3960, 5fojA, 0.5616, 3.21, 0.088, 130, 91, ELECTRON CRYO-MICROSCOPY OF GRAPEVINE FANLEAF VIRUS COMPLEX WITH NANOBODY
3961, 5cp7C, 0.5616, 3.66, 0.064, 218, 94, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3962, 5cp3H, 0.5616, 3.04, 0.057, 212, 87, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
3963, 4rgnH, 0.5616, 3.36, 0.099, 213, 91, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
3964, 4qrpK, 0.5616, 2.85, 0.080, 202, 87, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
3965, 4lriC, 0.5616, 3.08, 0.090, 223, 89, ANTI CMV FAB FRAGMENT
3966, 4k7pY, 0.5616, 3.27, 0.077, 219, 91, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3967, 4hxbL, 0.5616, 3.57, 0.064, 219, 94, CRYSTAL STRUCTURE OF 6B9 FAB
3968, 4g8gD, 0.5616, 3.08, 0.044, 204, 90, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
3969, 4g6kH, 0.5616, 3.37, 0.109, 220, 92, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
3970, 3tt1I, 0.5616, 3.07, 0.100, 212, 90, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3971, 3rjqB, 0.5616, 3.28, 0.054, 127, 92, CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12 IN COMPLEX WITH C186 GP120
3972, 3ri5J, 0.5616, 3.11, 0.100, 215, 90, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3973, 3ri5H, 0.5616, 3.11, 0.100, 221, 90, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
3974, 3ncyP, 0.5616, 3.36, 0.129, 219, 93, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
3975, 3eyoB, 0.5616, 3.39, 0.098, 212, 92, CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9
3976, 3bgfH, 0.5616, 3.26, 0.109, 216, 92, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
3977, 2zuqF, 0.5616, 3.31, 0.055, 214, 91, CRYSTAL STRUCTURE OF DSBB-FAB COMPLEX
3978, 2ltqF, 0.5616, 3.31, 0.055, 214, 91, HIGH RESOLUTION STRUCTURE OF DSBB C41S BY JOINT CALCULATION WITH SOLID-STATE NMR AND X-RAY DATA
3979, 1npuA, 0.5616, 3.04, 0.079, 116, 89, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE PD-1
3980, 1n6vA, 0.5616, 2.67, 0.057, 212, 88, AVERAGE STRUCTURE OF THE INTERFERON-BINDING ECTODOMAIN OF THE HUMAN TYPE I INTERFERON RECEPTOR
3981, 1n6uA, 0.5616, 2.83, 0.045, 212, 89, NMR STRUCTURE OF THE INTERFERON-BINDING ECTODOMAIN OF THE HUMAN INTERFERON RECEPTOR
3982, 1fn4D, 0.5616, 3.40, 0.077, 218, 91, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
3983, 6bfqC, 0.5615, 3.22, 0.090, 211, 89, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
3984, 5xhfD, 0.5615, 3.29, 0.110, 220, 91, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING P-AZIDO-L- PHENYLALANINE
3985, 5u3lB, 0.5615, 3.24, 0.033, 213, 91, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
3986, 5od0H, 0.5615, 3.18, 0.067, 215, 90, CRYSTAL STRUCTURE OF ACPA E4 
3987, 5hm1A, 0.5615, 2.98, 0.090, 119, 89, LLAMA VHH 2E7 IN COMPLEX WITH GP41
3988, 5h35B, 0.5615, 3.59, 0.053, 217, 94, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3989, 5gryA, 0.5615, 3.26, 0.055, 226, 91, CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY
3990, 5drwB, 0.5615, 3.85, 0.062, 218, 96, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL183
3991, 5cilH, 0.5615, 2.95, 0.079, 220, 89, CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (WDWD) WITH EPITOPE BOUND
3992, 5c14B, 0.5615, 3.23, 0.088, 201, 91, CRYSTAL STRUCTURE OF PECAM-1 D1D2 DOMAIN
3993, 4xcnJ, 0.5615, 3.00, 0.078, 219, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
3994, 4utbH, 0.5615, 3.17, 0.122, 225, 90, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3995, 4s10A, 0.5615, 3.18, 0.088, 127, 91, GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS
3996, 4qhkK, 0.5615, 3.38, 0.089, 218, 90, UCA (UNBOUND) FROM CH103 LINEAGE
3997, 4q5zO, 0.5615, 3.35, 0.077, 209, 91, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
3998, 4ms8C, 0.5615, 3.18, 0.045, 196, 89, 42F3 TCR PCPB9/H-2LD COMPLEX
3999, 4kxzQ, 0.5615, 3.25, 0.067, 217, 90, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4000, 4iofC, 0.5615, 3.42, 0.065, 216, 92, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
4001, 4dvrH, 0.5615, 3.01, 0.111, 219, 90, CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD- 557
4002, 3uc0I, 0.5615, 3.20, 0.087, 217, 92, CRYSTAL STRUCTURE OF DOMAIN I OF THE ENVELOPE GLYCOPROTEIN ECTODOMAIN FROM DENGUE VIRUS SEROTYPE 4 IN COMPLEX WITH THE FAB FRAGMENT OF THE CHIMPANZEE MONOCLONAL ANTIBODY 5H2
4003, 3sy0B, 0.5615, 3.24, 0.077, 222, 91, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
4004, 3rifH, 0.5615, 3.11, 0.100, 221, 90, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
4005, 3q6fD, 0.5615, 3.41, 0.087, 226, 92, CRYSTAL STRUCTURE OF FAB OF HUMAN MAB 2909 SPECIFIC FOR QUATERNARY NEUTRALIZING EPITOPE OF HIV-1 GP120
4006, 3mlxI, 0.5615, 3.26, 0.101, 228, 89, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE
4007, 2uudJ, 0.5615, 3.25, 0.077, 121, 91, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
4008, 2r1xB, 0.5615, 3.24, 0.077, 215, 91, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4009, 2r1wB, 0.5615, 3.23, 0.077, 219, 91, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4010, 2atpA, 0.5615, 2.87, 0.091, 118, 88, CRYSTAL STRUCTURE OF A CD8AB HETERODIMER
4011, 1jglL, 0.5615, 3.24, 0.033, 213, 90, CRYSTAL STRUCTURE OF IMMUNOGLOBULIN FAB FRAGMENT COMPLEXED WITH 17-BETA-ESTRADIOL
4012, 1i3vA, 0.5615, 3.26, 0.122, 129, 90, THREE-DIMENSIONAL STRUCTURE OF A LAMA VHH DOMAIN UNLIGANDED
4013, 6mivD, 0.5614, 3.05, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXQ (JJ300)/INKTCR TERNARY COMPLEX 
4014, 6mhrD, 0.5614, 3.33, 0.077, 217, 91, STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX 
4015, 6e0cM, 0.5614, 3.28, 0.055, 229, 91, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4016, 6ca9D, 0.5614, 3.09, 0.122, 229, 90, CRYSTAL STRUCTURE OF FAB PCT64_LMCA (SAR); THE LEAST MUTATED COMMON ANCESTOR OF THE HIV-1 BROADLY NEUTRALIZING ANTIBODY LINEAGE PCT64 
4017, 5yaxB, 0.5614, 3.35, 0.077, 230, 91, CRYSTAL STRUCTURE OF A HUMAN NEUTRALIZING ANTIBODY BOUND TO A HBV PRES1 PEPTIDE
4018, 5xmhD, 0.5614, 3.20, 0.077, 123, 91, CRYSTAL STRUCTURE OF AN IGM RHEUMATOID FACTOR YES8C IN COMPLEX WITH IGG1 FC
4019, 5tdpD, 0.5614, 3.26, 0.121, 214, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4020, 5ou8A, 0.5614, 2.08, 0.087, 174, 80, CRYSTAL STRUCTURE OF GLYCOPROTEIN VI IN COMPLEX WITH COLLAGEN-PEPTIDE (GPO)5 
4021, 5nmgI, 0.5614, 3.17, 0.089, 200, 90, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYFNTIAVL
4022, 5mhmB, 0.5614, 3.81, 0.059, 683, 101, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED1630
4023, 5iwlB, 0.5614, 3.62, 0.053, 232, 94, CD47-DIABODY COMPLEX
4024, 5fo9D, 0.5614, 3.56, 0.086, 642, 93, CRYSTAL STRUCTURE OF HUMAN COMPLEMENT C3B IN COMPLEX WITH CR1 (CCP15-17)
4025, 4y4fH, 0.5614, 3.05, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
4026, 4xbgE, 0.5614, 3.19, 0.077, 218, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4027, 4x29A, 0.5614, 3.16, 0.089, 306, 90, STRUCTURAL BASIS FOR THE ENHANCEMENT OF VIRULENCE BY ENTOMOPOXVIRUS FUSOLIN AND ITS IN VIVO CRYSTALLIZATION INTO VIRAL SPINDLES (COMPLEX WITH ZINC)
4028, 4whtH, 0.5614, 3.60, 0.043, 216, 94, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4029, 4rgnB, 0.5614, 3.36, 0.099, 213, 91, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4030, 4rauW, 0.5614, 3.32, 0.098, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4031, 4lptA, 0.5614, 2.67, 0.070, 93, 86, CRYSTAL STRUCTURE OF MONOMERIC TENCON VARIANT P54CR4-31
4032, 4glrJ, 0.5614, 3.31, 0.110, 228, 91, STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235
4033, 3w5nA, 0.5614, 3.17, 0.088, 1029, 91, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS ALPHA-L-RHAMNOSIDASE COMPLEXED WITH L-RHAMNOSE
4034, 3rifG, 0.5614, 3.11, 0.100, 214, 90, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
4035, 3pp4H, 0.5614, 3.19, 0.088, 220, 91, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
4036, 3o6kL, 0.5614, 3.65, 0.043, 217, 94, CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB 11H6H1
4037, 3kj4H, 0.5614, 3.20, 0.100, 219, 90, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
4038, 3i02B, 0.5614, 3.25, 0.099, 220, 91, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4039, 2x7lL, 0.5614, 3.27, 0.044, 217, 90, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4040, 2uudK, 0.5614, 3.60, 0.064, 113, 94, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN
4041, 2r2hB, 0.5614, 3.24, 0.077, 215, 91, STRUCTURE OF S25-2 IN COMPLEX WITH KO
4042, 2gk0A, 0.5614, 3.55, 0.065, 217, 93, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
4043, 2g2rA, 0.5614, 3.61, 0.043, 219, 94, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
4044, 2cjuL, 0.5614, 3.60, 0.064, 113, 94, CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ16-113.8 SCFV IN COMPLEX WITH PHOXGABA
4045, 1p4iH, 0.5614, 3.15, 0.080, 112, 88, CRYSTAL STRUCTURE OF SCFV AGAINST PEPTIDE GCN4
4046, 1hezB, 0.5614, 3.26, 0.088, 207, 91, ANTIBODY-ANTIGEN COMPLEX
4047, 6mu6H, 0.5613, 3.37, 0.055, 226, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-814508 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.2 ANGSTROM 
4048, 6mngA, 0.5613, 2.87, 0.011, 199, 87, 4738 TCR BOUND TO IAB PADI4 
4049, 6idgH, 0.5613, 3.21, 0.088, 221, 91, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
4050, 6eleH, 0.5613, 3.27, 0.088, 218, 91, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4051, 6banE, 0.5613, 3.33, 0.043, 111, 92, POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE OF ROR1 
4052, 5t3zD, 0.5613, 3.10, 0.100, 229, 90, 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074
4053, 5f9wB, 0.5613, 3.29, 0.099, 220, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4054, 4xwoE, 0.5613, 3.42, 0.076, 222, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4055, 4rzcE, 0.5613, 3.23, 0.133, 117, 90, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
4056, 4qgyA, 0.5613, 3.21, 0.111, 135, 90, CAMELID (LLAMA) NANOBODY N25 (VHH) AGAINST TYPE 6 SECRETION SYSTEM TSSM PROTEIN
4057, 4p23A, 0.5613, 3.13, 0.034, 199, 89, J809.B5 TCR BOUND TO IAB/3K
4058, 4okvB, 0.5613, 3.62, 0.053, 218, 94, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4059, 4nkdE, 0.5613, 3.33, 0.109, 121, 92, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4060, 4mnqD, 0.5613, 2.90, 0.080, 200, 87, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
4061, 4l8sA, 0.5613, 2.84, 0.034, 198, 87, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
4062, 4hf5H, 0.5613, 3.48, 0.098, 153, 92, CRYSTAL STRUCTURE OF FAB 8F8 IN COMPLEX A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4063, 3okkB, 0.5613, 3.22, 0.099, 217, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
4064, 3idxH, 0.5613, 3.26, 0.088, 229, 91, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
4065, 3gbnH, 0.5613, 3.46, 0.076, 160, 92, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ
4066, 2vq1A, 0.5613, 3.68, 0.074, 216, 94, ANTI TRIMERIC LEWIS X FAB54-5C10-A
4067, 2qqlH, 0.5613, 3.31, 0.088, 222, 91, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
4068, 2ny4C, 0.5613, 3.21, 0.022, 214, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E268C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
4069, 1zlvH, 0.5613, 3.29, 0.077, 213, 91, FAB 2G12 + MAN7
4070, 1edyA, 0.5613, 3.53, 0.085, 134, 94, CRYSTAL STRUCTURE OF RAT ALPHA 1-MACROGLOBULIN RECEPTOR BINDING DOMAIN
4071, 6oijH, 0.5612, 3.40, 0.033, 236, 92, MUSCARINIC ACETYLCHOLINE RECEPTOR 1-G11 PROTEIN COMPLEX 
4072, 6n51D, 0.5612, 3.17, 0.100, 123, 90, METABOTROPIC GLUTAMATE RECEPTOR 5 BOUND TO L-QUISQUALATE AND NB43 
4073, 6cw2A, 0.5612, 3.33, 0.088, 217, 91, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 1 
4074, 6azzF, 0.5612, 3.26, 0.099, 220, 91, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
4075, 5xhgB, 0.5612, 3.29, 0.110, 214, 91, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
4076, 5utyD, 0.5612, 3.08, 0.077, 242, 91, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M N300M N302M T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM
4077, 5m2mE, 0.5612, 3.23, 0.067, 127, 90, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
4078, 5kw9H, 0.5612, 3.11, 0.101, 215, 89, STRUCTURAL BASIS FOR NOROVIRUS NEUTRALIZATION BY A HBGA BLOCKING HUMAN IGA ANTIBODY
4079, 5ig7J, 0.5612, 3.01, 0.111, 219, 90, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
4080, 5bk5E, 0.5612, 3.41, 0.033, 217, 92, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
4081, 4xcyC, 0.5612, 3.07, 0.056, 221, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4082, 4tuoB, 0.5612, 3.75, 0.063, 219, 95, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4083, 4qhmA, 0.5612, 3.22, 0.122, 217, 90, I3.1 (UNBOUND) FROM CH103 LINEAGE
4084, 4ocxL, 0.5612, 3.57, 0.085, 214, 94, FAB COMPLEX WITH METHOTREXATE
4085, 4jryD, 0.5612, 2.97, 0.068, 201, 88, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
4086, 3zhkB, 0.5612, 3.25, 0.099, 119, 91, THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD
4087, 3thmH, 0.5612, 3.39, 0.109, 228, 92, CRYSTAL STRUCTURE OF FAS RECEPTOR EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB EP6B_B01
4088, 3qjfB, 0.5612, 2.87, 0.046, 240, 87, CRYSTAL STRUCTURE OF THE 2B4 TCR
4089, 3ngbH, 0.5612, 3.25, 0.088, 224, 91, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
4090, 3fo1L, 0.5612, 3.66, 0.053, 216, 94, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
4091, 3effC, 0.5612, 3.26, 0.022, 215, 91, THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION
4092, 3dv6B, 0.5612, 3.25, 0.088, 121, 91, CRYSTAL STRUCTURE OF SAG506-01 TETRAGONAL CRYSTAL 2
4093, 2uvfA, 0.5612, 2.79, 0.114, 571, 88, STRUCTURE OF YERSINIA ENTEROCOLITICA FAMILY 28 EXOPOLYGALACTURONASE IN COMPLEX WITH DIGALATURONIC ACID
4094, 2hrpN, 0.5612, 3.24, 0.099, 224, 91, ANTIGEN-ANTIBODY COMPLEX
4095, 2hffH, 0.5612, 3.28, 0.067, 212, 90, CRYSTAL STRUCTURE OF CB2 FAB
4096, 2fx7H, 0.5612, 3.00, 0.078, 228, 90, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 16-RESIDUE PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4097, 2fnbA, 0.5612, 2.83, 0.114, 95, 88, NMR STRUCTURE OF THE FIBRONECTIN ED-B DOMAIN NMR 20 STRUCTURES
4098, 2fd6H, 0.5612, 3.28, 0.132, 212, 91, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
4099, 2atpC, 0.5612, 2.98, 0.090, 119, 89, CRYSTAL STRUCTURE OF A CD8AB HETERODIMER
4100, 1svzA, 0.5612, 3.65, 0.064, 232, 94, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE
4101, 6r2sB, 0.5611, 3.31, 0.111, 218, 90, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
4102, 6mjjD, 0.5611, 3.05, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE MCD1D/XXM (JJ290) /INKTCR TERNARY COMPLEX 
4103, 6mj4D, 0.5611, 3.04, 0.068, 239, 88, CRYSTAL STRUCTURE OF MCD1D/INKTCR TERNARY COMPLEX BOUND TO GLYCOLIPID (XXW) 
4104, 5x2nH, 0.5611, 3.16, 0.100, 223, 90, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
4105, 5wduC, 0.5611, 3.30, 0.089, 228, 90, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
4106, 5vm6A, 0.5611, 3.21, 0.078, 129, 90, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T10 
4107, 5vjqE, 0.5611, 3.01, 0.057, 207, 88, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4108, 5vf2A, 0.5611, 3.70, 0.063, 237, 95, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE RE-REFINEMENT
4109, 5u3kL, 0.5611, 3.27, 0.044, 214, 91, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 662- 683 PEPTIDE
4110, 5tjeG, 0.5611, 2.83, 0.034, 112, 87, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
4111, 5oclH, 0.5611, 2.92, 0.091, 115, 88, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
4112, 5nblF, 0.5611, 3.28, 0.066, 124, 91, CRYSTAL STRUCTURE OF THE ARP4-N-ACTIN(APO-STATE) HETERODIMER BOUND BY A NANOBODY 
4113, 5lcvH, 0.5611, 3.32, 0.098, 226, 92, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
4114, 5kanG, 0.5611, 3.32, 0.110, 231, 91, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4115, 5jq6H, 0.5611, 3.31, 0.088, 204, 91, CRYSTAL STRUCTURE OF CLFA IN COMPLEX WITH THE FAB FRAGMENT OF TEFIBAZUMAB
4116, 5ir1B, 0.5611, 3.28, 0.078, 220, 90, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4117, 5i4fA, 0.5611, 3.70, 0.063, 237, 95, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE
4118, 5grzA, 0.5611, 3.22, 0.100, 225, 90, CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY
4119, 5ewiL, 0.5611, 3.47, 0.032, 217, 93, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
4120, 5bk5A, 0.5611, 3.44, 0.043, 219, 92, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
4121, 4zezI, 0.5611, 3.44, 0.065, 207, 92, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
4122, 4xwoR, 0.5611, 3.27, 0.033, 216, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4123, 4xwoD, 0.5611, 3.23, 0.033, 216, 91, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4124, 4wnqC, 0.5611, 3.16, 0.033, 200, 90, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4125, 4r7nO, 0.5611, 3.44, 0.076, 218, 92, FAB C2E3
4126, 4ocyL, 0.5611, 3.58, 0.085, 216, 94, FAB FOR METHOTREXATE (UNBOUND APO)
4127, 4ocsH, 0.5611, 3.26, 0.077, 230, 91, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
4128, 4m7jL, 0.5611, 3.62, 0.064, 219, 94, CRYSTAL STRUCTURE OF S25-26 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO TRISACCHARIDE
4129, 4aeiM, 0.5611, 3.60, 0.064, 217, 94, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4130, 3vw3H, 0.5611, 3.20, 0.099, 216, 91, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
4131, 3qctL, 0.5611, 3.66, 0.053, 218, 94, CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
4132, 3pp3I, 0.5611, 3.14, 0.110, 219, 91, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
4133, 3nn8B, 0.5611, 3.60, 0.064, 115, 94, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4134, 3hr5I, 0.5611, 3.30, 0.099, 220, 91, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4135, 3gbmH, 0.5611, 3.45, 0.076, 214, 92, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
4136, 2x7lB, 0.5611, 3.27, 0.044, 217, 90, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4137, 2j5lC, 0.5611, 3.41, 0.076, 225, 92, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
4138, 2iamD, 0.5611, 3.11, 0.080, 239, 87, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4139, 6oikH, 0.5610, 3.43, 0.033, 236, 92, MUSCARINIC ACETYLCHOLINE RECEPTOR 2-GO COMPLEX 
4140, 6novA, 0.5610, 3.33, 0.088, 212, 91, A FAB DERIVED FROM IXEKIZUMAB 
4141, 6eerD, 0.5610, 3.92, 0.067, 783, 104, STRUCTURE OF GLYCINE-BOUND GOXA FROM PSEUDOALTEROMONAS LUTEOVIOLACEA 
4142, 5vjoA, 0.5610, 3.04, 0.057, 206, 88, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4143, 5tztL, 0.5610, 3.62, 0.053, 219, 94, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4144, 5ijvD, 0.5610, 3.32, 0.067, 247, 90, CRYSTAL STRUCTURE OF BOVINE FAB E03
4145, 4y7mA, 0.5610, 3.22, 0.111, 129, 90, T6SS PROTEIN TSSM C-TERMINAL DOMAIN (835-1129) FROM EAEC
4146, 4s11A, 0.5610, 3.19, 0.100, 129, 90, GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS
4147, 4qxuL, 0.5610, 3.60, 0.064, 219, 94, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
4148, 4hkbG, 0.5610, 3.24, 0.110, 218, 91, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4149, 3x3gH, 0.5610, 3.36, 0.098, 224, 92, FAB FRAGMENT FROM ANTI TRAIL-R2 HUMAN AGONIST ANTIBODY KMTR2
4150, 3umtA, 0.5610, 3.21, 0.110, 227, 91, SCFV12 ANTI-BCLA ANTIBODY SINGLE CHAIN VARIABLE FRAGMENT
4151, 3l7fH, 0.5610, 3.09, 0.067, 221, 89, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4152, 3ifoB, 0.5610, 3.64, 0.053, 218, 94, X-RAY STRUCTURE OF AMYLOID BETA PEPTIDE:ANTIBODY (ABETA1-7:10D5) COMPLEX
4153, 3i75B, 0.5610, 3.23, 0.110, 223, 91, ANTIBODY STRUCTURE
4154, 3effB, 0.5610, 3.24, 0.066, 219, 91, THE CRYSTAL STRUCTURE OF FULL-LENGTH KCSA IN ITS CLOSED CONFORMATION
4155, 3bpcB, 0.5610, 3.24, 0.077, 214, 91, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
4156, 3bgfB, 0.5610, 3.27, 0.109, 216, 92, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4157, 2ygvC, 0.5610, 3.53, 0.052, 155, 97, CONSERVED N-TERMINAL DOMAIN OF THE YEAST HISTONE CHAPERONE ASF1 IN COMPLEX WITH THE C-TERMINAL FRAGMENT OF RAD53
4158, 2or9I, 0.5610, 3.38, 0.065, 228, 92, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
4159, 2ivfC, 0.5610, 3.35, 0.021, 214, 97, ETHYLBENZENE DEHYDROGENASE FROM AROMATOLEUM AROMATICUM
4160, 2gkiB, 0.5610, 3.30, 0.087, 238, 92, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
4161, 2g2rL, 0.5610, 3.62, 0.043, 219, 94, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
4162, 1s3kL, 0.5610, 3.62, 0.043, 216, 94, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
4163, 1rzgA, 0.5610, 3.20, 0.066, 223, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
4164, 1r24D, 0.5610, 3.32, 0.088, 217, 91, FAB FROM MURINE IGG3 KAPPA
4165, 1j05H, 0.5610, 3.20, 0.143, 121, 91, THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
4166, 1dqqB, 0.5610, 3.04, 0.069, 210, 87, CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63
4167, 1cfvH, 0.5610, 3.29, 0.077, 119, 91, MONOCLONAL ANTIBODY FRAGMENT FV4155 FROM E. COLI
4168, 6o3cB, 0.5609, 3.10, 0.099, 122, 91, CRYSTAL STRUCTURE OF ACTIVE SMOOTHENED BOUND TO SAG21K; CHOLESTEROL; AND NBSMO8 
4169, 6n4qL, 0.5609, 3.29, 0.078, 228, 90, CRYOEM STRUCTURE OF NAV1.7 VSD2 (ACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
4170, 6n4qJ, 0.5609, 3.29, 0.078, 228, 90, CRYOEM STRUCTURE OF NAV1.7 VSD2 (ACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
4171, 6dc7L, 0.5609, 3.61, 0.064, 218, 94, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4172, 6cqrJ, 0.5609, 3.35, 0.067, 245, 90, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4173, 5wobO, 0.5609, 3.34, 0.099, 209, 91, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
4174, 5w3oD, 0.5609, 3.24, 0.088, 116, 91, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:3 EMPTY PARTICLE)
4175, 5vsiL, 0.5609, 3.14, 0.045, 212, 89, CH1/CKAPPA FAB MUTANT 15.1
4176, 5n0aI, 0.5609, 3.18, 0.122, 131, 90, CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4177, 5m2mN, 0.5609, 3.23, 0.067, 127, 90, COMPLEX BETWEEN HUMAN TNF ALPHA AND LLAMA VHH3
4178, 5ljyH, 0.5609, 3.05, 0.115, 113, 87, STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN COMPLEX WITH SCFV A5
4179, 5lhnB, 0.5609, 3.42, 0.066, 135, 91, THE CATALYTIC DOMAIN OF MURINE UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN COMPLEX WITH THE ALLOSTERIC INHIBITORY NANOBODY NB7
4180, 5jxeG, 0.5609, 3.30, 0.120, 218, 92, HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB
4181, 5i1cH, 0.5609, 3.26, 0.088, 215, 91, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-20
4182, 5acgA, 0.5609, 3.06, 0.076, 234, 92, X-RAY STRUCTURE OF LPMO
4183, 4xcnE, 0.5609, 3.08, 0.078, 218, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4184, 4x6dG, 0.5609, 2.92, 0.080, 200, 87, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
4185, 4rzcC, 0.5609, 3.23, 0.133, 117, 90, FV M6P-1 IN COMPLEX WITH MANNOSE-6-PHOSPHATE
4186, 4rauQ, 0.5609, 3.31, 0.109, 219, 92, CRYSTAL STRUCTURE OF RTOFAB IN COMPLEX WITH HUMAN PF4
4187, 4ofyF, 0.5609, 2.94, 0.080, 407, 88, CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4
4188, 4n1hB, 0.5609, 3.26, 0.099, 126, 91, STRUCTURE OF A SINGLE-DOMAIN CAMELID ANTIBODY FRAGMENT CAB-F11N IN COMPLEX WITH THE BLAP BETA-LACTAMASE FROM BACILLUS LICHENIFORMIS
4189, 4k23L, 0.5609, 3.71, 0.043, 218, 94, STRUCTURE OF ANTI-UPAR FAB ATN-658
4190, 4hfwB, 0.5609, 3.24, 0.110, 221, 91, ANTI ROTAVIRUS ANTIBODY
4191, 4cadH, 0.5609, 3.23, 0.099, 221, 91, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4192, 3tpuM, 0.5609, 2.74, 0.057, 204, 87, 42F3 P5E8/H2-LD COMPLEX
4193, 3sycA, 0.5609, 3.46, 0.050, 310, 100, CRYSTAL STRUCTURE OF THE G PROTEIN-GATED INWARD RECTIFIER K+ CHANNEL GIRK2 (KIR3.2) D228N MUTANT
4194, 3quyD, 0.5609, 3.05, 0.068, 239, 88, STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1 -INKT TCR COMPLEX
4195, 3qctH, 0.5609, 3.23, 0.077, 219, 91, CRYSTAL STRUCTURE OF THE HUMANIZED APO LT3015 ANTI-LYSOPHOSPHATIDIC ACID ANTIBODY FAB FRAGMENT
4196, 3piqH, 0.5609, 3.43, 0.087, 224, 92, CRYSTAL STRUCTURE OF HUMAN 2909 FAB A QUATERNARY STRUCTURE-SPECIFIC ANTIBODY AGAINST HIV-1
4197, 3oknB, 0.5609, 3.23, 0.099, 216, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
4198, 3m4dE, 0.5609, 3.70, 0.052, 293, 97, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
4199, 3l1oH, 0.5609, 3.28, 0.066, 224, 91, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
4200, 3c09B, 0.5609, 3.20, 0.045, 175, 89, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
4201, 3anzF, 0.5609, 3.71, 0.052, 294, 97, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4202, 2axjB, 0.5609, 3.38, 0.067, 242, 90, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
4203, 1lo3Y, 0.5609, 3.32, 0.077, 220, 91, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
4204, 6bf7C, 0.5608, 3.29, 0.077, 217, 91, CRYO-EM STRUCTURE OF HUMAN INSULIN DEGRADING ENZYME IN COMPLEX WITH FAB H11-E HEAVY CHAIN FAB H11-E LIGHT CHAIN
4205, 6banG, 0.5608, 3.35, 0.033, 111, 92, POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE OF ROR1 
4206, 5odbA, 0.5608, 3.33, 0.087, 217, 92, CRYSTAL STRUCTURE OF THE RA-ASSOCIATED MAB D10 (CHIMERIC FAB FRAGMENT) 
4207, 5nlqA, 0.5608, 3.06, 0.076, 234, 92, AUXILIARY ACTIVITY 9
4208, 5mtnB, 0.5608, 2.70, 0.126, 94, 87, MONOBODY MB(LCK_1) BOUND TO LCK-SH2
4209, 5mhnB, 0.5608, 3.81, 0.059, 685, 101, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED2360
4210, 5hdoD, 0.5608, 3.17, 0.056, 124, 90, CRYSTAL STRUCTURE OF A NANOBODY RAISED AGAINST UROKINASE-TYPE PLASMINOGEN ACTIVATOR
4211, 4ztpL, 0.5608, 3.24, 0.077, 216, 91, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
4212, 4r8wH, 0.5608, 3.25, 0.120, 127, 92, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A NEUTRALIZING ANTIBODY CT149
4213, 4p99B, 0.5608, 3.53, 0.052, 415, 96, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
4214, 4lgsB, 0.5608, 3.15, 0.078, 129, 90, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH4)
4215, 4f37K, 0.5608, 3.67, 0.064, 218, 94, STRUCTURE OF THE TETHERED N-TERMINUS OF ALZHEIMER S DISEASE A PEPTIDE
4216, 4bglA, 0.5608, 3.23, 0.067, 124, 90, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM ARCHAEOGLOBUS FULGIDUS
4217, 3utpD, 0.5608, 2.96, 0.080, 199, 88, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
4218, 3u79G, 0.5608, 3.20, 0.033, 110, 91, AL-103 Y32F Y96F
4219, 3k3qA, 0.5608, 3.33, 0.088, 137, 91, CRYSTAL STRUCTURE OF A LLAMA ANTIBODY COMPLEXED WITH THE C. BOTULINUM NEUROTOXIN SEROTYPE A CATALYTIC DOMAIN
4220, 3idyH, 0.5608, 3.32, 0.076, 229, 92, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
4221, 3dviA, 0.5608, 3.25, 0.033, 109, 91, CRYSTAL STRUCTURE OF KAPPA 1 AMYLOIDOGENIC LIGHT CHAIN VARIABLE DOMAIN
4222, 3a0oA, 0.5608, 3.22, 0.057, 764, 88, CRYSTAL STRUCTURE OF ALGINATE LYASE FROM AGROBACTERIUM TUMEFACIENS C58
4223, 2x7lF, 0.5608, 3.28, 0.044, 217, 90, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4224, 2ny3C, 0.5608, 3.21, 0.022, 214, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E267C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
4225, 2nxzC, 0.5608, 3.21, 0.022, 214, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
4226, 2bveA, 0.5608, 3.26, 0.054, 119, 92, STRUCTURE OF THE N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH 2-PHENYL-PROP5AC
4227, 1n0xK, 0.5608, 3.39, 0.130, 224, 92, CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE
4228, 1m7iA, 0.5608, 3.54, 0.065, 215, 93, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE
4229, 1lo0Y, 0.5608, 3.31, 0.077, 220, 91, CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
4230, 1i3vB, 0.5608, 3.27, 0.122, 129, 90, THREE-DIMENSIONAL STRUCTURE OF A LAMA VHH DOMAIN UNLIGANDED
4231, 1ggbH, 0.5608, 3.27, 0.080, 215, 88, MAJOR ANTIGEN-INDUCED DOMAIN REARRANGEMENTS IN AN ANTIBODY
4232, 1fvcD, 0.5608, 3.30, 0.121, 120, 91, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4233, 6rcsA, 0.5607, 3.36, 0.121, 226, 91, PFRH5-BINDING MONOCLONAL ANTIBODY R5.016 
4234, 6mu7H, 0.5607, 3.39, 0.055, 226, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-818251 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.1 ANGSTROM 
4235, 6gs7H, 0.5607, 3.19, 0.100, 125, 90, CRYSTAL STRUCTURE OF PEPTIDE TRANSPORTER DTPA-NANOBODY IN GLYCINE BUFFER 
4236, 6cweD, 0.5607, 3.05, 0.068, 239, 88, STRUCTURE OF ALPHA-GSA[8;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4237, 6cueH, 0.5607, 3.35, 0.120, 117, 92, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4238, 6bf4L, 0.5607, 3.33, 0.044, 218, 91, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
4239, 6ba5G, 0.5607, 3.25, 0.044, 111, 91, POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE OF ROR1 
4240, 6a96O, 0.5607, 3.12, 0.110, 125, 91, CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25 
4241, 5wobW, 0.5607, 3.23, 0.078, 204, 90, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
4242, 5uk4m, 0.5607, 3.29, 0.088, 125, 91, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4243, 5nkqH, 0.5607, 2.34, 0.111, 87, 81, CRYSTAL STRUCTURE OF A DUAL TOPOLOGY FLUORIDE ION CHANNEL.
4244, 5ig7G, 0.5607, 3.03, 0.111, 216, 90, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
4245, 5eszH, 0.5607, 3.33, 0.076, 229, 92, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
4246, 5cjxA, 0.5607, 3.34, 0.065, 224, 92, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
4247, 4z7vH, 0.5607, 2.92, 0.057, 242, 87, L3-12 COMPLEX
4248, 4y4fD, 0.5607, 2.78, 0.047, 239, 86, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
4249, 4x0kA, 0.5607, 3.38, 0.109, 235, 92, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
4250, 4wy7H, 0.5607, 3.12, 0.078, 220, 90, CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI WITH EPITOPE BOUND
4251, 4udfZG, 0.5607, 3.13, 0.055, 122, 91, 
4252, 4udfZE, 0.5607, 3.13, 0.055, 122, 91, 
4253, 4udfZC, 0.5607, 3.13, 0.055, 122, 91, 
4254, 4udfZA, 0.5607, 3.13, 0.055, 122, 91, 
4255, 4udfXH, 0.5607, 3.13, 0.055, 122, 91, 
4256, 4udfXF, 0.5607, 3.13, 0.055, 122, 91, 
4257, 4udfXD, 0.5607, 3.13, 0.055, 122, 91, 
4258, 4udfXB, 0.5607, 3.13, 0.055, 122, 91, 
4259, 4udfX, 0.5607, 3.13, 0.055, 122, 91, 
4260, 4udfVG, 0.5607, 3.13, 0.055, 122, 91, 
4261, 4udfVE, 0.5607, 3.13, 0.055, 122, 91, 
4262, 4udfVC, 0.5607, 3.13, 0.055, 122, 91, 
4263, 4udfVA, 0.5607, 3.13, 0.055, 122, 91, 
4264, 4udfTH, 0.5607, 3.13, 0.055, 122, 91, 
4265, 4udfTF, 0.5607, 3.13, 0.055, 122, 91, 
4266, 4udfTD, 0.5607, 3.13, 0.055, 122, 91, 
4267, 4udfTB, 0.5607, 3.13, 0.055, 122, 91, 
4268, 4udfT, 0.5607, 3.13, 0.055, 122, 91, 
4269, 4udfRG, 0.5607, 3.13, 0.055, 122, 91, 
4270, 4udfRE, 0.5607, 3.13, 0.055, 122, 91, 
4271, 4udfRC, 0.5607, 3.13, 0.055, 122, 91, 
4272, 4udfRA, 0.5607, 3.13, 0.055, 122, 91, 
4273, 4udfPH, 0.5607, 3.13, 0.055, 122, 91, 
4274, 4udfPF, 0.5607, 3.13, 0.055, 122, 91, 
4275, 4udfPD, 0.5607, 3.13, 0.055, 122, 91, 
4276, 4udfPB, 0.5607, 3.13, 0.055, 122, 91, 
4277, 4udfP, 0.5607, 3.13, 0.055, 122, 91, 
4278, 4udfNG, 0.5607, 3.13, 0.055, 122, 91, 
4279, 4udfNE, 0.5607, 3.13, 0.055, 122, 91, 
4280, 4udfNC, 0.5607, 3.13, 0.055, 122, 91, 
4281, 4udfNA, 0.5607, 3.13, 0.055, 122, 91, 
4282, 4udfLH, 0.5607, 3.13, 0.055, 122, 91, 
4283, 4udfLF, 0.5607, 3.13, 0.055, 122, 91, 
4284, 4udfLD, 0.5607, 3.13, 0.055, 122, 91, 
4285, 4udfLB, 0.5607, 3.13, 0.055, 122, 91, 
4286, 4udfL, 0.5607, 3.13, 0.055, 122, 91, 
4287, 4udfJG, 0.5607, 3.13, 0.055, 122, 91, 
4288, 4udfJE, 0.5607, 3.13, 0.055, 122, 91, 
4289, 4udfJC, 0.5607, 3.13, 0.055, 122, 91, 
4290, 4udfJA, 0.5607, 3.13, 0.055, 122, 91, 
4291, 4udfHH, 0.5607, 3.13, 0.055, 122, 91, 
4292, 4udfHF, 0.5607, 3.13, 0.055, 122, 91, 
4293, 4udfHD, 0.5607, 3.13, 0.055, 122, 91, 
4294, 4udfHB, 0.5607, 3.13, 0.055, 122, 91, 
4295, 4udfH, 0.5607, 3.13, 0.055, 122, 91, 
4296, 4udfFI, 0.5607, 3.13, 0.055, 122, 91, 
4297, 4udfFG, 0.5607, 3.13, 0.055, 122, 91, 
4298, 4udfFE, 0.5607, 3.13, 0.055, 122, 91, 
4299, 4udfFC, 0.5607, 3.13, 0.055, 122, 91, 
4300, 4udfFA, 0.5607, 3.13, 0.055, 122, 91, 
4301, 4udfDH, 0.5607, 3.13, 0.055, 122, 91, 
4302, 4udfDF, 0.5607, 3.13, 0.055, 122, 91, 
4303, 4udfDD, 0.5607, 3.13, 0.055, 122, 91, 
4304, 4udfDB, 0.5607, 3.13, 0.055, 122, 91, 
4305, 4udfD, 0.5607, 3.13, 0.055, 122, 91, 
4306, 4udfBI, 0.5607, 3.13, 0.055, 122, 91, 
4307, 4udfBG, 0.5607, 3.13, 0.055, 122, 91, 
4308, 4udfBE, 0.5607, 3.13, 0.055, 122, 91, 
4309, 4udfBC, 0.5607, 3.13, 0.055, 122, 91, 
4310, 4udfBA, 0.5607, 3.13, 0.055, 122, 91, 
4311, 4tnvH, 0.5607, 3.13, 0.055, 122, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
4312, 4o58H, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ
4313, 4idjH, 0.5607, 3.13, 0.055, 122, 91, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
4314, 4hh9B, 0.5607, 3.13, 0.055, 122, 91, ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5
4315, 4ei6B, 0.5607, 3.13, 0.055, 122, 91, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
4316, 3u1sH, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF HUMAN FAB PGT145 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4317, 3sgdL, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
4318, 3se3C, 0.5607, 3.13, 0.055, 122, 91, HUMAN IFNA2-IFNAR TERNARY COMPLEX
4319, 3m2lG, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
4320, 3jwdP, 0.5607, 3.13, 0.055, 122, 91, STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY
4321, 3fo2A, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
4322, 3dggD, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF FABOX108
4323, 2yplD, 0.5607, 3.13, 0.055, 122, 91, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
4324, 2ny5L, 0.5607, 3.13, 0.055, 122, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T257S V275C S334A S375W Q428C A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
4325, 2nxyC, 0.5607, 3.13, 0.055, 122, 91, HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
4326, 1mcfA, 0.5607, 3.13, 0.055, 122, 91, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
4327, 1lo0H, 0.5607, 3.13, 0.055, 122, 91, CATALYTIC RETRO-DIELS-ALDERASE TRANSITION STATE ANALOGUE COMPLEX
4328, 1lmkC, 0.5607, 3.13, 0.055, 122, 91, THE STRUCTURE OF A BIVALENT DIABODY
4329, 1ggyB, 0.5607, 3.13, 0.055, 122, 91, HUMAN FACTOR XIII WITH YTTERBIUM BOUND IN THE ION SITE
4330, 1ft0B, 0.5607, 3.13, 0.055, 122, 91, CRYSTAL STRUCTURE OF TRUNCATED HUMAN RHOGDI K113A MUTANT
4331, 1f3rB, 0.5607, 3.13, 0.055, 122, 91, COMPLEX BETWEEN FV ANTIBODY FRAGMENT AND AN ANALOGUE OF THE MAIN IMMUNOGENIC REGION OF THE ACETYLCHOLINE RECEPTOR
4332, 1ai1H, 0.5607, 3.13, 0.055, 122, 91, HIV-1 V3 LOOP MIMIC
4333, 6eerA, 0.5606, 3.13, 0.055, 122, 91, STRUCTURE OF GLYCINE-BOUND GOXA FROM PSEUDOALTEROMONAS LUTEOVIOLACEA 
4334, 6dwcA, 0.5606, 3.13, 0.055, 122, 91, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
4335, 6a96L, 0.5606, 3.15, 0.100, 223, 90, CRYO-EM STRUCTURE OF THE HUMAN ALPHA5BETA3 GABAA RECEPTOR IN COMPLEX WITH GABA AND NB25 
4336, 5xhgD, 0.5606, 2.99, 0.067, 223, 89, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING NE-(O- AZIDOBENZYLOXYCARBONYL)-L-LYSINE
4337, 5vl2B, 0.5606, 3.22, 0.110, 224, 91, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
4338, 5m6iB, 0.5606, 3.27, 0.088, 229, 91, CRYSTAL STRUCTURE OF NON-CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER M8
4339, 5k9qG, 0.5606, 3.08, 0.079, 244, 89, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
4340, 5ik3C, 0.5606, 3.27, 0.078, 238, 90, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
4341, 5gs0Y, 0.5606, 3.67, 0.043, 218, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF TLR3 AND BI-SPECIFIC DIABODY
4342, 5gryG, 0.5606, 3.06, 0.093, 183, 86, CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY
4343, 5bqdA, 0.5606, 3.70, 0.052, 293, 97, CRYSTAL STRUCTURE OF TBX5 (1-239) DIMER
4344, 5bk2C, 0.5606, 3.08, 0.111, 219, 90, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH A PERISTERIC SYNTHETIC ANTIBODY
4345, 4x4xA, 0.5606, 3.65, 0.074, 216, 94, RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT.
4346, 4ww1B, 0.5606, 3.14, 0.089, 215, 90, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
4347, 4ut7H, 0.5606, 2.89, 0.045, 199, 88, CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4348, 4tqeL, 0.5606, 3.23, 0.022, 214, 91, STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT
4349, 4rrpI, 0.5606, 3.22, 0.022, 214, 91, CRYSTAL STRUCTURE OF THE FAB COMPLEXED WITH ANTIGEN ASF1P NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET PDR16
4350, 4qo1A, 0.5606, 3.20, 0.077, 216, 91, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
4351, 4g80C, 0.5606, 3.32, 0.066, 220, 91, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4352, 4f9lC, 0.5606, 3.57, 0.074, 238, 94, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
4353, 4eigB, 0.5606, 3.79, 0.050, 705, 101, CA1698 CAMEL ANTIBODY FRAGMENT IN COMPLEX WITH DHFR
4354, 3zhkA, 0.5606, 3.50, 0.041, 138, 97, THE CRYSTAL STRUCTURE OF SINGLE DOMAIN ANTIBODY 2X1 SCAFFOLD
4355, 3v7aF, 0.5606, 3.23, 0.077, 257, 91, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
4356, 3oklB, 0.5606, 3.21, 0.066, 221, 91, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
4357, 3m2lD, 0.5606, 4.05, 0.075, 767, 106, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
4358, 3m2lA, 0.5606, 3.43, 0.033, 217, 92, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
4359, 3jbf7, 0.5606, 3.07, 0.066, 124, 91, COMPLEX OF POLIOVIRUS WITH VHH PVSP19B
4360, 3bgfL, 0.5606, 3.31, 0.099, 220, 91, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
4361, 2x7lK, 0.5606, 3.26, 0.088, 126, 91, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4362, 2ny2C, 0.5606, 3.05, 0.067, 212, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T123C T257S S334A S375W G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
4363, 2nx5D, 0.5606, 3.30, 0.110, 231, 91, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4364, 2ai0L, 0.5606, 3.21, 0.121, 225, 91, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
4365, 1t66L, 0.5606, 3.02, 0.045, 107, 89, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4366, 1qfpA, 0.5606, 3.30, 0.055, 226, 91, N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE)
4367, 1qfoA, 0.5606, 3.82, 0.081, 197, 99, N-TERMINAL DOMAIN OF SIALOADHESIN (MOUSE) IN COMPLEX WITH 3 SIALYLLACTOSE
4368, 1q9lD, 0.5606, 3.38, 0.088, 228, 91, S25-2 FAB UNLIGANDED 2
4369, 1odaA, 0.5606, 3.14, 0.067, 118, 90, N-TERMINAL OF SIALOADHESIN IN COMPLEX WITH ME-A-9-N- (BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC (BIP COMPOUND)
4370, 1mf2N, 0.5606, 2.94, 0.092, 241, 87, ANTI HIV1 PROTEASE FAB COMPLEX
4371, 1majA, 0.5606, 3.31, 0.077, 146, 91, SOLUTION STRUCTURE OF AN ISOLATED ANTIBODY VL DOMAIN
4372, 1lo3H, 0.5606, 3.58, 0.064, 218, 94, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY: PRODUCT ANALOGUE
4373, 1knoF, 0.5606, 3.25, 0.089, 220, 90, CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
4374, 6rcoC, 0.5605, 3.39, 0.078, 127, 90, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
4375, 6i8sH, 0.5605, 3.31, 0.066, 219, 91, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4376, 6gfeH, 0.5605, 2.98, 0.057, 232, 88, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
4377, 6dcaN, 0.5605, 3.37, 0.120, 117, 92, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
4378, 5w1wT, 0.5605, 3.25, 0.099, 119, 91, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
4379, 5uelH, 0.5605, 3.18, 0.099, 220, 91, CRYSTAL STRUCTURE OF 354NC102 FAB
4380, 5tokD, 0.5605, 3.23, 0.099, 222, 91, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-L66
4381, 5m02G, 0.5605, 3.71, 0.052, 293, 97, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
4382, 4xtrC, 0.5605, 3.70, 0.052, 293, 97, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12
4383, 4ubdK, 0.5605, 3.27, 0.133, 123, 90, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
4384, 4rqsC, 0.5605, 3.20, 0.033, 212, 90, CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB
4385, 4p46A, 0.5605, 3.27, 0.044, 217, 90, J809.B5 Y31A TCR BOUND TO IAB3K
4386, 4lstH, 0.5605, 3.22, 0.022, 214, 91, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120
4387, 4lkxB, 0.5605, 2.93, 0.080, 188, 88, HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT
4388, 3v7aE, 0.5605, 3.58, 0.064, 217, 94, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
4389, 3u4aA, 0.5605, 3.66, 0.064, 219, 94, FROM SOIL TO STRUCTURE: A NOVEL DIMERIC FAMILY 3-BETA-GLUCOSIDASE ISOLATED FROM COMPOST USING METAGENOMIC ANALYSIS
4390, 3p0yH, 0.5605, 3.30, 0.054, 118, 92, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
4391, 3oayM, 0.5605, 3.28, 0.044, 115, 91, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4392, 3eifA, 0.5605, 3.07, 0.100, 222, 90, 1.9 ANGSTROM CRYSTAL STRUCTURE OF THE ACTIVE FORM OF THE C5A PEPTIDASE FROM STREPTOCOCCUS PYOGENES (SCPA)
4393, 2v7hB, 0.5605, 3.32, 0.054, 116, 92, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
4394, 2m2dA, 0.5605, 3.25, 0.088, 221, 91, HUMAN PROGRAMMED CELL DEATH 1 RECEPTOR
4395, 2kz1B, 0.5605, 3.44, 0.074, 113, 94, INTER-MOLECULAR INTERACTIONS IN A 44 KDA INTERFERON-RECEPTOR COMPLEX DETECTED BY ASYMMETRIC BACK-PROTONATION AND 2D NOESY
4396, 2jccL, 0.5605, 3.33, 0.066, 220, 91, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
4397, 2cu9A, 0.5605, 3.30, 0.098, 220, 92, CRYSTAL STRUCTURE OF HISTONE CHAPERONE CIA1
4398, 2a1wL, 0.5605, 2.93, 0.068, 222, 88, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM I
4399, 1u6aH, 0.5605, 3.09, 0.067, 214, 90, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
4400, 1q0yH, 0.5605, 3.24, 0.077, 429, 91, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
4401, 1nd0G, 0.5605, 3.70, 0.043, 215, 94, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4402, 1fvcB, 0.5605, 2.71, 0.047, 243, 85, X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING
4403, 6obdA, 0.5604, 3.15, 0.067, 232, 90, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
4404, 6o3bB, 0.5604, 3.32, 0.033, 123, 91, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
4405, 6h1fA, 0.5604, 3.18, 0.034, 187, 89, STRUCTURE OF THE NANOBODY-STABILIZED GELSOLIN D187N VARIANT (SECOND DOMAIN) 
4406, 6fy2X, 0.5604, 3.33, 0.077, 217, 91, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
4407, 6dbdA, 0.5604, 3.30, 0.121, 219, 91, CRYSTAL STRUCTURE OF VHH R326 
4408, 6cw9D, 0.5604, 3.18, 0.022, 214, 91, STRUCTURE OF ALPHA-GC[8;16P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4409, 6ck9H, 0.5604, 3.12, 0.034, 199, 89, CRYSTAL STRUCTURE OF HIV-1 CONC_BASE0 PREFUSION ENV TRIMER IN COMPLEX WITH HUMAN ANTIBODY FRAGMENT 3H109L AND 35O22 VARIANTS AT 3.5 ANGSTROM 
4410, 5x3jB, 0.5604, 3.24, 0.088, 222, 91, KFLA1895 D451A MUTANT IN COMPLEX WITH CYCLOBIS-(1->6)-ALPHA-NIGEROSYL
4411, 5uoeQ, 0.5604, 3.64, 0.064, 219, 94, CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE)
4412, 5uemH, 0.5604, 3.18, 0.099, 220, 91, CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
4413, 5tz8B, 0.5604, 3.49, 0.075, 739, 93, CRYSTAL STRUCTURE OF S. AUREUS TARS
4414, 5tdnD, 0.5604, 3.33, 0.088, 218, 91, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4415, 5nmfD, 0.5604, 3.42, 0.076, 218, 92, TCR IN COMPLEX WITH HLA A02 PRESENTING SLYNTIATL
4416, 5m7qB, 0.5604, 3.62, 0.080, 936, 100, ENGINEERING THE THERMOSTABILITY OF NANOBODIES - NBD2
4417, 5ijvH, 0.5604, 3.30, 0.109, 216, 92, CRYSTAL STRUCTURE OF BOVINE FAB E03
4418, 5ihuH, 0.5604, 3.11, 0.088, 118, 91, CRYSTAL STRUCTURE OF BOVINE FAB B11
4419, 5hyqD, 0.5604, 2.64, 0.046, 196, 87, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4420, 5gqbA, 0.5604, 2.78, 0.069, 194, 87, CRYSTAL STRUCTURE OF CHITINASE-H FROM O. FURNACALIS IN COMPLEX WITH CHITOHEPATOSE
4421, 5eszA, 0.5604, 3.52, 0.082, 161, 97, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH04 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE AE STRAIN A244
4422, 5e99H, 0.5604, 3.55, 0.064, 216, 94, BOVINE FAB FRAGMENT F08_B11
4423, 5bozH, 0.5604, 3.18, 0.078, 222, 90, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH9)(E1)
4424, 4whtY, 0.5604, 3.26, 0.077, 215, 91, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4425, 4u7sA, 0.5604, 3.46, 0.033, 219, 92, HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB) CRYSTALLIZED FOR 5 MONTHS
4426, 4pj8C, 0.5604, 3.34, 0.110, 120, 91, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
4427, 4p99A, 0.5604, 3.60, 0.054, 216, 93, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
4428, 4k3eI, 0.5604, 3.32, 0.099, 216, 91, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
4429, 4i13B, 0.5604, 3.16, 0.056, 127, 90, NANOBODY CA1697 BINDING TO THE DHFR.FOLATE BINARY COMPLEX
4430, 4hkbJ, 0.5604, 3.26, 0.110, 219, 91, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4431, 3wd5H, 0.5604, 3.07, 0.068, 111, 88, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
4432, 3u79F, 0.5604, 3.05, 0.068, 239, 88, AL-103 Y32F Y96F
4433, 3sgeI, 0.5604, 3.36, 0.066, 219, 91, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
4434, 3qxuC, 0.5604, 2.53, 0.085, 714, 82, FREE STRUCTURE OF AN ANTI-METHOTREXATE CDR1-3 GRAFT VHH ANTIBODY
4435, 3qa3H, 0.5604, 3.16, 0.022, 108, 90, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4436, 3g6jC, 0.5604, 3.14, 0.078, 230, 90, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
4437, 3dwtE, 0.5604, 3.41, 0.073, 558, 96, STRUCTURE OF CABBCII-10 NANOBODY
4438, 3dwtA, 0.5604, 3.27, 0.110, 213, 91, STRUCTURE OF CABBCII-10 NANOBODY
4439, 3d69H, 0.5604, 3.17, 0.089, 200, 90, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-FACTOR IX ANTIBODY 10C12
4440, 3bkcL, 0.5604, 3.18, 0.090, 119, 89, CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21 FORMB)
4441, 2x7lD, 0.5604, 3.16, 0.067, 246, 89, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4442, 2v7hH, 0.5604, 3.36, 0.067, 273, 90, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
4443, 2i60H, 0.5604, 3.29, 0.078, 213, 90, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4444, 2gj6D, 0.5604, 3.70, 0.141, 538, 92, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
4445, 2g5bB, 0.5604, 3.25, 0.077, 212, 91, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4446, 2axjA, 0.5604, 3.36, 0.067, 273, 90, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
4447, 1pz5A, 0.5604, 3.41, 0.076, 125, 92, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
4448, 1kfaM, 0.5604, 3.55, 0.043, 210, 93, CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
4449, 1dclB, 0.5604, 3.40, 0.077, 130, 91, MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED FROM AMMONIUM SULFATE
4450, 6fraB, 0.5603, 2.84, 0.045, 197, 88, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4451, 6ey0H, 0.5603, 3.52, 0.052, 415, 96, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
4452, 6cueQ, 0.5603, 3.21, 0.067, 261, 89, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4453, 5wobK, 0.5603, 3.40, 0.054, 128, 92, CRYSTAL STRUCTURE ANALYSIS OF FAB1-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN 
4454, 5vl2D, 0.5603, 3.26, 0.110, 218, 91, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
4455, 5uekA, 0.5603, 3.29, 0.110, 214, 91, STRUCTURE OF ANTIGEN-FAB 12E COMPLEX WITH HISTONE CHAPERONE ASF1
4456, 5tv1A, 0.5603, 3.18, 0.033, 111, 91, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
4457, 5n0aH, 0.5603, 3.64, 0.043, 219, 94, CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4458, 5i30H, 0.5603, 3.28, 0.055, 124, 91, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
4459, 5e9dI, 0.5603, 3.28, 0.110, 224, 91, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
4460, 5durH, 0.5603, 3.53, 0.085, 642, 94, INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH ANTIBODY 100F4
4461, 5cd3A, 0.5603, 3.41, 0.054, 125, 92, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4462, 4xvuL, 0.5603, 3.41, 0.054, 125, 92, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1
4463, 4r0lB, 0.5603, 3.26, 0.077, 218, 91, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
4464, 4q5zK, 0.5603, 3.62, 0.064, 218, 94, CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN
4465, 4onfH, 0.5603, 3.26, 0.044, 217, 90, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
4466, 3o6lL, 0.5603, 3.26, 0.077, 220, 91, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 15-MER TAT PEPTIDE
4467, 3k80B, 0.5603, 3.09, 0.089, 221, 90, STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI
4468, 3baeL, 0.5603, 3.15, 0.090, 200, 89, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-28)
4469, 3argC, 0.5603, 3.24, 0.066, 216, 91, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
4470, 2yklH, 0.5603, 3.37, 0.078, 242, 90, STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE-11-YL-METHYL-(4-ETHYLAMINO-4-OXO)-BUTANOATE
4471, 2x7lI, 0.5603, 3.54, 0.065, 215, 93, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4472, 2ojzL, 0.5603, 3.64, 0.064, 213, 94, ANTI-DNA ANTIBODY ED10
4473, 2g60L, 0.5603, 3.29, 0.087, 216, 92, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
4474, 1t66C, 0.5603, 2.81, 0.058, 240, 86, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4475, 1kj2B, 0.5603, 3.34, 0.044, 124, 91, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
4476, 1f4yH, 0.5603, 3.21, 0.089, 129, 90, CRYSTAL STRUCTURE OF AN ANTI-CARBOHYDRATE ANTIBODY DIRECTED AGAINST VIBRIO CHOLERAE O1 IN COMPLEX WITH ANTIGEN
4477, 1afvH, 0.5603, 3.35, 0.078, 207, 90, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
4478, 6mtjH, 0.5602, 3.37, 0.054, 126, 92, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 2.9 ANGSTROM 
4479, 6cw6D, 0.5602, 3.40, 0.052, 153, 96, STRUCTURE OF ALPHA-GC[8;18] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4480, 6cuhA, 0.5602, 3.33, 0.115, 337, 96, CRYSTAL STRUCTURE OF THE UNLIGANDED BC8B TCR 
4481, 6cnkJ, 0.5602, 3.24, 0.099, 131, 91, STRUCTURE OF THE 3ALPHA2BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4482, 6bi0H, 0.5602, 3.37, 0.066, 212, 91, TRASTUZUMAB FAB N158A D185A K190A (LIGHT CHAIN) TRIPLE MUTANT.
4483, 6azlB, 0.5602, 3.14, 0.090, 108, 89, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
4484, 5ou9A, 0.5602, 3.33, 0.088, 214, 91, CRYSTAL STRUCTURE OF GLYCOPROTEIN VI IN COMPLEX WITH COLLAGEN-PEPTIDE (GPO)3 
4485, 5lxgL, 0.5602, 3.33, 0.065, 220, 92, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
4486, 5kovE, 0.5602, 3.26, 0.033, 216, 91, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 CAPSID PROTEIN SPIKE IN COMPLEX WITH A SINGLE CHAIN VARIABLE FRAGMENT OF AN ASTROVIRUS NEUTRALIZING ANTIBODY AT 3.24-A RESOLUTION
4487, 5jxeD, 0.5602, 3.43, 0.043, 114, 92, HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB
4488, 5d1zB, 0.5602, 3.35, 0.089, 207, 90, ISDB NEAT1 BOUND BY CLONE D4-10
4489, 5bmfL, 0.5602, 3.24, 0.121, 212, 91, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
4490, 4wnqA, 0.5602, 3.44, 0.054, 217, 92, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4491, 4tukL, 0.5602, 3.19, 0.089, 124, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4492, 4ofyE, 0.5602, 3.66, 0.074, 218, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF SYG-1 D1-D2 AND SYG-2 D1-D4
4493, 4nhcH, 0.5602, 3.15, 0.089, 202, 90, CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41.
4494, 4m5zH, 0.5602, 2.60, 0.157, 181, 83, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 5J8 BOUND TO 2009 PANDEMIC INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4495, 4hg4R, 0.5602, 3.27, 0.044, 217, 90, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4496, 4hdiH, 0.5602, 3.61, 0.064, 218, 94, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4497, 4f58K, 0.5602, 3.62, 0.064, 213, 94, FAB STRUCTURE OF A NEUTRALIZING ANTIBODY L3 FROM AN EARLY SUBTYPE A HIV-1 INFECTED PATIENT
4498, 4dgyH, 0.5602, 3.67, 0.064, 219, 94, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 FORM
4499, 3u79B, 0.5602, 2.76, 0.058, 117, 86, AL-103 Y32F Y96F
4500, 3tpuC, 0.5602, 3.32, 0.055, 216, 91, 42F3 P5E8/H2-LD COMPLEX
4501, 3qxvB, 0.5602, 3.15, 0.110, 220, 91, STRUCTURE OF AN ANTI-METHOTREXATE CDR1-4 GRAFT VHH ANTIBODY IN COMPLEX WITH METHOTREXATE
4502, 3qeuD, 0.5602, 3.41, 0.077, 226, 91, THE CRYSTAL STRUCTURE OF TCR DMF5
4503, 3m3rD, 0.5602, 3.10, 0.045, 239, 89, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
4504, 3hr5H, 0.5602, 2.73, 0.058, 187, 86, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4505, 3fo2B, 0.5602, 3.44, 0.065, 218, 93, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
4506, 3dwtF, 0.5602, 3.00, 0.067, 212, 89, STRUCTURE OF CABBCII-10 NANOBODY
4507, 3au0A, 0.5602, 3.28, 0.078, 220, 90, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
4508, 2r8sH, 0.5602, 2.18, 0.086, 179, 81, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
4509, 2ny1C, 0.5602, 3.24, 0.033, 107, 90, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C T257S S334A S375W Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
4510, 1y0lB, 0.5602, 3.31, 0.078, 224, 90, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
4511, 1q9oB, 0.5602, 3.19, 0.110, 197, 91, S45-18 FAB UNLIGANDED
4512, 1ndmB, 0.5602, 3.30, 0.088, 218, 91, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME
4513, 1nd0E, 0.5602, 3.56, 0.075, 216, 93, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4514, 1lp9L, 0.5602, 3.16, 0.033, 200, 90, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
4515, 1himL, 0.5602, 3.70, 0.063, 218, 95, STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIBODY- ANTIGEN RECOGNITION
4516, 1d3iI, 0.5602, 3.00, 0.080, 407, 88, CRYO-EM STRUCTURE OF HUMAN RHINOVIRUS 14 (HRV14) COMPLEXED WITH A TWO-DOMAIN FRAGMENT OF ITS CELLULAR RECEPTOR INTERCELLULAR ADHESION MOLECULE-1 (D1D2-ICAM-1). IMPLICATIONS FOR VIRUS-RECEPTOR INTERACTIONS. ALPHA CARBONS ONLY
4517, 1d3eI, 0.5602, 2.92, 0.056, 228, 89, CRYO-EM STRUCTURE OF HUMAN RHINOVIRUS 16 (HRV16) COMPLEXED WITH A TWO-DOMAIN FRAGMENT OF ITS CELLULAR RECEPTOR INTERCELLULAR ADHESION MOLECULE-1 (D1D2-ICAM-1). IMPLICATIONS FOR VIRUS-RECEPTOR INTERACTIONS. ALPHA CARBONS ONLY
4518, 1blnD, 0.5602, 3.33, 0.088, 220, 91, ANTI-P-GLYCOPROTEIN FAB MRK-16
4519, 1b6uA, 0.5602, 3.25, 0.078, 214, 90, CRYSTAL STRUCTURE OF THE HUMAN KILLER CELL INHIBITORY RECEPTOR (KIR2DL3) SPECIFIC FOR HLA-CW3 RELATED ALLELES
4520, 6rcuB, 0.5601, 3.27, 0.099, 220, 91, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
4521, 6nm6H, 0.5601, 3.17, 0.089, 221, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO N6 FR3-03 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.2 ANGSTROM 
4522, 6gzpA, 0.5601, 3.27, 0.077, 226, 91, LLAMA NANOBODY PORM_02 STRUCTURE DETERMINED AT ROOM TEMPERATURE BY IN- SITU DIFFRACTION 
4523, 6ejmI, 0.5601, 3.27, 0.033, 111, 91, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT 5 
4524, 5x2mH, 0.5601, 2.74, 0.057, 204, 87, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4525, 5vhvA, 0.5601, 3.10, 0.112, 123, 89, PSEUDOMONAS FLUORESCENS ALKYLPURINE DNA GLYCOSYLASE ALKC BOUND TO DNA CONTAINING AN OXOCARBENIUM-INTERMEDIATE ANALOG
4526, 5ukbe, 0.5601, 3.31, 0.088, 202, 91, VSV N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1004
4527, 5ukbd, 0.5601, 3.71, 0.052, 293, 97, VSV N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1004
4528, 5ukbc, 0.5601, 3.44, 0.076, 220, 92, VSV N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1004
4529, 5ukbb, 0.5601, 3.35, 0.098, 214, 92, VSV N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1004
4530, 5ukba, 0.5601, 3.43, 0.054, 125, 92, VSV N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1004
4531, 5ucbB, 0.5601, 3.47, 0.097, 339, 93, STRUCTURE OF ANTIGEN-FAB COMPLEX WITH ENGINEERED SWITCH RESIDUE REGION.
4532, 5mesH, 0.5601, 3.39, 0.065, 218, 92, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29
4533, 5jhdE, 0.5601, 3.22, 0.022, 214, 91, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
4534, 5i66A, 0.5601, 3.27, 0.110, 226, 91, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
4535, 5drxL, 0.5601, 3.23, 0.077, 226, 91, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  4 CASE CLL240
4536, 5d1xB, 0.5601, 3.13, 0.057, 210, 88, ISDB NEAT2 BOUND BY D4-30
4537, 5chnA, 0.5601, 3.49, 0.043, 219, 92, FAB FRAGMENTS OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 5M16
4538, 5c8jF, 0.5601, 2.77, 0.069, 194, 87, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
4539, 4mnhD, 0.5601, 3.21, 0.110, 214, 91, STRUCTURE OF THE DP10.7 TCR
4540, 3tpuA, 0.5601, 2.91, 0.023, 185, 88, 42F3 P5E8/H2-LD COMPLEX
4541, 3tf7I, 0.5601, 2.91, 0.023, 185, 88, 42F3 QL9/H2-LD COMPLEX
4542, 3t77B, 0.5601, 3.42, 0.054, 218, 92, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
4543, 3rdtA, 0.5601, 2.70, 0.070, 199, 86, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
4544, 3fo0L, 0.5601, 3.18, 0.078, 222, 90, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
4545, 3dwtD, 0.5601, 3.32, 0.077, 226, 91, STRUCTURE OF CABBCII-10 NANOBODY
4546, 2gkiA, 0.5601, 3.46, 0.099, 121, 91, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
4547, 1y18H, 0.5601, 3.82, 0.042, 227, 95, FAB FRAGMENT OF CATALYTIC ELIMINATION ANTIBODY 34E4 E(H50)D MUTANT IN COMPLEX WITH HAPTEN
4548, 1wg3A, 0.5601, 3.14, 0.100, 219, 90, STRUCTURAL ANALYSIS OF YEAST NUCLEOSOME-ASSEMBLY FACTOR CIA1P
4549, 1kfaL, 0.5601, 3.44, 0.086, 361, 93, CRYSTAL STRUCTURE OF FAB FRAGMENT COMPLEXED WITH GIBBERELLIN A4
4550, 6nnjH, 0.5600, 3.24, 0.100, 122, 90, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO CH31 SCFV IN COMPLEX WITH CRYSTALLIZATION CHAPERONES 3H109L FAB AND 35O22 SCFV AT 3.1 ANGSTROM 
4551, 6n4rL, 0.5600, 3.24, 0.100, 122, 90, CRYOEM STRUCTURE OF NAV1.7 VSD2 (DEACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
4552, 6n4rJ, 0.5600, 3.24, 0.100, 122, 90, CRYOEM STRUCTURE OF NAV1.7 VSD2 (DEACTIVED STATE) IN COMPLEX WITH THE GATING MODIFIER TOXIN PROTX2 
4553, 5xf0A, 0.5600, 3.24, 0.100, 122, 90, SOLUTION STRUCTURE OF THE IGI DOMAIN OF CD147 
4554, 5vjoC, 0.5600, 3.24, 0.100, 122, 90, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4555, 5th9H, 0.5600, 3.53, 0.052, 153, 97, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
4556, 5oclA, 0.5600, 3.27, 0.110, 213, 91, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
4557, 5nlnA, 0.5600, 3.20, 0.067, 239, 89, AUXILIARY ACTIVITY 9
4558, 5i0yA, 0.5600, 3.18, 0.099, 218, 91, COPPER-BOUND E46Q VARIANT OF UROPATHOGENIC ESCHERICHIA COLI STRAIN F11 FETP
4559, 5h32K, 0.5600, 3.82, 0.062, 221, 96, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 5.0
4560, 5ff6B, 0.5600, 3.15, 0.078, 212, 90, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4561, 5eq4B, 0.5600, 3.24, 0.099, 214, 91, CRYSTAL STRUCTURE OF THE SRPA ADHESIN R347E MUTANT FROM STREPTOCOCCUS SANGUINIS
4562, 5e9dJ, 0.5600, 3.08, 0.022, 213, 89, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
4563, 5e9dE, 0.5600, 3.24, 0.044, 199, 91, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
4564, 5dd5H, 0.5600, 2.76, 0.057, 205, 87, CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES
4565, 5d1zG, 0.5600, 3.26, 0.033, 228, 90, ISDB NEAT1 BOUND BY CLONE D4-10
4566, 5bk5C, 0.5600, 3.25, 0.077, 224, 91, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
4567, 4y2dD, 0.5600, 3.20, 0.045, 199, 89, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
4568, 4xbgJ, 0.5600, 3.67, 0.064, 216, 94, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4569, 4ut9H, 0.5600, 3.16, 0.090, 125, 89, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10
4570, 4tyuB, 0.5600, 3.22, 0.110, 235, 91, HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB)
4571, 4nkiH, 0.5600, 3.27, 0.110, 226, 91, CRYSTAL STRUCTURE OF A FAB
4572, 4hzlH, 0.5600, 3.55, 0.052, 166, 97, NEUTRALIZING ANTIBODY MAB 8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN
4573, 4gejE, 0.5600, 3.64, 0.064, 217, 94, N-TERMINAL DOMAIN OF VDUP-1
4574, 4f9lD, 0.5600, 3.32, 0.077, 226, 91, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
4575, 4cadK, 0.5600, 3.29, 0.089, 228, 90, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4576, 3w5mA, 0.5600, 3.29, 0.089, 228, 90, CRYSTAL STRUCTURE OF STREPTOMYCES AVERMITILIS ALPHA-L-RHAMNOSIDASE
4577, 3qehG, 0.5600, 2.96, 0.079, 108, 89, CRYSTAL STRUCTURE OF HUMAN N12-I15 AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
4578, 3nz8B, 0.5600, 2.98, 0.057, 208, 87, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4579, 3ncyQ, 0.5600, 3.25, 0.089, 208, 90, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
4580, 3m4dD, 0.5600, 2.98, 0.101, 115, 89, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
4581, 3m4dC, 0.5600, 3.07, 0.076, 234, 92, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
4582, 3hi1H, 0.5600, 3.21, 0.054, 150, 93, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4583, 3hi1B, 0.5600, 3.34, 0.066, 127, 91, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4584, 2ojzM, 0.5600, 3.28, 0.078, 220, 90, ANTI-DNA ANTIBODY ED10
4585, 2f53D, 0.5600, 3.37, 0.098, 195, 92, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
4586, 1xgrB, 0.5600, 2.76, 0.106, 114, 85, STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4587, 1tqcC, 0.5600, 3.08, 0.102, 115, 88, OVINE RECOMBINANT PRP(114-234) ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
4588, 1r3kB, 0.5600, 3.39, 0.088, 225, 91, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
4589, 1lo4H, 0.5600, 3.41, 0.075, 222, 93, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
4590, 1knoD, 0.5600, 3.43, 0.043, 217, 92, CRYSTAL STRUCTURE OF THE COMPLEX OF A CATALYTIC ANTIBODY FAB WITH A TRANSITION STATE ANALOG: STRUCTURAL SIMILARITIES IN ESTERASE-LIKE ABZYMES
4591, 1jptH, 0.5600, 3.20, 0.079, 239, 89, CRYSTAL STRUCTURE OF FAB D3H44
4592, 1igfM, 0.5600, 3.07, 0.089, 217, 90, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
4593, 6mu8H, 0.5599, 3.28, 0.099, 127, 91, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-386150 IN COMPLEX WITH HUMAN ANTIBODIES 3H109L AND 35O22 AT 3.5 ANGSTROM 
4594, 6cwbD, 0.5599, 3.43, 0.043, 130, 92, STRUCTURE OF ALPHA-GSA[8;4P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4595, 6bywD, 0.5599, 3.29, 0.088, 221, 91, STRUCTURE OF GOXA FROM PSEUDOALTEROMONAS LUTEOVIOLACEA
4596, 6banC, 0.5599, 3.34, 0.099, 217, 91, POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE OF ROR1 
4597, 5w3lG, 0.5599, 3.37, 0.065, 142, 93, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (4 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
4598, 5vkmA, 0.5599, 2.99, 0.057, 232, 88, CRYSTAL STRUCTURE OF HUMAN CD22 IG DOMAINS 1-3 IN COMPLEX WITH ALPHA 2-6 SIALYLLACTOSE
4599, 5vjqC, 0.5599, 3.20, 0.099, 221, 91, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4600, 5occL, 0.5599, 3.12, 0.121, 1030, 91, CRYSTAL STRUCTURE OF CD32B (FC GAMMA RECEPTOR IIB) IN COMPLEX WITH HUMAN IGG1 FAB FRAGMENT (6G08) 
4601, 5nloA, 0.5599, 3.39, 0.087, 192, 92, AUXILIARY ACTIVITY 9
4602, 5nb5H, 0.5599, 3.66, 0.053, 217, 94, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
4603, 5mhmA, 0.5599, 3.24, 0.141, 218, 92, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED1630
4604, 5m6wG, 0.5599, 3.68, 0.052, 293, 96, PROPERDIN IN COMPLEX WITH ALTERNATIVE PATHWAY C3 CONVERTASE
4605, 5hyqB, 0.5599, 3.70, 0.052, 293, 97, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4606, 5fhcH, 0.5599, 3.28, 0.098, 225, 92, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
4607, 5dfvE, 0.5599, 3.28, 0.098, 225, 92, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
4608, 5cp7E, 0.5599, 3.62, 0.064, 218, 94, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4609, 5bk5G, 0.5599, 3.13, 0.122, 193, 90, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
4610, 4x80H, 0.5599, 2.90, 0.070, 210, 86, CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
4611, 4x27A, 0.5599, 3.65, 0.043, 219, 94, STRUCTURAL BASIS FOR THE ENHANCEMENT OF VIRULENCE BY ENTOMOPOXVIRUS FUSOLIN AND ITS IN VIVO CRYSTALLIZATION INTO VIRAL SPINDLES (COMPLEX WITH COPPER)
4612, 4tujB, 0.5599, 3.20, 0.111, 219, 90, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4613, 4h0iA, 0.5599, 3.29, 0.077, 220, 91, CRYSTAL STRUCTURE OF SCFV-2D10 IN COMPLEX WITH METHYL ALPHA-D- MANNOPYRANOSIDE
4614, 3u7yH, 0.5599, 3.31, 0.098, 220, 92, STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV
4615, 3qumA, 0.5599, 3.13, 0.067, 212, 90, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4616, 3hnsH, 0.5599, 3.40, 0.054, 219, 92, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
4617, 3eyvH, 0.5599, 3.35, 0.077, 226, 91, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
4618, 3dwtG, 0.5599, 3.07, 0.068, 239, 88, STRUCTURE OF CABBCII-10 NANOBODY
4619, 3durD, 0.5599, 4.10, 0.075, 775, 106, CRYSTAL STRUCTURE OF SAG173-04
4620, 3anzB, 0.5599, 3.34, 0.043, 111, 92, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4621, 2jixH, 0.5599, 3.13, 0.045, 107, 89, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
4622, 2jelL, 0.5599, 2.60, 0.072, 306, 83, JEL42 FAB/HPR COMPLEX
4623, 2i5yQ, 0.5599, 2.97, 0.057, 207, 87, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4624, 1xzwB, 0.5599, 3.23, 0.044, 216, 91, SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX
4625, 1xo8A, 0.5599, 3.07, 0.076, 234, 92, SOLUTION STRUCTURE OF AT1G01470 FROM ARABIDOPSIS THALIANA
4626, 1tzgH, 0.5599, 3.21, 0.122, 214, 90, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
4627, 1qbmH, 0.5599, 3.83, 0.059, 684, 101, FAB E8B ANTIBODY X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
4628, 1q9wD, 0.5599, 3.20, 0.022, 645, 89, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
4629, 1q9lB, 0.5599, 3.33, 0.088, 220, 91, S25-2 FAB UNLIGANDED 2
4630, 1nd0A, 0.5599, 3.31, 0.099, 215, 91, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4631, 1kj2E, 0.5599, 2.93, 0.135, 214, 89, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
4632, 1ehlH, 0.5599, 3.70, 0.074, 218, 94, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
4633, 1c08B, 0.5599, 3.45, 0.043, 217, 92, CRYSTAL STRUCTURE OF HYHEL-10 FV-HEN LYSOZYME COMPLEX
4634, 1ap2B, 0.5599, 3.22, 0.078, 223, 90, SINGLE CHAIN FV OF C219
4635, 6mtoL, 0.5598, 3.21, 0.088, 307, 91, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
4636, 6i04H, 0.5598, 3.73, 0.063, 217, 95, CRYSTAL STRUCTURE OF SEMA DOMAIN OF THE MET RECEPTOR IN COMPLEX WITH FAB 
4637, 6fy1H, 0.5598, 3.73, 0.063, 238, 95, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
4638, 6azzC, 0.5598, 3.08, 0.056, 221, 89, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
4639, 5w1wJ, 0.5598, 3.39, 0.054, 218, 92, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
4640, 5dqdH, 0.5598, 3.25, 0.088, 220, 91, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
4641, 5bs0E, 0.5598, 3.24, 0.110, 219, 91, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
4642, 5b3nA, 0.5598, 3.40, 0.054, 125, 92, THE CRYSTAL STRUCTURE OF ANTI-H4K20ME1_SCFV 15F11
4643, 5a2fA, 0.5598, 3.27, 0.088, 121, 91, TWO MEMBRANE DISTAL IGSF DOMAINS OF CD166
4644, 4y4hH, 0.5598, 3.73, 0.052, 295, 97, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
4645, 4xcnG, 0.5598, 3.43, 0.077, 217, 91, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4646, 4utbI, 0.5598, 3.62, 0.053, 217, 94, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4647, 4tnwH, 0.5598, 3.23, 0.022, 214, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
4648, 4rfnB, 0.5598, 2.44, 0.059, 426, 85, CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48
4649, 4mwfH, 0.5598, 3.47, 0.051, 151, 98, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
4650, 4lriA, 0.5598, 2.91, 0.067, 232, 89, ANTI CMV FAB FRAGMENT
4651, 4kv5K, 0.5598, 3.28, 0.099, 219, 91, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
4652, 4b5qA, 0.5598, 3.11, 0.067, 226, 90, THE LYTIC POLYSACCHARIDE MONOOXYGENASE GH61D STRUCTURE FROM THE BASIDIOMYCOTA FUNGUS PHANEROCHAETE CHRYSOSPORIUM
4653, 3qdjD, 0.5598, 3.28, 0.087, 222, 92, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
4654, 3o4lE, 0.5598, 3.48, 0.033, 219, 92, GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
4655, 3muhL, 0.5598, 2.93, 0.057, 117, 87, CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
4656, 3fo9L, 0.5598, 3.18, 0.121, 217, 91, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
4657, 3eyvB, 0.5598, 3.05, 0.057, 114, 87, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
4658, 3auvF, 0.5598, 3.32, 0.109, 120, 92, PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE
4659, 3anzI, 0.5598, 3.32, 0.066, 212, 91, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4660, 2uweL, 0.5598, 3.24, 0.100, 211, 90, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
4661, 2uvfB, 0.5598, 3.27, 0.121, 226, 91, STRUCTURE OF YERSINIA ENTEROCOLITICA FAMILY 28 EXOPOLYGALACTURONASE IN COMPLEX WITH DIGALATURONIC ACID
4662, 2r56H, 0.5598, 3.20, 0.099, 217, 91, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
4663, 2ny0C, 0.5598, 2.87, 0.058, 243, 86, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C T257S V275C S334A S375W A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
4664, 1xzwA, 0.5598, 3.27, 0.077, 222, 91, SWEET POTATO PURPLE ACID PHOSPHATASE/PHOSPHATE COMPLEX
4665, 1nqbC, 0.5598, 2.94, 0.057, 241, 87, TRIVALENT ANTIBODY FRAGMENT
4666, 1nbvL, 0.5598, 3.50, 0.054, 232, 93, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
4667, 1mnuL, 0.5598, 3.16, 0.056, 218, 90, UNLIGANDED BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
4668, 1jnhD, 0.5598, 3.19, 0.079, 239, 89, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4669, 1dsfH, 0.5598, 3.32, 0.087, 222, 92, THE CRYSTAL STRUCTURE OF THE DISULFIDE-STABILIZED FV FRAGMENT OF ANTICANCER ANTIBODY B1: CONFORMATIONAL INFLUENCE OF AN ENGINEERED DISULFIDE BOND
4670, 1ar2A, 0.5598, 3.23, 0.099, 203, 91, DISULFIDE-FREE IMMUNOGLOBULIN FRAGMENT
4671, 6njnO, 0.5597, 3.22, 0.110, 223, 91, STRUCTURE OF A COMPLEX 
4672, 6idhH, 0.5597, 3.32, 0.111, 217, 90, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
4673, 6i07A, 0.5597, 3.06, 0.124, 228, 89, CRYSTAL STRUCTURE OF EPCAM IN COMPLEX WITH SCFV 
4674, 6frbA, 0.5597, 3.47, 0.054, 217, 92, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
4675, 6eh7A, 0.5597, 3.34, 0.066, 110, 91, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4676, 6cphD, 0.5597, 3.15, 0.044, 217, 91, CRYSTAL STRUCTURE OF A TCR 
4677, 5wnaC, 0.5597, 3.27, 0.078, 199, 90, STRUCTURE OF ANTIBODY 3D3 BOUND TO THE CENTRAL CONSERVED REGION OF RSV 2 G
4678, 5w0dB, 0.5597, 3.07, 0.067, 245, 89, INFERRED PRECURSOR (UCA) OF THE HUMAN ANTIBODY LINEAGE K03.12 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4679, 5vl2G, 0.5597, 3.19, 0.066, 212, 91, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T4 
4680, 5th2B, 0.5597, 3.33, 0.066, 219, 91, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4681, 5oclE, 0.5597, 3.30, 0.099, 222, 91, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
4682, 5my6B, 0.5597, 3.32, 0.044, 224, 90, CRYSTAL STRUCTURE OF A HER2-NB COMPLEX
4683, 5mhoA, 0.5597, 3.73, 0.052, 294, 97, FXIIIA IN COMPLEX WITH THE INHIBITOR ZED2369
4684, 5m7qA, 0.5597, 2.80, 0.069, 194, 87, ENGINEERING THE THERMOSTABILITY OF NANOBODIES - NBD2
4685, 5kjrL, 0.5597, 2.79, 0.125, 567, 88, CRYSTAL STRUCTURE OF THE ADCC-POTENT ANTIBODY N60-I3 FAB IN COMPLEX WITH HIV-1 CLADE A/E GP120 W69A/S115W MUTANT AND M48U1.
4686, 5iw1C, 0.5597, 3.37, 0.077, 221, 91, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4687, 5ggsA, 0.5597, 3.22, 0.022, 214, 91, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
4688, 5f88B, 0.5597, 2.45, 0.059, 424, 85, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
4689, 5ezlH, 0.5597, 3.76, 0.063, 232, 95, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
4690, 4ydjA, 0.5597, 3.48, 0.054, 219, 93, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
4691, 4xwoC, 0.5597, 3.62, 0.053, 219, 94, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4692, 4tyuA, 0.5597, 3.39, 0.087, 214, 92, HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB)
4693, 4trpL, 0.5597, 3.05, 0.079, 119, 89, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.
4694, 4p3dB, 0.5597, 3.18, 0.011, 109, 90, MT1-MMP:FAB COMPLEX (FORM II)
4695, 4jm2C, 0.5597, 3.25, 0.099, 215, 91, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4696, 4hkbI, 0.5597, 3.22, 0.099, 217, 91, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4697, 4gejD, 0.5597, 3.38, 0.043, 228, 92, N-TERMINAL DOMAIN OF VDUP-1
4698, 4fqvI, 0.5597, 2.99, 0.045, 202, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
4699, 4fqvH, 0.5597, 3.00, 0.045, 202, 89, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
4700, 3whxB, 0.5597, 3.21, 0.033, 200, 90, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE1 COMPLEX
4701, 3tvmD, 0.5597, 3.32, 0.088, 225, 91, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
4702, 3omzC, 0.5597, 3.25, 0.110, 235, 91, CRYSTAL STRUCTURE OF MICA-SPECIFIC HUMAN GAMMA DELTA T CELL RECEPTOR
4703, 3o9wD, 0.5597, 3.35, 0.043, 125, 92, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
4704, 3ngbB, 0.5597, 3.34, 0.077, 216, 91, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
4705, 3mffA, 0.5597, 3.42, 0.088, 119, 91, 1F1E8HU TCR
4706, 3l95H, 0.5597, 2.82, 0.080, 115, 87, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
4707, 2uweE, 0.5597, 3.82, 0.059, 678, 101, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
4708, 2op4H, 0.5597, 3.21, 0.090, 131, 89, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
4709, 2i60L, 0.5597, 2.99, 0.056, 212, 90, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4710, 2b1aL, 0.5597, 3.26, 0.044, 189, 90, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
4711, 2arjQ, 0.5597, 3.03, 0.101, 219, 89, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
4712, 1rurH, 0.5597, 3.33, 0.077, 216, 91, CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9- 1.
4713, 1nkrA, 0.5597, 3.45, 0.054, 222, 92, INHIBITORY RECEPTOR (P58-CL42) FOR HUMAN NATURAL KILLER CELLS
4714, 1nbzB, 0.5597, 3.32, 0.075, 238, 93, CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K97A
4715, 1lp9E, 0.5597, 3.47, 0.087, 218, 92, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
4716, 1lgvB, 0.5597, 3.41, 0.077, 130, 91, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 100K
4717, 1k85A, 0.5597, 3.71, 0.063, 219, 95, SOLUTION STRUCTURE OF THE FIBRONECTIN TYPE III DOMAIN FROM BACILLUS CIRCULANS WL-12 CHITINASE A1.
4718, 1fieB, 0.5597, 3.61, 0.064, 218, 94, RECOMBINANT HUMAN COAGULATION FACTOR XIII
4719, 6n4yG, 0.5596, 3.25, 0.022, 214, 91, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43 
4720, 6n4yF, 0.5596, 3.26, 0.110, 220, 91, METABOTROPIC GLUTAMATE RECEPTOR 5 EXTRACELLULAR DOMAIN WITH NB43 
4721, 6eluC, 0.5596, 3.36, 0.065, 131, 93, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4722, 6dcwL, 0.5596, 3.08, 0.090, 215, 89, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
4723, 6cnjJ, 0.5596, 3.29, 0.099, 215, 91, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4724, 6bhzH, 0.5596, 3.60, 0.064, 216, 94, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT.
4725, 6azmB, 0.5596, 3.07, 0.068, 239, 88, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
4726, 6aodB, 0.5596, 2.85, 0.034, 209, 87, FXIA ANTIBODY COMPLEX
4727, 5y9fW, 0.5596, 3.11, 0.045, 239, 89, CRYSTAL STRUCTURE OF HPV59 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY 28F10
4728, 5kovI, 0.5596, 3.26, 0.088, 224, 91, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 CAPSID PROTEIN SPIKE IN COMPLEX WITH A SINGLE CHAIN VARIABLE FRAGMENT OF AN ASTROVIRUS NEUTRALIZING ANTIBODY AT 3.24-A RESOLUTION
4729, 5jqdD, 0.5596, 2.90, 0.046, 193, 87, ANTIBODY FAB FRAGMENT
4730, 4xbgG, 0.5596, 3.21, 0.078, 219, 90, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4731, 4qlrA, 0.5596, 2.79, 0.069, 194, 87, LLAMA NANOBODY N02 RAISED AGAINST EAEC T6SS TSSM
4732, 4mxwH, 0.5596, 3.26, 0.121, 217, 91, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
4733, 4k23H, 0.5596, 3.25, 0.022, 214, 91, STRUCTURE OF ANTI-UPAR FAB ATN-658
4734, 4hfwH, 0.5596, 3.10, 0.056, 215, 90, ANTI ROTAVIRUS ANTIBODY
4735, 4h0hB, 0.5596, 2.80, 0.092, 115, 87, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING 2D10 SCFV WITH PEPTIDE
4736, 3v6fB, 0.5596, 3.24, 0.110, 218, 91, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4737, 3ri5I, 0.5596, 2.83, 0.057, 195, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
4738, 3ri5G, 0.5596, 3.15, 0.068, 210, 88, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
4739, 3ri5F, 0.5596, 2.77, 0.069, 194, 87, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
4740, 3r0mB, 0.5596, 2.97, 0.056, 213, 90, CRYSTAL STRUCTURE OF ANTI-HIV LLAMA VHH ANTIBODY A12
4741, 3qfjD, 0.5596, 2.56, 0.105, 88, 86, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
4742, 3qa3K, 0.5596, 3.80, 0.050, 715, 101, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4743, 3oayH, 0.5596, 3.26, 0.099, 123, 91, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4744, 2nx5T, 0.5596, 3.28, 0.110, 123, 91, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4745, 2ntfB, 0.5596, 3.38, 0.033, 217, 92, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
4746, 2gjzA, 0.5596, 3.47, 0.043, 219, 92, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1)
4747, 2fx9M, 0.5596, 3.47, 0.065, 218, 93, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A THIOETHER-LINKED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4748, 2bnuA, 0.5596, 3.28, 0.121, 212, 91, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
4749, 1uacH, 0.5596, 3.31, 0.088, 225, 91, CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH TURKEY WHITE LYSOZYME
4750, 6o3bG, 0.5595, 3.23, 0.099, 211, 91, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
4751, 6mefH, 0.5595, 3.61, 0.074, 219, 94, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4752, 6gv1H, 0.5595, 3.44, 0.066, 225, 91, CRYSTAL STRUCTURE OF E.COLI MULTIDRUG/H+ ANTIPORTER MDFA IN OUTWARD OPEN CONFORMATION WITH BOUND FAB FRAGMENT 
4753, 6ey0G, 0.5595, 3.37, 0.099, 214, 91, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
4754, 6dztN, 0.5595, 3.01, 0.078, 219, 90, CRYO-EM STRUCTURE OF NUCLEOSOME IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4755, 6dfqB, 0.5595, 3.35, 0.088, 130, 91, MOUSE DIABETOGENIC TCR I.29 
4756, 6banA, 0.5595, 3.38, 0.065, 212, 92, POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE OF ROR1 
4757, 5vj6Q, 0.5595, 3.25, 0.099, 212, 91, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
4758, 5vj6O, 0.5595, 3.28, 0.110, 214, 91, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
4759, 5vj6M, 0.5595, 3.73, 0.063, 241, 95, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
4760, 5ukqH, 0.5595, 3.47, 0.022, 219, 93, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB
4761, 5tztB, 0.5595, 3.11, 0.111, 199, 90, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4762, 5nhwL, 0.5595, 3.11, 0.111, 200, 90, CRYSTAL STRUCTURE OF THE BIMAGRUMAB FAB
4763, 5gprA, 0.5595, 3.11, 0.111, 188, 90, CRYSTAL STRUCTURE OF CHITINASE-H FROM OSTRINIA FURNACALIS
4764, 5ezjA, 0.5595, 3.19, 0.077, 127, 91, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
4765, 5cjxD, 0.5595, 3.25, 0.089, 200, 90, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
4766, 5c8jD, 0.5595, 3.21, 0.122, 224, 90, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
4767, 5bk3H, 0.5595, 3.16, 0.078, 217, 90, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
4768, 4zfoH, 0.5595, 2.90, 0.068, 188, 88, J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)
4769, 4y4hD, 0.5595, 3.28, 0.121, 222, 91, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
4770, 4xwoX, 0.5595, 3.45, 0.054, 217, 93, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22
4771, 4x6dE, 0.5595, 3.27, 0.088, 214, 91, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
4772, 4ut9I, 0.5595, 3.00, 0.125, 203, 88, CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10
4773, 4unuB, 0.5595, 3.03, 0.057, 114, 87, MCG - A DIMER OF LAMBDA VARIABLE DOMAINS
4774, 4ub0H, 0.5595, 3.35, 0.099, 216, 91, NEW DESIGN FOR MONOVALENT BISPECIFIC IGG THROUGH CYSTEINE ENGINEERING OF THE CH1-CL INTERFACE
4775, 4p2rJ, 0.5595, 3.23, 0.122, 224, 90, CRYSTAL STRUCTURE OF THE 5CC7 TCR IN COMPLEX WITH 5C1/I-EK
4776, 4odwA, 0.5595, 3.23, 0.067, 208, 89, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
4777, 4nkoE, 0.5595, 3.32, 0.088, 129, 91, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4778, 4m8qA, 0.5595, 3.29, 0.077, 226, 91, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
4779, 4jhaH, 0.5595, 2.93, 0.047, 239, 86, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
4780, 4eupI, 0.5595, 3.31, 0.054, 111, 92, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
4781, 4a6yH, 0.5595, 3.40, 0.065, 224, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
4782, 3wbdB, 0.5595, 3.40, 0.065, 224, 92, CRYSTAL STRUCTURE OF ANTI-POLYSIALIC ACID ANTIBODY SINGLE CHAIN FV FRAGMENT (MAB735) COMPLEXED WITH OCTASIALIC ACID
4783, 3tpuG, 0.5595, 3.40, 0.065, 224, 92, 42F3 P5E8/H2-LD COMPLEX
4784, 3qw9A, 0.5595, 3.26, 0.067, 220, 90, CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN
4785, 3nrqB, 0.5595, 3.59, 0.053, 218, 94, CRYSTAL STRUCTURE OF COPPER-RECONSTITUTED FETP FROM UROPATHOGENIC ESCHERICHIA COLI STRAIN F11
4786, 3mbeH, 0.5595, 3.28, 0.066, 215, 91, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
4787, 3mbeD, 0.5595, 3.82, 0.140, 536, 93, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
4788, 3m4dB, 0.5595, 3.25, 0.121, 222, 91, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
4789, 3dwtB, 0.5595, 3.40, 0.065, 224, 92, STRUCTURE OF CABBCII-10 NANOBODY
4790, 2x1oA, 0.5595, 3.20, 0.033, 212, 90, GELSOLIN NANOBODY
4791, 2r56I, 0.5595, 3.34, 0.066, 219, 91, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
4792, 2qadH, 0.5595, 3.19, 0.143, 216, 91, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
4793, 2i27O, 0.5595, 3.19, 0.079, 239, 89, CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR ANCESTRAL VARIABLE DOMAIN
4794, 2hffB, 0.5595, 3.27, 0.033, 216, 91, CRYSTAL STRUCTURE OF CB2 FAB
4795, 2fx8K, 0.5595, 2.91, 0.057, 189, 87, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4796, 2fx8H, 0.5595, 3.29, 0.099, 127, 91, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH AN AIB-INDUCED PEPTIDE ENCOMPASSING THE 4E10 EPITOPE ON GP41
4797, 2ai0M, 0.5595, 3.04, 0.056, 109, 90, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
4798, 1op9A, 0.5595, 3.34, 0.120, 215, 92, COMPLEX OF HUMAN LYSOZYME WITH CAMELID VHH HL6 ANTIBODY FRAGMENT
4799, 6mtpA, 0.5594, 3.32, 0.044, 245, 90, CRYSTAL STRUCTURE OF VRC42.04 FAB IN COMPLEX WITH GP41 PEPTIDE 
4800, 6mlkL, 0.5594, 3.24, 0.100, 208, 90, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
4801, 6e3hL, 0.5594, 3.63, 0.074, 115, 94, CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ 
4802, 6aniI, 0.5594, 3.20, 0.088, 125, 91, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
4803, 5x2pH, 0.5594, 3.19, 0.044, 226, 90, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4804, 5wduD, 0.5594, 3.11, 0.090, 201, 89, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
4805, 5nmdA, 0.5594, 3.19, 0.099, 215, 91, TCR SPECIFIC FOR HLA A02 PRESENTING HIV EPITOPE SLYNTVATL
4806, 5j75A, 0.5594, 3.73, 0.063, 230, 95, FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342
4807, 5e9dD, 0.5594, 2.75, 0.057, 202, 87, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
4808, 5cexD, 0.5594, 3.52, 0.052, 170, 97, CRYSTAL STRUCTURE OF FAB 32H+109L A PUTATIVE PRECURSOR OF THE PGT121 FAMILY OF POTENT HIV-1 ANTIBODIES
4809, 4xccH, 0.5594, 3.22, 0.054, 149, 93, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
4810, 4x6bC, 0.5594, 2.98, 0.046, 236, 87, BK6 TCR APO STRUCTURE
4811, 4ktyA, 0.5594, 2.99, 0.046, 236, 87, FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND
4812, 4k07H, 0.5594, 3.72, 0.052, 293, 97, CRYSTAL STRUCTURE OF THE AMYLOID-FORMING IMMUNOGLOBULIN AL-103 CIS- PROLINE 95 MUTANT
4813, 4jfxB, 0.5594, 3.33, 0.077, 125, 91, STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE
4814, 4bglB, 0.5594, 3.01, 0.090, 120, 89, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM ARCHAEOGLOBUS FULGIDUS
4815, 3v6fE, 0.5594, 3.38, 0.077, 221, 91, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4816, 3riaH, 0.5594, 3.21, 0.088, 229, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
4817, 3rhwH, 0.5594, 3.09, 0.112, 108, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
4818, 3qehA, 0.5594, 3.32, 0.110, 214, 91, CRYSTAL STRUCTURE OF HUMAN N12-I15 AN ADCC AND NON-NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY
4819, 3mv9E, 0.5594, 3.19, 0.088, 227, 91, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
4820, 3kxfG, 0.5594, 3.01, 0.078, 227, 90, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
4821, 2orbH, 0.5594, 3.61, 0.064, 214, 94, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
4822, 2i5yL, 0.5594, 2.95, 0.102, 121, 88, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4823, 1xgtB, 0.5594, 3.12, 0.089, 217, 90, STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4824, 1ruqH, 0.5594, 3.50, 0.054, 217, 93, CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.
4825, 1qsfD, 0.5594, 3.65, 0.074, 219, 94, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
4826, 1igjA, 0.5594, 3.21, 0.132, 214, 91, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
4827, 1dqjB, 0.5594, 3.16, 0.100, 219, 90, CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME
4828, 6qn8G, 0.5593, 3.09, 0.056, 123, 89, STRUCTURE OF BOVINE ANTI-RSV FAB B13 
4829, 6njmL, 0.5593, 3.10, 0.090, 200, 89, STRUCTURE OF A COMPLEX 
4830, 6mhrA, 0.5593, 3.09, 0.089, 233, 90, STRUCTURE OF THE HUMAN 4-1BB / URELUMAB FAB COMPLEX 
4831, 6ii9P, 0.5593, 3.23, 0.089, 110, 90, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L3A-44 
4832, 6cnkK, 0.5593, 3.30, 0.067, 232, 90, STRUCTURE OF THE 3ALPHA2BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4833, 6bp2H, 0.5593, 3.14, 0.067, 226, 90, THERAPEUTIC HUMAN MONOCLONAL ANTIBODY MR191 BOUND TO A MARBURGVIRUS GLYCOPROTEIN
4834, 6ba5C, 0.5593, 2.94, 0.057, 186, 87, POTENT AND SELECTIVE ANTITUMOR ACTIVITY OF A T-CELL ENGAGING BISPECIFIC ANTIBODY TARGETING A MEMBRANE-PROXIMAL EPITOPE OF ROR1 
4835, 5xxoB, 0.5593, 3.83, 0.059, 695, 101, CRYSTAL STRUCTURE OF MUTANT (D286N) GH3 BETA-GLUCOSIDASE FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH SOPHOROTRIOSE
4836, 5xj3K, 0.5593, 3.16, 0.044, 108, 90, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
4837, 5xj3G, 0.5593, 3.44, 0.087, 225, 92, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
4838, 5x2oJ, 0.5593, 3.25, 0.067, 124, 90, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
4839, 5ir1D, 0.5593, 3.32, 0.099, 212, 91, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4840, 5iopB, 0.5593, 3.11, 0.111, 221, 90, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4841, 5eiiA, 0.5593, 3.11, 0.111, 221, 90, STRUCTURAL DETERMINATION OF AN PROTEIN COMPLEX OF A FAB WITH INCREASED SOLUBILITY
4842, 5cp7A, 0.5593, 3.42, 0.087, 216, 92, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4843, 5bk3E, 0.5593, 2.88, 0.057, 241, 87, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
4844, 4zptL, 0.5593, 3.21, 0.044, 204, 91, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
4845, 4xbgA, 0.5593, 3.35, 0.065, 212, 92, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4846, 4tvsb, 0.5593, 3.26, 0.033, 214, 91, LAP1(AA356-583) H.SAPIENS BOUND TO VHH-BS1
4847, 4o5iU, 0.5593, 2.90, 0.070, 210, 86, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4848, 4gejG, 0.5593, 3.26, 0.110, 218, 91, N-TERMINAL DOMAIN OF VDUP-1
4849, 4fqjH, 0.5593, 2.73, 0.116, 200, 86, INFLUENZA B/FLORIDA/4/2006 HEMAGGLUTININ FAB CR8071 COMPLEX
4850, 4c4uE, 0.5593, 3.62, 0.064, 216, 94, SUPEROXIDE REDUCTASE (NEELAREDOXIN) FROM ARCHAEOGLOBUS FULGIDUS E12Q MUTANT IN THE REDUCED FORM
4851, 3mugB, 0.5593, 3.14, 0.068, 210, 88, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4852, 3m4dF, 0.5593, 3.03, 0.080, 224, 88, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
4853, 2qadD, 0.5593, 3.28, 0.099, 215, 91, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
4854, 2i27N, 0.5593, 3.31, 0.088, 219, 91, CRYSTAL STRUCTURE ANALYSIS OF THE NURSE SHARK NEW ANTIGEN RECEPTOR ANCESTRAL VARIABLE DOMAIN
4855, 2gsiA, 0.5593, 3.28, 0.078, 216, 90, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4856, 2fatH, 0.5593, 3.31, 0.088, 218, 91, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
4857, 1yymQ, 0.5593, 3.31, 0.066, 219, 91, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4858, 1y0lH, 0.5593, 3.23, 0.044, 110, 90, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
4859, 1nbyB, 0.5593, 3.55, 0.096, 732, 94, CRYSTAL STRUCTURE OF HYHEL-63 COMPLEXED WITH HEL MUTANT K96A
4860, 1dvfC, 0.5593, 3.29, 0.066, 108, 91, IDIOTOPIC ANTIBODY D1.3 FV FRAGMENT-ANTIIDIOTOPIC ANTIBODY E5.2 FV FRAGMENT COMPLEX
4861, 6o3aB, 0.5592, 3.33, 0.099, 117, 91, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F7.B FAB 
4862, 6eluL, 0.5592, 3.17, 0.100, 220, 90, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4863, 6ejgC, 0.5592, 3.35, 0.077, 220, 91, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT 4 
4864, 6eduT, 0.5592, 3.27, 0.078, 215, 90, B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2); THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195 
4865, 6eduR, 0.5592, 3.39, 0.077, 220, 91, B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2); THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195 
4866, 6eduP, 0.5592, 3.66, 0.064, 218, 94, B41 SOSIP.664 IN COMPLEX WITH SOLUBLE CD4 (D1-D2); THE CO-RECEPTOR MIMICKING ANTIBODY 21C AND THE BROADLY NEUTRALIZING ANTIBODY 8ANC195 
4867, 6cvkA, 0.5592, 3.17, 0.067, 218, 90, HEPATITIS B E-ANTIGEN IN COMPLEX WITH SCFV E13 
4868, 6bj8D, 0.5592, 3.20, 0.044, 212, 90, TCR55 IN COMPLEX WITH PEP20/HLA-B35 
4869, 6b0sH, 0.5592, 3.15, 0.055, 227, 91, CRYSTAL STRUCTURE OF CIRCUMSPOROZOITE PROTEIN ATSR DOMAIN IN COMPLEX WITH 1710 ANTIBODY
4870, 5y9cH, 0.5592, 3.20, 0.078, 128, 90, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
4871, 5xwdD, 0.5592, 3.11, 0.078, 226, 90, CRYSTAL STRUCTURE OF THE COMPLEX OF 059-152-FV AND EGFR-ECD
4872, 5wcaH, 0.5592, 3.34, 0.065, 136, 93, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 27-1C08 FAB.
4873, 5w08Q, 0.5592, 3.30, 0.110, 222, 91, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4874, 5vsiH, 0.5592, 3.28, 0.067, 123, 89, CH1/CKAPPA FAB MUTANT 15.1
4875, 5u3lL, 0.5592, 3.23, 0.099, 237, 91, CRYSTAL STRUCTURE OF DH511.2 FAB IN COMPLEX WITH HIV-1 GP41 MPER 670- 683 PEPTIDE
4876, 5m2iI, 0.5592, 3.71, 0.052, 293, 97, STRUCTURE OF HUMAN TUMOR NECROSIS FACTOR (TNF) IN COMPLEX WITH THE LLAMA VHH1
4877, 5lx9H, 0.5592, 3.23, 0.077, 229, 91, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
4878, 5f3jC, 0.5592, 3.09, 0.112, 109, 89, CRYSTAL STRUCTURE OF DBP IN COMPLEX WITH INHIBITORY MONOCLONAL ANTIBODY 2D10
4879, 5cd3E, 0.5592, 3.44, 0.065, 215, 92, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4880, 5c0aD, 0.5592, 3.22, 0.132, 214, 91, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE
4881, 4w68B, 0.5592, 3.22, 0.022, 214, 91, CYTOPLASMICALLY PRODUCED HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) C22A/C99V VARIANT AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB)
4882, 4tnvU, 0.5592, 3.27, 0.110, 226, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
4883, 4q66J, 0.5592, 2.89, 0.070, 210, 86, STRUCTURE OF EXOMER BOUND TO ARF1.
4884, 4p24F, 0.5592, 3.24, 0.056, 107, 90, PORE FORMING TOXIN
4885, 4mnhB, 0.5592, 3.14, 0.101, 218, 89, STRUCTURE OF THE DP10.7 TCR
4886, 4l3eD, 0.5592, 3.41, 0.043, 217, 92, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
4887, 4kv5F, 0.5592, 3.36, 0.120, 231, 92, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
4888, 4jfdE, 0.5592, 3.30, 0.055, 131, 91, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
4889, 4i1nB, 0.5592, 3.30, 0.055, 131, 91, R104A-CA1697 NANOBODY BINDING TO THE BINARY DHFR.FOLATE COMPLEX
4890, 4h88H, 0.5592, 3.30, 0.055, 131, 91, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
4891, 4at6P, 0.5592, 3.26, 0.067, 241, 90, FAB FRAGMENT OF ANTIPORPHYRIN ANTIBODY 14H7
4892, 3tp4B, 0.5592, 3.16, 0.022, 201, 90, CRYSTAL STRUCTURE OF ENGINEERED PROTEIN AT THE RESOLUTION 1.98A NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR128
4893, 3stbB, 0.5592, 3.34, 0.110, 217, 91, A COMPLEX OF TWO EDITOSOME PROTEINS AND TWO NANOBODIES
4894, 3riaG, 0.5592, 3.14, 0.088, 210, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
4895, 3rhwG, 0.5592, 3.01, 0.045, 108, 89, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
4896, 3q3gH, 0.5592, 3.28, 0.110, 226, 91, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4897, 3m2lC, 0.5592, 3.31, 0.099, 235, 91, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
4898, 3bkjL, 0.5592, 3.09, 0.122, 220, 90, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
4899, 3aroA, 0.5592, 3.25, 0.033, 214, 91, CRYSTAL STRUCTURE ANALYSIS OF CHITINASE A FROM VIBRIO HARVEYI WITH NOVEL INHIBITORS - APO STRUCTURE
4900, 3abzB, 0.5592, 3.11, 0.101, 121, 89, CRYSTAL STRUCTURE OF SE-MET LABELED BETA-GLUCOSIDASE FROM KLUYVEROMYCES MARXIANUS
4901, 2ai0N, 0.5592, 3.27, 0.033, 228, 90, ANTI-COCAINE ANTIBODY 7.5.21 CRYSTAL FORM III
4902, 1ymmE, 0.5592, 3.36, 0.044, 228, 91, TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
4903, 1y0lD, 0.5592, 3.34, 0.065, 220, 92, CATALYTIC ELIMINATION ANTIBODY 34E4 IN COMPLEX WITH HAPTEN
4904, 1xgqB, 0.5592, 2.93, 0.080, 197, 87, STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME
4905, 1s3kH, 0.5592, 3.42, 0.054, 130, 92, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
4906, 1lilB, 0.5592, 3.14, 0.111, 221, 90, BENCE JONES PROTEIN CLE A LAMBDA III IMMUNOGLOBULIN LIGHT- CHAIN DIMER
4907, 1kxvC, 0.5592, 2.36, 0.061, 158, 82, CAMELID VHH DOMAINS IN COMPLEX WITH PORCINE PANCREATIC ALPHA-AMYLASE
4908, 1g9nL, 0.5592, 3.85, 0.061, 290, 98, HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
4909, 6mtpH, 0.5591, 3.22, 0.044, 197, 91, CRYSTAL STRUCTURE OF VRC42.04 FAB IN COMPLEX WITH GP41 PEPTIDE 
4910, 6iuvH, 0.5591, 3.16, 0.079, 199, 89, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
4911, 6eluI, 0.5591, 3.43, 0.065, 110, 92, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4912, 6ehwB, 0.5591, 3.24, 0.067, 245, 90, SCFV ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN DRUG DISCOVERY
4913, 6d6uL, 0.5591, 3.40, 0.054, 128, 92, HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL; CONFORMATION A 
4914, 6cw2B, 0.5591, 3.12, 0.133, 218, 90, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 1 
4915, 6cnvH, 0.5591, 3.08, 0.045, 212, 89, INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX 
4916, 6cnkF, 0.5591, 2.75, 0.047, 455, 85, STRUCTURE OF THE 3ALPHA2BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4917, 6c5kH, 0.5591, 3.40, 0.088, 126, 91, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
4918, 6azmD, 0.5591, 3.10, 0.111, 200, 90, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
4919, 5xhfC, 0.5591, 3.10, 0.111, 200, 90, CRYSTAL STRUCTURE OF TRASTUZUMAB FAB FRAGMENT BEARING P-AZIDO-L- PHENYLALANINE
4920, 5x2mJ, 0.5591, 3.25, 0.110, 224, 91, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4921, 5uk4p, 0.5591, 3.72, 0.052, 293, 97, VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
4922, 5tokF, 0.5591, 3.69, 0.064, 218, 94, CRYSTAL STRUCTURE OF THE RSV F GLYCOPROTEIN IN COMPLEX WITH THE NEUTRALIZING SINGLE-DOMAIN ANTIBODY F-VHH-L66
4923, 5oclB, 0.5591, 3.91, 0.124, 576, 97, NANOBODY-ANTI-VGLUT NANOBODY COMPLEX
4924, 5nbmF, 0.5591, 3.16, 0.100, 800, 90, CRYSTAL STRUCTURE OF THE ARP4-N-ACTIN(ATP-STATE) HETERODIMER BOUND BY A NANOBODY 
4925, 5m6iA, 0.5591, 3.59, 0.074, 216, 94, CRYSTAL STRUCTURE OF NON-CARDIOTOXIC BENCE-JONES LIGHT CHAIN DIMER M8
4926, 5h37M, 0.5591, 3.18, 0.077, 246, 91, CRYO-EM STRUCTURE OF ZIKA VIRUS COMPLEXED WITH FAB C10 AT PH 8.0
4927, 5h35H, 0.5591, 3.27, 0.132, 226, 91, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
4928, 5eziH, 0.5591, 2.91, 0.070, 210, 86, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
4929, 5bozK, 0.5591, 3.26, 0.110, 212, 91, RICIN A CHAIN BOUND TO CAMELID NANOBODY (VHH9)(E1)
4930, 4u7sB, 0.5591, 2.96, 0.034, 212, 88, HOMODIMERIC SINGLE DOMAIN ANTIBODY (SDAB) AGAINST STAPHYLOCOCCAL ENTEROTOXIN B (SEB) CRYSTALLIZED FOR 5 MONTHS
4931, 4tnvF, 0.5591, 3.14, 0.099, 119, 91, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
4932, 4ll1C, 0.5591, 3.33, 0.033, 214, 91, THE STRUCTURE OF THE TRX AND TXNIP COMPLEX
4933, 4jqiL, 0.5591, 3.00, 0.056, 218, 89, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
4934, 3gjeH, 0.5591, 3.01, 0.133, 228, 90, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
4935, 2vxvH, 0.5591, 3.43, 0.043, 217, 92, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
4936, 2oqjH, 0.5591, 3.31, 0.120, 237, 92, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4937, 2jccE, 0.5591, 3.21, 0.034, 106, 89, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
4938, 2ig2H, 0.5591, 3.21, 0.033, 199, 90, DIR PRIMAERSTRUKTUR DES KRISTALLISIERBAREN MONOKLONALEN IMMUNOGLOBULINS IGG1 KOL. II. AMINOSAEURESEQUENZ DER L- KETTE LAMBDA-TYP SUBGRUPPE I (GERMAN)
4939, 1yylL, 0.5591, 2.97, 0.091, 214, 88, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4940, 1ri8A, 0.5591, 3.44, 0.065, 218, 93, CRYSTAL STRUCTURE OF THE CAMELID SINGLE DOMAIN ANTIBODY 1D2L19 IN COMPLEX WITH HEN EGG WHITE LYSOZYME
4941, 1kj2A, 0.5591, 3.01, 0.080, 217, 88, MURINE ALLOREACTIVE SCFV TCR-PEPTIDE-MHC CLASS I MOLECULE COMPLEX
4942, 1fn4B, 0.5591, 3.33, 0.088, 225, 91, CRYSTAL STRUCTURE OF FAB198 AN EFFICIENT PROTECTOR OF ACETYLCHOLINE RECEPTOR AGAINST MYASTHENOGENIC ANTIBODIES
4943, 1d3lA, 0.5591, 3.20, 0.022, 213, 90, D1D2-ICAM-1 FULLY GLYCOSYLATED VARIATION OF D1-D2 INTERDOMAIN ANGLE IN DIFFERENT CRYSTAL STRUCTURES.
4944, 6n5bH, 0.5590, 3.17, 0.100, 217, 90, BROADLY PROTECTIVE ANTIBODIES DIRECTED TO A SUBDOMINANT INFLUENZA HEMAGGLUTININ EPITOPE 
4945, 6n35H, 0.5590, 3.28, 0.054, 125, 92, ANTI-HIV-1 FAB 2G12 + MAN1-2 RE-REFINEMENT 
4946, 6n32K, 0.5590, 3.20, 0.067, 123, 89, ANTI-HIV-1 FAB 2G12 RE-REFINEMENT 
4947, 6fb3B, 0.5590, 3.30, 0.078, 127, 90, TENEURIN 2 PARTIAL EXTRACELLULAR DOMAIN
4948, 6ek2I, 0.5590, 3.31, 0.066, 124, 91, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH SINGLE CHAIN FV FRAGMENT 10 
4949, 6dztM, 0.5590, 3.06, 0.067, 212, 90, CRYO-EM STRUCTURE OF NUCLEOSOME IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4950, 6dwaA, 0.5590, 2.99, 0.067, 109, 90, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4951, 6cnjF, 0.5590, 3.23, 0.066, 220, 91, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4952, 5zv3H, 0.5590, 3.25, 0.121, 222, 91, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
4953, 5ywcG, 0.5590, 3.32, 0.033, 125, 92, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
4954, 5ywcE, 0.5590, 3.43, 0.043, 130, 92, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
4955, 5ywcC, 0.5590, 3.14, 0.111, 222, 90, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
4956, 5ywcA, 0.5590, 3.34, 0.065, 280, 93, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH MG- ADP (CTD CLASS1 AT 4.3A) 
4957, 5yw9G, 0.5590, 3.26, 0.033, 185, 91, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
4958, 5yw9E, 0.5590, 3.32, 0.088, 220, 91, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
4959, 5yw9C, 0.5590, 3.26, 0.121, 222, 91, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
4960, 5yw9A, 0.5590, 3.15, 0.078, 224, 90, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (CLASS1 5.0A) 
4961, 5yw8A, 0.5590, 2.79, 0.069, 194, 87, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH ATPGAMMAS (ALL PARTICLES AT 4.4A) 
4962, 5ykfG, 0.5590, 3.32, 0.099, 238, 91, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
4963, 5ykfE, 0.5590, 3.27, 0.022, 214, 91, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
4964, 5ykfC, 0.5590, 3.08, 0.056, 124, 90, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
4965, 5ykfA, 0.5590, 3.20, 0.078, 111, 90, STRUCTURE OF PANCREATIC ATP-SENSITIVE POTASSIUM CHANNEL BOUND WITH GLIBENCLAMIDE AND ATPGAMMAS (3D CLASS1 AT 4.33A) 
4966, 5xj3E, 0.5590, 3.39, 0.067, 218, 90, COMPLEX STRUCTURE OF IPILIMUMAB-SCFV AND CTLA-4 
4967, 5wkzH, 0.5590, 2.85, 0.023, 185, 86, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
4968, 5whjL, 0.5590, 3.36, 0.054, 222, 92, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-FCRN ANTIBODY DX-2507
4969, 5occH, 0.5590, 3.16, 0.078, 218, 90, CRYSTAL STRUCTURE OF CD32B (FC GAMMA RECEPTOR IIB) IN COMPLEX WITH HUMAN IGG1 FAB FRAGMENT (6G08) 
4970, 5n0aM, 0.5590, 3.32, 0.121, 219, 91, CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4971, 5n0aL, 0.5590, 3.80, 0.090, 1836, 100, CRYSTAL STRUCTURE OF A259C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
4972, 5jueH, 0.5590, 3.29, 0.055, 226, 91, CRYSTAL STRUCTURE OF UIC2 FAB
4973, 5imlB, 0.5590, 3.38, 0.055, 226, 91, NANOBODY TARGETING HUMAN VSIG4 IN SPACEGROUP P212121
4974, 5f3jD, 0.5590, 3.44, 0.033, 217, 92, CRYSTAL STRUCTURE OF DBP IN COMPLEX WITH INHIBITORY MONOCLONAL ANTIBODY 2D10
4975, 5c8jH, 0.5590, 3.45, 0.065, 218, 93, A YIDC-LIKE PROTEIN IN THE ARCHAEAL PLASMA MEMBRANE
4976, 5c0nD, 0.5590, 3.29, 0.110, 219, 91, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
4977, 4zptB, 0.5590, 3.63, 0.061, 325, 99, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
4978, 4zo9B, 0.5590, 3.63, 0.061, 325, 99, CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH LAMINARIBIOSE
4979, 4xtrE, 0.5590, 3.63, 0.061, 325, 99, STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12
4980, 4tqeH, 0.5590, 3.63, 0.061, 325, 99, STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT
4981, 4tnvV, 0.5590, 3.63, 0.061, 325, 99, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
4982, 4tnvI, 0.5590, 3.63, 0.061, 325, 99, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
4983, 4q9cA, 0.5590, 3.63, 0.061, 325, 99, IGNAR ANTIBODY DOMAIN C3
4984, 4p99D, 0.5590, 3.63, 0.061, 325, 99, CA2+-STABILIZED ADHESIN HELPS AN ANTARCTIC BACTERIUM REACH OUT AND BIND ICE
4985, 4ow5A, 0.5590, 3.63, 0.061, 325, 99, STRUCTURAL BASIS FOR THE ENHANCEMENT OF VIRULENCE BY ENTOMOPOXVIRUS FUSOLIN AND ITS IN VIVO CRYSTALLIZATION INTO VIRAL SPINDLES
4986, 4olvH, 0.5590, 3.63, 0.061, 325, 99, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54F IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4987, 4kv5I, 0.5590, 3.63, 0.061, 325, 99, SCFV GC1009 IN COMPLEX WITH TGF-BETA1.
4988, 4hiiD, 0.5590, 3.63, 0.061, 325, 99, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
4989, 4cmhB, 0.5590, 3.63, 0.061, 325, 99, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
4990, 3wxvL, 0.5590, 3.18, 0.067, 108, 90, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1
4991, 3wfhB, 0.5590, 3.31, 0.088, 221, 91, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX
4992, 3vxtD, 0.5590, 3.07, 0.078, 211, 90, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
4993, 3vxrD, 0.5590, 3.44, 0.098, 222, 92, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
4994, 3v6fD, 0.5590, 3.10, 0.056, 110, 90, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4995, 3s3jA, 0.5590, 3.09, 0.056, 110, 90, TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR
4996, 3mffC, 0.5590, 3.16, 0.099, 225, 91, 1F1E8HU TCR
4997, 3fo9B, 0.5590, 3.31, 0.110, 125, 91, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
4998, 2xwxA, 0.5590, 3.38, 0.044, 228, 91, VIBRIO CHOLERAE COLONIZATION FACTOR GBPA CRYSTAL STRUCTURE
4999, 2hrpH, 0.5590, 3.13, 0.033, 213, 90, ANTIGEN-ANTIBODY COMPLEX
5000, 1yejL, 0.5590, 3.28, 0.055, 216, 91, CATALYTIC ANTIBODY COMPLEX
